Section 1 PE Tables - Results from the 2024 National Survey on Drug Use and Health: Detailed Tables, SAMHSA, CBHSQ

250520

Table 1.1A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Numbers in Thousands, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	145,076^b	149,927	70,537^a	73,637	47,657	48,224
Marijuana	133,529^a	137,055	61,816	64,194	43,647	44,266
Cocaine	42,280	42,408	5,012^a	4,257	1,814	1,671
Crack	9,871	10,634	997	749	507	392
Heroin	6,210	6,515	660	556	376	259
Hallucinogens	48,438^a	51,559	8,795^b	10,423	2,638	2,783
LSD	30,247	30,935	1,698	1,619	315	259
PCP	5,883	5,829	135	103	21	46
Ecstasy	22,276	22,060	2,153	2,013	471	532
Psilocybin	--	35,347	--	7,890	--	1,749
Inhalants³	--	31,989	--	3,155	--	1,124
Methamphetamine	16,130	15,294	2,621	2,384	1,596	1,418
Misuse of Prescription Psychotherapeutics	nr	nr	14,435	13,797	4,089	4,279
Pain Relievers	nr	nr	8,578	8,000	2,173	2,113
Prescription Opioids	--	--	8,196	7,570	2,029	1,951
Stimulants	nr	nr	3,922	3,899	1,163	1,239
Tranquilizers or Sedatives	nr	nr	4,722	4,575	1,236	1,480
Tranquilizers	nr	nr	3,993	3,829	1,053	1,259
Sedatives	nr	nr	1,063	920	284	254
Benzodiazepines	--	--	3,696	3,360	--	--
Opioids^2,4	--	--	8,520	7,795	2,298	2,117
Central Nervous System Stimulants	nr	nr	9,659	9,031	4,175	3,934
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	25,825	--	9,444
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	8,689	8,011	2,411	2,291
Illegally Made Fentanyl	1,432^a	1,911	627	668	311	418
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.1B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; Percentages, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	51.2	52.0	24.9	25.5	16.8	16.7
Marijuana	47.1	47.5	21.8	22.3	15.4	15.4
Cocaine	14.9	14.7	1.8^a	1.5	0.6	0.6
Crack	3.5	3.7	0.4	0.3	0.2	0.1
Heroin	2.2	2.3	0.2	0.2	0.1	0.1
Hallucinogens	17.1	17.9	3.1^b	3.6	0.9	1.0
LSD	10.7	10.7	0.6	0.6	0.1	0.1
PCP	2.1	2.0	<0.1	<0.1	<0.1	<0.1
Ecstasy	7.9	7.7	0.8	0.7	0.2	0.2
Psilocybin	--	12.3	--	2.7	--	0.6
Inhalants³	--	11.1	--	1.1	--	0.4
Methamphetamine	5.7	5.3	0.9	0.8	0.6	0.5
Misuse of Prescription Psychotherapeutics	nr	nr	5.1	4.8	1.4	1.5
Pain Relievers	nr	nr	3.0	2.8	0.8	0.7
Prescription Opioids	--	--	2.9	2.6	0.7	0.7
Stimulants	nr	nr	1.4	1.4	0.4	0.4
Tranquilizers or Sedatives	nr	nr	1.7	1.6	0.4	0.5
Tranquilizers	nr	nr	1.4	1.3	0.4	0.4
Sedatives	nr	nr	0.4	0.3	0.1	0.1
Benzodiazepines	--	--	1.3	1.2	--	--
Opioids^2,4	--	--	3.0^a	2.7	0.8	0.7
Central Nervous System Stimulants	nr	nr	3.4	3.1	1.5	1.4
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	9.0	--	3.3
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	3.1	2.8	0.9	0.8
Illegally Made Fentanyl	0.5^a	0.7	0.2	0.2	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.2A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Numbers in Thousands, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	5,332^b	6,275	3,816	3,916	1,864	1,950
Marijuana	3,462	3,363	2,894	2,694	1,563	1,554
Cocaine	84	109	63	72	22	13
Crack	9	25	4	8	4	<1
Heroin	18	22	4	10	4	1
Hallucinogens	518	591	387	405	110	123
LSD	250	222	144	112	33	15
PCP	33	28	22	1	4	<1
Ecstasy	131	127	75	57	18	8
Psilocybin	--	458	--	311	--	63
Inhalants³	--	3,092	--	967	--	272
Methamphetamine	84	87	40	57	29	35
Misuse of Prescription Psychotherapeutics	nr	nr	785	647	206	176
Pain Relievers	nr	nr	570^a	425	143	113
Prescription Opioids	--	--	511	395	128	106
Stimulants	nr	nr	230	203	32	33
Tranquilizers or Sedatives	nr	nr	173	172	44	38
Tranquilizers	nr	nr	119	126	38	28
Sedatives	nr	nr	68	64	14	11
Benzodiazepines	--	--	111	107	--	--
Opioids^2,4	--	--	515	400	132	107
Central Nervous System Stimulants	nr	nr	285	293	72	80
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	1,840	--	583
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	525	432	140	129
Illegally Made Fentanyl	43	56	36	38	9	23
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.2B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 to 17; Percentages, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	20.6^b	24.2	14.7	15.1	7.2	7.5
Marijuana	13.4	13.0	11.2	10.4	6.0	6.0
Cocaine	0.3	0.4	0.2	0.3	0.1	<0.1
Crack	<0.1	0.1	<0.1	<0.1	<0.1	<0.1
Heroin	0.1	0.1	<0.1	<0.1	<0.1	<0.1
Hallucinogens	2.0	2.3	1.5	1.6	0.4	0.5
LSD	1.0	0.9	0.6	0.4	0.1	0.1
PCP	0.1	0.1	0.1	<0.1	<0.1	<0.1
Ecstasy	0.5	0.5	0.3	0.2	0.1	<0.1
Psilocybin	--	1.8	--	1.2	--	0.2
Inhalants³	--	11.9	--	3.7	--	1.0
Methamphetamine	0.3	0.3	0.2	0.2	0.1	0.1
Misuse of Prescription Psychotherapeutics	nr	nr	3.0	2.5	0.8	0.7
Pain Relievers	nr	nr	2.2^a	1.6	0.6	0.4
Prescription Opioids	--	--	2.0	1.5	0.5	0.4
Stimulants	nr	nr	0.9	0.8	0.1	0.1
Tranquilizers or Sedatives	nr	nr	0.7	0.7	0.2	0.1
Tranquilizers	nr	nr	0.5	0.5	0.1	0.1
Sedatives	nr	nr	0.3	0.2	0.1	<0.1
Benzodiazepines	--	--	0.4	0.4	--	--
Opioids^2,4	--	--	2.0	1.5	0.5	0.4
Central Nervous System Stimulants	nr	nr	1.1	1.1	0.3	0.3
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	7.1	--	2.2
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	2.0	1.7	0.5	0.5
Illegally Made Fentanyl	0.2	0.2	0.1	0.1	<0.1	0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.3A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Numbers in Thousands, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	139,745^a	143,653	66,721^a	69,720	45,794	46,273
Marijuana	130,067^a	133,692	58,922^a	61,500	42,083	42,712
Cocaine	42,196	42,299	4,949^a	4,185	1,792	1,658
Crack	9,862	10,609	993	741	503	392
Heroin	6,191	6,493	656	546	372	258
Hallucinogens	47,920^a	50,968	8,408^b	10,018	2,528	2,660
LSD	29,997	30,713	1,554	1,507	282	244
PCP	5,849	5,802	113	102	17	46
Ecstasy	22,145	21,933	2,078	1,956	453	524
Psilocybin	--	34,889	--	7,579	--	1,686
Inhalants³	--	28,896	--	2,189	--	852
Methamphetamine	16,046	15,206	2,582	2,327	1,566	1,383
Misuse of Prescription Psychotherapeutics	nr	nr	13,651	13,150	3,884	4,103
Pain Relievers	nr	nr	8,008	7,575	2,030	2,000
Prescription Opioids	--	--	7,685	7,176	1,901	1,845
Stimulants	nr	nr	3,692	3,696	1,131	1,206
Tranquilizers or Sedatives	nr	nr	4,549	4,403	1,192	1,442
Tranquilizers	nr	nr	3,874	3,703	1,015	1,231
Sedatives	nr	nr	995	857	271	243
Benzodiazepines	--	--	3,585	3,253	--	--
Opioids^2,4	--	--	8,005	7,396	2,166	2,010
Central Nervous System Stimulants	nr	nr	9,374	8,738	4,103	3,854
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	23,985	--	8,861
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	8,164	7,580	2,271	2,163
Illegally Made Fentanyl	1,389^a	1,855	591	630	302	395
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.3B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 or Older; Percentages, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	54.3	54.8	25.9	26.6	17.8	17.6
Marijuana	50.5	51.0	22.9	23.4	16.3	16.3
Cocaine	16.4	16.1	1.9^a	1.6	0.7	0.6
Crack	3.8	4.0	0.4	0.3	0.2	0.1
Heroin	2.4	2.5	0.3	0.2	0.1	0.1
Hallucinogens	18.6	19.4	3.3^b	3.8	1.0	1.0
LSD	11.6	11.7	0.6	0.6	0.1	0.1
PCP	2.3	2.2	<0.1	<0.1	<0.1	<0.1
Ecstasy	8.6	8.4	0.8	0.7	0.2	0.2
Psilocybin	--	13.3	--	2.9	--	0.6
Inhalants³	--	11.0	--	0.8	--	0.3
Methamphetamine	6.2	5.8	1.0	0.9	0.6	0.5
Misuse of Prescription Psychotherapeutics	nr	nr	5.3	5.0	1.5	1.6
Pain Relievers	nr	nr	3.1	2.9	0.8	0.8
Prescription Opioids	--	--	3.0	2.7	0.7	0.7
Stimulants	nr	nr	1.4	1.4	0.4	0.5
Tranquilizers or Sedatives	nr	nr	1.8	1.7	0.5	0.5
Tranquilizers	nr	nr	1.5	1.4	0.4	0.5
Sedatives	nr	nr	0.4	0.3	0.1	0.1
Benzodiazepines	--	--	1.4	1.2	--	--
Opioids^2,4	--	--	3.1	2.8	0.8	0.8
Central Nervous System Stimulants	nr	nr	3.6	3.3	1.6	1.5
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	9.1	--	3.4
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	3.2	2.9	0.9	0.8
Illegally Made Fentanyl	0.5^a	0.7	0.2	0.2	0.1	0.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.4A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Numbers in Thousands, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	18,285	18,697	13,256	13,299	8,901	8,884
Marijuana	17,033	17,068	12,435	12,226	8,562	8,439
Cocaine	2,698^b	2,226	1,043^a	811	219	221
Crack	246^a	153	67	46	5	13
Heroin	224	180	27	51	12	14
Hallucinogens	5,259	5,661	2,276	2,364	599	489
LSD	3,000	2,817	501^a	369	69	60
PCP	135	153	1^a	27	<1	8
Ecstasy	2,151	1,920	521	405	94	94
Psilocybin	--	4,468	--	1,898	--	307
Inhalants³	--	3,461	--	690	--	191
Methamphetamine	569	464	108	161	49	77
Misuse of Prescription Psychotherapeutics	nr	nr	2,025	2,019	558	512
Pain Relievers	nr	nr	841	955	170	242
Prescription Opioids	--	--	801	897	169	214
Stimulants	nr	nr	1,066	973	308	210
Tranquilizers or Sedatives	nr	nr	576	571	159	160
Tranquilizers	nr	nr	522	522	138	131
Sedatives	nr	nr	90	76	23	35
Benzodiazepines	--	--	480	488	--	--
Opioids^2,4	--	--	806	925	173	221
Central Nervous System Stimulants	nr	nr	1,895	1,646	546	466
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	4,501	--	1,255
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	828	976	189	265
Illegally Made Fentanyl	181	176	78	99	24	63
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.4B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 18 to 25; Percentages, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	53.7	53.5	39.0	38.1	26.2	25.4
Marijuana	50.0	48.8	36.5	35.0	25.2	24.1
Cocaine	7.9^b	6.4	3.1^a	2.3	0.6	0.6
Crack	0.7^a	0.4	0.2	0.1	<0.1	<0.1
Heroin	0.7	0.5	0.1	0.1	<0.1	<0.1
Hallucinogens	15.5	16.2	6.7	6.8	1.8	1.4
LSD	8.8	8.1	1.5^a	1.1	0.2	0.2
PCP	0.4	0.4	<0.1^a	0.1	<0.1	<0.1
Ecstasy	6.3	5.5	1.5	1.2	0.3	0.3
Psilocybin	--	12.8	--	5.4	--	0.9
Inhalants³	--	9.9	--	2.0	--	0.5
Methamphetamine	1.7	1.3	0.3	0.5	0.1	0.2
Misuse of Prescription Psychotherapeutics	nr	nr	6.0	5.8	1.6	1.5
Pain Relievers	nr	nr	2.5	2.7	0.5	0.7
Prescription Opioids	--	--	2.4	2.6	0.5	0.6
Stimulants	nr	nr	3.1	2.8	0.9	0.6
Tranquilizers or Sedatives	nr	nr	1.7	1.6	0.5	0.5
Tranquilizers	nr	nr	1.5	1.5	0.4	0.4
Sedatives	nr	nr	0.3	0.2	0.1	0.1
Benzodiazepines	--	--	1.4	1.4	--	--
Opioids^2,4	--	--	2.4	2.6	0.5	0.6
Central Nervous System Stimulants	nr	nr	5.6^a	4.7	1.6	1.3
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	12.9	--	3.6
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	2.4	2.8	0.6	0.8
Illegally Made Fentanyl	0.5	0.5	0.2	0.3	0.1	0.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.5A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Numbers in Thousands, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	121,460^a	124,955	53,465^a	56,421	36,892	37,390
Marijuana	113,034^a	116,624	46,487^a	49,274	33,521	34,273
Cocaine	39,498	40,074	3,907	3,374	1,572	1,437
Crack	9,616	10,455	926	695	498	378
Heroin	5,967	6,313	629	495	360	244
Hallucinogens	42,661^a	45,307	6,132^b	7,653	1,929	2,171
LSD	26,997	27,896	1,053	1,137	213	184
PCP	5,715	5,649	113	76	17	37
Ecstasy	19,995	20,013	1,557	1,551	359	429
Psilocybin	--	30,421	--	5,681	--	1,379
Inhalants³	--	25,435	--	1,499	--	660
Methamphetamine	15,478	14,742	2,473	2,166	1,517	1,306
Misuse of Prescription Psychotherapeutics	nr	nr	11,625	11,131	3,326	3,591
Pain Relievers	nr	nr	7,167	6,620	1,860	1,758
Prescription Opioids	--	--	6,884	6,279	1,732	1,631
Stimulants	nr	nr	2,626	2,723	823	995
Tranquilizers or Sedatives	nr	nr	3,973	3,832	1,033	1,282
Tranquilizers	nr	nr	3,351	3,181	877	1,099
Sedatives	nr	nr	905	781	248	208
Benzodiazepines	--	--	3,105	2,766	--	--
Opioids^2,4	--	--	7,199	6,471	1,993	1,788
Central Nervous System Stimulants	nr	nr	7,479	7,092	3,557	3,388
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	19,484	--	7,606
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	7,336	6,604	2,082	1,898
Illegally Made Fentanyl	1,208^a	1,680	513	531	278	332
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.5B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 26 or Older; Percentages, 2023 and 2024
Drug	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
ILLICIT DRUGS^1,2	54.3	55.0	23.9	24.8	16.5	16.4
Marijuana	50.6	51.3	20.8	21.7	15.0	15.1
Cocaine	17.7	17.6	1.7	1.5	0.7	0.6
Crack	4.3	4.6	0.4	0.3	0.2	0.2
Heroin	2.7	2.8	0.3	0.2	0.2	0.1
Hallucinogens	19.1	19.9	2.7^b	3.4	0.9	1.0
LSD	12.1	12.3	0.5	0.5	0.1	0.1
PCP	2.6	2.5	0.1	<0.1	<0.1	<0.1
Ecstasy	8.9	8.8	0.7	0.7	0.2	0.2
Psilocybin	--	13.4	--	2.5	--	0.6
Inhalants³	--	11.2	--	0.7	--	0.3
Methamphetamine	6.9	6.5	1.1	1.0	0.7	0.6
Misuse of Prescription Psychotherapeutics	nr	nr	5.2	4.9	1.5	1.6
Pain Relievers	nr	nr	3.2	2.9	0.8	0.8
Prescription Opioids	--	--	3.1	2.8	0.8	0.7
Stimulants	nr	nr	1.2	1.2	0.4	0.4
Tranquilizers or Sedatives	nr	nr	1.8	1.7	0.5	0.6
Tranquilizers	nr	nr	1.5	1.4	0.4	0.5
Sedatives	nr	nr	0.4	0.3	0.1	0.1
Benzodiazepines	--	--	1.4	1.2	--	--
Opioids^2,4	--	--	3.2^a	2.8	0.9	0.8
Central Nervous System Stimulants	nr	nr	3.3	3.1	1.6	1.5
Illicit Drugs Other Than Marijuana^2,3,5	nr	nr	--	8.6	--	3.3
OPIOIDS INCLUDING ILLEGALLY MADE FENTANYL⁴	--	--	3.3^a	2.9	0.9	0.8
Illegally Made Fentanyl	0.5^a	0.7	0.2	0.2	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. ² Does not include illegally made fentanyl (IMF). ³ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁵ Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.6A – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	145,076^b	149,927	70,537^a	73,637	47,657	48,224
12-20	10,801^b	11,915	8,121	8,057	4,692	4,580
21 or Older	134,276	138,012	62,416	65,580	42,965	43,644
12-17	5,332^b	6,275	3,816	3,916	1,864	1,950
12-13	824^b	1,284	498^a	637	160	221
14-15	1,899	2,019	1,388	1,204	674	549
16-17	2,609^a	2,971	1,930	2,075	1,029	1,180
18 or Older	139,745^a	143,653	66,721^a	69,720	45,794	46,273
18-25	18,285	18,697	13,256	13,299	8,901	8,884
18-20	5,469	5,641	4,305	4,140	2,829	2,630
21-25	12,816	13,057	8,951	9,159	6,072	6,254
26 or Older	121,460^a	124,955	53,465^a	56,421	36,892	37,390
26-49	61,175^a	63,218	33,916	34,889	23,468	23,521
26-29	10,901	10,819	7,130	7,155	5,206	4,854
30-34	14,003	14,233	8,329	8,255	5,711	5,402
35-39	13,927	13,852	7,634	7,647	5,148	5,386
40-44	12,318	13,083	6,017	6,587	4,020	4,437
45-49	10,027^a	11,231	4,805	5,246	3,384	3,443
50 or Older	60,285	61,738	19,549^a	21,532	13,425	13,868
50-54	10,097	10,299	4,189	4,654	2,753	2,976
55-59	11,230	11,233	3,773	4,548	2,657	3,182
60-64	13,542	13,273	4,706	4,553	3,517	3,109
65 or Older	25,416	26,932	6,880	7,777	4,497	4,600
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.6B – Illicit Drug Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	51.2	52.0	24.9	25.5	16.8	16.7
12-20	28.4^b	30.9	21.3	20.9	12.3	11.9
21 or Older	54.7	55.3	25.4	26.3	17.5	17.5
12-17	20.6^b	24.2	14.7	15.1	7.2	7.5
12-13	10.3^b	15.9	6.3	7.9	2.0	2.7
14-15	20.8	22.8	15.2	13.6	7.4	6.2
16-17	29.5^a	33.0	21.9	23.1	11.7	13.1
18 or Older	54.3	54.8	25.9	26.6	17.8	17.6
18-25	53.7	53.5	39.0	38.1	26.2	25.4
18-20	45.0	44.9	35.4	33.0	23.3	20.9
21-25	58.6	58.3	40.9	40.9	27.7	27.9
26 or Older	54.3	55.0	23.9	24.8	16.5	16.4
26-49	59.1	59.7	32.8	33.0	22.7	22.2
26-29	62.0	61.9	40.5	41.0	29.6	27.8
30-34	61.8	60.5	36.8	35.1	25.2	23.0
35-39	60.0	59.8	32.9	33.0	22.2	23.2
40-44	58.1	58.4	28.4	29.4	19.0	19.8
45-49	53.2^b	58.4	25.5	27.3	18.0	17.9
50 or Older	50.2	50.8	16.3^a	17.7	11.2	11.4
50-54	54.1	52.3	22.4	23.6	14.7	15.1
55-59	54.7	57.7	18.4^a	23.4	12.9	16.3
60-64	59.2	59.0	20.6	20.2	15.4	13.8
65 or Older	43.9	45.0	11.9	13.0	7.8	7.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.7A – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	133,529^a	137,055	61,816	64,194	43,647	44,266
12-20	8,440	8,235	6,997	6,436	4,310	4,046
21 or Older	125,089	128,819	54,820	57,758	39,337	40,220
12-17	3,462	3,363	2,894	2,694	1,563	1,554
12-13	204	229	155	190	80	91
14-15	1,199^b	950	1,035^b	739	546^a	405
16-17	2,059	2,183	1,705	1,765	937	1,058
18 or Older	130,067^a	133,692	58,922^a	61,500	42,083	42,712
18-25	17,033	17,068	12,435	12,226	8,562	8,439
18-20	4,978	4,873	4,102	3,742	2,746	2,491
21-25	12,055	12,195	8,332	8,484	5,816	5,947
26 or Older	113,034^a	116,624	46,487^a	49,274	33,521	34,273
26-49	57,466^a	59,055	30,294	31,043	21,540	21,706
26-29	10,423	10,249	6,524	6,583	4,787	4,663
30-34	13,140	13,278	7,461	7,442	5,231	4,996
35-39	13,035	13,013	6,740	6,776	4,708	5,002
40-44	11,538	12,275	5,352	5,674	3,656	3,949
45-49	9,330	10,240	4,217	4,568	3,158	3,095
50 or Older	55,568	57,569	16,193^a	18,231	11,982	12,567
50-54	8,875	9,607	3,516	4,089	2,481	2,778
55-59	10,112	10,343	3,189	3,915	2,429	2,852
60-64	12,784	12,423	3,999	3,926	3,056	2,786
65 or Older	23,798	25,196	5,489	6,301	4,015	4,151
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.7B – Marijuana Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	47.1	47.5	21.8	22.3	15.4	15.4
12-20	22.2	21.4	18.4^a	16.7	11.3	10.5
21 or Older	51.0	51.6	22.3	23.1	16.0	16.1
12-17	13.4	13.0	11.2	10.4	6.0	6.0
12-13	2.6	2.8	1.9	2.3	1.0	1.1
14-15	13.1^a	10.7	11.3^b	8.3	6.0^a	4.6
16-17	23.3	24.3	19.3	19.6	10.6	11.8
18 or Older	50.5	51.0	22.9	23.4	16.3	16.3
18-25	50.0	48.8	36.5	35.0	25.2	24.1
18-20	41.0	38.8	33.8^b	29.8	22.6^a	19.8
21-25	55.1	54.5	38.1	37.9	26.6	26.6
26 or Older	50.6	51.3	20.8	21.7	15.0	15.1
26-49	55.5	55.8	29.3	29.3	20.8	20.5
26-29	59.3	58.7	37.1	37.7	27.2	26.7
30-34	58.0	56.5	32.9	31.7	23.1	21.2
35-39	56.2	56.2	29.1	29.2	20.3	21.6
40-44	54.4	54.8	25.3	25.3	17.2	17.6
45-49	49.5^a	53.2	22.4	23.7	16.8	16.1
50 or Older	46.3	47.4	13.5^a	15.0	10.0	10.3
50-54	47.5	48.8	18.8	20.8	13.3	14.1
55-59	49.2	53.1	15.5^a	20.1	11.8	14.7
60-64	55.9	55.2	17.5	17.4	13.4	12.4
65 or Older	41.1	42.1	9.5	10.5	6.9	6.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.8A – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	42,280	42,408	5,012^a	4,257	1,814	1,671
12-20	564^a	399	309	242	76	53
21 or Older	41,717	42,009	4,703^a	4,015	1,738	1,618
12-17	84	109	63	72	22	13
12-13	10	9	7	6	6	1
14-15	17	33	13	24	*	1
16-17	57	66	44	42	16	11
18 or Older	42,196	42,299	4,949^a	4,185	1,792	1,658
18-25	2,698^b	2,226	1,043^a	811	219	221
18-20	480^b	291	246	170	53	40
21-25	2,218	1,935	796	641	166	181
26 or Older	39,498	40,074	3,907	3,374	1,572	1,437
26-49	17,969	18,614	2,778	2,678	939	964
26-29	2,630	2,762	642	672	229	215
30-34	4,060	3,803	773	639	261	212
35-39	4,298	4,519	620	629	169	242
40-44	3,748	4,123	374	376	122	134
45-49	3,233	3,407	368	362	158	160
50 or Older	21,530	21,459	1,129^a	696	634	473
50-54	3,117	2,982	362	250	109	151
55-59	4,360	4,203	276	217	181	185
60-64	6,377	6,079	232	91	166	49
65 or Older	7,675	8,195	259	137	177	87
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.8B – Cocaine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	14.9	14.7	1.8^a	1.5	0.6	0.6
12-20	1.5^a	1.0	0.8	0.6	0.2	0.1
21 or Older	17.0	16.8	1.9^a	1.6	0.7	0.6
12-17	0.3	0.4	0.2	0.3	0.1	<0.1
12-13	0.1	0.1	0.1	0.1	0.1	<0.1
14-15	0.2	0.4	0.1	0.3	*	<0.1
16-17	0.7	0.7	0.5	0.5	0.2	0.1
18 or Older	16.4	16.1	1.9^a	1.6	0.7	0.6
18-25	7.9^b	6.4	3.1^a	2.3	0.6	0.6
18-20	3.9^b	2.3	2.0	1.4	0.4	0.3
21-25	10.1^a	8.6	3.6	2.9	0.8	0.8
26 or Older	17.7	17.6	1.7	1.5	0.7	0.6
26-49	17.4	17.6	2.7	2.5	0.9	0.9
26-29	15.0	15.8	3.7	3.8	1.3	1.2
30-34	17.9	16.2	3.4	2.7	1.1	0.9
35-39	18.5	19.5	2.7	2.7	0.7	1.0
40-44	17.7	18.4	1.8	1.7	0.6	0.6
45-49	17.1	17.7	2.0	1.9	0.8	0.8
50 or Older	17.9	17.7	0.9^a	0.6	0.5	0.4
50-54	16.7	15.1	1.9	1.3	0.6	0.8
55-59	21.2	21.6	1.3	1.1	0.9	1.0
60-64	27.9	27.0	1.0	0.4	0.7	0.2
65 or Older	13.2	13.7	0.4	0.2	0.3	0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.9A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	9,871	10,634	997	749	507	392
12-20	54	55	24	21	4	1
21 or Older	9,818	10,579	974	728	503	391
12-17	9	25	4	8	4	<1
12-13	4	1	4	1	4	<1
14-15	<1	17	*	7	*	*
16-17	5	7	<1	<1	*	*
18 or Older	9,862	10,609	993	741	503	392
18-25	246^a	153	67	46	5	13
18-20	45	30	20	13	<1	1
21-25	202^a	123	48	34	5	12
26 or Older	9,616	10,455	926	695	498	378
26-49	4,299	4,474	350	361	183	149
26-29	249	332	20	20	10	4
30-34	676	656	71	58	23	12
35-39	1,002	1,096	65	74	41	24
40-44	1,121	1,141	88	74	23	23
45-49	1,251	1,249	107	135	87	86
50 or Older	5,317	5,981	576	334	315	229
50-54	1,157	1,140	150	77	57	63
55-59	1,236	1,597	216	126	118	106
60-64	1,687	1,784	133	87	91	47
65 or Older	1,237	1,460	77	44	48	13
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.9B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	3.5	3.7	0.4	0.3	0.2	0.1
12-20	0.1	0.1	0.1	0.1	<0.1	<0.1
21 or Older	4.0	4.2	0.4	0.3	0.2	0.2
12-17	<0.1	0.1	<0.1	<0.1	<0.1	<0.1
12-13	0.1	<0.1	0.1	<0.1	0.1	<0.1
14-15	<0.1	0.2	*	0.1	*	*
16-17	0.1	0.1	<0.1	<0.1	*	*
18 or Older	3.8	4.0	0.4	0.3	0.2	0.1
18-25	0.7^a	0.4	0.2	0.1	<0.1	<0.1
18-20	0.4	0.2	0.2	0.1	<0.1	<0.1
21-25	0.9^a	0.5	0.2	0.2	<0.1	0.1
26 or Older	4.3	4.6	0.4	0.3	0.2	0.2
26-49	4.2	4.2	0.3	0.3	0.2	0.1
26-29	1.4	1.9	0.1	0.1	0.1	<0.1
30-34	3.0	2.8	0.3	0.2	0.1	0.1
35-39	4.3	4.7	0.3	0.3	0.2	0.1
40-44	5.3	5.1	0.4	0.3	0.1	0.1
45-49	6.6	6.5	0.6	0.7	0.5	0.4
50 or Older	4.4	4.9	0.5	0.3	0.3	0.2
50-54	6.2	5.8	0.8	0.4	0.3	0.3
55-59	6.0	8.2	1.1	0.6	0.6	0.5
60-64	7.4	7.9	0.6	0.4	0.4	0.2
65 or Older	2.1	2.4	0.1	0.1	0.1	<0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.10A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	48,438^a	51,559	8,795^b	10,423	2,638	2,783
12-20	1,714	1,918	1,055	1,074	292	249
21 or Older	46,724	49,641	7,740^b	9,349	2,347	2,534
12-17	518	591	387	405	110	123
12-13	54	48	31	24	9	6
14-15	161	170	122	104	16	29
16-17	304	373	234	277	85	87
18 or Older	47,920^a	50,968	8,408^b	10,018	2,528	2,660
18-25	5,259	5,661	2,276	2,364	599	489
18-20	1,196	1,327	668	669	182	127
21-25	4,063	4,334	1,608	1,695	417	362
26 or Older	42,661^a	45,307	6,132^b	7,653	1,929	2,171
26-49	23,802^a	25,426	5,167^b	6,402	1,728	1,797
26-29	4,017	4,327	1,280^a	1,678	365	418
30-34	5,358	5,582	1,531	1,451	444	421
35-39	5,491	5,682	1,258	1,458	384	440
40-44	4,834	5,301	598^b	1,110	274	340
45-49	4,102	4,534	499	705	262	178
50 or Older	18,859	19,881	965	1,251	201	374
50-54	3,579	3,602	397	579	58	163
55-59	3,262	3,864	263	208	53	94
60-64	4,878	4,805	167	289	33	79
65 or Older	7,139	7,611	139	176	58	37
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.10B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	17.1	17.9	3.1^b	3.6	0.9	1.0
12-20	4.5	5.0	2.8	2.8	0.8	0.6
21 or Older	19.0	19.9	3.2^b	3.7	1.0	1.0
12-17	2.0	2.3	1.5	1.6	0.4	0.5
12-13	0.7	0.6	0.4	0.3	0.1	0.1
14-15	1.8	1.9	1.3	1.2	0.2	0.3
16-17	3.4	4.2	2.6	3.1	1.0	1.0
18 or Older	18.6	19.4	3.3^b	3.8	1.0	1.0
18-25	15.5	16.2	6.7	6.8	1.8	1.4
18-20	9.8	10.6	5.5	5.3	1.5	1.0
21-25	18.6	19.4	7.3	7.6	1.9	1.6
26 or Older	19.1	19.9	2.7^b	3.4	0.9	1.0
26-49	23.0	24.0	5.0^b	6.1	1.7	1.7
26-29	22.8	24.8	7.3^a	9.6	2.1	2.4
30-34	23.6	23.7	6.8	6.2	2.0	1.8
35-39	23.7	24.5	5.4	6.3	1.7	1.9
40-44	22.8	23.7	2.8^b	5.0	1.3	1.5
45-49	21.8	23.6	2.6	3.7	1.4	0.9
50 or Older	15.7	16.4	0.8	1.0	0.2	0.3
50-54	19.2	18.3	2.1	2.9	0.3	0.8
55-59	15.9^a	19.8	1.3	1.1	0.3	0.5
60-64	21.3	21.3	0.7	1.3	0.1	0.4
65 or Older	12.3	12.7	0.2	0.3	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.11A – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	--	31,989	--	3,155	--	1,124
12-20	--	4,340	--	1,269	--	354
21 or Older	--	27,649	--	1,886	--	771
12-17	--	3,092	--	967	--	272
12-13	--	1,023	--	399	--	116
14-15	--	1,124	--	361	--	91
16-17	--	946	--	207	--	65
18 or Older	--	28,896	--	2,189	--	852
18-25	--	3,461	--	690	--	191
18-20	--	1,248	--	302	--	81
21-25	--	2,213	--	388	--	110
26 or Older	--	25,435	--	1,499	--	660
26-49	--	13,521	--	1,194	--	456
26-29	--	2,151	--	322	--	71
30-34	--	2,661	--	309	--	137
35-39	--	2,739	--	352	--	178
40-44	--	3,054	--	90	--	28
45-49	--	2,916	--	121	--	42
50 or Older	--	11,914	--	305	--	205
50-54	--	2,607	--	92	--	61
55-59	--	2,728	--	31	--	1
60-64	--	3,110	--	63	--	55
65 or Older	--	3,469	--	119	--	88
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.11B – Inhalant Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	--	11.1	--	1.1	--	0.4
12-20	--	11.3	--	3.3	--	0.9
21 or Older	--	11.1	--	0.8	--	0.3
12-17	--	11.9	--	3.7	--	1.0
12-13	--	12.6	--	4.9	--	1.4
14-15	--	12.7	--	4.1	--	1.0
16-17	--	10.5	--	2.3	--	0.7
18 or Older	--	11.0	--	0.8	--	0.3
18-25	--	9.9	--	2.0	--	0.5
18-20	--	9.9	--	2.4	--	0.6
21-25	--	9.9	--	1.7	--	0.5
26 or Older	--	11.2	--	0.7	--	0.3
26-49	--	12.8	--	1.1	--	0.4
26-29	--	12.3	--	1.8	--	0.4
30-34	--	11.3	--	1.3	--	0.6
35-39	--	11.8	--	1.5	--	0.8
40-44	--	13.6	--	0.4	--	0.1
45-49	--	15.2	--	0.6	--	0.2
50 or Older	--	9.8	--	0.3	--	0.2
50-54	--	13.2	--	0.5	--	0.3
55-59	--	14.0	--	0.2	--	<0.1
60-64	--	13.8	--	0.3	--	0.2
65 or Older	--	5.8	--	0.2	--	0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.12A – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	16,130	15,294	2,621	2,384	1,596	1,418
12-20	198	178	78	86	43	47
21 or Older	15,932	15,116	2,543	2,298	1,553	1,372
12-17	84	87	40	57	29	35
12-13	9	15	6	15	4	7
14-15	18	27	2^a	16	<1^a	6
16-17	56	45	32	26	25	23
18 or Older	16,046	15,206	2,582	2,327	1,566	1,383
18-25	569	464	108	161	49	77
18-20	114	91	39	29	13	11
21-25	455	373	69^a	132	36	65
26 or Older	15,478	14,742	2,473	2,166	1,517	1,306
26-49	7,456	7,707	1,681	1,431	1,113	839
26-29	576	744	200	193	115	84
30-34	1,389	1,225	355	288	207	135
35-39	2,016	1,855	463	343	362	203
40-44	1,738^a	2,162	323	316	181	234
45-49	1,736	1,720	338	291	248	184
50 or Older	8,022	7,035	793	735	404	467
50-54	1,482	1,173	282	272	100	166
55-59	1,678	1,675	246	226	132	188
60-64	2,180	1,840	148	123	72	60
65 or Older	2,681	2,347	117	115	100	53
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.12B – Methamphetamine Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	5.7	5.3	0.9	0.8	0.6	0.5
12-20	0.5	0.5	0.2	0.2	0.1	0.1
21 or Older	6.5	6.1	1.0	0.9	0.6	0.5
12-17	0.3	0.3	0.2	0.2	0.1	0.1
12-13	0.1	0.2	0.1	0.2	0.1	0.1
14-15	0.2	0.3	<0.1^a	0.2	<0.1^a	0.1
16-17	0.6	0.5	0.4	0.3	0.3	0.3
18 or Older	6.2	5.8	1.0	0.9	0.6	0.5
18-25	1.7	1.3	0.3	0.5	0.1	0.2
18-20	0.9	0.7	0.3	0.2	0.1	0.1
21-25	2.1	1.7	0.3^a	0.6	0.2	0.3
26 or Older	6.9	6.5	1.1	1.0	0.7	0.6
26-49	7.2	7.3	1.6	1.4	1.1	0.8
26-29	3.3	4.3	1.1	1.1	0.7	0.5
30-34	6.1	5.2	1.6	1.2	0.9	0.6
35-39	8.7	8.0	2.0	1.5	1.6	0.9
40-44	8.2	9.6	1.5	1.4	0.9	1.0
45-49	9.2	8.9	1.8	1.5	1.3	1.0
50 or Older	6.7	5.8	0.7	0.6	0.3	0.4
50-54	7.9	6.0	1.5	1.4	0.5	0.8
55-59	8.2	8.6	1.2	1.2	0.6	1.0
60-64	9.5	8.2	0.6	0.5	0.3	0.3
65 or Older	4.6	3.9	0.2	0.2	0.2	0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.13A – Any Use of Prescription Opioids in Past Year and Misuse of Prescription Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	60,821^a	63,149	8,196	7,570	2,029	1,951
12-20	4,384	4,784	760	674	181	163
21 or Older	56,437	58,365	7,436	6,896	1,848	1,788
12-17	2,686^a	2,998	511	395	128	106
12-13	655	710	135	91	28	23
14-15	988	1,073	172	150	67	49
16-17	1,043	1,215	204	153	32	33
18 or Older	58,134	60,151	7,685	7,176	1,901	1,845
18-25	4,888	4,731	801	897	169	214
18-20	1,697	1,786	249	279	53	57
21-25	3,190	2,945	552	618	116	157
26 or Older	53,246	55,420	6,884	6,279	1,732	1,631
26-49	21,906	22,117	3,867	3,468	977	873
26-29	2,794	2,908	550	535	172	135
30-34	4,515	4,330	992^b	594	256^b	121
35-39	5,099	4,937	873	814	226	227
40-44	4,701	5,244	682	861	159	237
45-49	4,797	4,697	771	664	162	154
50 or Older	31,340^a	33,303	3,017	2,811	756	758
50-54	4,641	5,093	586	584	133	257
55-59	4,991	4,973	512	588	112	137
60-64	6,601	6,530	894^a	535	321	183
65 or Older	15,106^a	16,708	1,025	1,104	189	181
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.13B – Any Use of Prescription Opioids in Past Year and Misuse of Prescription Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	21.5	21.9	2.9	2.6	0.7	0.7
12-20	11.5	12.4	2.0	1.7	0.5	0.4
21 or Older	23.0	23.4	3.0	2.8	0.8	0.7
12-17	10.4^a	11.6	2.0	1.5	0.5	0.4
12-13	8.2	8.8	1.7	1.1	0.4	0.3
14-15	10.8	12.1	1.9	1.7	0.7	0.6
16-17	11.8	13.5	2.3	1.7	0.4	0.4
18 or Older	22.6	22.9	3.0	2.7	0.7	0.7
18-25	14.4	13.5	2.4	2.6	0.5	0.6
18-20	14.0	14.2	2.0	2.2	0.4	0.5
21-25	14.6	13.2	2.5	2.8	0.5	0.7
26 or Older	23.8	24.4	3.1	2.8	0.8	0.7
26-49	21.2	20.9	3.7	3.3	0.9	0.8
26-29	15.9	16.6	3.1	3.1	1.0	0.8
30-34	19.9	18.4	4.4^b	2.5	1.1^b	0.5
35-39	22.0	21.3	3.8	3.5	1.0	1.0
40-44	22.2	23.4	3.2	3.8	0.8	1.1
45-49	25.4	24.4	4.1	3.4	0.9	0.8
50 or Older	26.1	27.4	2.5	2.3	0.6	0.6
50-54	24.9	25.8	3.1	3.0	0.7	1.3
55-59	24.3	25.5	2.5	3.0	0.5	0.7
60-64	28.9	29.0	3.9^a	2.4	1.4	0.8
65 or Older	26.1	27.9	1.8	1.8	0.3	0.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.14A – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	19,816	20,507	3,922	3,899	1,163	1,239
12-20	3,005	3,148	491	489	101	109
21 or Older	16,811	17,359	3,431	3,410	1,062	1,130
12-17	1,807	1,830	230	203	32	33
12-13	451	370	35	12	5	3
14-15	659	674	92	42	15	8
16-17	697	786	103	149	12	22
18 or Older	18,009	18,677	3,692	3,696	1,131	1,206
18-25	3,660	3,639	1,066	973	308	210
18-20	1,198	1,318	261	286	69	76
21-25	2,462	2,321	805	687	239^a	134
26 or Older	14,349	15,038	2,626	2,723	823	995
26-49	10,101	10,320	2,288	2,296	709	838
26-29	2,187	1,920	739	576	260	147
30-34	2,577	2,516	601	575	171	237
35-39	2,427	2,242	515	501	137	156
40-44	1,707^a	2,091	264	364	84	170
45-49	1,203^a	1,551	169	279	57	128
50 or Older	4,248	4,718	338	427	115	158
50-54	1,199	1,349	169	147	75	52
55-59	1,071	1,071	90	123	15	9
60-64	723	948	53	100	24	50
65 or Older	1,256	1,351	26	56	1	47
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.14B – Any Use of Prescription Stimulants in Past Year and Misuse of Prescription Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	7.0	7.1	1.4	1.4	0.4	0.4
12-20	7.9	8.2	1.3	1.3	0.3	0.3
21 or Older	6.9	7.0	1.4	1.4	0.4	0.5
12-17	7.0	7.1	0.9	0.8	0.1	0.1
12-13	5.7	4.6	0.4	0.1	0.1	<0.1
14-15	7.2	7.6	1.0	0.5	0.2	0.1
16-17	7.9	8.7	1.2	1.7	0.1	0.2
18 or Older	7.0	7.1	1.4	1.4	0.4	0.5
18-25	10.8	10.4	3.1	2.8	0.9	0.6
18-20	9.9	10.5	2.1	2.3	0.6	0.6
21-25	11.2	10.4	3.7	3.1	1.1^a	0.6
26 or Older	6.4	6.6	1.2	1.2	0.4	0.4
26-49	9.8	9.8	2.2	2.2	0.7	0.8
26-29	12.4	11.0	4.2	3.3	1.5	0.8
30-34	11.4	10.7	2.7	2.4	0.8	1.0
35-39	10.5	9.7	2.2	2.2	0.6	0.7
40-44	8.1	9.3	1.2	1.6	0.4	0.8
45-49	6.4	8.1	0.9	1.5	0.3	0.7
50 or Older	3.5	3.9	0.3	0.4	0.1	0.1
50-54	6.4	6.8	0.9	0.7	0.4	0.3
55-59	5.2	5.5	0.4	0.6	0.1	<0.1
60-64	3.2	4.2	0.2	0.4	0.1	0.2
65 or Older	2.2	2.3	<0.1	0.1	<0.1	0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.15A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	39,679	39,709	4,722	4,575	1,236	1,480
12-20	1,894	1,711	316	342	98	83
21 or Older	37,785	37,998	4,406	4,233	1,139	1,397
12-17	1,181^a	945	173	172	44	38
12-13	254	224	15	21	*	11
14-15	436	337	42	63	5	4
16-17	491	384	117	88	39	23
18 or Older	38,498	38,765	4,549	4,403	1,192	1,442
18-25	2,726	2,477	576	571	159	160
18-20	713	767	143	170	53	45
21-25	2,014^a	1,710	433	401	105	115
26 or Older	35,772	36,288	3,973	3,832	1,033	1,282
26-49	14,771	14,242	2,561	2,144	595	696
26-29	1,905	1,783	381	400	98	118
30-34	2,815	2,526	639^a	421	115	135
35-39	3,406	3,193	660	500	123	161
40-44	3,407	3,436	482	489	226	195
45-49	3,238	3,304	399	333	32^a	87
50 or Older	21,001	22,046	1,412	1,688	439	586
50-54	3,483	3,817	330	246	126	111
55-59	3,354	3,616	157^a	414	89	110
60-64	4,333	4,184	362	370	92	141
65 or Older	9,830	10,430	563	659	131	225
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.15B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year and Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	14.0	13.8	1.7	1.6	0.4	0.5
12-20	5.0	4.4	0.8	0.9	0.3	0.2
21 or Older	15.4	15.2	1.8	1.7	0.5	0.6
12-17	4.6^a	3.6	0.7	0.7	0.2	0.1
12-13	3.2	2.8	0.2	0.3	*	0.1
14-15	4.8	3.8	0.5	0.7	0.1	<0.1
16-17	5.6	4.3	1.3	1.0	0.4	0.3
18 or Older	14.9	14.8	1.8	1.7	0.5	0.5
18-25	8.0^a	7.1	1.7	1.6	0.5	0.5
18-20	5.9	6.1	1.2	1.4	0.4	0.4
21-25	9.2^b	7.6	2.0	1.8	0.5	0.5
26 or Older	16.0	16.0	1.8	1.7	0.5	0.6
26-49	14.3	13.5	2.5^a	2.0	0.6	0.7
26-29	10.8	10.2	2.2	2.3	0.6	0.7
30-34	12.4	10.7	2.8^a	1.8	0.5	0.6
35-39	14.7	13.8	2.8	2.2	0.5	0.7
40-44	16.1	15.3	2.3	2.2	1.1	0.9
45-49	17.2	17.2	2.1	1.7	0.2^a	0.5
50 or Older	17.5	18.1	1.2	1.4	0.4	0.5
50-54	18.7	19.4	1.8	1.2	0.7	0.6
55-59	16.3	18.6	0.8^a	2.1	0.4	0.6
60-64	19.0	18.6	1.6	1.6	0.4	0.6
65 or Older	17.0	17.4	1.0	1.1	0.2	0.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.16A – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	31,384	31,451	3,993	3,829	1,053	1,259
12-20	1,293^a	1,069	244	278	81	57
21 or Older	30,092	30,382	3,749	3,551	972	1,202
12-17	731^b	500	119	126	38	28
12-13	148	94	7	8	*	6
14-15	257	174	32	42	3	3
16-17	326	232	81	75	34	20
18 or Older	30,653	30,951	3,874	3,703	1,015	1,231
18-25	2,228^a	1,944	522	522	138	131
18-20	561	569	125	152	43	29
21-25	1,667^a	1,375	398	370	95	102
26 or Older	28,425	29,007	3,351	3,181	877	1,099
26-49	12,405	11,988	2,314	1,921	555	602
26-29	1,652	1,539	340	362	95	92
30-34	2,313	2,140	592^a	378	113	113
35-39	2,854	2,734	559	448	103	136
40-44	2,868	2,871	435	422	214	181
45-49	2,717	2,705	388	310	29	79
50 or Older	16,020	17,018	1,037	1,260	323	498
50-54	2,881	3,129	274	179	38	95
55-59	2,571	2,796	153	340	87	58
60-64	3,139	3,172	269	239	83	138
65 or Older	7,429	7,921	342	501	115	207
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.16B – Any Use of Prescription Tranquilizers in Past Year and Misuse of Prescription Tranquilizers in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	11.1	10.9	1.4	1.3	0.4	0.4
12-20	3.4^a	2.8	0.6	0.7	0.2	0.1
21 or Older	12.3	12.2	1.5	1.4	0.4	0.5
12-17	2.8^b	1.9	0.5	0.5	0.1	0.1
12-13	1.9	1.2	0.1	0.1	*	0.1
14-15	2.8	2.0	0.3	0.5	<0.1	<0.1
16-17	3.7	2.6	0.9	0.8	0.4	0.2
18 or Older	11.9	11.8	1.5	1.4	0.4	0.5
18-25	6.5^a	5.6	1.5	1.5	0.4	0.4
18-20	4.6	4.5	1.0	1.2	0.4	0.2
21-25	7.6^b	6.1	1.8	1.7	0.4	0.5
26 or Older	12.7	12.8	1.5	1.4	0.4	0.5
26-49	12.0	11.3	2.2^a	1.8	0.5	0.6
26-29	9.4	8.8	1.9	2.1	0.5	0.5
30-34	10.2	9.1	2.6^a	1.6	0.5	0.5
35-39	12.3	11.8	2.4	1.9	0.4	0.6
40-44	13.5	12.8	2.1	1.9	1.0	0.8
45-49	14.4	14.1	2.1	1.6	0.2	0.4
50 or Older	13.3	14.0	0.9	1.0	0.3	0.4
50-54	15.4	15.9	1.5	0.9	0.2	0.5
55-59	12.5	14.4	0.7	1.7	0.4	0.3
60-64	13.7	14.1	1.2	1.1	0.4	0.6
65 or Older	12.8	13.2	0.6	0.8	0.2	0.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.17A – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	14,666	13,762	1,063	920	284	254
12-20	847	844	106	87	24	27
21 or Older	13,819	12,918	957	833	260	226
12-17	583	545	68	64	14	11
12-13	134	144	8	13	*	6
14-15	212	202	17	32	2	1
16-17	236	199	43	18	12	4
18 or Older	14,083	13,217	995	857	271	243
18-25	875	830	90	76	23	35
18-20	264	299	38	24	10	17
21-25	611	531	53	52	13	18
26 or Older	13,208	12,387	905	781	248	208
26-49	4,556	4,038	401	341	90	120
26-29	505	437	67	42	21	26
30-34	967^a	672	135	77	20	32
35-39	995	868	121	108	29	32
40-44	1,108	1,049	55	77	12	18
45-49	981	1,013	24	36	8	12
50 or Older	8,652	8,349	504	440	158	88
50-54	1,323	1,405	122	72	88	15
55-59	1,342	1,275	5	73	2	52
60-64	1,983	1,532	145	135	51	3
65 or Older	4,004	4,137	232	160	16	18
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.17B – Any Use of Prescription Sedatives in Past Year and Misuse of Prescription Sedatives in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	5.2	4.8	0.4	0.3	0.1	0.1
12-20	2.2	2.2	0.3	0.2	0.1	0.1
21 or Older	5.6	5.2	0.4	0.3	0.1	0.1
12-17	2.2	2.1	0.3	0.2	0.1	<0.1
12-13	1.7	1.8	0.1	0.2	*	0.1
14-15	2.3	2.3	0.2	0.4	<0.1	<0.1
16-17	2.7	2.2	0.5	0.2	0.1	<0.1
18 or Older	5.5	5.0	0.4	0.3	0.1	0.1
18-25	2.6	2.4	0.3	0.2	0.1	0.1
18-20	2.2	2.4	0.3	0.2	0.1	0.1
21-25	2.8	2.4	0.2	0.2	0.1	0.1
26 or Older	5.9	5.4	0.4	0.3	0.1	0.1
26-49	4.4^a	3.8	0.4	0.3	0.1	0.1
26-29	2.9	2.5	0.4	0.2	0.1	0.1
30-34	4.3^b	2.9	0.6	0.3	0.1	0.1
35-39	4.3	3.7	0.5	0.5	0.1	0.1
40-44	5.2	4.7	0.3	0.3	0.1	0.1
45-49	5.2	5.3	0.1	0.2	<0.1	0.1
50 or Older	7.2	6.9	0.4	0.4	0.1	0.1
50-54	7.1	7.1	0.7	0.4	0.5	0.1
55-59	6.5	6.6	<0.1	0.4	<0.1	0.3
60-64	8.7	6.8	0.6	0.6	0.2	<0.1
65 or Older	6.9	6.9	0.4	0.3	<0.1	<0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.18A – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)
TOTAL	23,894	24,207	3,696	3,360
12-20	863	832	229	235
21 or Older	23,031	23,375	3,467	3,125
12-17	456	371	111	107
12-13	57	77	4	15
14-15	158	119	26	36
16-17	241	175	81	56
18 or Older	23,437	23,835	3,585	3,253
18-25	1,739	1,628	480	488
18-20	406	461	118	129
21-25	1,332	1,167	362	359
26 or Older	21,699	22,208	3,105	2,766
26-49	9,689	9,356	2,080^a	1,695
26-29	1,335	1,340	318	353
30-34	1,815	1,652	514	337
35-39	2,208	2,212	518	376
40-44	2,153	2,145	406	397
45-49	2,179	2,007	323	231
50 or Older	12,009	12,852	1,025	1,071
50-54	2,197	2,210	252	163
55-59	1,841	2,023	139	312
60-64	2,236	2,431	261	190
65 or Older	5,735	6,188	374	407
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.18B – Any Use and Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)
TOTAL	8.4	8.4	1.3	1.2
12-20	2.3	2.2	0.6	0.6
21 or Older	9.4	9.4	1.4	1.3
12-17	1.8	1.4	0.4	0.4
12-13	0.7	1.0	<0.1	0.2
14-15	1.7	1.3	0.3	0.4
16-17	2.7	1.9	0.9	0.6
18 or Older	9.1	9.1	1.4	1.2
18-25	5.1	4.7	1.4	1.4
18-20	3.3	3.7	1.0	1.0
21-25	6.1	5.2	1.7	1.6
26 or Older	9.7	9.8	1.4	1.2
26-49	9.4	8.8	2.0^a	1.6
26-29	7.6	7.7	1.8	2.0
30-34	8.0	7.0	2.3^a	1.4
35-39	9.5	9.5	2.2	1.6
40-44	10.2	9.6	1.9	1.8
45-49	11.6	10.4	1.7	1.2
50 or Older	10.0	10.6	0.9	0.9
50-54	11.8	11.2	1.3	0.8
55-59	9.0	10.4	0.7	1.6
60-64	9.8	10.8	1.1	0.8
65 or Older	9.9	10.3	0.6	0.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.19A – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year¹ (2023)	Any Use in Past Year¹ (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	60,980	63,203	8,520	7,795	2,298	2,117
12-20	4,388	4,789	764	683	185	165
21 or Older	56,592	58,414	7,756	7,112	2,114	1,952
12-17	2,690^a	2,998	515	400	132	107
12-13	659	710	139	91	33	24
14-15	988	1,074	172	155	67	49
16-17	1,043	1,215	204	153	32	34
18 or Older	58,290	60,204	8,005	7,396	2,166	2,010
18-25	4,889	4,741	806	925	173	221
18-20	1,697	1,790	249	283	53	58
21-25	3,191	2,951	557	642	120	163
26 or Older	53,401	55,464	7,199	6,471	1,993	1,788
26-49	22,012	22,160	4,129	3,588	1,189	999
26-29	2,800	2,910	579	540	198	139
30-34	4,523	4,351	1,013^b	622	275^b	126
35-39	5,144	4,939	979	846	316	283
40-44	4,729	5,257	740	888	204	266
45-49	4,816	4,703	818	693	196	186
50 or Older	31,389	33,303	3,070	2,883	804	789
50-54	4,659	5,093	605	595	138	285
55-59	4,993	4,973	518	623	138	140
60-64	6,602	6,530	895	561	321	183
65 or Older	15,134^a	16,708	1,052	1,104	207	181
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Any use of opioids includes the use of heroin or any use of prescription opioids. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.19B – Any Use of Opioids in Past Year and Misuse of Opioids in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Any Use in Past Year¹ (2023)	Any Use in Past Year¹ (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	21.5	21.9	3.0^a	2.7	0.8	0.7
12-20	11.5	12.4	2.0	1.8	0.5	0.4
21 or Older	23.1	23.4	3.2	2.8	0.9	0.8
12-17	10.4^a	11.6	2.0	1.5	0.5	0.4
12-13	8.3	8.8	1.7	1.1	0.4	0.3
14-15	10.8	12.1	1.9	1.7	0.7	0.6
16-17	11.8	13.5	2.3	1.7	0.4	0.4
18 or Older	22.6	23.0	3.1	2.8	0.8	0.8
18-25	14.4	13.6	2.4	2.6	0.5	0.6
18-20	14.0	14.3	2.0	2.3	0.4	0.5
21-25	14.6	13.2	2.5	2.9	0.6	0.7
26 or Older	23.9	24.4	3.2^a	2.8	0.9	0.8
26-49	21.3	20.9	4.0^a	3.4	1.1	0.9
26-29	15.9	16.7	3.3	3.1	1.1	0.8
30-34	20.0	18.5	4.5^b	2.6	1.2^b	0.5
35-39	22.2	21.3	4.2	3.7	1.4	1.2
40-44	22.3	23.5	3.5	4.0	1.0	1.2
45-49	25.6	24.4	4.3	3.6	1.0	1.0
50 or Older	26.2	27.4	2.6	2.4	0.7	0.6
50-54	25.0	25.8	3.2	3.0	0.7	1.4
55-59	24.3	25.5	2.5	3.2	0.7	0.7
60-64	28.9	29.0	3.9	2.5	1.4	0.8
65 or Older	26.1	27.9	1.8	1.8	0.4	0.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Any use of opioids includes the use of heroin or any use of prescription opioids. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.20A – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Any Use in Past Year¹ (2023)	Any Use in Past Year¹ (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	24,686	24,907	9,659	9,031	4,175	3,934
12-20	3,197	3,296	772	697	206	201
21 or Older	21,489	21,611	8,887	8,334	3,969	3,733
12-17	1,835	1,890	285	293	72	80
12-13	454	385	44	32	11	10
14-15	672	692	106	61	16	15
16-17	709	813	135	200	45	55
18 or Older	22,850	23,017	9,374	8,738	4,103	3,854
18-25	4,298	4,191	1,895	1,646	546	466
18-20	1,362	1,406	487	404	134	121
21-25	2,937	2,785	1,408	1,242	412	345
26 or Older	18,552	18,827	7,479	7,092	3,557	3,388
26-49	12,837	12,967	5,546	5,409	2,460	2,413
26-29	2,673	2,519	1,314	1,256	586	417
30-34	3,255	3,017	1,417	1,218	540	501
35-39	3,065	2,921	1,294	1,301	582	564
40-44	2,153	2,529	786	876	341	494
45-49	1,691	1,981	735	759	410	438
50 or Older	5,715	5,859	1,933	1,682	1,097	974
50-54	1,583	1,751	636	612	243	338
55-59	1,493	1,440	535	494	326	316
60-64	1,046	1,140	378	307	251	158
65 or Older	1,593	1,529	384	269	278	163
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.20B – Any Use of Central Nervous System Stimulants in Past Year and Misuse of Central Nervous System Stimulants in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Any Use in Past Year¹ (2023)	Any Use in Past Year¹ (2024)	Misuse in Past Year (2023)	Misuse in Past Year (2024)	Misuse in Past Month (2023)	Misuse in Past Month (2024)
TOTAL	8.7	8.6	3.4	3.1	1.5	1.4
12-20	8.4	8.6	2.0	1.8	0.5	0.5
21 or Older	8.8	8.7	3.6	3.3	1.6	1.5
12-17	7.1	7.3	1.1	1.1	0.3	0.3
12-13	5.7	4.8	0.6	0.4	0.1	0.1
14-15	7.4	7.8	1.2	0.7	0.2	0.2
16-17	8.0	9.0	1.5	2.2	0.5	0.6
18 or Older	8.9	8.8	3.6	3.3	1.6	1.5
18-25	12.6	12.0	5.6^a	4.7	1.6	1.3
18-20	11.2	11.2	4.0	3.2	1.1	1.0
21-25	13.4	12.4	6.4	5.5	1.9	1.5
26 or Older	8.3	8.3	3.3	3.1	1.6	1.5
26-49	12.4	12.3	5.4	5.1	2.4	2.3
26-29	15.2	14.4	7.5	7.2	3.3	2.4
30-34	14.4	12.8	6.3	5.2	2.4	2.1
35-39	13.2	12.6	5.6	5.6	2.5	2.4
40-44	10.2	11.3	3.7	3.9	1.6	2.2
45-49	9.0	10.3	3.9	3.9	2.2	2.3
50 or Older	4.8	4.8	1.6	1.4	0.9	0.8
50-54	8.5	8.9	3.4	3.1	1.3	1.7
55-59	7.3	7.4	2.6	2.5	1.6	1.6
60-64	4.6	5.1	1.7	1.4	1.1	0.7
65 or Older	2.7	2.6	0.7	0.4	0.5	0.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.21A – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Numbers in Thousands, 2023 and 2024
Age Category	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	--	25,825	--	9,444
12-20	--	3,162	--	951
21 or Older	--	22,662	--	8,493
12-17	--	1,840	--	583
12-13	--	494	--	149
14-15	--	614	--	188
16-17	--	732	--	246
18 or Older	--	23,985	--	8,861
18-25	--	4,501	--	1,255
18-20	--	1,323	--	368
21-25	--	3,178	--	887
26 or Older	--	19,484	--	7,606
26-49	--	13,135	--	5,082
26-29	--	2,780	--	926
30-34	--	2,737	--	1,001
35-39	--	3,093	--	1,241
40-44	--	2,591	--	1,132
45-49	--	1,933	--	781
50 or Older	--	6,349	--	2,524
50-54	--	1,562	--	745
55-59	--	1,428	--	597
60-64	--	1,324	--	544
65 or Older	--	2,035	--	638
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.21B – Use of Illicit Drugs Other Than Marijuana in Past Year and Past Month: Among People Aged 12 or Older; by Detailed Age Category, Percentages, 2023 and 2024
Age Category	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	--	9.0	--	3.3
12-20	--	8.2	--	2.5
21 or Older	--	9.1	--	3.4
12-17	--	7.1	--	2.2
12-13	--	6.1	--	1.8
14-15	--	6.9	--	2.1
16-17	--	8.1	--	2.7
18 or Older	--	9.1	--	3.4
18-25	--	12.9	--	3.6
18-20	--	10.5	--	2.9
21-25	--	14.2	--	4.0
26 or Older	--	8.6	--	3.3
26-49	--	12.4	--	4.8
26-29	--	15.9	--	5.3
30-34	--	11.6	--	4.3
35-39	--	13.4	--	5.4
40-44	--	11.6	--	5.1
45-49	--	10.0	--	4.1
50 or Older	--	5.2	--	2.1
50-54	--	7.9	--	3.8
55-59	--	7.3	--	3.1
60-64	--	5.9	--	2.4
65 or Older	--	3.4	--	1.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.22A – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Numbers in Thousands, 2023 and 2024
Prescription Drug/Age Group	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Misuse in Past Year among Past Year Any Users (2023)	Misuse in Past Year among Past Year Any Users (2024)
PRESCRIPTION PSYCHOTHERAPEUTICS	--	98,945	14,435	13,797	--	13,797
12-17	--	5,048	785	647	--	647
18 or Older	--	93,897	13,651	13,150	--	13,150
18-25	--	8,960	2,025	2,019	--	2,019
26 or Older	--	84,937	11,625	11,131	--	11,131
PAIN RELIEVERS	--	69,909	8,578	8,000	--	8,000
12-17	--	3,259	570^a	425	--	425
18 or Older	--	66,650	8,008	7,575	--	7,575
18-25	--	5,314	841	955	--	955
26 or Older	--	61,336	7,167	6,620	--	6,620
PRESCRIPTION OPIOIDS	60,821^a	63,149	8,196	7,570	8,196	7,570
12-17	2,686^a	2,998	511	395	511	395
18 or Older	58,134	60,151	7,685	7,176	7,685	7,176
18-25	4,888	4,731	801	897	801	897
26 or Older	53,246	55,420	6,884	6,279	6,884	6,279
STIMULANTS	19,816	20,507	3,922	3,899	3,922	3,899
12-17	1,807	1,830	230	203	230	203
18 or Older	18,009	18,677	3,692	3,696	3,692	3,696
18-25	3,660	3,639	1,066	973	1,066	973
26 or Older	14,349	15,038	2,626	2,723	2,626	2,723
TRANQUILIZERS OR SEDATIVES	39,679	39,709	4,722	4,575	4,722	4,575
12-17	1,181^a	945	173	172	173	172
18 or Older	38,498	38,765	4,549	4,403	4,549	4,403
18-25	2,726	2,477	576	571	576	571
26 or Older	35,772	36,288	3,973	3,832	3,973	3,832
TRANQUILIZERS	31,384	31,451	3,993	3,829	3,993	3,829
12-17	731^b	500	119	126	119	126
18 or Older	30,653	30,951	3,874	3,703	3,874	3,703
18-25	2,228^a	1,944	522	522	522	522
26 or Older	28,425	29,007	3,351	3,181	3,351	3,181
SEDATIVES	14,666	13,762	1,063	920	1,063	920
12-17	583	545	68	64	68	64
18 or Older	14,083	13,217	995	857	995	857
18-25	875	830	90	76	90	76
26 or Older	13,208	12,387	905	781	905	781
BENZODIAZEPINES	23,894	24,207	3,696	3,360	3,696	3,360
12-17	456	371	111	107	111	107
18 or Older	23,437	23,835	3,585	3,253	3,585	3,253
18-25	1,739	1,628	480	488	480	488
26 or Older	21,699	22,208	3,105	2,766	3,105	2,766
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.22B – Any Use and Misuse of Prescription Psychotherapeutics in Past Year: Among People Aged 12 or Older; Misuse of Prescription Psychotherapeutics in Past Year: Among Past Year Any Users Aged 12 or Older; by Age Group, Percentages, 2023 and 2024
Prescription Drug/Age Group	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Misuse in Past Year among Past Year Any Users (2023)	Misuse in Past Year among Past Year Any Users (2024)
PRESCRIPTION PSYCHOTHERAPEUTICS	--	34.3	5.1	4.8	--	13.9
12-17	--	19.5	3.0	2.5	--	12.8
18 or Older	--	35.8	5.3	5.0	--	14.0
18-25	--	25.6	6.0	5.8	--	22.5
26 or Older	--	37.4	5.2	4.9	--	13.1
PAIN RELIEVERS	--	24.3	3.0	2.8	--	11.4
12-17	--	12.6	2.2^a	1.6	--	13.0
18 or Older	--	25.4	3.1	2.9	--	11.4
18-25	--	15.2	2.5	2.7	--	18.0
26 or Older	--	27.0	3.2	2.9	--	10.8
PRESCRIPTION OPIOIDS	21.5	21.9	2.9	2.6	13.5^a	12.0
12-17	10.4^a	11.6	2.0	1.5	19.0^b	13.2
18 or Older	22.6	22.9	3.0	2.7	13.2	11.9
18-25	14.4	13.5	2.4	2.6	16.4	19.0
26 or Older	23.8	24.4	3.1	2.8	12.9^a	11.3
STIMULANTS	7.0	7.1	1.4	1.4	19.8	19.0
12-17	7.0	7.1	0.9	0.8	12.8	11.1
18 or Older	7.0	7.1	1.4	1.4	20.5	19.8
18-25	10.8	10.4	3.1	2.8	29.1	26.7
26 or Older	6.4	6.6	1.2	1.2	18.3	18.1
TRANQUILIZERS OR SEDATIVES	14.0	13.8	1.7	1.6	11.9	11.5
12-17	4.6^a	3.6	0.7	0.7	14.7	18.2
18 or Older	14.9	14.8	1.8	1.7	11.8	11.4
18-25	8.0^a	7.1	1.7	1.6	21.1	23.1
26 or Older	16.0	16.0	1.8	1.7	11.1	10.6
TRANQUILIZERS	11.1	10.9	1.4	1.3	12.7	12.2
12-17	2.8^b	1.9	0.5	0.5	16.3^a	25.2
18 or Older	11.9	11.8	1.5	1.4	12.6	12.0
18-25	6.5^a	5.6	1.5	1.5	23.4	26.8
26 or Older	12.7	12.8	1.5	1.4	11.8	11.0
SEDATIVES	5.2	4.8	0.4	0.3	7.2	6.7
12-17	2.2	2.1	0.3	0.2	11.6	11.7
18 or Older	5.5	5.0	0.4	0.3	7.1	6.5
18-25	2.6	2.4	0.3	0.2	10.3	9.1
26 or Older	5.9	5.4	0.4	0.3	6.9	6.3
BENZODIAZEPINES	8.4	8.4	1.3	1.2	15.5	13.9
12-17	1.8	1.4	0.4	0.4	24.4	28.7
18 or Older	9.1	9.1	1.4	1.2	15.3	13.6
18-25	5.1	4.7	1.4	1.4	27.6	30.0
26 or Older	9.7	9.8	1.4	1.2	14.3	12.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.23A – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	145,076^b	149,927	5,332^b	6,275	139,745^a	143,653	18,285	18,697	121,460^a	124,955
SEX
Male	75,280	76,888	2,500^b	3,055	72,781	73,834	9,036	9,203	63,745	64,631
Female	69,796^b	73,039	2,832^b	3,220	66,964^b	69,819	9,249	9,495	57,715^a	60,324
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	123,879^a	126,718	3,920^b	4,617	119,959	122,101	14,007	14,487	105,952	107,614
AIAN	762	744	52	51	711	693	79	87	632	606
Asian	4,248^a	5,098	187	267	4,061	4,832	642	833	3,419	3,999
Black or African American	16,848	17,203	806^a	1,011	16,042	16,192	2,384	2,453	13,657	13,739
NHPI	*	*	*	*	*	*	*	*	*	*
White	97,504	98,942	2,598^a	2,949	94,906	95,994	10,133	10,316	84,773	85,678
Two or More Races	3,961	4,163	249	322	3,712	3,841	716	755	2,996	3,085
Hispanic or Latino	21,198^b	23,209	1,412^a	1,658	19,786^b	21,551	4,278	4,210	15,508^b	17,341
EDUCATION LEVEL
< High School	da	da	da	da	10,144	10,214	1,757	1,655	8,386	8,558
High School Graduate	da	da	da	da	35,613	35,949	5,845	6,173	29,768	29,776
Some College/Associate’s Degree	da	da	da	da	45,391	46,518	7,305	7,290	38,086	39,228
College Graduate	da	da	da	da	48,597^b	50,972	3,378	3,579	45,220	47,393
EMPLOYMENT STATUS
Full-Time	da	da	da	da	71,262	70,897	8,242	8,326	63,020	62,571
Part-Time	da	da	da	da	18,268	18,666	4,550	4,618	13,719	14,049
Unemployed	da	da	da	da	6,345^b	7,590	1,693^a	2,013	4,652^a	5,577
Other¹	da	da	da	da	43,870	46,499	3,800	3,741	40,070^a	42,758
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.23B – Illicit Drug Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	51.2	52.0	20.6^b	24.2	54.3	54.8	53.7	53.5	54.3	55.0
SEX
Male	54.3	54.5	18.9^b	23.0	58.1	57.8	52.9	52.4	58.9	58.7
Female	48.2	49.6	22.4^b	25.4	50.7	51.9	54.5	54.6	50.1	51.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	53.6	54.2	20.5^b	24.2	56.6	56.9	54.3	55.3	56.9	57.1
AIAN	56.9	54.6	21.9	24.5	64.4	60.0	55.8	56.2	65.7	60.6
Asian	24.3	27.4	12.8	17.6	25.3	28.2	29.0	34.7	24.7	27.2
Black or African American	48.5	48.8	22.4^b	28.3	51.5	51.1	52.3	53.4	51.3	50.7
NHPI	*	*	*	*	*	*	*	*	*	*
White	57.2	58.0	20.3^b	23.3	60.3	60.8	57.4	58.2	60.6	61.1
Two or More Races	63.9	64.2	26.8	30.9	70.5	70.6	65.4	65.9	71.8	71.8
Hispanic or Latino	40.6	42.5	20.8	24.0	43.5	45.1	51.8	48.0	41.7	44.5
EDUCATION LEVEL
< High School	da	da	da	da	41.4	42.5	49.2	46.8	40.1	41.7
High School Graduate	da	da	da	da	51.3	51.1	50.6	50.7	51.4	51.2
Some College/Associate’s Degree	da	da	da	da	58.9	59.7	55.5	55.0	59.6	60.7
College Graduate	da	da	da	da	56.2	56.6	58.7	59.8	56.0	56.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	58.9	58.5	59.6	59.3	58.8	58.4
Part-Time	da	da	da	da	57.9	57.6	54.5	52.4	59.2	59.5
Unemployed	da	da	da	da	55.5	58.9	50.7	54.8	57.4	60.5
Other¹	da	da	da	da	46.9	48.5	44.7	44.3	47.1	49.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drug use in lifetime includes the misuse of prescription psychotherapeutics even though those estimates are not reported due to potential underreporting in lifetime prescription psychotherapeutics estimates. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.24A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	70,537^a	73,637	3,816	3,916	66,721^a	69,720	13,256	13,299	53,465^a	56,421
SEX
Male	37,581	39,437	1,731	1,840	35,850	37,597	6,754	6,648	29,096^a	30,950
Female	32,957	34,199	2,086	2,077	30,871	32,123	6,503	6,652	24,368	25,471
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	59,250	61,644	2,806	2,950	56,444	58,694	10,325	10,350	46,119	48,344
AIAN	491	403	38	33	453	371	60	66	393	305
Asian	2,176	2,245	95	117	2,080	2,128	466	533	1,614	1,595
Black or African American	9,613	9,547	590	666	9,023	8,881	1,868	1,824	7,155	7,057
NHPI	*	233	*	*	*	218	*	*	*	189
White	44,397^a	46,866	1,879	1,926	42,518	44,940	7,359	7,317	35,159^a	37,623
Two or More Races	2,240	2,350	187	193	2,053	2,157	543	581	1,510	1,576
Hispanic or Latino	11,287	11,993	1,010	966	10,277	11,026	2,931	2,949	7,346	8,077
EDUCATION LEVEL
< High School	da	da	da	da	5,252	5,264	1,285	1,243	3,968	4,021
High School Graduate	da	da	da	da	17,956	19,111	4,413	4,528	13,542	14,583
Some College/Associate’s Degree	da	da	da	da	22,687	23,520	5,317	5,166	17,370	18,354
College Graduate	da	da	da	da	20,826	21,825	2,241	2,363	18,585	19,463
EMPLOYMENT STATUS
Full-Time	da	da	da	da	34,937	35,234	5,922	5,899	29,015	29,335
Part-Time	da	da	da	da	9,265	9,570	3,371	3,330	5,893	6,240
Unemployed	da	da	da	da	4,341	4,948	1,347	1,427	2,995	3,521
Other¹	da	da	da	da	18,178^a	19,969	2,616	2,643	15,562^a	17,326
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.24B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	24.9	25.5	14.7	15.1	25.9	26.6	39.0	38.1	23.9	24.8
SEX
Male	27.1	28.0	13.1	13.9	28.6	29.4	39.6	37.9	26.9	28.1
Female	22.8	23.2	16.5	16.4	23.4	23.9	38.3	38.3	21.1	21.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	25.6	26.4	14.7	15.5	26.6	27.4	40.1	39.5	24.8	25.7
AIAN	36.7	29.6	16.0	15.6	41.1	32.1	42.6	42.5	40.8	30.5
Asian	12.4	12.0	6.5	7.7	13.0	12.4	21.1	22.2	11.7	10.8
Black or African American	27.7	27.1	16.4	18.7	29.0	28.0	41.0	39.7	26.9	26.1
NHPI	*	18.8	*	*	*	18.8	*	*	*	18.7
White	26.1^a	27.5	14.7	15.2	27.0^a	28.4	41.7	41.3	25.1^a	26.8
Two or More Races	36.2	36.2	20.1	18.5	39.0	39.6	49.7	50.7	36.2	36.7
Hispanic or Latino	21.6	22.0	14.9	14.0	22.6	23.1	35.5	33.6	19.8	20.7
EDUCATION LEVEL
< High School	da	da	da	da	21.5	21.9	35.9	35.2	19.0	19.6
High School Graduate	da	da	da	da	25.8	27.2	38.2	37.2	23.4	25.1
Some College/Associate’s Degree	da	da	da	da	29.4	30.2	40.4	39.0	27.2	28.4
College Graduate	da	da	da	da	24.1	24.2	39.0	39.5	23.0	23.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	28.9	29.1	42.8	42.0	27.1	27.4
Part-Time	da	da	da	da	29.4	29.5	40.3	37.8	25.4	26.4
Unemployed	da	da	da	da	37.9	38.4	40.3	38.9	37.0	38.2
Other¹	da	da	da	da	19.4	20.8	30.7	31.3	18.3	19.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.25A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	47,657	48,224	1,864	1,950	45,794	46,273	8,901	8,884	36,892	37,390
SEX
Male	26,541	26,972	846	883	25,695	26,089	4,629	4,530	21,066	21,559
Female	21,117	21,251	1,017	1,067	20,099	20,185	4,273	4,354	15,827	15,830
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	40,321	41,195	1,309	1,442	39,011	39,753	7,093	7,018	31,919	32,735
AIAN	365	280	11	20	355	260	41	50	314	210
Asian	1,189	1,294	29	33	1,161	1,262	243	286	917	976
Black or African American	6,753	6,462	270	333	6,483	6,129	1,420	1,333	5,063	4,796
NHPI	*	122	*	2	*	121	*	*	*	94
White	30,210	31,307	883	975	29,327	30,332	4,969	4,895	24,358	25,437
Two or More Races	1,559	1,729	112	80	1,448	1,649	402	427	1,045	1,222
Hispanic or Latino	7,337	7,029	554	508	6,782	6,521	1,808	1,866	4,974	4,655
EDUCATION LEVEL
< High School	da	da	da	da	3,874	3,688	920	891	2,953	2,797
High School Graduate	da	da	da	da	13,125	13,500	3,135	3,116	9,990	10,384
Some College/Associate’s Degree	da	da	da	da	15,774	16,329	3,529	3,396	12,244	12,933
College Graduate	da	da	da	da	13,022	12,756	1,317	1,481	11,704	11,275
EMPLOYMENT STATUS
Full-Time	da	da	da	da	23,679	23,107	4,055	4,049	19,625	19,058
Part-Time	da	da	da	da	6,422	6,233	2,166	2,084	4,255	4,149
Unemployed	da	da	da	da	3,180	3,502	1,029	1,001	2,151	2,502
Other¹	da	da	da	da	12,513	13,431	1,651	1,750	10,862	11,681
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.25B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	16.8	16.7	7.2	7.5	17.8	17.6	26.2	25.4	16.5	16.4
SEX
Male	19.1	19.1	6.4	6.7	20.5	20.4	27.1	25.8	19.5	19.6
Female	14.6	14.4	8.0	8.4	15.2	15.0	25.2	25.0	13.7	13.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	17.4	17.6	6.8	7.6	18.4	18.5	27.5	26.8	17.1	17.4
AIAN	27.3	20.6	4.5	9.5	32.1	22.6	28.9	32.5	32.6^a	21.0
Asian	6.8	6.9	2.0	2.2	7.2	7.4	11.0	11.9	6.6	6.6
Black or African American	19.4	18.3	7.5	9.3	20.8	19.3	31.1	29.0	19.0	17.7
NHPI	*	9.9	*	2.0	*	10.4	*	*	*	9.3
White	17.7	18.3	6.9	7.7	18.6	19.2	28.2	27.6	17.4	18.1
Two or More Races	25.2	26.7	12.0	7.7	27.5	30.3	36.8	37.2	25.1	28.4
Hispanic or Latino	14.0	12.9	8.2	7.4	14.9	13.7	21.9	21.3	13.4	11.9
EDUCATION LEVEL
< High School	da	da	da	da	15.8	15.3	25.7	25.2	14.1	13.6
High School Graduate	da	da	da	da	18.9	19.2	27.2	25.6	17.2	17.9
Some College/Associate’s Degree	da	da	da	da	20.5	21.0	26.8	25.6	19.2	20.0
College Graduate	da	da	da	da	15.0	14.2	22.9	24.8	14.5	13.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	19.6	19.1	29.3	28.9	18.3	17.8
Part-Time	da	da	da	da	20.4	19.2	25.9	23.7	18.3	17.6
Unemployed	da	da	da	da	27.8	27.2	30.8	27.3	26.6	27.1
Other¹	da	da	da	da	13.4	14.0	19.4	20.7	12.8	13.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.26A – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	133,529^a	137,055	3,462	3,363	130,067^a	133,692	17,033	17,068	113,034^a	116,624
SEX
Male	69,100	70,404	1,550	1,566	67,550	68,838	8,370	8,352	59,180	60,486
Female	64,429^a	66,651	1,913	1,797	62,517^a	64,854	8,663	8,716	53,854^a	56,138
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	114,665	116,715	2,505	2,496	112,160	114,220	13,126	13,250	99,034	100,969
AIAN	635	625	35	25	601	599	*	78	530	521
Asian	3,579	4,053	75	54	3,504	3,999	541	611	2,963	3,388
Black or African American	15,503	15,807	510	540	14,993	15,267	2,232	2,260	12,761	13,006
NHPI	*	504	*	3	*	*	*	*	*	*
White	90,714	91,894	1,697	1,699	89,017	90,195	9,559	9,539	79,457	80,657
Two or More Races	3,730	3,832	170	174	3,559	3,658	675	722	2,885	2,937
Hispanic or Latino	18,864^a	20,339	957	867	17,907^a	19,472	3,906	3,818	14,000^b	15,655
EDUCATION LEVEL
< High School	da	da	da	da	9,180	8,940	1,580	1,434	7,600	7,506
High School Graduate	da	da	da	da	33,181	33,658	5,447	5,666	27,734	27,991
Some College/Associate’s Degree	da	da	da	da	42,537	43,644	6,834	6,606	35,702	37,039
College Graduate	da	da	da	da	45,169^b	47,450	3,171	3,362	41,998	44,088
EMPLOYMENT STATUS
Full-Time	da	da	da	da	66,653	66,496	7,831	7,746	58,822	58,750
Part-Time	da	da	da	da	17,000	17,316	4,170	4,145	12,830	13,172
Unemployed	da	da	da	da	5,836^b	7,014	1,607^a	1,902	4,230^a	5,113
Other¹	da	da	da	da	40,578	42,865	3,425	3,275	37,153	39,590
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.26B – Marijuana Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	47.1	47.5	13.4	13.0	50.5	51.0	50.0	48.8	50.6	51.3
SEX
Male	49.9	49.9	11.7	11.8	53.9	53.9	49.0	47.6	54.6	54.9
Female	44.5	45.3	15.1	14.2	47.3	48.2	51.1	50.1	46.7	47.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	49.6	50.0	13.1	13.1	52.9	53.2	50.9	50.6	53.2	53.6
AIAN	47.4	45.8	14.7	12.1	54.4	51.9	*	50.5	55.1	52.1
Asian	20.5	21.7	5.2	3.5	21.9	23.4	24.4	25.4	21.4	23.0
Black or African American	44.6	44.8	14.2	15.1	48.1	48.2	48.9	49.2	48.0	48.0
NHPI	*	40.7	*	3.8	*	*	*	*	*	*
White	53.3	53.9	13.2	13.5	56.5	57.1	54.2	53.8	56.8	57.5
Two or More Races	60.2	59.1	18.4	16.7	67.6	67.2	61.7	63.0	69.1	68.3
Hispanic or Latino	36.1	37.2	14.1	12.6	39.4	40.8	47.3	43.5	37.7	40.2
EDUCATION LEVEL
< High School	da	da	da	da	37.5	37.2	44.2	40.6	36.3	36.6
High School Graduate	da	da	da	da	47.8	47.9	47.2	46.6	47.9	48.1
Some College/Associate’s Degree	da	da	da	da	55.2	56.0	51.9	49.8	55.9	57.3
College Graduate	da	da	da	da	52.2	52.7	55.1	56.2	52.0	52.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	55.1	54.9	56.6	55.2	54.9	54.8
Part-Time	da	da	da	da	53.9	53.4	49.9	47.1	55.3	55.8
Unemployed	da	da	da	da	51.0	54.4	48.1	51.8	52.2	55.4
Other¹	da	da	da	da	43.4	44.8	40.3	38.8	43.7	45.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.27A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	61,816	64,194	2,894	2,694	58,922^a	61,500	12,435	12,226	46,487^a	49,274
SEX
Male	33,187	34,598	1,291	1,239	31,896	33,359	6,323	6,186	25,573	27,173
Female	28,629	29,595	1,603	1,454	27,026	28,141	6,112	6,040	20,914	22,101
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	52,310	54,208	2,131	2,040	50,179	52,167	9,741	9,528	40,438^a	42,639
AIAN	405	332	31	22	374	310	52	63	322	246
Asian	1,751	1,765	60	46	1,691	1,719	421	416	1,269	1,304
Black or African American	8,519	8,420	427	434	8,092	7,986	1,770	1,744	6,322	6,241
NHPI	*	179	*	3	*	176	*	*	*	148
White	39,287^a	41,442	1,446	1,400	37,841	40,042	6,963	6,716	30,878^a	33,327
Two or More Races	2,040	2,069	153	135	1,888	1,934	510	561	1,378	1,373
Hispanic or Latino	9,506	9,986	763	653	8,743	9,333	2,694	2,698	6,049	6,634
EDUCATION LEVEL
< High School	da	da	da	da	4,502	4,352	1,209	1,133	3,293	3,218
High School Graduate	da	da	da	da	15,953	17,003	4,162	4,178	11,791	12,826
Some College/Associate’s Degree	da	da	da	da	20,204	20,909	4,990	4,706	15,214	16,202
College Graduate	da	da	da	da	18,263	19,236	2,074	2,209	16,189	17,027
EMPLOYMENT STATUS
Full-Time	da	da	da	da	31,222	31,738	5,604	5,498	25,619	26,239
Part-Time	da	da	da	da	8,551	8,448	3,199	3,044	5,352	5,404
Unemployed	da	da	da	da	3,947	4,392	1,286	1,342	2,661	3,050
Other¹	da	da	da	da	15,202^a	16,922	2,346	2,342	12,856^a	14,580
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.27B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	21.8	22.3	11.2	10.4	22.9	23.4	36.5	35.0	20.8	21.7
SEX
Male	23.9	24.5	9.7	9.3	25.4	26.1	37.0	35.2	23.6	24.7
Female	19.8	20.1	12.7	11.5	20.4	20.9	36.0	34.7	18.2	18.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22.6	23.2	11.1	10.7	23.7	24.3	37.8	36.4	21.7	22.6
AIAN	30.2	24.3	13.2	10.4	33.9	26.8	36.8	40.9	33.5	24.7
Asian	10.0	9.5	4.1	3.0	10.5	10.0	19.0	17.3	9.2	8.9
Black or African American	24.5	23.9	11.9	12.2	26.0	25.2	38.8	38.0	23.8	23.0
NHPI	*	14.4	*	3.5	*	15.2	*	*	*	14.7
White	23.1^a	24.3	11.3	11.1	24.0^a	25.3	39.5	37.9	22.1^b	23.8
Two or More Races	32.9	31.9	16.4	13.0	35.8	35.5	46.6	48.9	33.0	31.9
Hispanic or Latino	18.2	18.3	11.2	9.5	19.2	19.6	32.6	30.8	16.3	17.0
EDUCATION LEVEL
< High School	da	da	da	da	18.4	18.1	33.8	32.0	15.7	15.7
High School Graduate	da	da	da	da	23.0	24.2	36.1	34.3	20.4	22.1
Some College/Associate’s Degree	da	da	da	da	26.2	26.9	37.9	35.5	23.8	25.1
College Graduate	da	da	da	da	21.1	21.4	36.1	36.9	20.0	20.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	25.8	26.2	40.5	39.2	23.9	24.5
Part-Time	da	da	da	da	27.1	26.1	38.3^a	34.6	23.1	22.9
Unemployed	da	da	da	da	34.5	34.1	38.5	36.6	32.9	33.1
Other¹	da	da	da	da	16.2^a	17.7	27.6	27.7	15.1^a	16.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.28A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	43,647	44,266	1,563	1,554	42,083	42,712	8,562	8,439	33,521	34,273
SEX
Male	24,161	24,833	706	714	23,455	24,119	4,434	4,346	19,021	19,773
Female	19,486	19,433	858	841	18,628	18,592	4,128	4,093	14,500	14,499
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	37,160	37,938	1,138	1,143	36,022	36,795	6,824	6,675	29,198	30,120
AIAN	338	263	9	12	329	250	40	50	289	200
Asian	1,007	1,116	26	22	982	1,093	230	260	751	833
Black or African American	6,308	6,001	212	253	6,096	5,748	1,396	1,288	4,699	4,460
NHPI	*	115	*	2	*	114	*	*	*	87
White	27,772	28,903	784	796	26,988	28,107	4,746	4,633	22,242	23,474
Two or More Races	1,496	1,540	103	57	1,393	1,483	394	417	999	1,066
Hispanic or Latino	6,487	6,328	425	411	6,062	5,917	1,738	1,764	4,323	4,153
EDUCATION LEVEL
< High School	da	da	da	da	3,509	3,311	883	839	2,625	2,472
High School Graduate	da	da	da	da	11,995	12,628	3,055	2,964	8,940	9,664
Some College/Associate’s Degree	da	da	da	da	14,623	15,068	3,387	3,219	11,236	11,849
College Graduate	da	da	da	da	11,956	11,705	1,236	1,418	10,720	10,287
EMPLOYMENT STATUS
Full-Time	da	da	da	da	21,842	21,606	3,919	3,893	17,923	17,713
Part-Time	da	da	da	da	5,976	5,704	2,079	1,947	3,896	3,757
Unemployed	da	da	da	da	2,948	3,198	992	973	1,956	2,225
Other¹	da	da	da	da	11,318	12,205	1,572	1,626	9,746	10,578
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.28B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	15.4	15.4	6.0	6.0	16.3	16.3	25.2	24.1	15.0	15.1
SEX
Male	17.4	17.6	5.3	5.4	18.7	18.9	26.0	24.8	17.6	17.9
Female	13.5	13.2	6.8	6.6	14.1	13.8	24.3	23.5	12.6	12.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	16.1	16.2	6.0	6.0	17.0	17.1	26.5	25.5	15.7	16.0
AIAN	25.2	19.3	3.8	5.9	29.8	21.7	28.2	32.2	30.0	20.0
Asian	5.8	6.0	1.8	1.5	6.1	6.4	10.4	10.8	5.4	5.7
Black or African American	18.1	17.0	5.9	7.1	19.6	18.1	30.6	28.0	17.7	16.5
NHPI	*	9.3	*	2.0	*	9.8	*	*	*	8.6
White	16.3	16.9	6.1	6.3	17.1	17.8	26.9	26.1	15.9	16.7
Two or More Races	24.2	23.7	11.1^a	5.5	26.5	27.2	36.1	36.4	24.0	24.8
Hispanic or Latino	12.4	11.6	6.3	6.0	13.3	12.4	21.0	20.1	11.6	10.7
EDUCATION LEVEL
< High School	da	da	da	da	14.3	13.8	24.7	23.7	12.6	12.1
High School Graduate	da	da	da	da	17.3	18.0	26.5	24.4	15.4	16.6
Some College/Associate’s Degree	da	da	da	da	19.0	19.3	25.7	24.3	17.6	18.3
College Graduate	da	da	da	da	13.8	13.0	21.5	23.7	13.3	12.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	18.1	17.8	28.3	27.7	16.7	16.5
Part-Time	da	da	da	da	18.9	17.6	24.9	22.1	16.8	15.9
Unemployed	da	da	da	da	25.8	24.8	29.7	26.5	24.1	24.1
Other¹	da	da	da	da	12.1	12.7	18.5	19.3	11.5	12.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.29A – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	42,280	42,408	84	109	42,196	42,299	2,698^b	2,226	39,498	40,074
SEX
Male	24,366	25,032	29	54	24,337	24,978	1,372	1,186	22,964	23,792
Female	17,915	17,376	55	55	17,860	17,321	1,326^a	1,040	16,534	16,282
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	36,456	36,345	55	70	36,401	36,274	2,154^a	1,796	34,247	34,478
AIAN	257	194	<1	1	257	194	7^a	23	250	170
Asian	754	775	1	*	753	775	45	64	707	711
Black or African American	2,910	3,299	2	7	2,908	3,293	107	82	2,801	3,211
NHPI	*	93	*	<1	*	93	*	*	*	91
White	31,089	30,904	45	61	31,043	30,843	1,852^a	1,544	29,191	29,299
Two or More Races	1,288	1,079	7	2	1,281	1,077	139	81	1,142	995
Hispanic or Latino	5,825	6,063	29	38	5,796	6,025	544	429	5,251	5,596
EDUCATION LEVEL
< High School	da	da	da	da	3,070	3,597	225	206	2,846	3,391
High School Graduate	da	da	da	da	11,594	10,905	852	715	10,742	10,190
Some College/Associate’s Degree	da	da	da	da	14,455	14,265	972^a	762	13,483	13,503
College Graduate	da	da	da	da	13,077	13,531	649	542	12,428	12,989
EMPLOYMENT STATUS
Full-Time	da	da	da	da	21,803	20,682	1,403^a	1,151	20,400	19,531
Part-Time	da	da	da	da	4,983	5,300	516	406	4,467	4,894
Unemployed	da	da	da	da	1,883	2,101	239	262	1,644	1,839
Other¹	da	da	da	da	13,528	14,216	541	406	12,988	13,810
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.29B – Cocaine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	14.9	14.7	0.3	0.4	16.4	16.1	7.9^b	6.4	17.7	17.6
SEX
Male	17.6	17.8	0.2	0.4	19.4	19.6	8.0^a	6.8	21.2	21.6
Female	12.4	11.8	0.4	0.4	13.5	12.9	7.8^b	6.0	14.4	13.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	15.8	15.6	0.3	0.4	17.2	16.9	8.4^b	6.9	18.4	18.3
AIAN	19.2	14.2	0.1	0.3	23.3	16.8	4.8^a	15.1	26.0	17.0
Asian	4.3	4.2	0.1	*	4.7	4.5	2.1	2.7	5.1	4.8
Black or African American	8.4	9.4	<0.1	0.2	9.3	10.4	2.4	1.8	10.5	11.9
NHPI	*	7.5	*	0.2	*	8.0	*	*	*	9.0
White	18.3	18.1	0.4	0.5	19.7	19.5	10.5^a	8.7	20.9	20.9
Two or More Races	20.8	16.6	0.7	0.2	24.3	19.8	12.7	7.1	27.4	23.2
Hispanic or Latino	11.1	11.1	0.4	0.6	12.8	12.6	6.6	4.9	14.1	14.4
EDUCATION LEVEL
< High School	da	da	da	da	12.5^a	15.0	6.3	5.8	13.6^a	16.5
High School Graduate	da	da	da	da	16.7	15.5	7.4^a	5.9	18.5	17.5
Some College/Associate’s Degree	da	da	da	da	18.8	18.3	7.4^a	5.7	21.1	20.9
College Graduate	da	da	da	da	15.1	15.0	11.3	9.1	15.4	15.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	18.0	17.1	10.1^a	8.2	19.0	18.2
Part-Time	da	da	da	da	15.8	16.4	6.2^a	4.6	19.3	20.7
Unemployed	da	da	da	da	16.5	16.3	7.1	7.1	20.3	19.9
Other¹	da	da	da	da	14.5	14.8	6.4	4.8	15.3	15.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.30A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	5,012^a	4,257	63	72	4,949^a	4,185	1,043^a	811	3,907	3,374
SEX
Male	3,220	2,903	26	31	3,194	2,871	578^a	421	2,616	2,450
Female	1,792^b	1,354	37	41	1,755^b	1,314	465	390	1,290^a	924
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,969	3,451	38	47	3,931	3,403	819^a	645	3,112	2,758
AIAN	24	15	<1	*	24	15	5	6	19	9
Asian	129	161	1	*	128	161	36	26	92	135
Black or African American	488	466	*	4	488	462	38	37	450	425
NHPI	*	3	*	<1	*	3	*	*	*	2
White	3,185^a	2,638	32	43	3,154^a	2,595	699	556	2,455	2,040
Two or More Races	127	168	5	1	122	167	41	19	81	148
Hispanic or Latino	1,043	806	25	24	1,018	782	224	166	794	616
EDUCATION LEVEL
< High School	da	da	da	da	494	385	78	66	415	318
High School Graduate	da	da	da	da	1,259	1,348	270	264	989	1,084
Some College/Associate’s Degree	da	da	da	da	1,672^a	1,252	445^a	284	1,227	968
College Graduate	da	da	da	da	1,525	1,200	249	196	1,275	1,004
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,658	2,230	557	427	2,101	1,803
Part-Time	da	da	da	da	706	512	239^b	119	467	393
Unemployed	da	da	da	da	478	438	99	98	378	340
Other¹	da	da	da	da	1,107	1,005	147	166	960	838
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.30B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.8^a	1.5	0.2	0.3	1.9^a	1.6	3.1^a	2.3	1.7	1.5
SEX
Male	2.3	2.1	0.2	0.2	2.5	2.2	3.4^a	2.4	2.4	2.2
Female	1.2^b	0.9	0.3	0.3	1.3^b	1.0	2.7	2.2	1.1^b	0.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.7	1.5	0.2	0.2	1.9	1.6	3.2^a	2.5	1.7	1.5
AIAN	1.8	1.1	<0.1	*	2.1	1.3	3.7	3.8	1.9	0.9
Asian	0.7	0.9	0.1	*	0.8	0.9	1.6	1.1	0.7	0.9
Black or African American	1.4	1.3	*	0.1	1.6	1.5	0.8	0.8	1.7	1.6
NHPI	*	0.3	*	0.2	*	0.3	*	*	*	0.2
White	1.9^a	1.5	0.2	0.3	2.0^a	1.6	4.0	3.1	1.8	1.5
Two or More Races	2.1	2.6	0.6	0.1	2.3	3.1	3.7	1.6	1.9	3.4
Hispanic or Latino	2.0	1.5	0.4	0.4	2.2	1.6	2.7	1.9	2.1	1.6
EDUCATION LEVEL
< High School	da	da	da	da	2.0	1.6	2.2	1.9	2.0	1.6
High School Graduate	da	da	da	da	1.8	1.9	2.3	2.2	1.7	1.9
Some College/Associate’s Degree	da	da	da	da	2.2^a	1.6	3.4^b	2.1	1.9	1.5
College Graduate	da	da	da	da	1.8^a	1.3	4.3	3.3	1.6^a	1.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2.2	1.8	4.0	3.0	2.0	1.7
Part-Time	da	da	da	da	2.2	1.6	2.9^b	1.4	2.0	1.7
Unemployed	da	da	da	da	4.2	3.4	3.0	2.7	4.7	3.7
Other¹	da	da	da	da	1.2	1.0	1.7	2.0	1.1	1.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.31A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,814	1,671	22	13	1,792	1,658	219	221	1,572	1,437
SEX
Male	1,183	1,166	4	10	1,179	1,157	118	130	1,061	1,027
Female	631	504	18	3	612	501	101	91	511	410
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,487	1,362	15	6	1,472	1,356	189	156	1,283	1,200
AIAN	8^a	1	*	*	8^a	1	*	*	6	1
Asian	46	102	1	*	44	102	4	3	40	99
Black or African American	249	235	*	*	249	235	7	12	242	223
NHPI	*	2	*	<1	*	2	*	<1	*	2
White	1,128	916	10	5	1,118	910	169	131	949	779
Two or More Races	40	107	*	1	36	106	7	10	29	96
Hispanic or Latino	327	308	8	6	320	302	30	65	290	237
EDUCATION LEVEL
< High School	da	da	da	da	266	212	22	31	244	181
High School Graduate	da	da	da	da	404	596	49	76	354	520
Some College/Associate’s Degree	da	da	da	da	642	489	77	66	566	424
College Graduate	da	da	da	da	479	361	71	49	408	312
EMPLOYMENT STATUS
Full-Time	da	da	da	da	861	715	141	115	720	600
Part-Time	da	da	da	da	204	238	43	26	161	212
Unemployed	da	da	da	da	232	165	17	19	215	146
Other¹	da	da	da	da	495	540	19^a	62	476	478
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.31B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.6	0.6	0.1	<0.1	0.7	0.6	0.6	0.6	0.7	0.6
SEX
Male	0.9	0.8	<0.1	0.1	0.9	0.9	0.7	0.7	1.0	0.9
Female	0.4	0.3	0.1	<0.1	0.5	0.4	0.6	0.5	0.4	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.6	0.6	0.1	<0.1	0.7	0.6	0.7	0.6	0.7	0.6
AIAN	0.6^a	0.1	*	*	0.7^a	0.1	*	*	0.7	0.1
Asian	0.3	0.5	0.1	*	0.3	0.6	0.2	0.1	0.3	0.7
Black or African American	0.7	0.7	*	*	0.8	0.7	0.2	0.3	0.9	0.8
NHPI	*	0.1	*	0.2	*	0.1	*	<0.1	*	0.2
White	0.7	0.5	0.1	<0.1	0.7	0.6	1.0	0.7	0.7	0.6
Two or More Races	0.6	1.6	*	0.1	0.7	1.9	0.6	0.9	0.7	2.2
Hispanic or Latino	0.6	0.6	0.1	0.1	0.7	0.6	0.4	0.7	0.8	0.6
EDUCATION LEVEL
< High School	da	da	da	da	1.1	0.9	0.6	0.9	1.2	0.9
High School Graduate	da	da	da	da	0.6	0.8	0.4	0.6	0.6	0.9
Some College/Associate’s Degree	da	da	da	da	0.8	0.6	0.6	0.5	0.9	0.7
College Graduate	da	da	da	da	0.6	0.4	1.2	0.8	0.5	0.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.7	0.6	1.0	0.8	0.7	0.6
Part-Time	da	da	da	da	0.6	0.7	0.5	0.3	0.7	0.9
Unemployed	da	da	da	da	2.0	1.3	0.5	0.5	2.7	1.6
Other¹	da	da	da	da	0.5	0.6	0.2^a	0.7	0.6	0.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.32A – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	9,871	10,634	9	25	9,862	10,609	246^a	153	9,616	10,455
SEX
Male	5,873^a	6,980	4	7	5,868^a	6,973	129	78	5,739^a	6,895
Female	3,999	3,653	5	18	3,994	3,635	117	75	3,877	3,560
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8,659	9,498	8	17	8,652	9,481	197^a	125	8,454	9,356
AIAN	104	83	<1	*	104	83	1	3	103	80
Asian	65	89	*	*	65	89	*	7	65	82
Black or African American	1,369	1,533	*	*	1,369	1,533	19	6	1,350	1,527
NHPI	*	40	*	*	*	40	*	*	*	40
White	6,778	7,446	4	17	6,774	7,429	156	104	6,618	7,325
Two or More Races	238	306	*	*	234	306	22	4	212	302
Hispanic or Latino	1,212	1,136	2	8	1,210	1,128	49	29	1,161	1,099
EDUCATION LEVEL
< High School	da	da	da	da	1,234	1,575	40	33	1,194	1,542
High School Graduate	da	da	da	da	3,829	3,641	115	90	3,714	3,550
Some College/Associate’s Degree	da	da	da	da	3,556	3,812	85^a	30	3,471	3,782
College Graduate	da	da	da	da	1,244	1,582	7^a	1	1,237	1,581
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4,546	4,401	109	57	4,436	4,345
Part-Time	da	da	da	da	999	1,241	56^b	14	943	1,228
Unemployed	da	da	da	da	741	654	29	26	712	628
Other¹	da	da	da	da	3,577	4,312	52	57	3,524	4,255
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.32B – Crack Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	3.5	3.7	<0.1	0.1	3.8	4.0	0.7^a	0.4	4.3	4.6
SEX
Male	4.2^a	5.0	<0.1	0.1	4.7^a	5.5	0.8	0.4	5.3^a	6.3
Female	2.8	2.5	<0.1	0.1	3.0	2.7	0.7	0.4	3.4	3.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.7	4.1	<0.1	0.1	4.1	4.4	0.8^a	0.5	4.5	5.0
AIAN	7.8	6.1	<0.1	*	9.4	7.2	0.5	1.9	10.7	8.0
Asian	0.4	0.5	*	*	0.4	0.5	*	0.3	0.5	0.6
Black or African American	3.9	4.3	*	*	4.4	4.8	0.4	0.1	5.1	5.6
NHPI	*	3.2	*	*	*	3.5	*	*	*	4.0
White	4.0	4.4	<0.1	0.1	4.3	4.7	0.9	0.6	4.7	5.2
Two or More Races	3.8	4.7	*	*	4.4	5.6	2.0	0.4	5.1	7.0
Hispanic or Latino	2.3	2.1	<0.1	0.1	2.7	2.4	0.6	0.3	3.1	2.8
EDUCATION LEVEL
< High School	da	da	da	da	5.0	6.6	1.1	0.9	5.7	7.5
High School Graduate	da	da	da	da	5.5	5.2	1.0	0.7	6.4	6.1
Some College/Associate’s Degree	da	da	da	da	4.6	4.9	0.6^a	0.2	5.4	5.9
College Graduate	da	da	da	da	1.4	1.8	0.1^a	<0.1	1.5	1.9
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.8	3.6	0.8	0.4	4.1	4.1
Part-Time	da	da	da	da	3.2	3.8	0.7^b	0.2	4.1	5.2
Unemployed	da	da	da	da	6.5	5.1	0.9	0.7	8.8	6.8
Other¹	da	da	da	da	3.8	4.5	0.6	0.7	4.1	4.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.33A – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	997	749	4	8	993	741	67	46	926	695
SEX
Male	635	518	4	*	631	518	39	26	592	492
Female	362	231	*	8	362	223	28	21	334	203
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	876	637	4	<1	872	637	40	24	831	612
AIAN	10^a	1	<1	*	10^a	1	<1	<1	10^a	1
Asian	*	16	*	*	*	16	*	*	*	16
Black or African American	254	149	*	*	254	149	5	3	249	146
NHPI	*	2	*	*	*	2	*	*	*	2
White	571	458	*	<1	571	457	35	21	536	436
Two or More Races	26	12	*	*	22	12	<1	*	22	12
Hispanic or Latino	122	112	*	8	122	105	27	22	95	83
EDUCATION LEVEL
< High School	da	da	da	da	153	139	10	17	143	122
High School Graduate	da	da	da	da	399	392	47	23	352	369
Some College/Associate’s Degree	da	da	da	da	354^a	162	8	7	345^a	155
College Graduate	da	da	da	da	87	48	1	*	86	48
EMPLOYMENT STATUS
Full-Time	da	da	da	da	334^b	92	49^a	2	285^a	90
Part-Time	da	da	da	da	81	93	12	6	69	86
Unemployed	da	da	da	da	211	93	2	9	210	84
Other¹	da	da	da	da	367	463	5	29	362	434
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.33B – Crack Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.4	0.3	<0.1	<0.1	0.4	0.3	0.2	0.1	0.4	0.3
SEX
Male	0.5	0.4	<0.1	*	0.5	0.4	0.2	0.1	0.5	0.4
Female	0.2	0.2	*	0.1	0.3	0.2	0.2	0.1	0.3	0.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.3	<0.1	<0.1	0.4	0.3	0.2	0.1	0.4	0.3
AIAN	0.8^a	0.1	<0.1	*	0.9^a	0.1	<0.1	0.1	1.0^a	0.1
Asian	*	0.1	*	*	*	0.1	*	*	*	0.1
Black or African American	0.7	0.4	*	*	0.8	0.5	0.1	0.1	0.9	0.5
NHPI	*	0.1	*	*	*	0.1	*	*	*	0.2
White	0.3	0.3	*	<0.1	0.4	0.3	0.2	0.1	0.4	0.3
Two or More Races	0.4	0.2	*	*	0.4	0.2	<0.1	*	0.5	0.3
Hispanic or Latino	0.2	0.2	*	0.1	0.3	0.2	0.3	0.3	0.3	0.2
EDUCATION LEVEL
< High School	da	da	da	da	0.6	0.6	0.3	0.5	0.7	0.6
High School Graduate	da	da	da	da	0.6	0.6	0.4	0.2	0.6	0.6
Some College/Associate’s Degree	da	da	da	da	0.5^a	0.2	0.1	0.1	0.5^a	0.2
College Graduate	da	da	da	da	0.1	0.1	<0.1	*	0.1	0.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.3^b	0.1	0.4^a	<0.1	0.3^a	0.1
Part-Time	da	da	da	da	0.3	0.3	0.1	0.1	0.3	0.4
Unemployed	da	da	da	da	1.8	0.7	<0.1	0.2	2.6	0.9
Other¹	da	da	da	da	0.4	0.5	0.1	0.3	0.4	0.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.34A – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	507	392	4	<1	503	392	5	13	498	378
SEX
Male	341	288	4	*	337	288	<1^a	12	337	276
Female	166	103	*	<1	166	103	5	1	161	102
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	449	362	4	*	445	362	5	6	440	356
AIAN	3	*	*	*	3	*	*	*	3	*
Asian	*	16	*	*	*	16	*	*	*	16
Black or African American	141	106	*	*	141	106	*	*	141	106
NHPI	*	2	*	*	*	2	*	*	*	2
White	272	230	*	*	272	230	5	6	267	225
Two or More Races	19	8	*	*	15	8	*	*	15	8
Hispanic or Latino	58	30	*	<1	58	30	<1	8	58	22
EDUCATION LEVEL
< High School	da	da	da	da	117	84	1	2	116	82
High School Graduate	da	da	da	da	145	205	2	8	143	197
Some College/Associate’s Degree	da	da	da	da	216^a	82	<1	3	216^a	79
College Graduate	da	da	da	da	25	21	1	*	24	21
EMPLOYMENT STATUS
Full-Time	da	da	da	da	188^a	33	5	*	184^a	33
Part-Time	da	da	da	da	20	63	*	4	20	59
Unemployed	da	da	da	da	107	48	<1	3	107	45
Other¹	da	da	da	da	187	247	<1	6	187	241
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.34B – Crack Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.2	0.1	<0.1	<0.1	0.2	0.1	<0.1	<0.1	0.2	0.2
SEX
Male	0.2	0.2	<0.1	*	0.3	0.2	<0.1^a	0.1	0.3	0.3
Female	0.1	0.1	*	<0.1	0.1	0.1	<0.1	<0.1	0.1	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.2	0.2	<0.1	*	0.2	0.2	<0.1	<0.1	0.2	0.2
AIAN	0.2	*	*	*	0.3	*	*	*	0.3	*
Asian	*	0.1	*	*	*	0.1	*	*	*	0.1
Black or African American	0.4	0.3	*	*	0.5	0.3	*	*	0.5	0.4
NHPI	*	0.1	*	*	*	0.1	*	*	*	0.2
White	0.2	0.1	*	*	0.2	0.1	<0.1	<0.1	0.2	0.2
Two or More Races	0.3	0.1	*	*	0.3	0.2	*	*	0.3	0.2
Hispanic or Latino	0.1	0.1	*	<0.1	0.1	0.1	<0.1	0.1	0.2	0.1
EDUCATION LEVEL
< High School	da	da	da	da	0.5	0.4	<0.1	0.1	0.6	0.4
High School Graduate	da	da	da	da	0.2	0.3	<0.1	0.1	0.2	0.3
Some College/Associate’s Degree	da	da	da	da	0.3^a	0.1	<0.1	<0.1	0.3^a	0.1
College Graduate	da	da	da	da	<0.1	<0.1	<0.1	*	<0.1	<0.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.2^a	<0.1	<0.1	*	0.2^a	<0.1
Part-Time	da	da	da	da	0.1	0.2	*	<0.1	0.1	0.3
Unemployed	da	da	da	da	0.9	0.4	<0.1	0.1	1.3	0.5
Other¹	da	da	da	da	0.2	0.3	<0.1	0.1	0.2	0.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.35A – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	48,438^a	51,559	518	591	47,920^a	50,968	5,259	5,661	42,661^a	45,307
SEX
Male	28,507	30,297	275	286	28,231^a	30,011	2,762^a	3,169	25,469	26,842
Female	19,932	21,262	243	305	19,689	20,957	2,497	2,492	17,192	18,465
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	41,887^a	44,591	355	427	41,531^a	44,164	4,138	4,499	37,393^a	39,665
AIAN	306	280	2	4	304	275	24	42	281	234
Asian	1,077	1,104	14	7	1,063	1,098	166	207	897	891
Black or African American	3,270	3,467	39	34	3,231	3,433	467	487	2,765	2,946
NHPI	*	196	*	1	*	195	*	*	*	184
White	35,382^b	37,940	270	362	35,111^a	37,578	3,239	3,449	31,873	34,129
Two or More Races	1,663	1,603	29	19	1,634	1,584	236	302	1,398	1,283
Hispanic or Latino	6,552	6,968	163	164	6,389	6,804	1,121	1,163	5,268	5,642
EDUCATION LEVEL
< High School	da	da	da	da	2,829	3,155	493	542	2,336	2,612
High School Graduate	da	da	da	da	11,664	11,820	1,638	1,749	10,026	10,072
Some College/Associate’s Degree	da	da	da	da	17,107	17,430	2,133	2,186	14,973	15,245
College Graduate	da	da	da	da	16,320^b	18,563	995	1,185	15,326^b	17,378
EMPLOYMENT STATUS
Full-Time	da	da	da	da	26,067	26,867	2,572	2,683	23,495	24,184
Part-Time	da	da	da	da	6,265	6,353	1,246	1,230	5,018	5,122
Unemployed	da	da	da	da	2,229^b	3,121	513^a	698	1,717^b	2,423
Other¹	da	da	da	da	13,359	14,627	928	1,050	12,431	13,577
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.35B – Hallucinogen Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	17.1	17.9	2.0	2.3	18.6	19.4	15.5	16.2	19.1	19.9
SEX
Male	20.6	21.5	2.1	2.2	22.5	23.5	16.2	18.0	23.5	24.4
Female	13.8	14.4	1.9	2.4	14.9	15.6	14.7	14.3	14.9	15.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	18.1^a	19.1	1.9	2.2	19.6^a	20.6	16.1	17.2	20.1	21.1
AIAN	22.9	20.5	0.9	2.1	27.6	23.8	16.7	26.8	29.2	23.4
Asian	6.2	5.9	1.0	0.4	6.6	6.4	7.5	8.6	6.5	6.0
Black or African American	9.4	9.8	1.1	1.0	10.4	10.8	10.2	10.6	10.4	10.9
NHPI	*	15.8	*	1.2	*	16.9	*	*	*	18.2
White	20.8^a	22.2	2.1	2.9	22.3^a	23.8	18.4	19.5	22.8^a	24.3
Two or More Races	26.9	24.7	3.1	1.8	31.0	29.1	21.6	26.3	33.5	29.8
Hispanic or Latino	12.5	12.8	2.4	2.4	14.1	14.3	13.6	13.3	14.2	14.5
EDUCATION LEVEL
< High School	da	da	da	da	11.6	13.1	13.8	15.3	11.2	12.7
High School Graduate	da	da	da	da	16.8	16.8	14.2	14.4	17.3	17.3
Some College/Associate’s Degree	da	da	da	da	22.2	22.4	16.2	16.5	23.4	23.6
College Graduate	da	da	da	da	18.9^a	20.6	17.3	19.8	19.0^a	20.7
EMPLOYMENT STATUS
Full-Time	da	da	da	da	21.5	22.2	18.6	19.1	21.9	22.6
Part-Time	da	da	da	da	19.9	19.6	14.9	14.0	21.6	21.7
Unemployed	da	da	da	da	19.5^b	24.2	15.3	19.0	21.2^a	26.3
Other¹	da	da	da	da	14.3	15.3	10.9	12.4	14.6	15.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.36A – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	8,795^b	10,423	387	405	8,408^b	10,018	2,276	2,364	6,132^b	7,653
SEX
Male	5,294^b	6,516	220	207	5,074^b	6,309	1,240	1,381	3,834^b	4,928
Female	3,501	3,907	167	198	3,334	3,709	1,036	984	2,298	2,725
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,290^b	8,793	268	288	7,022^b	8,506	1,840	1,887	5,182^b	6,618
AIAN	54	49	1	3	52	46	5	*	*	*
Asian	348	383	4	*	344	383	105	80	239	302
Black or African American	925	809	21	27	904	782	246	207	657	575
NHPI	5	22	*	1	4	21	*	4	4	17
White	5,692^b	7,043	220	249	5,471^b	6,794	1,375	1,449	4,096^b	5,345
Two or More Races	267^a	488	20	7	247^b	481	108	141	139^a	340
Hispanic or Latino	1,505	1,630	119	118	1,386	1,512	436	477	950	1,035
EDUCATION LEVEL
< High School	da	da	da	da	513	524	168	201	346	323
High School Graduate	da	da	da	da	1,808	2,036	708	708	1,100	1,327
Some College/Associate’s Degree	da	da	da	da	2,838	3,355	981	959	1,857^a	2,397
College Graduate	da	da	da	da	3,249^b	4,103	420	497	2,829^a	3,606
EMPLOYMENT STATUS
Full-Time	da	da	da	da	5,038^a	5,812	1,094	1,065	3,944^a	4,747
Part-Time	da	da	da	da	1,379	1,534	629	560	750	975
Unemployed	da	da	da	da	625^a	930	226	300	399^a	630
Other¹	da	da	da	da	1,365	1,742	326	440	1,039	1,302
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.36B – Hallucinogen Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	3.1^b	3.6	1.5	1.6	3.3^b	3.8	6.7	6.8	2.7^b	3.4
SEX
Male	3.8^b	4.6	1.7	1.6	4.0^b	4.9	7.3	7.9	3.5^b	4.5
Female	2.4	2.7	1.3	1.6	2.5	2.8	6.1	5.7	2.0	2.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.2^b	3.8	1.4	1.5	3.3^b	4.0	7.1	7.2	2.8^b	3.5
AIAN	4.0	3.6	0.6	1.4	4.7	4.0	3.6	*	*	*
Asian	2.0	2.1	0.3	*	2.1	2.2	4.7	3.3	1.7	2.1
Black or African American	2.7	2.3	0.6	0.8	2.9	2.5	5.4	4.5	2.5	2.1
NHPI	0.4	1.8	*	1.2	0.4	1.8	*	2.5	0.4	1.7
White	3.3^b	4.1	1.7	2.0	3.5^b	4.3	7.8	8.2	2.9^b	3.8
Two or More Races	4.3^a	7.5	2.2	0.7	4.7^b	8.8	9.9	12.3	3.3^a	7.9
Hispanic or Latino	2.9	3.0	1.7	1.7	3.1	3.2	5.3	5.4	2.6	2.7
EDUCATION LEVEL
< High School	da	da	da	da	2.1	2.2	4.7	5.7	1.7	1.6
High School Graduate	da	da	da	da	2.6	2.9	6.1	5.8	1.9	2.3
Some College/Associate’s Degree	da	da	da	da	3.7	4.3	7.4	7.2	2.9^a	3.7
College Graduate	da	da	da	da	3.8^a	4.6	7.3	8.3	3.5^a	4.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4.2^a	4.8	7.9	7.6	3.7^a	4.4
Part-Time	da	da	da	da	4.4	4.7	7.5	6.4	3.2	4.1
Unemployed	da	da	da	da	5.5	7.2	6.8	8.2	4.9	6.8
Other¹	da	da	da	da	1.5	1.8	3.8	5.2	1.2	1.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.37A – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	2,638	2,783	110	123	2,528	2,660	599	489	1,929	2,171
SEX
Male	1,601	1,779	66	60	1,535	1,719	309	288	1,226	1,430
Female	1,037	1,004	44	62	993	942	290	201	703	741
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,193	2,390	85	89	2,108	2,301	517^a	385	1,591	1,916
AIAN	*	9	1	<1	*	9	<1	*	*	4
Asian	115	106	1	*	114	106	38	5	76	100
Black or African American	319	306	11	<1	308	305	86	75	222	230
NHPI	4	8	*	*	*	8	*	1	*	*
White	1,674	1,816	61	83	1,612	1,733	372	280	1,240	1,453
Two or More Races	63	146	9	5	54^a	140	20	18	33^a	122
Hispanic or Latino	445	393	25	34	420	359	82	104	338	255
EDUCATION LEVEL
< High School	da	da	da	da	206	156	38	47	168	108
High School Graduate	da	da	da	da	536	590	194	164	342	425
Some College/Associate’s Degree	da	da	da	da	782	691	226	160	555	532
College Graduate	da	da	da	da	1,005	1,224	141	118	864	1,106
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,509	1,637	310	224	1,198	1,413
Part-Time	da	da	da	da	352	374	163	110	190	264
Unemployed	da	da	da	da	194	166	72	60	121	106
Other¹	da	da	da	da	473	482	54	95	420	388
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.37B – Hallucinogen Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.9	1.0	0.4	0.5	1.0	1.0	1.8	1.4	0.9	1.0
SEX
Male	1.2	1.3	0.5	0.5	1.2	1.3	1.8	1.6	1.1	1.3
Female	0.7	0.7	0.3	0.5	0.8	0.7	1.7	1.2	0.6	0.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.9	1.0	0.4	0.5	1.0	1.1	2.0^a	1.5	0.9	1.0
AIAN	*	0.7	0.5	0.2	*	0.8	0.1	*	*	0.4
Asian	0.7	0.6	0.1	*	0.7	0.6	1.7	0.2	0.5	0.7
Black or African American	0.9	0.9	0.3	<0.1	1.0	1.0	1.9	1.6	0.8	0.9
NHPI	0.4	0.7	*	*	*	0.7	*	0.9	*	*
White	1.0	1.1	0.5	0.7	1.0	1.1	2.1	1.6	0.9	1.0
Two or More Races	1.0	2.2	1.0	0.5	1.0^a	2.6	1.9	1.6	0.8^a	2.8
Hispanic or Latino	0.9	0.7	0.4	0.5	0.9	0.8	1.0	1.2	0.9	0.7
EDUCATION LEVEL
< High School	da	da	da	da	0.8	0.6	1.1	1.3	0.8	0.5
High School Graduate	da	da	da	da	0.8	0.8	1.7	1.4	0.6	0.7
Some College/Associate’s Degree	da	da	da	da	1.0	0.9	1.7	1.2	0.9	0.8
College Graduate	da	da	da	da	1.2	1.4	2.4	2.0	1.1	1.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.2	1.4	2.2	1.6	1.1	1.3
Part-Time	da	da	da	da	1.1	1.2	1.9	1.3	0.8	1.1
Unemployed	da	da	da	da	1.7	1.3	2.2	1.6	1.5	1.2
Other¹	da	da	da	da	0.5	0.5	0.6	1.1	0.5	0.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.38A – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	31,989	--	3,092	--	28,896	--	3,461	--	25,435
SEX
Male	--	19,260	--	1,531	--	17,730	--	1,791	--	15,939
Female	--	12,729	--	1,562	--	11,167	--	1,670	--	9,496
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	27,141	--	2,277	--	24,864	--	2,689	--	22,176
AIAN	--	149	--	24	--	125	--	13	--	112
Asian	--	1,201	--	199	--	1,002	--	227	--	775
Black or African American	--	2,133	--	504	--	1,629	--	344	--	1,285
NHPI	--	110	--	*	--	96	--	4	--	92
White	--	22,681	--	1,372	--	21,309	--	1,987	--	19,322
Two or More Races	--	868	--	164	--	703	--	114	--	589
Hispanic or Latino	--	4,848	--	816	--	4,032	--	772	--	3,260
EDUCATION LEVEL
< High School	da	da	da	da	--	1,799	--	374	--	1,425
High School Graduate	da	da	da	da	--	5,953	--	1,090	--	4,863
Some College/Associate’s Degree	da	da	da	da	--	9,533	--	1,365	--	8,168
College Graduate	da	da	da	da	--	11,612	--	632	--	10,980
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	15,006	--	1,423	--	13,583
Part-Time	da	da	da	da	--	4,054	--	890	--	3,164
Unemployed	da	da	da	da	--	1,757	--	363	--	1,394
Other¹	da	da	da	da	--	8,080	--	785	--	7,294
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.38B – Inhalant Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	11.1	--	11.9	--	11.0	--	9.9	--	11.2
SEX
Male	--	13.7	--	11.5	--	13.9	--	10.2	--	14.5
Female	--	8.6	--	12.3	--	8.3	--	9.6	--	8.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	11.6	--	12.0	--	11.6	--	10.3	--	11.8
AIAN	--	10.9	--	11.4	--	10.9	--	8.5	--	11.2
Asian	--	6.4	--	13.1	--	5.8	--	9.4	--	5.3
Black or African American	--	6.1	--	14.1	--	5.1	--	7.5	--	4.7
NHPI	--	8.9	--	*	--	8.3	--	2.7	--	9.1
White	--	13.3	--	10.9	--	13.5	--	11.2	--	13.8
Two or More Races	--	13.4	--	15.8	--	12.9	--	10.0	--	13.7
Hispanic or Latino	--	8.9	--	11.8	--	8.4	--	8.8	--	8.4
EDUCATION LEVEL
< High School	da	da	da	da	--	7.5	--	10.6	--	6.9
High School Graduate	da	da	da	da	--	8.5	--	9.0	--	8.4
Some College/Associate’s Degree	da	da	da	da	--	12.2	--	10.3	--	12.6
College Graduate	da	da	da	da	--	12.9	--	10.6	--	13.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	12.4	--	10.1	--	12.7
Part-Time	da	da	da	da	--	12.5	--	10.1	--	13.4
Unemployed	da	da	da	da	--	13.6	--	9.9	--	15.1
Other¹	da	da	da	da	--	8.4	--	9.3	--	8.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.39A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	3,155	--	967	--	2,189	--	690	--	1,499
SEX
Male	--	1,966	--	468	--	1,498	--	353	--	1,145
Female	--	1,189	--	499	--	690	--	336	--	354
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	2,585	--	752	--	1,833	--	501	--	1,332
AIAN	--	13	--	8	--	6	--	1	--	5
Asian	--	192	--	56	--	136	--	38	--	98
Black or African American	--	402	--	215	--	187	--	40	--	147
NHPI	--	12	--	*	--	1	--	*	--	1
White	--	1,827	--	412	--	1,415	--	405	--	1,010
Two or More Races	--	138	--	50	--	89	--	18	--	71
Hispanic or Latino	--	570	--	215	--	356	--	189	--	167
EDUCATION LEVEL
< High School	da	da	da	da	--	180	--	92	--	88
High School Graduate	da	da	da	da	--	429	--	204	--	225
Some College/Associate’s Degree	da	da	da	da	--	635	--	280	--	355
College Graduate	da	da	da	da		944		114		830
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	1,145	--	243	--	902
Part-Time	da	da	da	da	--	335	--	210	--	124
Unemployed	da	da	da	da	--	230	--	69	--	161
Other¹	da	da	da	da	--	479	--	168	--	312
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.39B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	1.1	--	3.7	--	0.8	--	2.0	--	0.7
SEX
Male	--	1.4	--	3.5	--	1.2	--	2.0	--	1.0
Female	--	0.8	--	3.9	--	0.5	--	1.9	--	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	1.1	--	3.9	--	0.9	--	1.9	--	0.7
AIAN	--	1.0	--	3.6	--	0.5	--	0.4	--	0.5
Asian	--	1.0	--	3.7	--	0.8	--	1.6	--	0.7
Black or African American	--	1.1	--	6.0	--	0.6	--	0.9	--	0.5
NHPI	--	1.0	--	*	--	0.1	--	*	--	0.1
White	--	1.1	--	3.3	--	0.9	--	2.3	--	0.7
Two or More Races	--	2.1	--	4.8	--	1.6	--	1.6	--	1.6
Hispanic or Latino	--	1.0	--	3.1	--	0.7	--	2.2	--	0.4
EDUCATION LEVEL
< High School	da	da	da	da	--	0.7	--	2.6	--	0.4
High School Graduate	da	da	da	da	--	0.6	--	1.7	--	0.4
Some College/Associate’s Degree	da	da	da	da	--	0.8	--	2.1	--	0.5
College Graduate	da	da	da	da		1.0		1.9		1.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	0.9	--	1.7	--	0.8
Part-Time	da	da	da	da	--	1.0	--	2.4	--	0.5
Unemployed	da	da	da	da	--	1.8	--	1.9	--	1.7
Other¹	da	da	da	da	--	0.5	--	2.0	--	0.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.40A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	1,124	--	272	--	852	--	191	--	660
SEX
Male	--	850	--	136	--	714	--	111	--	603
Female	--	275	--	137	--	138	--	81	--	57
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	926	--	221	--	705	--	123	--	582
AIAN	--	8	--	*	--	1	--	<1	--	1
Asian	--	91	--	*	--	79	--	10	--	68
Black or African American	--	197	--	79	--	119	--	14	--	105
NHPI	--	*	--	*	--	*	--	*	--	*
White	--	591	--	104	--	487	--	93	--	394
Two or More Races	--	39	--	20	--	19	--	5	--	14
Hispanic or Latino	--	198	--	52	--	147	--	69	--	78
EDUCATION LEVEL
< High School	da	da	da	da	--	65	--	35	--	30
High School Graduate	da	da	da	da	--	167	--	59	--	107
Some College/Associate’s Degree	da	da	da	da	--	249	--	80	--	169
College Graduate	da	da	da	da		372		17		355
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	438	--	72	--	366
Part-Time	da	da	da	da	--	94	--	72	--	21
Unemployed	da	da	da	da	--	104	--	27	--	77
Other¹	da	da	da	da	--	216	--	20	--	196
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.40B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.4	--	1.0	--	0.3	--	0.5	--	0.3
SEX
Male	--	0.6	--	1.0	--	0.6	--	0.6	--	0.5
Female	--	0.2	--	1.1	--	0.1	--	0.5	--	<0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	0.4	--	1.2	--	0.3	--	0.5	--	0.3
AIAN	--	0.6	--	*	--	0.1	--	0.1	--	0.1
Asian	--	0.5	--	*	--	0.5	--	0.4	--	0.5
Black or African American	--	0.6	--	2.2	--	0.4	--	0.3	--	0.4
NHPI	--	*	--	*	--	*	--	*	--	*
White	--	0.3	--	0.8	--	0.3	--	0.5	--	0.3
Two or More Races	--	0.6	--	1.9	--	0.3	--	0.5	--	0.3
Hispanic or Latino	--	0.4	--	0.7	--	0.3	--	0.8	--	0.2
EDUCATION LEVEL
< High School	da	da	da	da	--	0.3	--	1.0	--	0.1
High School Graduate	da	da	da	da	--	0.2	--	0.5	--	0.2
Some College/Associate’s Degree	da	da	da	da	--	0.3	--	0.6	--	0.3
College Graduate	da	da	da	da		0.4		0.3		0.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	0.4	--	0.5	--	0.3
Part-Time	da	da	da	da	--	0.3	--	0.8	--	0.1
Unemployed	da	da	da	da	--	0.8	--	0.7	--	0.8
Other¹	da	da	da	da	--	0.2	--	0.2	--	0.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.41A – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	16,130	15,294	84	87	16,046	15,206	569	464	15,478	14,742
SEX
Male	9,613	9,450	22	35	9,591	9,415	312	257	9,279	9,159
Female	6,517	5,844	61	53	6,455	5,791	257	207	6,198	5,584
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14,112	12,952	60	73	14,052	12,879	469^a	323	13,582	12,556
AIAN	215	133	<1	*	214	133	3	*	211	126
Asian	180	254	*	*	180	246	6	7	173	239
Black or African American	549	448	2	4	548	443	37	12	511	431
NHPI	*	31	*	*	*	31	<1	*	*	31
White	12,510	11,576	54	54	12,456	11,522	377	284	12,079	11,237
Two or More Races	530	511	4	6	526	505	46^a	13	480	492
Hispanic or Latino	2,018	2,341	23	14	1,995	2,327	99	141	1,896	2,186
EDUCATION LEVEL
< High School	da	da	da	da	1,625	1,674	135	87	1,490	1,588
High School Graduate	da	da	da	da	5,481	4,904	237	254	5,244	4,650
Some College/Associate’s Degree	da	da	da	da	5,866	5,893	177	106	5,689	5,787
College Graduate	da	da	da	da	3,074	2,735	20	17	3,054	2,718
EMPLOYMENT STATUS
Full-Time	da	da	da	da	7,319	6,557	245^a	143	7,074	6,414
Part-Time	da	da	da	da	1,628	1,682	109^a	49	1,519	1,633
Unemployed	da	da	da	da	987	1,134	69	104	918	1,031
Other¹	da	da	da	da	6,112	5,834	146	168	5,967	5,665
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.41B – Methamphetamine Use in Lifetime: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	5.7	5.3	0.3	0.3	6.2	5.8	1.7	1.3	6.9	6.5
SEX
Male	6.9	6.7	0.2	0.3	7.7	7.4	1.8	1.5	8.6	8.3
Female	4.5	4.0	0.5	0.4	4.9	4.3	1.5	1.2	5.4	4.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6.1	5.5	0.3	0.4	6.6	6.0	1.8^a	1.2	7.3	6.7
AIAN	16.0	9.8	0.2	*	19.4	11.5	2.3	*	21.9	12.6
Asian	1.0	1.4	*	*	1.1	1.4	0.3	0.3	1.3	1.6
Black or African American	1.6	1.3	<0.1	0.1	1.8	1.4	0.8	0.3	1.9	1.6
NHPI	*	2.5	*	*	*	2.7	<0.1	*	*	3.0
White	7.3	6.8	0.4	0.4	7.9	7.3	2.1	1.6	8.6	8.0
Two or More Races	8.6	7.9	0.5	0.6	10.0	9.3	4.2^a	1.1	11.5	11.4
Hispanic or Latino	3.9	4.3	0.3	0.2	4.4	4.9	1.2	1.6	5.1	5.6
EDUCATION LEVEL
< High School	da	da	da	da	6.6	7.0	3.8	2.4	7.1	7.7
High School Graduate	da	da	da	da	7.9	7.0	2.1	2.1	9.1	8.0
Some College/Associate’s Degree	da	da	da	da	7.6	7.6	1.3	0.8	8.9	9.0
College Graduate	da	da	da	da	3.6	3.0	0.3	0.3	3.8	3.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	6.0	5.4	1.8^b	1.0	6.6	6.0
Part-Time	da	da	da	da	5.2	5.2	1.3^a	0.6	6.5	6.9
Unemployed	da	da	da	da	8.6	8.8	2.1	2.8	11.3	11.2
Other¹	da	da	da	da	6.5	6.1	1.7	2.0	7.0	6.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.42A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	2,621	2,384	40	57	2,582	2,327	108	161	2,473	2,166
SEX
Male	1,637	1,580	20	15	1,617	1,565	54	106	1,562	1,459
Female	984	804	19	42	965	763	54	56	911	707
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,129	1,965	23	50	2,107	1,915	84	115	2,023	1,800
AIAN	58	19	<1	*	58	19	2	1	56	19
Asian	28	49	*	*	28	41	*	*	28	41
Black or African American	135	131	1	4	134	127	4	6	130	121
NHPI	*	8	*	*	*	8	*	*	*	8
White	1,744	1,648	17	32	1,727	1,616	75	100	1,653	1,517
Two or More Races	63	110	4	6	58	104	4	9	55	95
Hispanic or Latino	492	419	17	7	475	412	24	46	451	366
EDUCATION LEVEL
< High School	da	da	da	da	423	421	43	37	380	384
High School Graduate	da	da	da	da	972	1,008	42	88	930	920
Some College/Associate’s Degree	da	da	da	da	935	733	21	35	914	697
College Graduate	da	da	da	da	251	166	2	1	249	165
EMPLOYMENT STATUS
Full-Time	da	da	da	da	868^a	578	28	38	841^a	540
Part-Time	da	da	da	da	281	231	30^a	6	252	225
Unemployed	da	da	da	da	418	384	18	39	400	345
Other¹	da	da	da	da	1,014	1,134	33^a	78	982	1,055
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.42B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.9	0.8	0.2	0.2	1.0	0.9	0.3	0.5	1.1	1.0
SEX
Male	1.2	1.1	0.2	0.1	1.3	1.2	0.3	0.6	1.4	1.3
Female	0.7	0.5	0.2	0.3	0.7	0.6	0.3	0.3	0.8	0.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.9	0.8	0.1	0.3	1.0	0.9	0.3	0.4	1.1	1.0
AIAN	4.3	1.4	0.2	*	5.2	1.7	1.3	0.3	5.8	1.9
Asian	0.2	0.3	*	*	0.2	0.2	*	*	0.2	0.3
Black or African American	0.4	0.4	<0.1	0.1	0.4	0.4	0.1	0.1	0.5	0.4
NHPI	*	0.6	*	*	*	0.7	*	*	*	0.8
White	1.0	1.0	0.1	0.3	1.1	1.0	0.4	0.6	1.2	1.1
Two or More Races	1.0	1.7	0.5	0.6	1.1	1.9	0.3	0.8	1.3	2.2
Hispanic or Latino	0.9	0.8	0.2	0.1	1.0	0.9	0.3	0.5	1.2	0.9
EDUCATION LEVEL
< High School	da	da	da	da	1.7	1.8	1.2	1.1	1.8	1.9
High School Graduate	da	da	da	da	1.4	1.4	0.4	0.7	1.6	1.6
Some College/Associate’s Degree	da	da	da	da	1.2	0.9	0.2	0.3	1.4	1.1
College Graduate	da	da	da	da	0.3	0.2	<0.1	<0.1	0.3	0.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.7^a	0.5	0.2	0.3	0.8^a	0.5
Part-Time	da	da	da	da	0.9	0.7	0.4^a	0.1	1.1	1.0
Unemployed	da	da	da	da	3.7	3.0	0.5	1.1	4.9	3.7
Other¹	da	da	da	da	1.1	1.2	0.4^a	0.9	1.2	1.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.43A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,596	1,418	29	35	1,566	1,383	49	77	1,517	1,306
SEX
Male	996	958	18	8	978	949	32	57	945	892
Female	600	461	11	27	589	434	17	19	572	414
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,253	1,193	18	34	1,235	1,158	37	60	1,198	1,098
AIAN	21	7	<1	*	21	7	<1	<1	21	7
Asian	25	27	*	*	25	27	*	*	25	27
Black or African American	75	69	*	4	75	64	*	6	75	59
NHPI	*	2	*	*	*	2	*	*	*	2
White	1,036	998	14	27	1,022	971	35	49	986	922
Two or More Races	40	91	*	3	36	88	2	5	34	83
Hispanic or Latino	343	225	11	1	331	225	12	17	320	208
EDUCATION LEVEL
< High School	da	da	da	da	220	236	23	11	197	225
High School Graduate	da	da	da	da	601	620	22	39	579	581
Some College/Associate’s Degree	da	da	da	da	583	402	2	26	582	376
College Graduate	da	da	da	da	162	124	2	*	160	124
EMPLOYMENT STATUS
Full-Time	da	da	da	da	571^a	320	15	16	555^a	305
Part-Time	da	da	da	da	162	66	9	<1	153	66
Unemployed	da	da	da	da	192	239	9	8	183	230
Other¹	da	da	da	da	641	758	16^a	52	625	706
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.43B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.6	0.5	0.1	0.1	0.6	0.5	0.1	0.2	0.7	0.6
SEX
Male	0.7	0.7	0.1	0.1	0.8	0.7	0.2	0.3	0.9	0.8
Female	0.4	0.3	0.1	0.2	0.4	0.3	0.1	0.1	0.5	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.5	0.5	0.1	0.2	0.6	0.5	0.1	0.2	0.6	0.6
AIAN	1.6	0.5	<0.1	*	1.9	0.6	<0.1	0.1	2.2	0.7
Asian	0.1	0.1	*	*	0.2	0.2	*	*	0.2	0.2
Black or African American	0.2	0.2	*	0.1	0.2	0.2	*	0.1	0.3	0.2
NHPI	*	0.1	*	*	*	0.1	*	*	*	0.2
White	0.6	0.6	0.1	0.2	0.6	0.6	0.2	0.3	0.7	0.7
Two or More Races	0.6	1.4	*	0.3	0.7	1.6	0.2	0.4	0.8	1.9
Hispanic or Latino	0.7	0.4	0.2	<0.1	0.7	0.5	0.1	0.2	0.9	0.5
EDUCATION LEVEL
< High School	da	da	da	da	0.9	1.0	0.6	0.3	0.9	1.1
High School Graduate	da	da	da	da	0.9	0.9	0.2	0.3	1.0	1.0
Some College/Associate’s Degree	da	da	da	da	0.8	0.5	<0.1	0.2	0.9	0.6
College Graduate	da	da	da	da	0.2	0.1	<0.1	*	0.2	0.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.5^a	0.3	0.1	0.1	0.5^a	0.3
Part-Time	da	da	da	da	0.5	0.2	0.1	<0.1	0.7	0.3
Unemployed	da	da	da	da	1.7	1.9	0.3	0.2	2.3	2.5
Other¹	da	da	da	da	0.7	0.8	0.2^a	0.6	0.7	0.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.44A – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	60,821^a	63,149	2,686^a	2,998	58,134	60,151	4,888	4,731	53,246	55,420
SEX
Male	27,156^b	29,377	1,273^a	1,502	25,883^a	27,875	2,146	2,093	23,737^a	25,781
Female	33,664	33,772	1,413	1,496	32,251	32,277	2,741	2,638	29,510	29,639
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	51,692	52,953	1,964	2,105	49,728	50,848	3,718	3,594	46,010	47,254
AIAN	346	333	24	24	322	309	32	39	291	271
Asian	1,794	2,397	82	119	1,713	2,278	198	226	1,514	2,053
Black or African American	7,845	7,676	385	424	7,460	7,253	635	667	6,824	6,586
NHPI	*	207	*	*	*	194	*	*	*	175
White	39,780	40,871	1,358	1,386	38,422	39,485	2,645	2,454	35,777	37,031
Two or More Races	1,639	1,468	111	140	1,528	1,329	192	190	1,337	1,138
Hispanic or Latino	9,128^a	10,196	722	893	8,406	9,303	1,170	1,137	7,236	8,166
EDUCATION LEVEL
< High School	da	da	da	da	5,738	5,633	484	542	5,255	5,090
High School Graduate	da	da	da	da	15,959	16,694	1,680	1,835	14,279	14,858
Some College/Associate’s Degree	da	da	da	da	20,846	20,638	1,979	1,793	18,867	18,846
College Graduate	da	da	da	da	15,591^a	17,187	746^a	561	14,845^a	16,625
EMPLOYMENT STATUS
Full-Time	da	da	da	da	24,147	23,750	2,001	1,847	22,146	21,902
Part-Time	da	da	da	da	6,373	6,714	1,091	1,212	5,282	5,503
Unemployed	da	da	da	da	2,288	2,523	422	508	1,866	2,014
Other¹	da	da	da	da	25,327	27,165	1,374	1,164	23,952	26,000
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.44B – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	21.5	21.9	10.4^a	11.6	22.6	22.9	14.4	13.5	23.8	24.4
SEX
Male	19.6^a	20.8	9.6^a	11.3	20.6	21.8	12.6	11.9	21.9^a	23.4
Female	23.2	22.9	11.2	11.8	24.4	24.0	16.2	15.2	25.6	25.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22.4	22.7	10.3	11.1	23.4	23.7	14.4	13.7	24.7	25.1
AIAN	25.9	24.4	10.3	11.3	29.2	26.8	22.4	24.9	30.2	27.1
Asian	10.3	12.9	5.6	7.8	10.7	13.3	9.0	9.4	11.0	13.9
Black or African American	22.6	21.8	10.7	11.9	23.9	22.9	13.9	14.5	25.7	24.3
NHPI	*	16.7	*	*	*	16.7	*	*	*	17.3
White	23.4	24.0	10.6	11.0	24.4	25.0	15.0	13.8	25.6	26.4
Two or More Races	26.5	22.6	12.0	13.4	29.0	24.4	17.5	16.6	32.0	26.5
Hispanic or Latino	17.5	18.7	10.6	12.9	18.5	19.5	14.2	13.0	19.5	21.0
EDUCATION LEVEL
< High School	da	da	da	da	23.4	23.4	13.5	15.3	25.1	24.8
High School Graduate	da	da	da	da	23.0	23.7	14.6	15.1	24.6	25.5
Some College/Associate’s Degree	da	da	da	da	27.1	26.5	15.0	13.5	29.5	29.2
College Graduate	da	da	da	da	18.0	19.1	13.0^a	9.4	18.4	19.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	20.0	19.6	14.5	13.2	20.7	20.4
Part-Time	da	da	da	da	20.2	20.7	13.1	13.8	22.8	23.3
Unemployed	da	da	da	da	20.0	19.6	12.6	13.8	23.0	21.8
Other¹	da	da	da	da	27.1	28.4	16.1	13.8	28.2	29.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.45A – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	8,196	7,570	511	395	7,685	7,176	801	897	6,884	6,279
SEX
Male	4,262	3,940	218	161	4,044	3,779	413	385	3,631	3,394
Female	3,933	3,630	293	234	3,641	3,397	388	512	3,253	2,885
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6,765	6,143	346	253	6,419	5,890	621	685	5,798	5,205
AIAN	76	45	5	8	71	38	*	*	63	31
Asian	266	258	18	13	249	244	21	28	228	217
Black or African American	1,223	1,037	85^b	32	1,138	1,005	136	139	1,002	866
NHPI	39	34	*	*	*	34	3	*	*	32
White	4,914	4,504	224	182	4,690	4,321	411	489	4,278	3,833
Two or More Races	247	266	12	18	235	248	43	21	192	227
Hispanic or Latino	1,431	1,427	165	142	1,266	1,286	180	212	1,086	1,074
EDUCATION LEVEL
< High School	da	da	da	da	874	910	125	108	750	801
High School Graduate	da	da	da	da	2,426	2,400	285	358	2,141	2,042
Some College/Associate’s Degree	da	da	da	da	2,672	2,435	303	339	2,369	2,096
College Graduate	da	da	da	da	1,712	1,430	88	91	1,624	1,339
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3,526^a	2,927	336	342	3,190^a	2,585
Part-Time	da	da	da	da	653	864	159	226	494	638
Unemployed	da	da	da	da	455	563	70	120	385	443
Other¹	da	da	da	da	3,051	2,822	236	209	2,815	2,613
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.45B – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	2.9	2.6	2.0	1.5	3.0	2.7	2.4	2.6	3.1	2.8
SEX
Male	3.1	2.8	1.6	1.2	3.2	3.0	2.4	2.2	3.4	3.1
Female	2.7	2.5	2.3	1.8	2.8	2.5	2.3	2.9	2.8	2.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2.9	2.6	1.8	1.3	3.0	2.7	2.4	2.6	3.1	2.8
AIAN	5.7	3.3	2.2	3.6	6.4	3.3	*	*	6.5	3.1
Asian	1.5	1.4	1.2	0.9	1.6	1.4	0.9	1.1	1.6	1.5
Black or African American	3.5	2.9	2.4^b	0.9	3.7	3.2	3.0	3.0	3.8	3.2
NHPI	3.5	2.7	*	*	*	2.9	2.1	*	*	3.1
White	2.9	2.6	1.7	1.4	3.0	2.7	2.3	2.8	3.1	2.7
Two or More Races	4.0	4.1	1.3	1.7	4.5	4.6	3.9	1.8	4.6	5.3
Hispanic or Latino	2.7	2.6	2.4	2.1	2.8	2.7	2.2	2.4	2.9	2.8
EDUCATION LEVEL
< High School	da	da	da	da	3.6	3.8	3.5	3.1	3.6	3.9
High School Graduate	da	da	da	da	3.5	3.4	2.5	2.9	3.7	3.5
Some College/Associate’s Degree	da	da	da	da	3.5	3.1	2.3	2.6	3.7	3.2
College Graduate	da	da	da	da	2.0	1.6	1.5	1.5	2.0	1.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2.9^a	2.4	2.4	2.4	3.0^a	2.4
Part-Time	da	da	da	da	2.1	2.7	1.9	2.6	2.1	2.7
Unemployed	da	da	da	da	4.0	4.4	2.1	3.3	4.8	4.8
Other¹	da	da	da	da	3.3	2.9	2.8	2.5	3.3	3.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.46A – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	2,029	1,951	128	106	1,901	1,845	169	214	1,732	1,631
SEX
Male	1,066	958	64	28	1,002	930	97	79	905	851
Female	963	993	64	78	899	915	71	135	827	780
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,627	1,533	61	59	1,566	1,474	125	133	1,441	1,342
AIAN	16	8	1	1	15	7	<1	*	15^a	2
Asian	68	21	1	10	67	12	3	2	64	10
Black or African American	302	234	20	7	282	227	27	32	255	195
NHPI	2	2	*	*	2	2	*	*	2	*
White	1,204	1,172	35	37	1,169	1,135	85	90	1,084	1,045
Two or More Races	35	95	4	4	31	92	9	3	22	89
Hispanic or Latino	402	418	67	47	335	371	44	82	291	289
EDUCATION LEVEL
< High School	da	da	da	da	232	268	25	33	207	235
High School Graduate	da	da	da	da	759	611	49^a	107	710	505
Some College/Associate’s Degree	da	da	da	da	565	673	89	46	476	626
College Graduate	da	da	da	da	345	293	6	28	339	265
EMPLOYMENT STATUS
Full-Time	da	da	da	da	891^a	586	77	46	815^a	539
Part-Time	da	da	da	da	141	242	20^a	72	122	170
Unemployed	da	da	da	da	106	180	16	39	90	142
Other¹	da	da	da	da	762	837	56	57	706	780
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.46B – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.7	0.7	0.5	0.4	0.7	0.7	0.5	0.6	0.8	0.7
SEX
Male	0.8	0.7	0.5	0.2	0.8	0.7	0.6	0.4	0.8	0.8
Female	0.7	0.7	0.5	0.6	0.7	0.7	0.4	0.8	0.7	0.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.7	0.7	0.3	0.3	0.7	0.7	0.5	0.5	0.8	0.7
AIAN	1.2	0.6	0.4	0.6	1.4	0.6	0.2	*	1.5^a	0.2
Asian	0.4	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.5	0.1
Black or African American	0.9	0.7	0.6	0.2	0.9	0.7	0.6	0.7	1.0	0.7
NHPI	0.1	0.1	*	*	0.2	0.1	*	*	0.2	*
White	0.7	0.7	0.3	0.3	0.7	0.7	0.5	0.5	0.8	0.7
Two or More Races	0.6	1.5	0.5	0.3	0.6	1.7	0.8	0.2	0.5	2.1
Hispanic or Latino	0.8	0.8	1.0	0.7	0.7	0.8	0.5	0.9	0.8	0.7
EDUCATION LEVEL
< High School	da	da	da	da	0.9	1.1	0.7	0.9	1.0	1.1
High School Graduate	da	da	da	da	1.1	0.9	0.4^a	0.9	1.2	0.9
Some College/Associate’s Degree	da	da	da	da	0.7	0.9	0.7	0.3	0.7	1.0
College Graduate	da	da	da	da	0.4	0.3	0.1	0.5	0.4	0.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.7^a	0.5	0.6	0.3	0.8^a	0.5
Part-Time	da	da	da	da	0.4	0.7	0.2^a	0.8	0.5	0.7
Unemployed	da	da	da	da	0.9	1.4	0.5	1.0	1.1	1.5
Other¹	da	da	da	da	0.8	0.9	0.7	0.7	0.8	0.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.47A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	19,816	20,507	1,807	1,830	18,009	18,677	3,660	3,639	14,349	15,038
SEX
Male	8,771	9,487	981	973	7,790	8,514	1,720	1,927	6,070	6,587
Female	11,045	11,021	826	858	10,219	10,163	1,940	1,712	8,279	8,451
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	17,391	17,755	1,494	1,536	15,897	16,219	3,060	2,921	12,837	13,298
AIAN	93	57	22	10	71	47	15	3	56	44
Asian	707	676	45	49	663	628	84	172	578	456
Black or African American	1,582	1,331	76^a	126	1,506	1,205	259	213	1,247	992
NHPI	30	*	*	*	25	*	*	*	16	*
White	14,511	14,981	1,283	1,286	13,227	13,695	2,582	2,400	10,645	11,294
Two or More Races	468	636	63	65	405	571	111	130	295	441
Hispanic or Latino	2,425	2,752	313	294	2,112	2,458	600	719	1,512	1,740
EDUCATION LEVEL
< High School	da	da	da	da	1,157^a	847	262	326	895^b	521
High School Graduate	da	da	da	da	3,587	4,096	977	1,090	2,610	3,007
Some College/Associate’s Degree	da	da	da	da	6,413	6,511	1,718	1,571	4,695	4,939
College Graduate	da	da	da	da	6,852	7,222	702	652	6,150	6,570
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9,568	10,113	1,371	1,396	8,196	8,717
Part-Time	da	da	da	da	2,635	2,633	1,042	992	1,593	1,641
Unemployed	da	da	da	da	1,178	1,115	367	363	811	752
Other¹	da	da	da	da	4,628	4,815	879	888	3,749	3,927
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.47B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	7.0	7.1	7.0	7.1	7.0	7.1	10.8	10.4	6.4	6.6
SEX
Male	6.3	6.7	7.4	7.3	6.2	6.7	10.1	11.0	5.6	6.0
Female	7.6	7.5	6.5	6.8	7.7	7.6	11.4^a	9.8	7.2	7.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7.5	7.6	7.8	8.1	7.5	7.6	11.9	11.2	6.9	7.1
AIAN	7.0	4.2	9.3	4.7	6.4	4.1	10.5^a	2.2	5.8	4.4
Asian	4.0	3.6	3.1	3.2	4.1	3.7	3.8	7.2	4.2	3.1
Black or African American	4.6	3.8	2.1^a	3.5	4.8	3.8	5.7	4.6	4.7	3.7
NHPI	2.7	*	*	*	2.4	*	*	*	1.7	*
White	8.5	8.8	10.0	10.2	8.4	8.7	14.6	13.5	7.6	8.1
Two or More Races	7.6	9.8	6.7	6.2	7.7	10.5	10.1	11.3	7.1	10.3
Hispanic or Latino	4.6	5.0	4.6	4.3	4.6	5.2	7.3	8.2	4.1	4.5
EDUCATION LEVEL
< High School	da	da	da	da	4.7^a	3.5	7.3	9.2	4.3^b	2.5
High School Graduate	da	da	da	da	5.2	5.8	8.5	9.0	4.5	5.2
Some College/Associate’s Degree	da	da	da	da	8.3	8.4	13.1	11.9	7.3	7.6
College Graduate	da	da	da	da	7.9	8.0	12.2	10.9	7.6	7.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	7.9	8.3	9.9	10.0	7.6	8.1
Part-Time	da	da	da	da	8.4	8.1	12.5	11.3	6.9	7.0
Unemployed	da	da	da	da	10.3	8.7	11.0	9.9	10.0	8.2
Other¹	da	da	da	da	4.9	5.0	10.3	10.5	4.4	4.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.48A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	3,922	3,899	230	203	3,692	3,696	1,066	973	2,626	2,723
SEX
Male	2,001	2,122	102	101	1,898	2,021	505	492	1,393	1,529
Female	1,922	1,777	128	102	1,794	1,675	561	481	1,233	1,194
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,457	3,402	177	160	3,281	3,242	892	752	2,388	2,490
AIAN	16	7	4	2	12	5	1	*	11	4
Asian	141	173	11	15	130	157	35	42	95	115
Black or African American	270	226	12	19	258	206	73	37	185	170
NHPI	5	9	*	*	5	9	*	*	*	7
White	2,942	2,878	141	115	2,802	2,763	769	643	2,033	2,120
Two or More Races	84	110	9	8	75	102	14	26	61	75
Hispanic or Latino	465	497	54	43	411	454	174	221	237	233
EDUCATION LEVEL
< High School	da	da	da	da	188	151	57	84	132	67
High School Graduate	da	da	da	da	696	769	210	239	485	530
Some College/Associate’s Degree	da	da	da	da	1,289	1,320	526	444	763	876
College Graduate	da	da	da	da	1,519	1,457	273	206	1,246	1,250
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,188	2,214	432	414	1,756	1,800
Part-Time	da	da	da	da	566	502	312	231	254	271
Unemployed	da	da	da	da	225	259	98	115	128	145
Other¹	da	da	da	da	713	721	225	213	488	507
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.48B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.4	1.4	0.9	0.8	1.4	1.4	3.1	2.8	1.2	1.2
SEX
Male	1.4	1.5	0.8	0.8	1.5	1.6	3.0	2.8	1.3	1.4
Female	1.3	1.2	1.0	0.8	1.4	1.2	3.3	2.8	1.1	1.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.5	1.5	0.9	0.8	1.5	1.5	3.5	2.9	1.3	1.3
AIAN	1.2	0.5	1.5	1.0	1.1	0.4	1.0	*	1.1	0.4
Asian	0.8	0.9	0.8	1.0	0.8	0.9	1.6	1.8	0.7	0.8
Black or African American	0.8	0.6	0.3	0.5	0.8	0.7	1.6	0.8	0.7	0.6
NHPI	0.4	0.7	*	*	0.5	0.8	*	*	*	0.7
White	1.7	1.7	1.1	0.9	1.8	1.7	4.4	3.6	1.5	1.5
Two or More Races	1.4	1.7	1.0	0.8	1.4	1.9	1.2	2.3	1.5	1.8
Hispanic or Latino	0.9	0.9	0.8	0.6	0.9	1.0	2.1	2.5	0.6	0.6
EDUCATION LEVEL
< High School	da	da	da	da	0.8	0.6	1.6	2.4	0.6	0.3
High School Graduate	da	da	da	da	1.0	1.1	1.8	2.0	0.8	0.9
Some College/Associate’s Degree	da	da	da	da	1.7	1.7	4.0	3.3	1.2	1.4
College Graduate	da	da	da	da	1.8	1.6	4.7	3.5	1.5	1.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.8	1.8	3.1	2.9	1.6	1.7
Part-Time	da	da	da	da	1.8	1.6	3.7	2.6	1.1	1.1
Unemployed	da	da	da	da	2.0	2.0	2.9	3.1	1.6	1.6
Other¹	da	da	da	da	0.8	0.8	2.6	2.5	0.6	0.6
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.49A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,163	1,239	32	33	1,131	1,206	308	210	823	995
SEX
Male	641	656	16	23	624	633	154	90	470	543
Female	522	584	15	11	507	573	154	121	353	453
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,019	1,129	30	26	989	1,104	267^a	162	722	942
AIAN	<1	2	<1	*	*	1	*	<1	*	1
Asian	33	99	*	*	33	99	14	*	19	89
Black or African American	81	67	4	*	77	67	32	8	46	59
NHPI	*	*	*	*	*	*	*	*	*	*
White	867	904	25	23	842	881	219	140	624	741
Two or More Races	37	57	<1	2	36	55	2	4	34	52
Hispanic or Latino	144	110	2	8	142	102	41	49	101	54
EDUCATION LEVEL
< High School	da	da	da	da	82	39	19	24	63	15
High School Graduate	da	da	da	da	221	245	40	79	180	166
Some College/Associate’s Degree	da	da	da	da	435	481	200^a	78	236	403
College Graduate	da	da	da	da	393	442	49	30	344	412
EMPLOYMENT STATUS
Full-Time	da	da	da	da	635	841	95	96	540	744
Part-Time	da	da	da	da	185	134	122	57	63	78
Unemployed	da	da	da	da	53	34	19	18	34	16
Other¹	da	da	da	da	258	197	72	40	186	158
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.49B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.4	0.4	0.1	0.1	0.4	0.5	0.9	0.6	0.4	0.4
SEX
Male	0.5	0.5	0.1	0.2	0.5	0.5	0.9	0.5	0.4	0.5
Female	0.4	0.4	0.1	0.1	0.4	0.4	0.9	0.7	0.3	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.5	0.2	0.1	0.5	0.5	1.0^a	0.6	0.4	0.5
AIAN	<0.1	0.2	<0.1	*	*	0.1	*	<0.1	*	0.1
Asian	0.2	0.5	*	*	0.2	0.6	0.7	*	0.1	0.6
Black or African American	0.2	0.2	0.1	*	0.2	0.2	0.7	0.2	0.2	0.2
NHPI	*	*	*	*	*	*	*	*	*	*
White	0.5	0.5	0.2	0.2	0.5	0.6	1.2	0.8	0.4	0.5
Two or More Races	0.6	0.9	<0.1	0.2	0.7	1.0	0.2	0.3	0.8	1.2
Hispanic or Latino	0.3	0.2	<0.1	0.1	0.3	0.2	0.5	0.6	0.3	0.1
EDUCATION LEVEL
< High School	da	da	da	da	0.3	0.2	0.5	0.7	0.3	0.1
High School Graduate	da	da	da	da	0.3	0.3	0.3	0.6	0.3	0.3
Some College/Associate’s Degree	da	da	da	da	0.6	0.6	1.5^b	0.6	0.4	0.6
College Graduate	da	da	da	da	0.5	0.5	0.8	0.5	0.4	0.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.5	0.7	0.7	0.7	0.5	0.7
Part-Time	da	da	da	da	0.6	0.4	1.5	0.6	0.3	0.3
Unemployed	da	da	da	da	0.5	0.3	0.6	0.5	0.4	0.2
Other¹	da	da	da	da	0.3	0.2	0.8	0.5	0.2	0.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.50A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	39,679	39,709	1,181^a	945	38,498	38,765	2,726	2,477	35,772	36,288
SEX
Male	14,834	15,351	473	492	14,360	14,859	1,059	958	13,301	13,901
Female	24,846	24,358	708^b	452	24,138	23,906	1,667	1,519	22,470	22,387
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	34,357	34,472	907^a	723	33,450	33,749	2,226	1,982	31,224	31,767
AIAN	241	172	10	9	232	164	12	16	219	147
Asian	1,267	961	32	49	1,235	912	57	96	1,178	816
Black or African American	3,260	3,004	127	109	3,133	2,895	247	178	2,887	2,716
NHPI	73	131	1	*	73	130	6	*	66	121
White	28,604	29,184	689^a	520	27,915	28,663	1,798	1,550	26,117	27,113
Two or More Races	911	1,021	49	35	863	986	106	133	756	854
Hispanic or Latino	5,322	5,237	275	222	5,048	5,015	500	494	4,547	4,521
EDUCATION LEVEL
< High School	da	da	da	da	2,922^a	2,299	311^b	189	2,611	2,110
High School Graduate	da	da	da	da	9,112	9,312	819	832	8,293	8,480
Some College/Associate’s Degree	da	da	da	da	12,446	13,387	1,059	1,069	11,387	12,319
College Graduate	da	da	da	da	14,018	13,767	537^a	387	13,481	13,380
EMPLOYMENT STATUS
Full-Time	da	da	da	da	16,292	14,942	1,127	940	15,166	14,002
Part-Time	da	da	da	da	4,705	5,249	665	643	4,040	4,607
Unemployed	da	da	da	da	1,477	1,506	326^a	225	1,151	1,282
Other¹	da	da	da	da	16,023	17,067	609	669	15,414	16,397
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.50B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	14.0	13.8	4.6^a	3.6	14.9	14.8	8.0^a	7.1	16.0	16.0
SEX
Male	10.7	10.9	3.6	3.7	11.5	11.6	6.2	5.5	12.3	12.6
Female	17.2	16.5	5.6^b	3.6	18.3	17.8	9.8	8.7	19.5	19.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14.9	14.8	4.7^a	3.8	15.8	15.7	8.6^a	7.6	16.8	16.9
AIAN	18.0	12.6	4.1	4.2	21.0	14.2	8.8	10.6	22.8	14.7
Asian	7.2	5.2	2.2	3.3	7.7	5.3	2.6	4.0	8.5^a	5.5
Black or African American	9.4	8.5	3.5	3.1	10.1	9.1	5.4	3.9	10.9	10.0
NHPI	6.6	10.6	0.7	*	7.1	11.3	5.3	*	7.3	12.0
White	16.8	17.1	5.4	4.1	17.7	18.1	10.2^a	8.7	18.7	19.3
Two or More Races	14.7	15.7	5.2	3.4	16.4	18.1	9.7	11.6	18.1	19.9
Hispanic or Latino	10.2	9.6	4.0	3.2	11.1	10.5	6.1	5.6	12.2	11.6
EDUCATION LEVEL
< High School	da	da	da	da	11.9^a	9.6	8.7^b	5.3	12.5	10.3
High School Graduate	da	da	da	da	13.1	13.2	7.1	6.8	14.3	14.6
Some College/Associate’s Degree	da	da	da	da	16.2	17.2	8.0	8.1	17.8	19.1
College Graduate	da	da	da	da	16.2	15.3	9.3^b	6.5	16.7	15.9
EMPLOYMENT STATUS
Full-Time	da	da	da	da	13.5^a	12.3	8.1^a	6.7	14.2	13.1
Part-Time	da	da	da	da	14.9	16.2	8.0	7.3	17.4	19.5
Unemployed	da	da	da	da	12.9	11.7	9.7^b	6.1	14.2	13.9
Other¹	da	da	da	da	17.1	17.8	7.2	7.9	18.1	18.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.51A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	4,722	4,575	173	172	4,549	4,403	576	571	3,973	3,832
SEX
Male	2,284	2,293	63	57	2,221	2,236	271	217	1,950	2,019
Female	2,439	2,282	111	115	2,328	2,167	305	354	2,023	1,813
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,929	3,830	135	127	3,794	3,704	461	433	3,333	3,271
AIAN	10	47	<1	*	10	46	2	*	7	38
Asian	120	96	4	*	116	96	9	18	107	78
Black or African American	382	283	14	8	368	274	46	27	322	248
NHPI	*	9	*	*	*	9	*	*	*	9
White	3,265	3,193	106	111	3,159	3,081	366	353	2,793	2,728
Two or More Races	134	203	11	6	122	197	37	28	85	169
Hispanic or Latino	793	744	38	45	755	699	114	138	641	561
EDUCATION LEVEL
< High School	da	da	da	da	288	337	79	47	209	289
High School Graduate	da	da	da	da	1,202	1,224	169	233	1,033	991
Some College/Associate’s Degree	da	da	da	da	1,451	1,452	228	235	1,223	1,217
College Graduate	da	da	da	da	1,607	1,390	100	56	1,507	1,334
EMPLOYMENT STATUS
Full-Time	da	da	da	da	2,252^b	1,671	268	192	1,984^a	1,480
Part-Time	da	da	da	da	576	733	142	162	435	572
Unemployed	da	da	da	da	262	332	73	55	189	278
Other¹	da	da	da	da	1,458	1,666	93	163	1,366	1,503
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.51B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.7	1.6	0.7	0.7	1.8	1.7	1.7	1.6	1.8	1.7
SEX
Male	1.6	1.6	0.5	0.4	1.8	1.8	1.6	1.2	1.8	1.8
Female	1.7	1.5	0.9	0.9	1.8	1.6	1.8	2.0	1.8	1.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.7	1.6	0.7	0.7	1.8	1.7	1.8	1.7	1.8	1.7
AIAN	0.7	3.4	0.1	*	0.9	4.0	1.5	*	0.8	3.8
Asian	0.7	0.5	0.3	*	0.7	0.6	0.4	0.7	0.8	0.5
Black or African American	1.1	0.8	0.4	0.2	1.2	0.9	1.0	0.6	1.2	0.9
NHPI	*	0.8	*	*	*	0.8	*	*	*	0.9
White	1.9	1.9	0.8	0.9	2.0	2.0	2.1	2.0	2.0	1.9
Two or More Races	2.2	3.1	1.2	0.6	2.3	3.6	3.4	2.4	2.0	3.9
Hispanic or Latino	1.5	1.4	0.6	0.7	1.7	1.5	1.4	1.6	1.7	1.4
EDUCATION LEVEL
< High School	da	da	da	da	1.2	1.4	2.2	1.3	1.0	1.4
High School Graduate	da	da	da	da	1.7	1.7	1.5	1.9	1.8	1.7
Some College/Associate’s Degree	da	da	da	da	1.9	1.9	1.7	1.8	1.9	1.9
College Graduate	da	da	da	da	1.9	1.5	1.7	0.9	1.9	1.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.9^b	1.4	1.9	1.4	1.9^a	1.4
Part-Time	da	da	da	da	1.8	2.3	1.7	1.8	1.9	2.4
Unemployed	da	da	da	da	2.3	2.6	2.2	1.5	2.3	3.0
Other¹	da	da	da	da	1.6	1.7	1.1	1.9	1.6	1.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.52A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,236	1,480	44	38	1,192	1,442	159	160	1,033	1,282
SEX
Male	521	792	10	10	511	783	81	44	430^a	739
Female	715	688	34	28	681	660	78	116	603	543
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	960^a	1,325	29	36	930^a	1,288	129	124	802^a	1,164
AIAN	1^a	14	<1	*	1	13	<1	*	1	12
Asian	2	35	*	*	2	35	*	2	2	34
Black or African American	60	71	1	3	60	68	9	7	51	61
NHPI	*	*	*	*	*	*	*	*	*	*
White	846	1,111	24	28	821	1,083	103	108	719	975
Two or More Races	37	94	*	5	32	89	17	6	16	83
Hispanic or Latino	276	155	15	1	261	154	30	36	231	118
EDUCATION LEVEL
< High School	da	da	da	da	138	66	39^a	6	99	59
High School Graduate	da	da	da	da	339	430	42	73	297	356
Some College/Associate’s Degree	da	da	da	da	336	447	47	62	289	385
College Graduate	da	da	da	da	379	500	31	18	348	481
EMPLOYMENT STATUS
Full-Time	da	da	da	da	461	508	75	43	386	465
Part-Time	da	da	da	da	195	362	47	50	148	312
Unemployed	da	da	da	da	93	121	22	10	71	111
Other¹	da	da	da	da	443	451	14	57	428	394
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.52B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.4	0.5	0.2	0.1	0.5	0.5	0.5	0.5	0.5	0.6
SEX
Male	0.4	0.6	0.1	0.1	0.4	0.6	0.5	0.3	0.4^a	0.7
Female	0.5	0.5	0.3	0.2	0.5	0.5	0.5	0.7	0.5	0.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4^a	0.6	0.2	0.2	0.4^a	0.6	0.5	0.5	0.4^a	0.6
AIAN	0.1^a	1.0	<0.1	*	0.1	1.1	0.2	*	0.1	1.2
Asian	<0.1	0.2	*	*	<0.1	0.2	*	0.1	<0.1	0.2
Black or African American	0.2	0.2	<0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2
NHPI	*	*	*	*	*	*	*	*	*	*
White	0.5	0.7	0.2	0.2	0.5	0.7	0.6	0.6	0.5	0.7
Two or More Races	0.6	1.4	*	0.4	0.6	1.6	1.5	0.5	0.4	1.9
Hispanic or Latino	0.5	0.3	0.2	<0.1	0.6	0.3	0.4	0.4	0.6	0.3
EDUCATION LEVEL
< High School	da	da	da	da	0.6	0.3	1.1^a	0.2	0.5	0.3
High School Graduate	da	da	da	da	0.5	0.6	0.4	0.6	0.5	0.6
Some College/Associate’s Degree	da	da	da	da	0.4	0.6	0.4	0.5	0.5	0.6
College Graduate	da	da	da	da	0.4	0.6	0.5	0.3	0.4	0.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.4	0.4	0.5	0.3	0.4	0.4
Part-Time	da	da	da	da	0.6	1.1	0.6	0.6	0.6	1.3
Unemployed	da	da	da	da	0.8	0.9	0.7	0.3	0.9	1.2
Other¹	da	da	da	da	0.5	0.5	0.2^a	0.7	0.5	0.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.53A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	31,384	31,451	731^b	500	30,653	30,951	2,228^a	1,944	28,425	29,007
SEX
Male	11,088	11,502	259	240	10,829	11,262	857	717	9,973	10,545
Female	20,296	19,949	473^b	260	19,824	19,689	1,372	1,227	18,452	18,462
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	26,973	27,318	563^a	401	26,410	26,917	1,813^a	1,544	24,598	25,373
AIAN	215	123	4	6	210	117	*	*	199	103
Asian	944	799	30	24	914	775	47	48	867	726
Black or African American	2,398	2,291	71	40	2,327	2,251	205^a	123	2,122	2,128
NHPI	66	122	*	<1	66	122	6	*	59	*
White	22,649	23,132	431^a	301	22,219	22,831	1,448	1,235	20,770	21,595
Two or More Races	701	851	26	29	675	821	94	120	580	701
Hispanic or Latino	4,411	4,133	168	99	4,242	4,034	416	400	3,827	3,634
EDUCATION LEVEL
< High School	da	da	da	da	2,343^a	1,878	263^b	142	2,080	1,735
High School Graduate	da	da	da	da	7,268	7,537	686	671	6,582	6,866
Some College/Associate’s Degree	da	da	da	da	9,951	10,656	839	818	9,112	9,838
College Graduate	da	da	da	da	11,090	10,880	440^a	313	10,650	10,567
EMPLOYMENT STATUS
Full-Time	da	da	da	da	12,772	11,943	954^a	738	11,818	11,205
Part-Time	da	da	da	da	3,862	4,414	528	522	3,334	3,892
Unemployed	da	da	da	da	1,147	1,193	260^a	163	887	1,030
Other¹	da	da	da	da	12,872	13,400	487	520	12,385	12,880
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.53B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	11.1	10.9	2.8^b	1.9	11.9	11.8	6.5^a	5.6	12.7	12.8
SEX
Male	8.0	8.2	2.0	1.8	8.6	8.8	5.0	4.1	9.2	9.6
Female	14.0	13.5	3.7^b	2.1	15.0	14.6	8.1	7.1	16.0	15.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	11.7	11.7	2.9^a	2.1	12.5	12.5	7.0^a	5.9	13.2	13.5
AIAN	16.0	9.1	1.9	3.1	19.0^a	10.1	*	*	20.7^a	10.3
Asian	5.4	4.3	2.0	1.6	5.7	4.5	2.1	2.0	6.3	4.9
Black or African American	6.9	6.5	2.0	1.1	7.5	7.1	4.5^a	2.7	8.0	7.9
NHPI	6.0	9.8	*	<0.1	6.4	10.5	5.3	*	6.6	*
White	13.3	13.6	3.4^a	2.4	14.1	14.5	8.2^a	7.0	14.8	15.4
Two or More Races	11.3	13.1	2.8	2.8	12.8	15.1	8.6	10.5	13.9	16.3
Hispanic or Latino	8.4	7.6	2.5^a	1.4	9.3	8.5	5.0	4.6	10.3	9.3
EDUCATION LEVEL
< High School	da	da	da	da	9.6	7.8	7.3^b	4.0	10.0	8.5
High School Graduate	da	da	da	da	10.5	10.7	5.9	5.5	11.4	11.8
Some College/Associate’s Degree	da	da	da	da	12.9	13.7	6.4	6.2	14.3	15.2
College Graduate	da	da	da	da	12.8	12.1	7.7^a	5.2	13.2	12.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	10.6	9.9	6.9^b	5.3	11.0	10.5
Part-Time	da	da	da	da	12.2	13.6	6.3	5.9	14.4	16.5
Unemployed	da	da	da	da	10.0	9.3	7.8^b	4.5	11.0	11.2
Other¹	da	da	da	da	13.8	14.0	5.7	6.2	14.6	14.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.54A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	3,993	3,829	119	126	3,874	3,703	522	522	3,351	3,181
SEX
Male	1,885	1,925	40	41	1,845	1,884	248	183	1,597	1,701
Female	2,108	1,903	80	85	2,028	1,819	274	339	1,754	1,480
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,225	3,146	87	95	3,138	3,051	409	394	2,729	2,658
AIAN	10	34	<1	*	10	33	2	*	7	*
Asian	116	83	*	*	116	83	9	5	107	78
Black or African American	296	251	8	6	288	245	41	23	247	222
NHPI	*	9	*	*	*	9	*	*	*	9
White	2,679	2,626	69	87	2,609	2,538	321	331	2,288	2,208
Two or More Races	106	143	9	<1	97	142	36	28	62	115
Hispanic or Latino	768	683	33	31	735	652	113	128	622	524
EDUCATION LEVEL
< High School	da	da	da	da	257	320	76	37	181	283
High School Graduate	da	da	da	da	1,110	1,083	144^a	227	967	855
Some College/Associate’s Degree	da	da	da	da	1,263	1,221	210	203	1,053	1,018
College Graduate	da	da	da	da	1,243	1,080	92	55	1,151	1,024
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,921^a	1,458	239	188	1,682^a	1,270
Part-Time	da	da	da	da	511	679	129	140	382	539
Unemployed	da	da	da	da	252	307	73	51	179	256
Other¹	da	da	da	da	1,190	1,259	81	142	1,109	1,117
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.54B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.4	1.3	0.5	0.5	1.5	1.4	1.5	1.5	1.5	1.4
SEX
Male	1.4	1.4	0.3	0.3	1.5	1.5	1.5	1.0	1.5	1.5
Female	1.5	1.3	0.6	0.7	1.5	1.4	1.6	1.9	1.5	1.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.4	1.3	0.5	0.5	1.5	1.4	1.6	1.5	1.5	1.4
AIAN	0.7	2.5	<0.1	*	0.9	2.9	1.5	*	0.8	*
Asian	0.7	0.4	*	*	0.7	0.5	0.4	0.2	0.8	0.5
Black or African American	0.9	0.7	0.2	0.2	0.9	0.8	0.9	0.5	0.9	0.8
NHPI	*	0.8	*	*	*	0.8	*	*	*	0.9
White	1.6	1.5	0.5	0.7	1.7	1.6	1.8	1.9	1.6	1.6
Two or More Races	1.7	2.2	1.0	<0.1	1.8	2.6	3.3	2.4	1.5	2.7
Hispanic or Latino	1.5	1.2	0.5	0.5	1.6	1.4	1.4	1.5	1.7	1.3
EDUCATION LEVEL
< High School	da	da	da	da	1.0	1.3	2.1	1.0	0.9	1.4
High School Graduate	da	da	da	da	1.6	1.5	1.2	1.9	1.7	1.5
Some College/Associate’s Degree	da	da	da	da	1.6	1.6	1.6	1.5	1.6	1.6
College Graduate	da	da	da	da	1.4	1.2	1.6	0.9	1.4	1.2
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.6^a	1.2	1.7	1.3	1.6^a	1.2
Part-Time	da	da	da	da	1.6	2.1	1.5	1.6	1.6	2.3
Unemployed	da	da	da	da	2.2	2.4	2.2	1.4	2.2	2.8
Other¹	da	da	da	da	1.3	1.3	0.9	1.7	1.3	1.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.55A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,053	1,259	38	28	1,015	1,231	138	131	877	1,099
SEX
Male	440	692	10	8	431	684	67	35	364^a	649
Female	612	566	28	20	584	546	70	96	514	450
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	820	1,107	23	27	797	1,081	111	99	687^a	982
AIAN	1	5	<1	*	1	5	<1	*	1	4
Asian	2	34	*	*	2	34	*	*	2	34
Black or African American	52	46	1	2	51	44	3	5	48	39
NHPI	*	*	*	*	*	*	*	*	*	*
White	719	935	18	24	701	911	90	87	611	824
Two or More Races	32	88	*	*	28	88	17	6	12	82
Hispanic or Latino	233	151	15	1	218	150	27	32	191	118
EDUCATION LEVEL
< High School	da	da	da	da	113	62	39^a	3	75	59
High School Graduate	da	da	da	da	284	373	30	64	254	309
Some College/Associate’s Degree	da	da	da	da	308	392	42	48	266	344
College Graduate	da	da	da	da	310	404	27	16	283	388
EMPLOYMENT STATUS
Full-Time	da	da	da	da	404	415	62	38	342	376
Part-Time	da	da	da	da	171	336	42	40	128	296
Unemployed	da	da	da	da	93	95	22	8	71	87
Other¹	da	da	da	da	347	385	12	45	336	341
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.55B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.4	0.4	0.1	0.1	0.4	0.5	0.4	0.4	0.4	0.5
SEX
Male	0.3	0.5	0.1	0.1	0.3	0.5	0.4	0.2	0.3^a	0.6
Female	0.4	0.4	0.2	0.2	0.4	0.4	0.4	0.6	0.4	0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.5	0.1	0.1	0.4	0.5	0.4	0.4	0.4	0.5
AIAN	0.1	0.3	<0.1	*	0.1	0.4	0.2	*	0.1	0.4
Asian	<0.1	0.2	*	*	<0.1	0.2	*	*	<0.1	0.2
Black or African American	0.1	0.1	<0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.1
NHPI	*	*	*	*	*	*	*	*	*	*
White	0.4	0.5	0.1	0.2	0.4	0.6	0.5	0.5	0.4	0.6
Two or More Races	0.5	1.4	*	*	0.5	1.6	1.5	0.5	0.3	1.9
Hispanic or Latino	0.4	0.3	0.2	<0.1	0.5	0.3	0.3	0.4	0.5	0.3
EDUCATION LEVEL
< High School	da	da	da	da	0.5	0.3	1.1^a	0.1	0.4	0.3
High School Graduate	da	da	da	da	0.4	0.5	0.3	0.5	0.4	0.5
Some College/Associate’s Degree	da	da	da	da	0.4	0.5	0.3	0.4	0.4	0.5
College Graduate	da	da	da	da	0.4	0.4	0.5	0.3	0.4	0.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.3	0.3	0.4	0.3	0.3	0.4
Part-Time	da	da	da	da	0.5	1.0	0.5	0.5	0.6	1.3
Unemployed	da	da	da	da	0.8	0.7	0.7	0.2	0.9	0.9
Other¹	da	da	da	da	0.4	0.4	0.1	0.5	0.4	0.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.56A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	14,666	13,762	583	545	14,083	13,217	875	830	13,208	12,387
SEX
Male	5,955	5,649	260	290	5,695	5,359	296	344	5,399	5,015
Female	8,711	8,113	323	254	8,388	7,858	579	487	7,809	7,372
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	12,895	12,010	435	396	12,460	11,614	707	675	11,752	10,938
AIAN	72	75	6	4	65	71	*	4	58	67
Asian	405	279	19	29	386	250	12^a	62	374	188
Black or African American	1,432	1,123	64	71	1,368	1,052	72	81	1,297	971
NHPI	*	15	<1	*	*	14	*	*	*	8
White	10,564	10,255	317	282	10,248	9,973	587	505	9,661	9,468
Two or More Races	400	264	30^a	10	370	254	28	17	342	237
Hispanic or Latino	1,771	1,753	148	149	1,624	1,604	168	155	1,456	1,448
EDUCATION LEVEL
< High School	da	da	da	da	1,088^b	648	90	78	997^b	570
High School Graduate	da	da	da	da	3,376	2,952	242	285	3,134	2,666
Some College/Associate’s Degree	da	da	da	da	4,347	4,884	384	358	3,962	4,526
College Graduate	da	da	da	da	5,273	4,733	159	109	5,114	4,624
EMPLOYMENT STATUS
Full-Time	da	da	da	da	5,886^b	4,672	308	289	5,579^b	4,383
Part-Time	da	da	da	da	1,703	1,600	228	192	1,476	1,408
Unemployed	da	da	da	da	549	513	110	84	439	429
Other¹	da	da	da	da	5,945	6,432	231	265	5,715	6,167
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.56B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	5.2	4.8	2.2	2.1	5.5	5.0	2.6	2.4	5.9	5.4
SEX
Male	4.3	4.0	2.0	2.2	4.5	4.2	1.7	2.0	5.0	4.6
Female	6.0	5.5	2.6	2.0	6.3	5.8	3.4	2.8	6.8	6.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	5.6	5.1	2.3	2.1	5.9	5.4	2.7	2.6	6.3	5.8
AIAN	5.4	5.5	2.7	1.8	5.9	6.2	*	2.6	6.0	6.7
Asian	2.3	1.5	1.3	1.9	2.4	1.5	0.6^a	2.6	2.7	1.3
Black or African American	4.1	3.2	1.8	2.0	4.4	3.3	1.6	1.8	4.9	3.6
NHPI	*	1.2	0.1	*	*	1.2	*	*	*	0.8
White	6.2	6.0	2.5	2.2	6.5	6.3	3.3	2.8	6.9	6.8
Two or More Races	6.5	4.1	3.2^a	1.0	7.0	4.7	2.6	1.5	8.2	5.5
Hispanic or Latino	3.4	3.2	2.2	2.2	3.6	3.4	2.0	1.8	3.9	3.7
EDUCATION LEVEL
< High School	da	da	da	da	4.4^b	2.7	2.5	2.2	4.8^b	2.8
High School Graduate	da	da	da	da	4.9	4.2	2.1	2.3	5.4	4.6
Some College/Associate’s Degree	da	da	da	da	5.6	6.3	2.9	2.7	6.2	7.0
College Graduate	da	da	da	da	6.1	5.3	2.8	1.8	6.3	5.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4.9^b	3.9	2.2	2.1	5.2^b	4.1
Part-Time	da	da	da	da	5.4	4.9	2.7	2.2	6.4	6.0
Unemployed	da	da	da	da	4.8	4.0	3.3	2.3	5.4	4.7
Other¹	da	da	da	da	6.4	6.7	2.7	3.1	6.7	7.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.57A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,063	920	68	64	995	857	90	76	905	781
SEX
Male	603	449	31	17	572	432	40	48	532	384
Female	460	472	37	47	423	425	50	28	373	397
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	907	838	54	49	853	789	85	62	768	727
AIAN	3	14	<1	*	3	13	<1	*	3	13
Asian	4	13	4	*	*	13	*	13	*	*
Black or African American	92	42	5	3	86	39	10	5	77	34
NHPI	<1	*	*	*	<1	*	*	*	<1	*
White	774	698	42	40	732	658	73	40	659	618
Two or More Races	34	72	2	6	31	66	3	4	29	62
Hispanic or Latino	156	82	14	14	142	68	5	14	137	54
EDUCATION LEVEL
< High School	da	da	da	da	41	30	7	15	34	15
High School Graduate	da	da	da	da	221	187	42	17	179	170
Some College/Associate’s Degree	da	da	da	da	271	286	34	40	238	246
College Graduate	da	da	da	da	462	354	9	4	454	351
EMPLOYMENT STATUS
Full-Time	da	da	da	da	455	258	40^a	13	415	245
Part-Time	da	da	da	da	125	78	14	25	110	54
Unemployed	da	da	da	da	19	45	6	5	12	40
Other¹	da	da	da	da	397	475	30	33	367	442
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.57B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.4	0.3	0.3	0.2	0.4	0.3	0.3	0.2	0.4	0.3
SEX
Male	0.4	0.3	0.2	0.1	0.5	0.3	0.2	0.3	0.5	0.3
Female	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.2	0.3	0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.2	0.4	0.4
AIAN	0.2	1.0	0.1	*	0.3	1.1	0.2	*	0.3	1.3
Asian	<0.1	0.1	0.3	*	*	0.1	*	0.5	*	*
Black or African American	0.3	0.1	0.2	0.1	0.3	0.1	0.2	0.1	0.3	0.1
NHPI	<0.1	*	*	*	<0.1	*	*	*	<0.1	*
White	0.5	0.4	0.3	0.3	0.5	0.4	0.4	0.2	0.5	0.4
Two or More Races	0.5	1.1	0.2	0.6	0.6	1.2	0.3	0.4	0.7	1.4
Hispanic or Latino	0.3	0.2	0.2	0.2	0.3	0.1	0.1	0.2	0.4	0.1
EDUCATION LEVEL
< High School	da	da	da	da	0.2	0.1	0.2	0.4	0.2	0.1
High School Graduate	da	da	da	da	0.3	0.3	0.4	0.1	0.3	0.3
Some College/Associate’s Degree	da	da	da	da	0.4	0.4	0.3	0.3	0.4	0.4
College Graduate	da	da	da	da	0.5	0.4	0.1	0.1	0.6	0.4
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.4	0.2	0.3^a	0.1	0.4	0.2
Part-Time	da	da	da	da	0.4	0.2	0.2	0.3	0.5	0.2
Unemployed	da	da	da	da	0.2	0.4	0.2	0.1	0.2	0.4
Other¹	da	da	da	da	0.4	0.5	0.3	0.4	0.4	0.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.58A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	284	254	14	11	271	243	23	35	248	208
SEX
Male	147	123	4	2	143	121	15	14	128	108
Female	138	130	10	9	128	122	8	21	119	100
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	196	245	11	10	185	235	20	27	165	208
AIAN	<1	9	*	*	<1	8	<1	*	*	8
Asian	*	2	*	*	*	2	*	2	*	*
Black or African American	9	26	*	<1	9	26	7	4	3	22
NHPI	*	*	*	*	*	*	*	*	*	*
White	181	195	11	4	170	191	14	22	157	169
Two or More Races	5	13	*	5	5	8	*	*	5	8
Hispanic or Latino	88	8	3	1	85	8	3	7	83	<1
EDUCATION LEVEL
< High School	da	da	da	da	25	10	*	6	25	5
High School Graduate	da	da	da	da	87	64	13	12	75	52
Some College/Associate’s Degree	da	da	da	da	40	67	7	15	33	53
College Graduate	da	da	da	da	118	102	3	2	115	99
EMPLOYMENT STATUS
Full-Time	da	da	da	da	89	112	14	4	75	107
Part-Time	da	da	da	da	66	27	5	10	61	17
Unemployed	da	da	da	da	*	27	*	3	*	24
Other¹	da	da	da	da	115	78	4	18	111	60
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.58B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.1	0.1	0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1
SEX
Male	0.1	0.1	<0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1
Female	0.1	0.1	0.1	0.1	0.1	0.1	<0.1	0.1	0.1	0.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
AIAN	<0.1	0.7	*	*	<0.1	0.7	0.2	*	*	0.8
Asian	*	<0.1	*	*	*	<0.1	*	0.1	*	*
Black or African American	<0.1	0.1	*	<0.1	<0.1	0.1	0.1	0.1	<0.1	0.1
NHPI	*	*	*	*	*	*	*	*	*	*
White	0.1	0.1	0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1
Two or More Races	0.1	0.2	*	0.4	0.1	0.2	*	*	0.1	0.2
Hispanic or Latino	0.2	<0.1	<0.1	<0.1	0.2	<0.1	<0.1	0.1	0.2	<0.1
EDUCATION LEVEL
< High School	da	da	da	da	0.1	<0.1	*	0.2	0.1	<0.1
High School Graduate	da	da	da	da	0.1	0.1	0.1	0.1	0.1	0.1
Some College/Associate’s Degree	da	da	da	da	0.1	0.1	0.1	0.1	0.1	0.1
College Graduate	da	da	da	da	0.1	0.1	0.1	<0.1	0.1	0.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.1	0.1	0.1	<0.1	0.1	0.1
Part-Time	da	da	da	da	0.2	0.1	0.1	0.1	0.3	0.1
Unemployed	da	da	da	da	*	0.2	*	0.1	*	0.3
Other¹	da	da	da	da	0.1	0.1	<0.1	0.2	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.59A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	23,894	24,207	456	371	23,437	23,835	1,739	1,628	21,699	22,208
SEX
Male	8,472	8,944	181	185	8,291	8,758	697	625	7,594	8,134
Female	15,421	15,263	275^a	186	15,146	15,077	1,042	1,003	14,104	14,074
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	20,544	21,251	355	282	20,189	20,969	1,442	1,281	18,747	19,688
AIAN	168	98	2	5	166	92	*	*	155	79
Asian	626	504	23	19	603	485	32	29	571	456
Black or African American	1,507	1,675	54	34	1,452	1,640	144	117	1,309	1,523
NHPI	36	111	*	*	36	111	6	*	29	*
White	17,640	18,143	251	206	17,389	17,937	1,168	1,010	16,222	16,927
Two or More Races	567	721	24	18	543	703	81	109	462	595
Hispanic or Latino	3,349	2,955	101	89	3,248	2,866	297	347	2,951	2,520
EDUCATION LEVEL
< High School	da	da	da	da	1,762	1,568	201^a	115	1,561	1,453
High School Graduate	da	da	da	da	5,627	5,818	521	586	5,107	5,232
Some College/Associate’s Degree	da	da	da	da	7,622	8,000	667	682	6,955	7,318
College Graduate	da	da	da	da	8,426	8,450	350	245	8,076	8,206
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9,691	8,987	742	602	8,948	8,385
Part-Time	da	da	da	da	2,938	3,408	413	426	2,526	2,983
Unemployed	da	da	da	da	921	1,011	211	147	709	863
Other¹	da	da	da	da	9,888	10,429	373	453	9,515	9,977
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.59B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	8.4	8.4	1.8	1.4	9.1	9.1	5.1	4.7	9.7	9.8
SEX
Male	6.1	6.3	1.4	1.4	6.6	6.9	4.1	3.6	7.0	7.4
Female	10.6	10.4	2.2^a	1.5	11.5	11.2	6.1	5.8	12.2	12.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8.9	9.1	1.9	1.5	9.5	9.8	5.6	4.9	10.1	10.5
AIAN	12.5	7.2	0.9	2.6	15.0	8.0	*	*	16.1	7.9
Asian	3.6	2.7	1.6	1.3	3.8	2.8	1.4	1.2	4.1	3.1
Black or African American	4.3	4.8	1.5	1.0	4.7	5.2	3.2	2.5	4.9	5.6
NHPI	3.3	8.9	*	*	3.5	9.6	5.3	*	3.3	*
White	10.4	10.6	2.0	1.6	11.0	11.4	6.6	5.7	11.6	12.1
Two or More Races	9.2	11.1	2.6	1.7	10.3	12.9	7.4	9.5	11.1	13.8
Hispanic or Latino	6.4	5.4	1.5	1.3	7.1	6.0	3.6	4.0	7.9	6.5
EDUCATION LEVEL
< High School	da	da	da	da	7.2	6.5	5.6^a	3.3	7.5	7.1
High School Graduate	da	da	da	da	8.1	8.3	4.5	4.8	8.8	9.0
Some College/Associate’s Degree	da	da	da	da	9.9	10.3	5.1	5.1	10.9	11.3
College Graduate	da	da	da	da	9.7	9.4	6.1^a	4.1	10.0	9.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	8.0	7.4	5.4	4.3	8.4	7.8
Part-Time	da	da	da	da	9.3	10.5	4.9	4.8	10.9	12.6
Unemployed	da	da	da	da	8.0	7.8	6.3^a	4.0	8.8	9.4
Other¹	da	da	da	da	10.6	10.9	4.4	5.4	11.2	11.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.60A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	3,696	3,360	111	107	3,585	3,253	480	488	3,105	2,766
SEX
Male	1,859	1,668	39	38	1,820	1,630	238	183	1,583	1,447
Female	1,837	1,692	73	69	1,765	1,623	242	304	1,522	1,319
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,016	2,826	79	79	2,937	2,747	380	355	2,557	2,393
AIAN	8	35	<1	*	8	34	2	*	7	*
Asian	116	70	*	*	116	70	9	5	107	66
Black or African American	244	220	8	8	236	212	26	20	210	193
NHPI	4	9	*	*	4	9	*	*	4	9
White	2,550	2,348	63	65	2,487	2,283	308	295	2,179	1,987
Two or More Races	93	143	8	5	86	139	35	28	51	111
Hispanic or Latino	681	534	33	28	648	506	100	133	548	373
EDUCATION LEVEL
< High School	da	da	da	da	233	242	76	41	157	200
High School Graduate	da	da	da	da	1,010	925	140	195	870	730
Some College/Associate’s Degree	da	da	da	da	1,123	1,082	186	198	938	884
College Graduate	da	da	da	da	1,219	1,004	79	53	1,141	952
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,783^a	1,298	222	163	1,561^a	1,135
Part-Time	da	da	da	da	482	595	119	134	363	461
Unemployed	da	da	da	da	238	289	64	48	174	242
Other¹	da	da	da	da	1,081	1,072	74^a	143	1,007	929
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.60B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.3	1.2	0.4	0.4	1.4	1.2	1.4	1.4	1.4	1.2
SEX
Male	1.3	1.2	0.3	0.3	1.5	1.3	1.4	1.0	1.5	1.3
Female	1.3	1.1	0.6	0.5	1.3	1.2	1.4	1.8	1.3	1.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.3	1.2	0.4	0.4	1.4	1.3	1.5	1.4	1.4	1.3
AIAN	0.6	2.6	<0.1	*	0.8	3.0	1.2	*	0.7	*
Asian	0.7	0.4	*	*	0.7	0.4	0.4	0.2	0.8	0.4
Black or African American	0.7	0.6	0.2	0.2	0.8	0.7	0.6	0.4	0.8	0.7
NHPI	0.3	0.8	*	*	0.4	0.8	*	*	0.4	0.9
White	1.5	1.4	0.5	0.5	1.6	1.4	1.7	1.7	1.6	1.4
Two or More Races	1.5	2.2	0.8	0.5	1.6	2.5	3.2	2.4	1.2	2.6
Hispanic or Latino	1.3	1.0	0.5	0.4	1.4	1.1	1.2	1.5	1.5	1.0
EDUCATION LEVEL
< High School	da	da	da	da	1.0	1.0	2.1	1.2	0.7	1.0
High School Graduate	da	da	da	da	1.5	1.3	1.2	1.6	1.5	1.3
Some College/Associate’s Degree	da	da	da	da	1.5	1.4	1.4	1.5	1.5	1.4
College Graduate	da	da	da	da	1.4	1.1	1.4	0.9	1.4	1.1
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.5^b	1.1	1.6	1.2	1.5^a	1.1
Part-Time	da	da	da	da	1.5	1.8	1.4	1.5	1.6	2.0
Unemployed	da	da	da	da	2.1	2.2	1.9	1.3	2.1	2.6
Other¹	da	da	da	da	1.2	1.1	0.9^a	1.7	1.2	1.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.61A – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	60,980	63,203	2,690^a	2,998	58,290	60,204	4,889	4,741	53,401	55,464
SEX
Male	27,291^a	29,398	1,277^a	1,502	26,014^a	27,896	2,147	2,098	23,867^a	25,798
Female	33,689	33,805	1,413	1,496	32,276	32,309	2,742	2,643	29,534	29,666
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	51,836	52,994	1,968	2,105	49,868	50,889	3,719	3,600	46,149	47,289
AIAN	349	333	24	24	325	310	32	39	294	271
Asian	1,794	2,397	82	119	1,713	2,278	198	226	1,514	2,053
Black or African American	7,891	7,678	385	424	7,506	7,255	635	668	6,871	6,586
NHPI	*	207	*	*	*	194	*	*	*	175
White	39,865	40,908	1,358	1,386	38,507	39,522	2,646	2,457	35,861	37,065
Two or More Races	1,648	1,470	115	140	1,533	1,330	192	192	1,341	1,138
Hispanic or Latino	9,145^a	10,209	722	894	8,422	9,316	1,170	1,141	7,252	8,175
EDUCATION LEVEL
< High School	da	da	da	da	5,765	5,645	484	547	5,281	5,098
High School Graduate	da	da	da	da	16,035	16,730	1,680	1,841	14,355	14,889
Some College/Associate’s Degree	da	da	da	da	20,891	20,642	1,979	1,793	18,912	18,849
College Graduate	da	da	da	da	15,600^a	17,188	746^a	561	14,854^a	16,627
EMPLOYMENT STATUS
Full-Time	da	da	da	da	24,205	23,763	2,001	1,852	22,204	21,911
Part-Time	da	da	da	da	6,389	6,715	1,091	1,212	5,298	5,503
Unemployed	da	da	da	da	2,290	2,532	422	512	1,868	2,021
Other¹	da	da	da	da	25,406	27,194	1,375	1,166	24,031	26,029
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.61B – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	21.5	21.9	10.4^a	11.6	22.6	23.0	14.4	13.6	23.9	24.4
SEX
Male	19.7	20.8	9.6^a	11.3	20.8	21.8	12.6	11.9	22.0	23.4
Female	23.3	23.0	11.2	11.8	24.4	24.0	16.2	15.2	25.6	25.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	22.4	22.7	10.3	11.1	23.5	23.7	14.4	13.8	24.8	25.1
AIAN	26.1	24.4	10.3	11.3	29.5	26.8	22.4	24.9	30.5	27.1
Asian	10.3	12.9	5.6	7.8	10.7	13.3	9.0	9.4	11.0	13.9
Black or African American	22.7	21.8	10.7	11.9	24.1	22.9	13.9	14.5	25.8	24.3
NHPI	*	16.7	*	*	*	16.7	*	*	*	17.3
White	23.4	24.0	10.6	11.0	24.4	25.0	15.0	13.9	25.6	26.4
Two or More Races	26.6	22.7	12.4	13.4	29.1	24.4	17.6	16.7	32.1	26.5
Hispanic or Latino	17.5	18.7	10.6	12.9	18.5	19.5	14.2	13.0	19.5	21.0
EDUCATION LEVEL
< High School	da	da	da	da	23.5	23.5	13.5	15.5	25.3	24.9
High School Graduate	da	da	da	da	23.1	23.8	14.6	15.1	24.8	25.6
Some College/Associate’s Degree	da	da	da	da	27.1	26.5	15.0	13.5	29.6	29.2
College Graduate	da	da	da	da	18.0	19.1	13.0^a	9.4	18.4	19.8
EMPLOYMENT STATUS
Full-Time	da	da	da	da	20.0	19.6	14.5	13.2	20.7	20.4
Part-Time	da	da	da	da	20.3	20.7	13.1	13.8	22.8	23.3
Unemployed	da	da	da	da	20.0	19.6	12.6	13.9	23.1	21.9
Other¹	da	da	da	da	27.2	28.4	16.2	13.8	28.3	29.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.62A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	8,520	7,795	515	400	8,005	7,396	806	925	7,199	6,471
SEX
Male	4,470	4,080	222	161	4,248	3,919	415	395	3,834	3,524
Female	4,049	3,715	293	239	3,756	3,477	391^a	530	3,365	2,946
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,002	6,342	350	257	6,652	6,084	626	710	6,027	5,375
AIAN	79	51	5	8	74	43	*	*	66	36
Asian	266	258	18	13	249	244	21	28	228	217
Black or African American	1,269	1,048	85^b	32	1,184	1,016	136	141	1,049	875
NHPI	53	34	*	*	51	34	3	*	*	32
White	5,078	4,680	224	187	4,854	4,493	416	510	4,439	3,983
Two or More Races	256	272	16	18	240	254	43	22	197	232
Hispanic or Latino	1,518	1,454	165	142	1,353	1,311	180	215	1,173	1,096
EDUCATION LEVEL
< High School	da	da	da	da	929	942	127	113	802	829
High School Graduate	da	da	da	da	2,561	2,503	288	376	2,274	2,126
Some College/Associate’s Degree	da	da	da	da	2,793	2,486	303	345	2,490	2,142
College Graduate	da	da	da	da	1,722	1,465	88	91	1,633	1,374
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3,670^a	2,955	338	346	3,332^a	2,609
Part-Time	da	da	da	da	682	877	159	226	523	651
Unemployed	da	da	da	da	463	602	70^a	138	393	464
Other¹	da	da	da	da	3,190	2,962	238	215	2,951	2,747
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.62B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	3.0^a	2.7	2.0	1.5	3.1	2.8	2.4	2.6	3.2^a	2.8
SEX
Male	3.2	2.9	1.7	1.2	3.4	3.1	2.4	2.2	3.5	3.2
Female	2.8	2.5	2.3	1.9	2.8	2.6	2.3	3.0	2.9	2.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.0	2.7	1.8	1.4	3.1	2.8	2.4	2.7	3.2	2.9
AIAN	5.9	3.7	2.2	3.6	6.7	3.7	*	*	6.8	3.6
Asian	1.5	1.4	1.2	0.9	1.6	1.4	0.9	1.1	1.6	1.5
Black or African American	3.7	3.0	2.4^b	0.9	3.8	3.2	3.0	3.1	3.9	3.2
NHPI	4.8	2.7	*	*	5.0	2.9	2.1	*	*	3.1
White	3.0	2.7	1.7	1.5	3.1	2.8	2.4	2.9	3.2	2.8
Two or More Races	4.1	4.2	1.7	1.7	4.6	4.7	4.0	2.0	4.7	5.4
Hispanic or Latino	2.9	2.7	2.4	2.1	3.0	2.7	2.2	2.5	3.2	2.8
EDUCATION LEVEL
< High School	da	da	da	da	3.8	3.9	3.5	3.2	3.8	4.0
High School Graduate	da	da	da	da	3.7	3.6	2.5	3.1	3.9	3.7
Some College/Associate’s Degree	da	da	da	da	3.6	3.2	2.3	2.6	3.9	3.3
College Graduate	da	da	da	da	2.0	1.6	1.5	1.5	2.0	1.6
EMPLOYMENT STATUS
Full-Time	da	da	da	da	3.0^a	2.4	2.4	2.5	3.1^a	2.4
Part-Time	da	da	da	da	2.2	2.7	1.9	2.6	2.3	2.8
Unemployed	da	da	da	da	4.0	4.7	2.1^a	3.7	4.8	5.0
Other¹	da	da	da	da	3.4	3.1	2.8	2.5	3.5	3.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.63A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	2,298	2,117	132	107	2,166	2,010	173	221	1,993	1,788
SEX
Male	1,253	1,039	68	28	1,185	1,011	98	83	1,086	927
Female	1,046	1,078	64	79	982	999	75	138	907	861
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,795	1,666	65	59	1,730	1,607	129	138	1,601	1,468
AIAN	19	9	1	1	18	7	<1	*	18^b	3
Asian	68	21	1	10	67	12	3	2	64	10
Black or African American	317	239	20	7	297	233	27	34	270	199
NHPI	2	2	*	*	2	2	*	*	2	*
White	1,346	1,286	35	37	1,312	1,249	89	92	1,222	1,157
Two or More Races	43	108	8	4	34	105	10	4	25	101
Hispanic or Latino	503	451	67	48	436	403	44	83	392	320
EDUCATION LEVEL
< High School	da	da	da	da	275	313	27	36	248	277
High School Graduate	da	da	da	da	884	667	49^a	111	835	557
Some College/Associate’s Degree	da	da	da	da	653	722	90	46	563	676
College Graduate	da	da	da	da	354	307	6	28	347	279
EMPLOYMENT STATUS
Full-Time	da	da	da	da	999^b	620	79	46	920^a	574
Part-Time	da	da	da	da	146	258	20^a	73	126	185
Unemployed	da	da	da	da	141	205	16	43	125	162
Other¹	da	da	da	da	881	926	58	59	823	867
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.63B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.8	0.7	0.5	0.4	0.8	0.8	0.5	0.6	0.9	0.8
SEX
Male	0.9	0.7	0.5	0.2	0.9	0.8	0.6	0.5	1.0	0.8
Female	0.7	0.7	0.5	0.6	0.7	0.7	0.4	0.8	0.8	0.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	0.8	0.7	0.3	0.3	0.8	0.7	0.5	0.5	0.9	0.8
AIAN	1.4	0.6	0.4	0.6	1.7	0.6	0.2	*	1.9^b	0.3
Asian	0.4	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.5	0.1
Black or African American	0.9	0.7	0.6	0.2	1.0	0.7	0.6	0.7	1.0	0.7
NHPI	0.1	0.1	*	*	0.2	0.1	*	*	0.2	*
White	0.8	0.8	0.3	0.3	0.8	0.8	0.5	0.5	0.9	0.8
Two or More Races	0.7	1.7	0.9	0.3	0.7	1.9	0.9	0.4	0.6	2.3
Hispanic or Latino	1.0	0.8	1.0	0.7	1.0	0.8	0.5	0.9	1.1	0.8
EDUCATION LEVEL
< High School	da	da	da	da	1.1	1.3	0.8	1.0	1.2	1.4
High School Graduate	da	da	da	da	1.3	0.9	0.4^a	0.9	1.4	1.0
Some College/Associate’s Degree	da	da	da	da	0.8	0.9	0.7	0.3	0.9	1.0
College Graduate	da	da	da	da	0.4	0.3	0.1	0.5	0.4	0.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	0.8^b	0.5	0.6	0.3	0.9^a	0.5
Part-Time	da	da	da	da	0.5	0.8	0.2^a	0.8	0.5	0.8
Unemployed	da	da	da	da	1.2	1.6	0.5	1.2	1.5	1.8
Other¹	da	da	da	da	0.9	1.0	0.7	0.7	1.0	1.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.64A – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	24,686	24,907	1,835	1,890	22,850	23,017	4,298	4,191	18,552	18,827
SEX
Male	12,035	12,540	995	1,002	11,041	11,537	2,099	2,192	8,942	9,345
Female	12,650	12,367	841	887	11,810	11,480	2,200	1,998	9,610	9,482
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	21,237	21,225	1,509	1,576	19,728	19,649	3,538	3,359	16,190	16,290
AIAN	160	88	22	10	138	78	22	9	116	70
Asian	803	828	46	57	757	771	112	192	645	579
Black or African American	2,071	1,818	76^a	134	1,996	1,684	279	239	1,716	1,445
NHPI	*	*	*	*	*	*	*	*	*	*
White	17,492	17,601	1,296	1,304	16,197	16,297	2,970	2,772	13,227	13,525
Two or More Races	577^a	810	64	71	513^a	739	146	145	366^a	594
Hispanic or Latino	3,449	3,682	326	314	3,123	3,368	760	832	2,362	2,537
EDUCATION LEVEL
< High School	da	da	da	da	1,809	1,452	339	377	1,471^a	1,075
High School Graduate	da	da	da	da	5,177	5,759	1,204	1,294	3,973	4,464
Some College/Associate’s Degree	da	da	da	da	8,014	7,734	1,936	1,727	6,078	6,006
College Graduate	da	da	da	da	7,850	8,073	819	792	7,031	7,281
EMPLOYMENT STATUS
Full-Time	da	da	da	da	11,807	11,958	1,747	1,686	10,060	10,272
Part-Time	da	da	da	da	3,224	3,174	1,158	1,073	2,066	2,101
Unemployed	da	da	da	da	1,677	1,609	408	424	1,269	1,184
Other¹	da	da	da	da	6,142	6,277	985	1,007	5,157	5,270
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.64B – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	8.7	8.6	7.1	7.3	8.9	8.8	12.6	12.0	8.3	8.3
SEX
Male	8.7	8.9	7.5	7.6	8.8	9.0	12.3	12.5	8.3	8.5
Female	8.7	8.4	6.6	7.0	8.9	8.5	13.0	11.5	8.3	8.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	9.2	9.1	7.9	8.3	9.3	9.2	13.7	12.8	8.7	8.6
AIAN	12.0	6.5	9.5	4.7	12.5	6.8	15.3^a	5.6	12.1	7.0
Asian	4.6	4.4	3.1	3.8	4.7	4.5	5.1	8.0	4.7	3.9
Black or African American	6.0	5.2	2.1^a	3.7	6.4	5.3	6.1	5.2	6.5	5.3
NHPI	*	*	*	*	*	*	*	*	*	*
White	10.3	10.3	10.1	10.3	10.3	10.3	16.8	15.6	9.5	9.6
Two or More Races	9.3^a	12.5	6.9	6.8	9.7^a	13.6	13.4	12.6	8.8^a	13.8
Hispanic or Latino	6.6	6.7	4.8	4.5	6.9	7.1	9.2	9.5	6.4	6.5
EDUCATION LEVEL
< High School	da	da	da	da	7.4	6.0	9.5	10.7	7.0^a	5.2
High School Graduate	da	da	da	da	7.5	8.2	10.4	10.6	6.9	7.7
Some College/Associate’s Degree	da	da	da	da	10.4	9.9	14.7	13.0	9.5	9.3
College Graduate	da	da	da	da	9.1	9.0	14.2	13.2	8.7	8.7
EMPLOYMENT STATUS
Full-Time	da	da	da	da	9.8	9.9	12.6	12.0	9.4	9.6
Part-Time	da	da	da	da	10.2	9.8	13.9	12.2	8.9	8.9
Unemployed	da	da	da	da	14.7	12.5	12.2	11.6	15.7	12.8
Other¹	da	da	da	da	6.6	6.6	11.6	11.9	6.1	6.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.65A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	9,659	9,031	285	293	9,374	8,738	1,895	1,646	7,479	7,092
SEX
Male	5,795	5,633	136	133	5,659	5,500	977	852	4,682	4,648
Female	3,864	3,398	149	160	3,715	3,238	918	794	2,797	2,444
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,988	7,531	217	230	7,770	7,301	1,530	1,286	6,241	6,015
AIAN	86	38	4	2	82	36	8	6	74	30
Asian	239	340	12	24	226	316	63	67	163	249
Black or African American	782	757	13	27	769	729	97	69	673	660
NHPI	*	15	*	<1	*	15	*	*	*	13
White	6,544	6,029	173	162	6,371	5,866	1,308	1,096	5,063	4,771
Two or More Races	228	352	15	14	214	338	52	45	162^a	292
Hispanic or Latino	1,672	1,500	68	63	1,604	1,437	365	360	1,238	1,076
EDUCATION LEVEL
< High School	da	da	da	da	896	801	157	139	739	663
High School Graduate	da	da	da	da	2,467	2,658	480	509	1,988	2,149
Some College/Associate’s Degree	da	da	da	da	3,215	2,788	827^a	633	2,388	2,155
College Graduate	da	da	da	da	2,796	2,491	431	365	2,364	2,125
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4,899	4,388	889	756	4,010	3,633
Part-Time	da	da	da	da	1,289	1,135	469	335	820	799
Unemployed	da	da	da	da	824	851	181	198	644	653
Other¹	da	da	da	da	2,362	2,363	356	357	2,005	2,006
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.65B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	3.4	3.1	1.1	1.1	3.6	3.3	5.6^a	4.7	3.3	3.1
SEX
Male	4.2	4.0	1.0	1.0	4.5	4.3	5.7	4.9	4.3	4.2
Female	2.7^a	2.3	1.2	1.3	2.8^a	2.4	5.4	4.6	2.4	2.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3.5	3.2	1.1	1.2	3.7	3.4	5.9^a	4.9	3.3	3.2
AIAN	6.4	2.8	1.7	1.0	7.4	3.1	5.9	4.0	7.7	3.0
Asian	1.4	1.8	0.8	1.6	1.4	1.8	2.8	2.8	1.2	1.7
Black or African American	2.3	2.1	0.4	0.8	2.5	2.3	2.1	1.5	2.5	2.4
NHPI	*	1.2	*	0.2	*	1.3	*	*	*	1.3
White	3.8	3.5	1.4	1.3	4.0	3.7	7.4	6.2	3.6	3.4
Two or More Races	3.7	5.4	1.6	1.4	4.1	6.2	4.7	4.0	3.9^a	6.8
Hispanic or Latino	3.2	2.7	1.0	0.9	3.5	3.0	4.4	4.1	3.3	2.8
EDUCATION LEVEL
< High School	da	da	da	da	3.7	3.3	4.4	3.9	3.5	3.2
High School Graduate	da	da	da	da	3.6	3.8	4.2	4.2	3.4	3.7
Some College/Associate’s Degree	da	da	da	da	4.2	3.6	6.3^a	4.8	3.7	3.3
College Graduate	da	da	da	da	3.2	2.8	7.5	6.1	2.9	2.5
EMPLOYMENT STATUS
Full-Time	da	da	da	da	4.0	3.6	6.4	5.4	3.7	3.4
Part-Time	da	da	da	da	4.1	3.5	5.6^a	3.8	3.5	3.4
Unemployed	da	da	da	da	7.2	6.6	5.4	5.4	7.9	7.1
Other¹	da	da	da	da	2.5	2.5	4.2	4.2	2.4	2.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.66A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	4,175	3,934	72	80	4,103	3,854	546	466	3,557	3,388
SEX
Male	2,629	2,494	34	40	2,595	2,454	287	256	2,308	2,198
Female	1,546	1,439	38	40	1,509	1,400	260	210	1,249	1,189
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	3,401	3,318	58	66	3,343	3,252	466	346	2,877	2,906
AIAN	28	10	<1	*	28	9	*	<1	26	9
Asian	85	201	1	*	84	201	18	12	65^a	189
Black or African American	351	342	4	4	347	338	39	25	308	312
NHPI	*	2	*	<1	*	2	*	<1	*	2
White	2,755	2,528	48	55	2,707	2,473	395	293	2,312	2,180
Two or More Races	110^a	236	4	6	105^a	230	11	14	94^a	215
Hispanic or Latino	774	616	13	14	760	602	81	120	680	482
EDUCATION LEVEL
< High School	da	da	da	da	501	429	60	57	441	372
High School Graduate	da	da	da	da	1,139	1,345	109	168	1,030	1,177
Some College/Associate’s Degree	da	da	da	da	1,515	1,226	269	167	1,247	1,059
College Graduate	da	da	da	da	948	854	108	74	840	780
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1,870	1,726	232	209	1,638	1,518
Part-Time	da	da	da	da	543	402	169^a	79	374	323
Unemployed	da	da	da	da	388	401	42	38	347	362
Other¹	da	da	da	da	1,303	1,325	104	140	1,199	1,185
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.66B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.5	1.4	0.3	0.3	1.6	1.5	1.6	1.3	1.6	1.5
SEX
Male	1.9	1.8	0.3	0.3	2.1	1.9	1.7	1.5	2.1	2.0
Female	1.1	1.0	0.3	0.3	1.1	1.0	1.5	1.2	1.1	1.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.5	1.4	0.3	0.3	1.6	1.5	1.8^a	1.3	1.5	1.5
AIAN	2.1	0.7	<0.1	*	2.5	0.8	*	0.2	2.7	0.9
Asian	0.5	1.1	0.1	*	0.5	1.2	0.8	0.5	0.5	1.3
Black or African American	1.0	1.0	0.1	0.1	1.1	1.1	0.9	0.6	1.2	1.2
NHPI	*	0.1	*	0.2	*	0.1	*	<0.1	*	0.2
White	1.6	1.5	0.4	0.4	1.7	1.6	2.2	1.7	1.7	1.6
Two or More Races	1.8^a	3.6	0.5	0.6	2.0^a	4.2	1.0	1.3	2.3^a	5.0
Hispanic or Latino	1.5	1.1	0.2	0.2	1.7	1.3	1.0	1.4	1.8	1.2
EDUCATION LEVEL
< High School	da	da	da	da	2.0	1.8	1.7	1.6	2.1	1.8
High School Graduate	da	da	da	da	1.6	1.9	0.9	1.4	1.8	2.0
Some College/Associate’s Degree	da	da	da	da	2.0	1.6	2.0	1.3	2.0	1.6
College Graduate	da	da	da	da	1.1	0.9	1.9	1.2	1.0	0.9
EMPLOYMENT STATUS
Full-Time	da	da	da	da	1.5	1.4	1.7	1.5	1.5	1.4
Part-Time	da	da	da	da	1.7	1.2	2.0^a	0.9	1.6	1.4
Unemployed	da	da	da	da	3.4	3.1	1.2	1.0	4.3	3.9
Other¹	da	da	da	da	1.4	1.4	1.2	1.7	1.4	1.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.67A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	25,825	--	1,840	--	23,985	--	4,501	--	19,484
SEX
Male	--	14,805	--	886	--	13,919	--	2,328	--	11,592
Female	--	11,019	--	954	--	10,066	--	2,173	--	7,892
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	21,282	--	1,370	--	19,912	--	3,517	--	16,395
AIAN	--	153	--	14	--	139	--	18	--	121
Asian	--	924	--	85	--	839	--	193	--	646
Black or African American	--	2,608	--	293	--	2,314	--	406	--	1,909
NHPI	--	66	--	*	--	54	--	5	--	49
White	--	16,577	--	888	--	15,688	--	2,698	--	12,990
Two or More Races	--	955	--	77	--	878	--	197	--	681
Hispanic or Latino	--	4,543	--	470	--	4,073	--	984	--	3,089
EDUCATION LEVEL
< High School	da	da	da	da	--	1,990	--	405	--	1,586
High School Graduate	da	da	da	da	--	6,415	--	1,415	--	4,999
Some College/Associate’s Degree	da	da	da	da	--	7,769	--	1,808	--	5,961
College Graduate	da	da	da	da	--	7,811	--	873	--	6,938
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	11,858	--	1,936	--	9,922
Part-Time	da	da	da	da	--	3,455	--	1,114	--	2,341
Unemployed	da	da	da	da	--	2,089	--	536	--	1,553
Other¹	da	da	da	da	--	6,583	--	914	--	5,669
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.67B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	9.0	--	7.1	--	9.1	--	12.9	--	8.6
SEX
Male	--	10.5	--	6.7	--	10.9	--	13.3	--	10.5
Female	--	7.5	--	7.5	--	7.5	--	12.5	--	6.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	9.1	--	7.2	--	9.3	--	13.4	--	8.7
AIAN	--	11.2	--	6.9	--	12.0	--	11.6	--	12.1
Asian	--	5.0	--	5.6	--	4.9	--	8.0	--	4.4
Black or African American	--	7.4	--	8.2	--	7.3	--	8.8	--	7.0
NHPI	--	5.4	--	*	--	4.7	--	3.5	--	4.8
White	--	9.7	--	7.0	--	9.9	--	15.2	--	9.3
Two or More Races	--	14.7	--	7.4	--	16.1	--	17.2	--	15.8
Hispanic or Latino	--	8.3	--	6.8	--	8.5	--	11.2	--	7.9
EDUCATION LEVEL
< High School	da	da	da	da	--	8.3	--	11.4	--	7.7
High School Graduate	da	da	da	da	--	9.1	--	11.6	--	8.6
Some College/Associate’s Degree	da	da	da	da	--	10.0	--	13.6	--	9.2
College Graduate	da	da	da	da	--	8.7	--	14.6	--	8.3
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	9.8	--	13.8	--	9.3
Part-Time	da	da	da	da	--	10.7	--	12.7	--	9.9
Unemployed	da	da	da	da	--	16.2	--	14.6	--	16.8
Other¹	da	da	da	da	--	6.9	--	10.8	--	6.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.68A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	9,444	--	583	--	8,861	--	1,255	--	7,606
SEX
Male	--	5,635	--	265	--	5,371	--	606	--	4,764
Female	--	3,809	--	319	--	3,490	--	649	--	2,842
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	7,916	--	435	--	7,481	--	946	--	6,535
AIAN	--	37	--	8	--	29	--	*	--	23
Asian	--	347	--	22	--	326	--	29	--	296
Black or African American	--	1,005	--	91	--	914	--	144	--	770
NHPI	--	12	--	<1	--	12	--	4	--	9
White	--	6,091	--	283	--	5,808	--	727	--	5,081
Two or More Races	--	424	--	32	--	393	--	37	--	356
Hispanic or Latino	--	1,528	--	148	--	1,380	--	308	--	1,072
EDUCATION LEVEL
< High School	da	da	da	da	--	815	--	129	--	686
High School Graduate	da	da	da	da	--	2,503	--	443	--	2,061
Some College/Associate’s Degree	da	da	da	da	--	2,831	--	469	--	2,362
College Graduate	da	da	da	da	--	2,712	--	214	--	2,498
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	4,166	--	498	--	3,669
Part-Time	da	da	da	da	--	1,259	--	333	--	926
Unemployed	da	da	da	da	--	756	--	130	--	626
Other¹	da	da	da	da	--	2,679	--	293	--	2,386
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.68B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	3.3	--	2.2	--	3.4	--	3.6	--	3.3
SEX
Male	--	4.0	--	2.0	--	4.2	--	3.5	--	4.3
Female	--	2.6	--	2.5	--	2.6	--	3.7	--	2.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	--	3.4	--	2.3	--	3.5	--	3.6	--	3.5
AIAN	--	2.7	--	3.8	--	2.5	--	*	--	2.3
Asian	--	1.9	--	1.4	--	1.9	--	1.2	--	2.0
Black or African American	--	2.9	--	2.6	--	2.9	--	3.1	--	2.8
NHPI	--	1.0	--	0.2	--	1.0	--	2.4	--	0.9
White	--	3.6	--	2.2	--	3.7	--	4.1	--	3.6
Two or More Races	--	6.5	--	3.0	--	7.2	--	3.2	--	8.3
Hispanic or Latino	--	2.8	--	2.1	--	2.9	--	3.5	--	2.8
EDUCATION LEVEL
< High School	da	da	da	da	--	3.4	--	3.6	--	3.3
High School Graduate	da	da	da	da	--	3.6	--	3.6	--	3.5
Some College/Associate’s Degree	da	da	da	da	--	3.6	--	3.5	--	3.7
College Graduate	da	da	da	da	--	3.0	--	3.6	--	3.0
EMPLOYMENT STATUS
Full-Time	da	da	da	da	--	3.4	--	3.5	--	3.4
Part-Time	da	da	da	da	--	3.9	--	3.8	--	3.9
Unemployed	da	da	da	da	--	5.9	--	3.5	--	6.8
Other¹	da	da	da	da	--	2.8	--	3.5	--	2.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Other employment includes students, people keeping house or caring for children full time, retired or disabled people, or other people not in the labor force. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.69A – Any Use and Misuse of Fentanyl in Past Year and Use of Illegally Made Fentanyl (IMF) in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Numbers in Thousands, 2023 and 2024
Demographic Characteristic	Any Fentanyl Use¹ (2023)	Any Fentanyl Use¹ (2024)	Fentanyl Misuse² (2023)	Fentanyl Misuse² (2024)	IMF Use (2023)	IMF Use (2024)
TOTAL	2,894	3,486	828	816	627	668
AGE GROUP
12-17	150	137	50	41	36	38
18 or Older	2,743^a	3,348	779	774	591	630
18-25	325	300	110	119	78	99
26 or Older	2,418^a	3,049	668	656	513	531
SEX
Male	1,346	1,609	405	519	339	418
Female	1,548	1,876	424	297	287	250
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	2,419	2,891	725	667	534	557
AIAN	23	20	11	9	7	4
Asian	37	46	14	9	14	8
Black or African American	295	370	106	81	63	73
NHPI	6	16	*	10	*	5
White	1,949	2,271	562	479	429	393
Two or More Races	109	168	29	78	17	73
Hispanic or Latino	475	595	103	149	93	111
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.69B – Any Use and Misuse of Fentanyl in Past Year and Use of Illegally Made Fentanyl (IMF) in Past Year: Among People Aged 12 or Older; by Demographic Characteristics, Percentages, 2023 and 2024
Demographic Characteristic	Any Fentanyl Use¹ (2023)	Any Fentanyl Use¹ (2024)	Fentanyl Misuse² (2023)	Fentanyl Misuse² (2024)	IMF Use (2023)	IMF Use (2024)
TOTAL	1.0	1.2	0.3	0.3	0.2	0.2
AGE GROUP
12-17	0.6	0.5	0.2	0.2	0.1	0.1
18 or Older	1.1	1.3	0.3	0.3	0.2	0.2
18-25	1.0	0.9	0.3	0.3	0.2	0.3
26 or Older	1.1^a	1.3	0.3	0.3	0.2	0.2
SEX
Male	1.0	1.1	0.3	0.4	0.2	0.3
Female	1.1	1.3	0.3	0.2	0.2	0.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1.0	1.2	0.3	0.3	0.2	0.2
AIAN	1.7	1.5	0.8	0.7	0.5	0.3
Asian	0.2	0.2	0.1	<0.1	0.1	<0.1
Black or African American	0.8	1.0	0.3	0.2	0.2	0.2
NHPI	0.5	1.3	*	0.8	*	0.4
White	1.1	1.3	0.3	0.3	0.3	0.2
Two or More Races	1.8	2.6	0.5	1.2	0.3	1.1
Hispanic or Latino	0.9	1.1	0.2	0.3	0.2	0.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.70A – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	70,537^a	73,637	3,816	3,916	66,721^a	69,720	13,256	13,299	53,465^a	56,421
GEOGRAPHIC REGION
Northeast	12,933	13,119	594	622	12,339	12,497	2,553	2,417	9,786	10,080
Midwest	15,083^a	16,457	769	757	14,314^a	15,700	2,938	2,952	11,377^a	12,748
South	24,497	24,808	1,540	1,570	22,957	23,238	4,458	4,545	18,499	18,693
West	18,024	19,253	913	968	17,111	18,285	3,308	3,385	13,803	14,900
COUNTY TYPE
Large Metro	39,750	41,737	2,084	2,183	37,666	39,554	7,061	7,326	30,604	32,228
Small Metro	22,376	23,528	1,253	1,323	21,123	22,206	4,645	4,469	16,479	17,736
Nonmetro	8,412	8,372	480	411	7,932	7,961	1,550	1,504	6,382	6,457
Urbanized	3,622	3,617	168	161	3,454	3,456	792	845	2,662	2,612
Less Urbanized	4,247	4,339	262	218	3,985	4,121	679	605	3,306	3,515
Completely Rural	543	416	*	32	493	384	79	54	414	330
POVERTY LEVEL¹
Less Than 100%	12,549	13,325	762	818	11,788	12,507	3,102	2,991	8,686	9,516
100-199%	13,525	13,964	912	912	12,612	13,052	3,258	3,143	9,354	9,909
200% or More	44,451	46,328	2,143	2,186	42,309	44,141	6,884	7,145	35,425	36,996
HEALTH INSURANCE²
Private	40,294^a	42,764	1,958	2,096	38,336	40,668	7,582	7,741	30,754	32,927
Medicaid/CHIP	18,368	18,373	1,765	1,712	16,603	16,661	3,783^b	3,207	12,821	13,454
Other³	12,869	13,580	204	174	12,665	13,406	1,001	972	11,665	12,433
No Coverage	7,538	7,616	113^a	183	7,425	7,433	1,582^a	1,909	5,844	5,524
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.70B – Illicit Drug Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	24.9	25.5	14.7	15.1	25.9	26.6	39.0	38.1	23.9	24.8
GEOGRAPHIC REGION
Northeast	26.4	26.4	14.6	15.3	27.5	27.4	44.4	40.9	25.0	25.4
Midwest	25.9^a	27.9	14.2	14.0	27.1^a	29.3	41.2	40.5	24.9^a	27.6
South	22.4	22.2	15.0	15.2	23.2	23.0	34.0	33.6	21.5	21.3
West	26.9	28.3	14.8	15.8	28.1	29.5	41.2	41.1	26.1	27.7
COUNTY TYPE
Large Metro	25.3	25.8	14.6	14.9	26.4	26.9	38.5	39.3	24.6	25.1
Small Metro	25.1	25.5	15.1	15.8	26.2	26.5	40.6^a	37.4	23.8	24.7
Nonmetro	22.4	24.3	14.2	14.2	23.2	25.2	36.4	34.5	21.3^a	23.7
Urbanized	23.9	25.4	13.8	14.2	24.8	26.3	42.1	38.8	22.1	23.9
Less Urbanized	22.0	24.9	14.1	14.3	22.8	25.9	32.6	31.9	21.5^a	25.0
Completely Rural	17.5	14.9	*	13.6	17.6	15.0	26.9	19.4	16.5	14.4
POVERTY LEVEL¹
Less Than 100%	27.8	28.7	13.3	14.8	29.9	30.6	36.9	35.8	28.0	29.2
100-199%	24.9	25.1	17.0	17.1	25.7	25.9	41.4^a	37.0	22.8	23.7
200% or More	24.2	24.9	14.4	14.5	25.0	25.8	38.8	39.8	23.4	24.2
HEALTH INSURANCE²
Private	23.6	24.3	14.0	14.3	24.4	25.3	39.8	39.3	22.3	23.3
Medicaid/CHIP	30.2	31.1	16.1	16.4	33.3	34.3	39.7^a	35.7	31.8	34.0
Other³	16.4	17.2	14.6	12.6	16.4	17.2	35.5	34.8	15.7	16.6
No Coverage	31.7	30.2	9.0^a	15.1	33.0	31.0	35.3	37.9	32.4	29.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.71A – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	47,657	48,224	1,864	1,950	45,794	46,273	8,901	8,884	36,892	37,390
GEOGRAPHIC REGION
Northeast	8,934	9,027	273	332	8,661	8,694	1,732	1,703	6,930	6,991
Midwest	10,506	10,872	388	374	10,117	10,499	1,948	2,019	8,169	8,480
South	15,840	15,843	677	784	15,163	15,059	2,965	2,940	12,198	12,119
West	12,377	12,482	525	460	11,852	12,021	2,256	2,222	9,596	9,799
COUNTY TYPE
Large Metro	26,642	27,459	1,009	1,037	25,632	26,422	4,781	4,953	20,851	21,469
Small Metro	15,035	15,093	633	695	14,402	14,397	3,061	2,919	11,340	11,478
Nonmetro	5,981	5,672	221	218	5,760	5,454	1,059	1,012	4,701	4,442
Urbanized	2,618	2,450	81	90	2,537	2,360	526	562	2,011	1,798
Less Urbanized	3,033	2,969	131	118	2,902	2,851	480	416	2,422	2,435
Completely Rural	330	253	10	10	320	244	53	34	268	209
POVERTY LEVEL¹
Less Than 100%	8,881	9,333	401	412	8,480	8,921	2,071	2,068	6,409	6,853
100-199%	9,701	9,454	411	465	9,290	8,988	2,303	2,007	6,988	6,981
200% or More	29,068	29,427	1,052	1,073	28,016	28,354	4,520	4,799	23,495	23,555
HEALTH INSURANCE²
Private	26,089	26,666	953	1,004	25,135	25,662	4,970	4,993	20,165	20,669
Medicaid/CHIP	13,327	13,093	885	865	12,441	12,228	2,670^a	2,233	9,772	9,996
Other³	8,689	8,718	88	101	8,601	8,617	665	638	7,936	7,979
No Coverage	5,567	5,429	57	108	5,509	5,321	1,082^a	1,331	4,427	3,990
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.71B – Illicit Drug Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	16.8	16.7	7.2	7.5	17.8	17.6	26.2	25.4	16.5	16.4
GEOGRAPHIC REGION
Northeast	18.2	18.1	6.7	8.1	19.3	19.0	30.1	28.8	17.7	17.6
Midwest	18.0	18.5	7.1	6.9	19.2	19.6	27.3	27.7	17.9	18.3
South	14.5	14.2	6.6	7.6	15.3	14.9	22.6	21.8	14.2	13.8
West	18.5	18.3	8.5	7.5	19.5	19.4	28.1	27.0	18.2	18.2
COUNTY TYPE
Large Metro	17.0	17.0	7.1	7.1	18.0	18.0	26.1	26.6	16.8	16.7
Small Metro	16.9	16.4	7.7	8.3	17.8	17.2	26.8	24.4	16.4	16.0
Nonmetro	15.9	16.4	6.5	7.5	16.8	17.2	24.9	23.2	15.7	16.3
Urbanized	17.3	17.2	6.6	7.9	18.2	18.0	27.9	25.8	16.7	16.4
Less Urbanized	15.7	17.0	7.0	7.8	16.6	17.9	23.0	21.9	15.7	17.3
Completely Rural	10.6	9.1	3.1	4.1	11.4	9.5	18.0	12.3	10.7	9.2
POVERTY LEVEL¹
Less Than 100%	19.7	20.1	7.0	7.5	21.5	21.8	24.6	24.7	20.6	21.0
100-199%	17.9	17.0	7.7	8.7	19.0	17.9	29.2^b	23.6	17.0	16.7
200% or More	15.8	15.8	7.1	7.1	16.6	16.6	25.5	26.8	15.5	15.4
HEALTH INSURANCE²
Private	15.2	15.2	6.8	6.9	16.0	15.9	26.1	25.3	14.6	14.6
Medicaid/CHIP	21.9	22.2	8.1	8.3	25.0	25.2	28.0^a	24.9	24.3	25.3
Other³	11.1	11.0	6.3	7.3	11.1	11.1	23.6	22.8	10.7	10.6
No Coverage	23.4	21.5	4.6^a	8.9	24.5	22.2	24.1	26.4	24.5^a	21.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.72A – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	61,816	64,194	2,894	2,694	58,922^a	61,500	12,435	12,226	46,487^a	49,274
GEOGRAPHIC REGION
Northeast	11,615	11,785	463	463	11,152	11,322	2,409	2,279	8,743	9,044
Midwest	13,574^a	14,775	604	538	12,970^a	14,236	2,810	2,776	10,159^a	11,460
South	20,586	20,846	1,073	1,067	19,513	19,779	4,128	4,041	15,385	15,738
West	16,041	16,787	754	626	15,287	16,162	3,087	3,130	12,200	13,032
COUNTY TYPE
Large Metro	34,699	36,324	1,582	1,413	33,117	34,911	6,611	6,750	26,506	28,162
Small Metro	19,769	20,605	954	978	18,815	19,627	4,377	4,077	14,437	15,550
Nonmetro	7,349	7,265	358	303	6,991	6,962	1,447	1,399	5,544	5,563
Urbanized	3,250	3,138	128	106	3,122	3,032	761	791	2,361	2,241
Less Urbanized	3,641	3,782	195	172	3,447	3,611	615	556	2,831	3,054
Completely Rural	457	344	35	26	422	319	70	52	352	267
POVERTY LEVEL¹
Less Than 100%	10,939	11,197	558	566	10,380	10,631	2,881	2,755	7,499	7,876
100-199%	11,843	12,055	710	665	11,133	11,390	3,042	2,872	8,090	8,518
200% or More	39,024	40,923	1,625	1,463	37,398	39,461	6,500	6,581	30,898	32,880
HEALTH INSURANCE²
Private	35,571	37,528	1,508	1,396	34,063	36,132	7,148	7,133	26,915^a	28,999
Medicaid/CHIP	16,165	15,792	1,355	1,230	14,810	14,562	3,510^b	2,928	11,300	11,634
Other³	10,638	11,449	133	125	10,505	11,324	928	881	9,577	10,443
No Coverage	6,699	6,698	74	128	6,625	6,571	1,458^a	1,751	5,167	4,820
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.72B – Marijuana Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	21.8	22.3	11.2	10.4	22.9	23.4	36.5	35.0	20.8	21.7
GEOGRAPHIC REGION
Northeast	23.7	23.7	11.4	11.3	24.8	24.8	41.9	38.6	22.3	22.8
Midwest	23.3	25.1	11.1	10.0	24.6^a	26.6	39.4	38.1	22.2^a	24.8
South	18.8	18.7	10.5	10.3	19.7	19.5	31.5	29.9	17.9	18.0
West	23.9	24.7	12.3	10.2	25.1	26.1	38.4	38.0	23.1	24.3
COUNTY TYPE
Large Metro	22.1	22.5	11.1	9.6	23.2	23.8	36.0	36.2	21.3	22.0
Small Metro	22.2	22.4	11.5	11.7	23.3	23.4	38.3^b	34.1	20.8	21.6
Nonmetro	19.5	21.0	10.6	10.5	20.4	22.0	34.0	32.1	18.5	20.4
Urbanized	21.4	22.0	10.5	9.3	22.4	23.1	40.4	36.3	19.6	20.5
Less Urbanized	18.8^a	21.7	10.5	11.3	19.7	22.7	29.5	29.3	18.4^a	21.8
Completely Rural	14.7	12.3	11.5	10.8	15.1	12.4	23.9	18.5	14.0	11.7
POVERTY LEVEL¹
Less Than 100%	24.2	24.1	9.8	10.3	26.3	26.0	34.3	32.9	24.2	24.2
100-199%	21.8	21.7	13.3	12.5	22.7	22.6	38.6^a	33.8	19.7	20.4
200% or More	21.2	22.0	10.9	9.7	22.1	23.1	36.7	36.7	20.4	21.5
HEALTH INSURANCE²
Private	20.8	21.4	10.8	9.5	21.7	22.4	37.5	36.2	19.5	20.5
Medicaid/CHIP	26.6	26.8	12.4	11.8	29.7	30.0	36.8^a	32.6	28.0	29.4
Other³	13.5	14.5	9.6	9.1	13.6	14.6	32.9	31.5	12.9	13.9
No Coverage	28.2	26.6	6.0^a	10.6	29.4	27.4	32.5	34.7	28.6	25.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.73A – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	43,647	44,266	1,563	1,554	42,083	42,712	8,562	8,439	33,521	34,273
GEOGRAPHIC REGION
Northeast	8,237	8,366	242	255	7,995	8,112	1,664	1,645	6,331	6,466
Midwest	9,857	10,082	331	306	9,527	9,775	1,877	1,944	7,650	7,831
South	14,170	14,301	524	618	13,646	13,683	2,841	2,720	10,805	10,963
West	11,382	11,517	467	375	10,915	11,142	2,180	2,130	8,735	9,013
COUNTY TYPE
Large Metro	24,322	25,155	867	778	23,456	24,376	4,614	4,711	18,842	19,665
Small Metro	13,861	13,919	503	605	13,358	13,314	2,918	2,773	10,440	10,541
Nonmetro	5,464	5,193	194	171	5,270	5,021	1,031	955	4,239	4,067
Urbanized	2,404	2,243	71	61	2,334	2,182	517	540	1,817	1,641
Less Urbanized	2,733	2,717	115	101	2,618	2,615	461	381	2,157	2,234
Completely Rural	326	233	8	*	318	224	53	33	265	191
POVERTY LEVEL¹
Less Than 100%	7,988	8,522	320	326	7,668	8,196	1,956	1,988	5,712	6,208
100-199%	8,877	8,695	349	372	8,528	8,323	2,241^a	1,879	6,287	6,445
200% or More	26,774	27,038	895	856	25,879	26,182	4,357	4,562	21,522	21,619
HEALTH INSURANCE²
Private	24,046	24,597	815	803	23,232	23,794	4,767	4,705	18,464	19,089
Medicaid/CHIP	12,074	11,864	729	690	11,344	11,174	2,570^b	2,101	8,774	9,073
Other³	7,775	7,985	78	79	7,696	7,906	648	617	7,048	7,289
No Coverage	5,147	5,012	39^a	86	5,109	4,926	1,041^a	1,303	4,068	3,623
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.73B – Marijuana Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	15.4	15.4	6.0	6.0	16.3	16.3	25.2	24.1	15.0	15.1
GEOGRAPHIC REGION
Northeast	16.8	16.8	5.9	6.2	17.8	17.8	29.0	27.8	16.2	16.3
Midwest	16.9	17.1	6.1	5.7	18.0	18.3	26.3	26.7	16.7	16.9
South	13.0	12.8	5.1	6.0	13.8	13.5	21.7	20.1	12.6	12.5
West	17.0	16.9	7.6	6.1	17.9	18.0	27.1	25.8	16.5	16.8
COUNTY TYPE
Large Metro	15.5	15.6	6.1	5.3	16.4	16.6	25.2	25.3	15.2	15.3
Small Metro	15.6	15.1	6.1	7.2	16.6	15.9	25.5	23.2	15.1	14.7
Nonmetro	14.5	15.0	5.7	5.9	15.4	15.9	24.2	21.9	14.1	14.9
Urbanized	15.8	15.7	5.8	5.4	16.7	16.6	27.4	24.8	15.1	15.0
Less Urbanized	14.1	15.6	6.2	6.7	15.0	16.4	22.1	20.1	14.0	15.9
Completely Rural	10.5	8.3	2.7	*	11.3	8.7	18.0	11.9	10.6	8.4
POVERTY LEVEL¹
Less Than 100%	17.7	18.3	5.6	5.9	19.4	20.0	23.3	23.8	18.4	19.1
100-199%	16.3	15.6	6.5	7.0	17.4	16.5	28.5^b	22.1	15.3	15.4
200% or More	14.6	14.5	6.0	5.7	15.3	15.3	24.6	25.4	14.2	14.1
HEALTH INSURANCE²
Private	14.1	14.0	5.8	5.5	14.8	14.8	25.0	23.9	13.4	13.5
Medicaid/CHIP	19.9	20.1	6.7	6.6	22.8	23.0	27.0^a	23.4	21.8	22.9
Other³	9.9	10.1	5.6	5.7	10.0	10.2	23.0	22.1	9.5	9.7
No Coverage	21.6	19.9	3.1^a	7.1	22.7	20.5	23.2	25.9	22.5^a	19.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.74A – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	5,012^a	4,257	63	72	4,949^a	4,185	1,043^a	811	3,907	3,374
GEOGRAPHIC REGION
Northeast	924	908	4	2	921	906	197	142	723	763
Midwest	919	789	19	13	901	776	201	149	699	627
South	1,637	1,356	24	33	1,614	1,323	320	291	1,294	1,032
West	1,531	1,203	17	23	1,514	1,180	324	229	1,190	952
COUNTY TYPE
Large Metro	2,989	2,707	33	25	2,956	2,682	563	505	2,392	2,177
Small Metro	1,503^a	1,129	27	38	1,476^a	1,091	364^b	216	1,112	875
Nonmetro	521	421	3	9	518	412	115	90	402	322
Urbanized	231	220	<1	<1	231	220	51	58	180	162
Less Urbanized	280	195	3	8	278	187	62	32	216	155
Completely Rural	9	5	*	*	9	5	2	1	7	5
POVERTY LEVEL¹
Less Than 100%	1,064	992	7	20	1,058	972	209	140	849	832
100-199%	836	850	15	20	821	830	266	181	555	648
200% or More	3,112^b	2,415	42	32	3,070^b	2,383	568	489	2,502^a	1,894
HEALTH INSURANCE²
Private	2,515^a	2,051	36	23	2,479	2,028	646	505	1,833	1,523
Medicaid/CHIP	1,540	1,333	26	38	1,514	1,295	207	176	1,307	1,119
Other³	706^a	386	*	5	706^a	381	93	45	613^a	335
No Coverage	733	711	3	11	730	701	127	97	602	604
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.74B – Cocaine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.8^a	1.5	0.2	0.3	1.9^a	1.6	3.1^a	2.3	1.7	1.5
GEOGRAPHIC REGION
Northeast	1.9	1.8	0.1	0.1	2.0	2.0	3.4	2.4	1.8	1.9
Midwest	1.6	1.3	0.3	0.2	1.7	1.5	2.8	2.0	1.5	1.4
South	1.5	1.2	0.2	0.3	1.6	1.3	2.4	2.2	1.5	1.2
West	2.3	1.8	0.3	0.4	2.5	1.9	4.0	2.8	2.3	1.8
COUNTY TYPE
Large Metro	1.9	1.7	0.2	0.2	2.1	1.8	3.1	2.7	1.9	1.7
Small Metro	1.7^a	1.2	0.3	0.5	1.8^a	1.3	3.2^b	1.8	1.6	1.2
Nonmetro	1.4	1.2	0.1	0.3	1.5	1.3	2.7	2.1	1.3	1.2
Urbanized	1.5	1.5	<0.1	<0.1	1.7	1.7	2.7	2.7	1.5	1.5
Less Urbanized	1.4	1.1	0.2	0.6	1.6	1.2	3.0	1.7	1.4	1.1
Completely Rural	0.3	0.2	*	*	0.3	0.2	0.8	0.2	0.3	0.2
POVERTY LEVEL¹
Less Than 100%	2.4	2.1	0.1	0.4	2.7	2.4	2.5	1.7	2.7	2.6
100-199%	1.5	1.5	0.3	0.4	1.7	1.6	3.4	2.1	1.4	1.5
200% or More	1.7^b	1.3	0.3	0.2	1.8^b	1.4	3.2	2.7	1.7^a	1.2
HEALTH INSURANCE²
Private	1.5^a	1.2	0.3	0.2	1.6^a	1.3	3.4^a	2.6	1.3	1.1
Medicaid/CHIP	2.5	2.3	0.2	0.4	3.0	2.7	2.2	2.0	3.2	2.8
Other³	0.9^a	0.5	*	0.4	0.9^a	0.5	3.3	1.6	0.8^a	0.4
No Coverage	3.1	2.8	0.2	0.9	3.2	2.9	2.8	1.9	3.3	3.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.75A – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,814	1,671	22	13	1,792	1,658	219	221	1,572	1,437
GEOGRAPHIC REGION
Northeast	365	406	*	2	365	404	51	34	314	370
Midwest	342	294	5	<1	337	293	32	39	304	255
South	531	566	17	3	514	563	70	90	444	473
West	576	404	*	7	576	397	66	59	510	339
COUNTY TYPE
Large Metro	1,109	1,108	12	1	1,097	1,107	128	148	969	959
Small Metro	489	420	11	11	479	409	73	64	405	345
Nonmetro	216	143	*	1	216	142	18	10	198	132
Urbanized	121	96	*	<1	121	95	10	9	111	87
Less Urbanized	93	44	*	<1	93	44	8	1	85	42
Completely Rural	2	3	*	*	2	3	*	*	2	3
POVERTY LEVEL¹
Less Than 100%	459	502	1	3	458	499	37	41	421	458
100-199%	250	378	10	2	240	376	59	43	181	333
200% or More	1,105^a	790	11	7	1,094^a	783	123	137	970^a	645
HEALTH INSURANCE²
Private	923^a	587	15	6	908^a	581	149	111	759^a	470
Medicaid/CHIP	618	750	8	7	611	743	37	80	573	663
Other³	413^a	171	*	*	413^a	171	19	12	394^a	160
No Coverage	199	253	*	*	199	253	28	26	172	227
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.75B – Cocaine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.6	0.6	0.1	<0.1	0.7	0.6	0.6	0.6	0.7	0.6
GEOGRAPHIC REGION
Northeast	0.7	0.8	*	0.1	0.8	0.9	0.9	0.6	0.8	0.9
Midwest	0.6	0.5	0.1	<0.1	0.6	0.5	0.5	0.5	0.7	0.6
South	0.5	0.5	0.2	<0.1	0.5	0.6	0.5	0.7	0.5	0.5
West	0.9	0.6	*	0.1	0.9	0.6	0.8	0.7	1.0	0.6
COUNTY TYPE
Large Metro	0.7	0.7	0.1	<0.1	0.8	0.8	0.7	0.8	0.8	0.7
Small Metro	0.6	0.5	0.1	0.1	0.6	0.5	0.6	0.5	0.6	0.5
Nonmetro	0.6	0.4	*	<0.1	0.6	0.4	0.4	0.2	0.7	0.5
Urbanized	0.8	0.7	*	<0.1	0.9	0.7	0.5	0.4	0.9	0.8
Less Urbanized	0.5	0.3	*	<0.1	0.5	0.3	0.4	0.1	0.6	0.3
Completely Rural	0.1	0.1	*	*	0.1	0.1	*	*	0.1	0.1
POVERTY LEVEL¹
Less Than 100%	1.0	1.1	<0.1	0.1	1.2	1.2	0.4	0.5	1.4	1.4
100-199%	0.5	0.7	0.2	<0.1	0.5	0.7	0.7	0.5	0.4	0.8
200% or More	0.6^a	0.4	0.1	<0.1	0.6^a	0.5	0.7	0.8	0.6^a	0.4
HEALTH INSURANCE²
Private	0.5^a	0.3	0.1	<0.1	0.6^a	0.4	0.8	0.6	0.5^a	0.3
Medicaid/CHIP	1.0	1.3	0.1	0.1	1.2	1.5	0.4	0.9	1.4	1.7
Other³	0.5^a	0.2	*	*	0.5^a	0.2	0.7	0.4	0.5^a	0.2
No Coverage	0.8	1.0	*	*	0.9	1.1	0.6	0.5	1.0	1.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.76A – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	9,871	10,634	997	749	507	392
GEOGRAPHIC REGION
Northeast	1,719	1,988	248	241	162	119
Midwest	1,910	2,187	221	125	113	68
South	3,677	3,936	362	311	145	170
West	2,566	2,523	167	73	87	35
COUNTY TYPE
Large Metro	4,823	5,500	557	384	332	166
Small Metro	3,510	3,628	327	258	107	173
Nonmetro	1,538	1,505	113	107	68	53
Urbanized	750	610	41	51	23	33
Less Urbanized	707	777	68	53	45	18
Completely Rural	81	118	3	3	*	3
POVERTY LEVEL¹
Less Than 100%	2,815	3,009	457	396	234	220
100-199%	2,095	2,434	176	204	60	128
200% or More	4,961	5,191	364^a	149	213^a	44
HEALTH INSURANCE²
Private	3,873	4,484	237	83	170	43
Medicaid/CHIP	3,719	4,074	479	525	206	294
Other³	2,663	2,729	298^a	115	179	67
No Coverage	1,333	1,129	128	104	36	13
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.76B – Crack Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	3.5	3.7	0.4	0.3	0.2	0.1
GEOGRAPHIC REGION
Northeast	3.5	4.0	0.5	0.5	0.3	0.2
Midwest	3.3	3.7	0.4	0.2	0.2	0.1
South	3.4	3.5	0.3	0.3	0.1	0.2
West	3.8	3.7	0.2	0.1	0.1	0.1
COUNTY TYPE
Large Metro	3.1	3.4	0.4	0.2	0.2	0.1
Small Metro	3.9	3.9	0.4	0.3	0.1	0.2
Nonmetro	4.1	4.4	0.3	0.3	0.2	0.2
Urbanized	4.9	4.3	0.3	0.4	0.2	0.2
Less Urbanized	3.7	4.5	0.4	0.3	0.2	0.1
Completely Rural	2.6	4.2	0.1	0.1	*	0.1
POVERTY LEVEL¹
Less Than 100%	6.2	6.5	1.0	0.9	0.5	0.5
100-199%	3.9	4.4	0.3	0.4	0.1	0.2
200% or More	2.7	2.8	0.2^a	0.1	0.1^a	<0.1
HEALTH INSURANCE²
Private	2.3	2.6	0.1	<0.1	0.1	<0.1
Medicaid/CHIP	6.1	6.9	0.8	0.9	0.3	0.5
Other³	3.4	3.4	0.4^a	0.1	0.2	0.1
No Coverage	5.6	4.5	0.5	0.4	0.2	0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.77A – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	48,438^a	51,559	8,795^b	10,423	2,638	2,783
GEOGRAPHIC REGION
Northeast	8,219	8,763	1,756	1,990	521	588
Midwest	9,164^a	10,313	1,342^a	1,653	398	461
South	16,990	17,478	2,664^a	3,304	843	844
West	14,066	15,005	3,032	3,476	876	890
COUNTY TYPE
Large Metro	26,072^b	29,069	5,289^b	6,687	1,623	1,900
Small Metro	16,197	16,731	2,696	2,826	805	709
Nonmetro	6,170	5,758	810	910	211	174
Urbanized	2,609	2,518	407	391	82	73
Less Urbanized	3,148	2,928	356	491	113	95
Completely Rural	412	312	47	28	16	6
POVERTY LEVEL¹
Less Than 100%	6,951	7,015	1,435	1,454	416	400
100-199%	8,016	8,715	1,470	1,777	444	458
200% or More	33,460	35,827	5,882^b	7,191	1,774	1,925
HEALTH INSURANCE²
Private	29,623	31,423	5,203^b	6,571	1,484	1,662
Medicaid/CHIP	10,628	10,459	2,260	1,982	723	595
Other³	11,237	11,432	927	829	265	154
No Coverage	4,158^a	4,979	1,034^b	1,467	366	446
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.77B – Hallucinogen Use in Lifetime, Past Year, and Past Month: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Lifetime (2023)	Lifetime (2024)	Past Year (2023)	Past Year (2024)	Past Month (2023)	Past Month (2024)
TOTAL	17.1	17.9	3.1^b	3.6	0.9	1.0
GEOGRAPHIC REGION
Northeast	16.8	17.6	3.6	4.0	1.1	1.2
Midwest	15.7^a	17.5	2.3	2.8	0.7	0.8
South	15.6	15.7	2.4^a	3.0	0.8	0.8
West	21.0	22.0	4.5	5.1	1.3	1.3
COUNTY TYPE
Large Metro	16.6^a	18.0	3.4^b	4.1	1.0	1.2
Small Metro	18.2	18.1	3.0	3.1	0.9	0.8
Nonmetro	16.4	16.7	2.2	2.6	0.6	0.5
Urbanized	17.2	17.7	2.7	2.7	0.5	0.5
Less Urbanized	16.3	16.8	1.8	2.8	0.6	0.5
Completely Rural	13.3	11.1	1.5	1.0	0.5	0.2
POVERTY LEVEL¹
Less Than 100%	15.4	15.1	3.2	3.1	0.9	0.9
100-199%	14.7	15.7	2.7	3.2	0.8	0.8
200% or More	18.2	19.3	3.2^b	3.9	1.0	1.0
HEALTH INSURANCE²
Private	17.3	17.9	3.0^b	3.7	0.9	0.9
Medicaid/CHIP	17.5	17.7	3.7	3.4	1.2	1.0
Other³	14.3	14.4	1.2	1.0	0.3	0.2
No Coverage	17.5	19.8	4.3^a	5.8	1.5	1.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.78A – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	3,155	--	967	--	2,189	--	690	--	1,499
GEOGRAPHIC REGION
Northeast	--	583	--	121	--	462	--	142	--	321
Midwest	--	489	--	173	--	316	--	128	--	188
South	--	1,038	--	373	--	665	--	216	--	448
West	--	1,045	--	299	--	746	--	204	--	542
COUNTY TYPE
Large Metro	--	2,060	--	571	--	1,489	--	397	--	1,092
Small Metro	--	826	--	300	--	526	--	228	--	298
Nonmetro	--	269	--	96	--	173	--	64	--	109
Urbanized	--	127	--	39	--	87	--	45	--	42
Less Urbanized	--	133	--	50	--	84	--	16	--	67
Completely Rural	--	9	--	7	--	3	--	3	--	<1
POVERTY LEVEL¹
Less Than 100%	--	610	--	190	--	420	--	202	--	217
100-199%	--	483	--	195	--	288	--	133	--	155
200% or More	--	2,061	--	581	--	1,480	--	353	--	1,126
HEALTH INSURANCE²
Private	--	1,990	--	519	--	1,472	--	471	--	1,000
Medicaid/CHIP	--	872	--	405	--	467	--	144	--	323
Other³	--	258	--	40	--	218	--	42	--	176
No Coverage	--	309	--	52	--	256	--	59	--	197
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.78B – Inhalant Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	1.1	--	3.7	--	0.8	--	2.0	--	0.7
GEOGRAPHIC REGION
Northeast	--	1.2	--	3.0	--	1.0	--	2.4	--	0.8
Midwest	--	0.8	--	3.2	--	0.6	--	1.8	--	0.4
South	--	0.9	--	3.6	--	0.7	--	1.6	--	0.5
West	--	1.5	--	4.9	--	1.2	--	2.5	--	1.0
COUNTY TYPE
Large Metro	--	1.3	--	3.9	--	1.0	--	2.1	--	0.9
Small Metro	--	0.9	--	3.6	--	0.6	--	1.9	--	0.4
Nonmetro	--	0.8	--	3.3	--	0.5	--	1.5	--	0.4
Urbanized	--	0.9	--	3.5	--	0.7	--	2.1	--	0.4
Less Urbanized	--	0.8	--	3.3	--	0.5	--	0.9	--	0.5
Completely Rural	--	0.3	--	2.8	--	0.1	--	0.9	--	<0.1
POVERTY LEVEL¹
Less Than 100%	--	1.3	--	3.4	--	1.0	--	2.4	--	0.7
100-199%	--	0.9	--	3.7	--	0.6	--	1.6	--	0.4
200% or More	--	1.1	--	3.8	--	0.9	--	2.0	--	0.7
HEALTH INSURANCE²
Private	--	1.1	--	3.5	--	0.9	--	2.4	--	0.7
Medicaid/CHIP	--	1.5	--	3.9	--	1.0	--	1.6	--	0.8
Other³	--	0.3	--	2.9	--	0.3	--	1.5	--	0.2
No Coverage	--	1.2	--	4.3	--	1.1	--	1.2	--	1.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.79A – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	1,124	--	272	--	852	--	191	--	660
GEOGRAPHIC REGION
Northeast	--	208	--	44	--	164	--	40	--	124
Midwest	--	213	--	59	--	154	--	40	--	114
South	--	348	--	100	--	249	--	45	--	203
West	--	355	--	70	--	285	--	66	--	219
COUNTY TYPE
Large Metro	--	767	--	167	--	600	--	109	--	491
Small Metro	--	265	--	75	--	191	--	70	--	121
Nonmetro	--	92	--	30	--	62	--	13	--	49
Urbanized	--	57	--	21	--	36	--	4	--	31
Less Urbanized	--	34	--	8	--	26	--	9	--	17
Completely Rural	--	1	--	*	--	*	--	*	--	*
POVERTY LEVEL¹
Less Than 100%	--	183	--	58	--	125	--	39	--	86
100-199%	--	147	--	70	--	77	--	40	--	37
200% or More	--	794	--	144	--	650	--	113	--	537
HEALTH INSURANCE²
Private	--	730	--	133	--	597	--	123	--	473
Medicaid/CHIP	--	320	--	137	--	184	--	58	--	126
Other³	--	116	--	10	--	106	--	12	--	94
No Coverage	--	115	--	8	--	107	--	13	--	93
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.79B – Inhalant Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	0.4	--	1.0	--	0.3	--	0.5	--	0.3
GEOGRAPHIC REGION
Northeast	--	0.4	--	1.1	--	0.4	--	0.7	--	0.3
Midwest	--	0.4	--	1.1	--	0.3	--	0.5	--	0.2
South	--	0.3	--	1.0	--	0.2	--	0.3	--	0.2
West	--	0.5	--	1.1	--	0.5	--	0.8	--	0.4
COUNTY TYPE
Large Metro	--	0.5	--	1.1	--	0.4	--	0.6	--	0.4
Small Metro	--	0.3	--	0.9	--	0.2	--	0.6	--	0.2
Nonmetro	--	0.3	--	1.0	--	0.2	--	0.3	--	0.2
Urbanized	--	0.4	--	1.8	--	0.3	--	0.2	--	0.3
Less Urbanized	--	0.2	--	0.5	--	0.2	--	0.5	--	0.1
Completely Rural	--	<0.1	--	*	--	*	--	*	--	*
POVERTY LEVEL¹
Less Than 100%	--	0.4	--	1.1	--	0.3	--	0.5	--	0.3
100-199%	--	0.3	--	1.3	--	0.2	--	0.5	--	0.1
200% or More	--	0.4	--	1.0	--	0.4	--	0.6	--	0.4
HEALTH INSURANCE²
Private	--	0.4	--	0.9	--	0.4	--	0.6	--	0.3
Medicaid/CHIP	--	0.5	--	1.3	--	0.4	--	0.6	--	0.3
Other³	--	0.1	--	0.7	--	0.1	--	0.4	--	0.1
No Coverage	--	0.5	--	0.7	--	0.4	--	0.3	--	0.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.80A – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	2,621	2,384	40	57	2,582	2,327	108	161	2,473	2,166
GEOGRAPHIC REGION
Northeast	276	293	1	27	275	266	17	11	258	255
Midwest	442	454	7	5	435	449	22	47	413	403
South	1,137	991	24	13	1,114	979	41	71	1,073	907
West	767	645	9	12	758	633	28	32	730	601
COUNTY TYPE
Large Metro	1,252	1,150	35	38	1,217	1,112	51	53	1,166	1,059
Small Metro	811	655	5	12	807	643	19^a	65	788	579
Nonmetro	558	579	*	7	558	572	39	44	519	528
Urbanized	200	166	*	4	200	162	11	10	189	152
Less Urbanized	317	331	*	3	317	328	26	33	290	295
Completely Rural	41	82	*	*	41	82	*	1	40	81
POVERTY LEVEL¹
Less Than 100%	936	1,100	3	15	933	1,085	45	62	888	1,023
100-199%	775	512	8	8	766	504	17^a	55	749^a	448
200% or More	911	772	29	34	882	739	46	44	836	694
HEALTH INSURANCE²
Private	519	575	35	38	485	537	39	43	446	494
Medicaid/CHIP	1,280	1,302	5	19	1,275	1,283	50	92	1,225	1,191
Other³	436	289	*	<1	436	288	8	1	427	287
No Coverage	617	373	<1	*	616	373	18	30	599	343
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.80B – Methamphetamine Use in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.9	0.8	0.2	0.2	1.0	0.9	0.3	0.5	1.1	1.0
GEOGRAPHIC REGION
Northeast	0.6	0.6	<0.1	0.7	0.6	0.6	0.3	0.2	0.7	0.6
Midwest	0.8	0.8	0.1	0.1	0.8	0.8	0.3	0.6	0.9	0.9
South	1.0	0.9	0.2	0.1	1.1	1.0	0.3	0.5	1.2	1.0
West	1.1	0.9	0.1	0.2	1.2	1.0	0.4	0.4	1.4	1.1
COUNTY TYPE
Large Metro	0.8	0.7	0.2	0.3	0.9	0.8	0.3	0.3	0.9	0.8
Small Metro	0.9	0.7	0.1	0.1	1.0	0.8	0.2^a	0.5	1.1	0.8
Nonmetro	1.5	1.7	*	0.2	1.6	1.8	0.9	1.0	1.7	1.9
Urbanized	1.3	1.2	*	0.3	1.4	1.2	0.6	0.5	1.6	1.4
Less Urbanized	1.6	1.9	*	0.2	1.8	2.1	1.3	1.7	1.9	2.1
Completely Rural	1.3	2.9	*	*	1.5	3.2	*	0.2	1.6	3.6
POVERTY LEVEL¹
Less Than 100%	2.1	2.4	<0.1	0.3	2.4	2.7	0.5	0.7	2.9	3.1
100-199%	1.4	0.9	0.2	0.2	1.6	1.0	0.2	0.7	1.8^a	1.1
200% or More	0.5	0.4	0.2	0.2	0.5	0.4	0.3	0.2	0.6	0.5
HEALTH INSURANCE²
Private	0.3	0.3	0.2	0.3	0.3	0.3	0.2	0.2	0.3	0.3
Medicaid/CHIP	2.1	2.2	<0.1	0.2	2.6	2.6	0.5	1.0	3.0	3.0
Other³	0.6	0.4	*	<0.1	0.6	0.4	0.3	<0.1	0.6	0.4
No Coverage	2.6^a	1.5	<0.1	*	2.7^a	1.6	0.4	0.6	3.3^a	1.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.81A – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,596	1,418	29	35	1,566	1,383	49	77	1,517	1,306
GEOGRAPHIC REGION
Northeast	148	184	<1	24	147	160	3	5	145	155
Midwest	288	323	4	4	284	319	7	27	277	292
South	623	527	23	5	600	522	25	36	575	486
West	536	384	2	1	534	382	14	8	521	374
COUNTY TYPE
Large Metro	874	676	27	24	848	651	22	15	825	637
Small Metro	422	378	3	8	419	370	6^a	37	413	333
Nonmetro	299	365	*	3	299	362	21	25	278	337
Urbanized	129	120	*	3	129	117	4	6	125	110
Less Urbanized	163	181	*	*	163	181	16	18	146	163
Completely Rural	7	64	*	*	7	64	*	<1	7	63
POVERTY LEVEL¹
Less Than 100%	589	679	<1	6	589	673	27	25	562	647
100-199%	487^a	254	8	2	479	253	6	31	473^a	221
200% or More	519	486	21	28	498	458	15	20	483	438
HEALTH INSURANCE²
Private	291	272	25	27	266	245	12	21	254	224
Medicaid/CHIP	767	833	5	9	762	824	26	41	737	783
Other³	276	198	*	<1	276	197	5	1	270	196
No Coverage	353	231	<1	*	353	231	9	16	344	215
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.81B – Methamphetamine Use in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.6	0.5	0.1	0.1	0.6	0.5	0.1	0.2	0.7	0.6
GEOGRAPHIC REGION
Northeast	0.3	0.4	<0.1	0.6	0.3	0.4	0.1	0.1	0.4	0.4
Midwest	0.5	0.5	0.1	0.1	0.5	0.6	0.1	0.4	0.6	0.6
South	0.6	0.5	0.2	0.1	0.6	0.5	0.2	0.3	0.7	0.6
West	0.8	0.6	<0.1	<0.1	0.9	0.6	0.2	0.1	1.0	0.7
COUNTY TYPE
Large Metro	0.6	0.4	0.2	0.2	0.6	0.4	0.1	0.1	0.7	0.5
Small Metro	0.5	0.4	<0.1	0.1	0.5	0.4	0.1^a	0.3	0.6	0.5
Nonmetro	0.8	1.1	*	0.1	0.9	1.1	0.5	0.6	0.9	1.2
Urbanized	0.8	0.8	*	0.3	0.9	0.9	0.2	0.3	1.0	1.0
Less Urbanized	0.8	1.0	*	*	0.9	1.1	0.8	0.9	0.9	1.2
Completely Rural	0.2	2.3	*	*	0.3	2.5	*	0.1	0.3	2.8
POVERTY LEVEL¹
Less Than 100%	1.3	1.5	<0.1	0.1	1.5	1.6	0.3	0.3	1.8	2.0
100-199%	0.9^a	0.5	0.2	<0.1	1.0^a	0.5	0.1	0.4	1.2^a	0.5
200% or More	0.3	0.3	0.1	0.2	0.3	0.3	0.1	0.1	0.3	0.3
HEALTH INSURANCE²
Private	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.2
Medicaid/CHIP	1.3	1.4	<0.1	0.1	1.5	1.7	0.3	0.5	1.8	2.0
Other³	0.4	0.2	*	<0.1	0.4	0.3	0.2	<0.1	0.4	0.3
No Coverage	1.5	0.9	<0.1	*	1.6	1.0	0.2	0.3	1.9	1.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.82A – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	60,821^a	63,149	2,686^a	2,998	58,134	60,151	4,888	4,731	53,246	55,420
GEOGRAPHIC REGION
Northeast	8,745	9,140	436	444	8,309	8,696	709	678	7,600	8,017
Midwest	12,890	13,081	548	618	12,341	12,463	956	985	11,385	11,478
South	25,476	26,115	1,221	1,226	24,255	24,889	2,047	2,052	22,208	22,837
West	13,710	14,813	482^b	709	13,229	14,104	1,176	1,016	12,053	13,088
COUNTY TYPE
Large Metro	30,827^a	33,400	1,455	1,546	29,371^a	31,855	2,495	2,341	26,876^a	29,514
Small Metro	20,718	20,831	895	1,059	19,823	19,773	1,710	1,704	18,113	18,068
Nonmetro	9,276	8,917	336	393	8,940	8,524	683	686	8,257	7,838
Urbanized	3,934	3,541	147	187	3,787	3,353	309	315	3,478	3,039
Less Urbanized	4,666	4,709	162	178	4,503	4,531	340	327	4,164	4,205
Completely Rural	676	667	26	28	650	639	34	44	616	595
POVERTY LEVEL¹
Less Than 100%	10,678	11,191	585	589	10,093	10,602	1,226	1,173	8,868	9,430
100-199%	12,388	13,321	547	675	11,840	12,647	1,169	1,139	10,671	11,508
200% or More	37,752	38,614	1,554	1,734	36,198	36,880	2,490	2,398	33,708	34,482
HEALTH INSURANCE²
Private	35,090	35,943	1,436	1,593	33,654	34,350	2,799	2,555	30,854	31,796
Medicaid/CHIP	15,156	15,358	1,189	1,345	13,967	14,013	1,492	1,444	12,476	12,569
Other³	21,566	22,748	146	154	21,420	22,594	422	412	20,998	22,181
No Coverage	3,611	3,922	111	119	3,501	3,803	554	556	2,946	3,247
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.82B – Any Use of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	21.5	21.9	10.4^a	11.6	22.6	22.9	14.4	13.5	23.8	24.4
GEOGRAPHIC REGION
Northeast	17.9	18.4	10.7	10.9	18.5	19.0	12.3	11.5	19.4	20.2
Midwest	22.1	22.2	10.1	11.4	23.4	23.3	13.4	13.5	24.9	24.8
South	23.3	23.4	11.9	11.9	24.5	24.6	15.6	15.2	25.9	26.0
West	20.5	21.8	7.8^b	11.6	21.7	22.8	14.6	12.3	22.8	24.4
COUNTY TYPE
Large Metro	19.7	20.7	10.2	10.5	20.6	21.7	13.6	12.6	21.6^a	23.0
Small Metro	23.3	22.6	10.8	12.7	24.6	23.6	15.0	14.3	26.1	25.1
Nonmetro	24.7	25.8	9.9^a	13.6	26.1	27.0	16.0	15.7	27.5	28.7
Urbanized	25.9	24.8	12.0	16.5	27.2	25.5	16.4	14.5	28.8	27.7
Less Urbanized	24.1	27.0	8.7	11.7	25.8	28.4	16.3	17.2	27.0	30.0
Completely Rural	21.7	23.8	8.6	11.9	23.2	24.9	11.6	15.8	24.5	26.1
POVERTY LEVEL¹
Less Than 100%	23.6	24.1	10.2	10.7	25.6	25.9	14.6	14.0	28.6	29.0
100-199%	22.8	23.9	10.2	12.7	24.2	25.1	14.8	13.4	26.0	27.5
200% or More	20.5	20.8	10.5	11.5	21.4	21.6	14.0	13.4	22.3	22.5
HEALTH INSURANCE²
Private	20.5	20.5	10.3	10.9	21.4	21.3	14.7^a	13.0	22.4	22.5
Medicaid/CHIP	24.9	26.0	10.9^a	12.9	28.0	28.9	15.7	16.1	31.0	31.8
Other³	27.5	28.7	10.5	11.2	27.8	29.0	15.0	14.8	28.2	29.6
No Coverage	15.2	15.6	8.8	9.9	15.5	15.8	12.4	11.0	16.3	17.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.83A – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	8,196	7,570	511	395	7,685	7,176	801	897	6,884	6,279
GEOGRAPHIC REGION
Northeast	1,170	1,213	65	44	1,105	1,169	114	125	991	1,043
Midwest	1,607	1,504	110	64	1,496	1,440	140	135	1,356	1,305
South	3,532	3,161	237	207	3,295	2,954	361	457	2,934	2,498
West	1,887	1,693	98	80	1,789	1,613	186	180	1,603	1,433
COUNTY TYPE
Large Metro	4,468	4,008	280	210	4,188	3,798	418	460	3,770	3,337
Small Metro	2,498	2,345	166	123	2,332	2,221	281	295	2,051	1,926
Nonmetro	1,230	1,218	65	61	1,165	1,156	102	141	1,063	1,015
Urbanized	488	490	29	30	460	459	48	70	412	390
Less Urbanized	656	671	34	30	622	641	52	70	570	570
Completely Rural	85	57	2	*	83	56	2	1	81	55
POVERTY LEVEL¹
Less Than 100%	1,725^a	2,285	129	116	1,596^a	2,169	239	234	1,357^a	1,935
100-199%	1,663	1,820	117	113	1,547	1,707	211	237	1,336	1,470
200% or More	4,807^b	3,463	265^a	166	4,542^b	3,298	351	424	4,191^b	2,874
HEALTH INSURANCE²
Private	4,099^a	3,408	227	171	3,873^a	3,237	384	477	3,489^a	2,761
Medicaid/CHIP	2,481	2,819	266	207	2,216	2,612	282	286	1,933	2,326
Other³	1,972	1,634	41	16	1,932	1,618	71	78	1,861	1,540
No Coverage	814	840	9	24	805	816	139	105	666	712
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.83B – Misuse of Prescription Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	2.9	2.6	2.0	1.5	3.0	2.7	2.4	2.6	3.1	2.8
GEOGRAPHIC REGION
Northeast	2.4	2.4	1.6	1.1	2.5	2.6	2.0	2.1	2.5	2.6
Midwest	2.8	2.6	2.0	1.2	2.8	2.7	2.0	1.9	3.0	2.8
South	3.2	2.8	2.3	2.0	3.3	2.9	2.8	3.4	3.4	2.8
West	2.8	2.5	1.6	1.3	2.9	2.6	2.3	2.2	3.0	2.7
COUNTY TYPE
Large Metro	2.8	2.5	2.0	1.4	2.9	2.6	2.3	2.5	3.0	2.6
Small Metro	2.8	2.5	2.0	1.5	2.9	2.7	2.5	2.5	3.0	2.7
Nonmetro	3.3	3.5	1.9	2.1	3.4	3.7	2.4	3.2	3.5	3.7
Urbanized	3.2	3.4	2.3	2.7	3.3	3.5	2.5	3.2	3.4	3.6
Less Urbanized	3.4	3.8	1.8	2.0	3.6	4.0	2.5	3.7	3.7	4.1
Completely Rural	2.7	2.0	0.7	*	3.0	2.2	0.7	0.3	3.2	2.4
POVERTY LEVEL¹
Less Than 100%	3.8^a	4.9	2.3	2.1	4.0^a	5.3	2.8	2.8	4.4^a	5.9
100-199%	3.1	3.3	2.2	2.1	3.2	3.4	2.7	2.8	3.2	3.5
200% or More	2.6^b	1.9	1.8^a	1.1	2.7^b	1.9	2.0	2.4	2.8^b	1.9
HEALTH INSURANCE²
Private	2.4^a	1.9	1.6	1.2	2.5^a	2.0	2.0	2.4	2.5^b	2.0
Medicaid/CHIP	4.1	4.8	2.4	2.0	4.4	5.4	3.0	3.2	4.8	5.9
Other³	2.5	2.1	2.9	1.1	2.5	2.1	2.5	2.8	2.5	2.1
No Coverage	3.4	3.3	0.7	2.0	3.6	3.4	3.1	2.1	3.7	3.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.84A – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	2,029	1,951	128	106	1,901	1,845	169	214	1,732	1,631
GEOGRAPHIC REGION
Northeast	242	402	12	13	230	389	8	30	223	359
Midwest	358	381	31^a	5	327	376	26	39	301	337
South	891	768	58	70	833	698	89	112	743	587
West	538	400	27	18	511	382	45	34	465	348
COUNTY TYPE
Large Metro	1,132	1,078	69	78	1,063	1,000	91	114	972	886
Small Metro	576	520	47	15	528	505	60	58	469	448
Nonmetro	322	353	12	14	310	339	18	42	292	297
Urbanized	120	135	10	4	110	130	3^a	25	107	105
Less Urbanized	195	197	1	8	195	189	15	*	179	172
Completely Rural	7	21	1	*	6	20	*	<1	6	20
POVERTY LEVEL¹
Less Than 100%	497	750	52	29	445	721	55	67	390	654
100-199%	474	439	23	36	451	403	41	64	409	339
200% or More	1,058	762	53	42	1,005	721	72	84	933^a	637
HEALTH INSURANCE²
Private	959	689	42	46	916	643	80	95	837	547
Medicaid/CHIP	816	893	88	43	727	850	62	98	665	752
Other³	356	400	7	12	349	388	14	16	334	372
No Coverage	196	221	3	12	193	210	27	14	165	195
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.84B – Misuse of Prescription Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.7	0.7	0.5	0.4	0.7	0.7	0.5	0.6	0.8	0.7
GEOGRAPHIC REGION
Northeast	0.5	0.8	0.3	0.3	0.5	0.9	0.1	0.5	0.6	0.9
Midwest	0.6	0.6	0.6^a	0.1	0.6	0.7	0.4	0.5	0.7	0.7
South	0.8	0.7	0.6	0.7	0.8	0.7	0.7	0.8	0.9	0.7
West	0.8	0.6	0.4	0.3	0.8	0.6	0.6	0.4	0.9	0.6
COUNTY TYPE
Large Metro	0.7	0.7	0.5	0.5	0.7	0.7	0.5	0.6	0.8	0.7
Small Metro	0.6	0.6	0.6	0.2	0.7	0.6	0.5	0.5	0.7	0.6
Nonmetro	0.9	1.0	0.4	0.5	0.9	1.1	0.4	1.0	1.0	1.1
Urbanized	0.8	0.9	0.8	0.4	0.8	1.0	0.1^a	1.2	0.9	1.0
Less Urbanized	1.0	1.1	<0.1	0.6	1.1	1.2	0.7	*	1.2	1.2
Completely Rural	0.2	0.8	0.4	*	0.2	0.8	*	0.1	0.2	0.9
POVERTY LEVEL¹
Less Than 100%	1.1	1.6	0.9	0.5	1.1	1.8	0.7	0.8	1.3	2.0
100-199%	0.9	0.8	0.4	0.7	0.9	0.8	0.5	0.7	1.0	0.8
200% or More	0.6^a	0.4	0.4	0.3	0.6	0.4	0.4	0.5	0.6^a	0.4
HEALTH INSURANCE²
Private	0.6	0.4	0.3	0.3	0.6	0.4	0.4	0.5	0.6^a	0.4
Medicaid/CHIP	1.3	1.5	0.8	0.4	1.5	1.8	0.7	1.1	1.7	1.9
Other³	0.5	0.5	0.5	0.9	0.5	0.5	0.5	0.6	0.4	0.5
No Coverage	0.8	0.9	0.2	1.0	0.9	0.9	0.6	0.3	0.9	1.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.85A – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	19,816	20,507	1,807	1,830	18,009	18,677	3,660	3,639	14,349	15,038
GEOGRAPHIC REGION
Northeast	3,299	3,290	281	254	3,019	3,037	655	649	2,363	2,388
Midwest	4,207	4,627	403	390	3,805	4,237	883	888	2,922	3,349
South	8,072	8,091	757	814	7,315	7,278	1,273	1,333	6,042	5,945
West	4,237	4,498	366	373	3,871	4,125	849	770	3,022	3,356
COUNTY TYPE
Large Metro	10,765	10,868	968	959	9,797	9,909	1,844	1,883	7,954	8,025
Small Metro	6,492^a	7,373	650	690	5,842^a	6,682	1,425	1,353	4,417^b	5,329
Nonmetro	2,559	2,267	189	181	2,369	2,086	391	402	1,979	1,683
Urbanized	1,060	962	76	83	984	879	236	217	748	662
Less Urbanized	1,338	1,143	95	85	1,243	1,058	134	169	1,109	889
Completely Rural	161	162	18	13	142	149	21	16	122	133
POVERTY LEVEL¹
Less Than 100%	2,782	2,994	230	254	2,552	2,740	812	767	1,740	1,973
100-199%	3,555	3,047	310	293	3,246	2,754	822	686	2,424	2,068
200% or More	13,474	14,453	1,267	1,284	12,207	13,169	2,022	2,173	10,185	10,996
HEALTH INSURANCE²
Private	12,851	13,863	1,154	1,204	11,697	12,659	2,466	2,542	9,231	10,118
Medicaid/CHIP	4,724	4,371	588	626	4,136	3,745	838	787	3,299	2,958
Other³	3,123	3,345	130	82	2,993	3,263	314	257	2,680	3,006
No Coverage	1,367	1,381	49	53	1,319	1,328	271	285	1,048	1,043
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.85B – Any Use of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	7.0	7.1	7.0	7.1	7.0	7.1	10.8	10.4	6.4	6.6
GEOGRAPHIC REGION
Northeast	6.7	6.6	6.9	6.2	6.7	6.7	11.4	11.0	6.0	6.0
Midwest	7.2	7.9	7.4	7.2	7.2	7.9	12.4	12.2	6.4	7.2
South	7.4	7.3	7.4	7.9	7.4	7.2	9.7	9.9	7.0	6.8
West	6.3	6.6	6.0	6.1	6.4	6.7	10.6	9.3	5.7	6.2
COUNTY TYPE
Large Metro	6.9	6.7	6.8	6.5	6.9	6.7	10.1	10.1	6.4	6.3
Small Metro	7.3	8.0	7.9	8.2	7.2	8.0	12.5	11.3	6.4^a	7.4
Nonmetro	6.8	6.6	5.6	6.2	6.9	6.6	9.2	9.2	6.6	6.2
Urbanized	7.0	6.7	6.2	7.3	7.1	6.7	12.5	10.0	6.2	6.0
Less Urbanized	6.9	6.5	5.1	5.6	7.1	6.6	6.4	8.9	7.2	6.3
Completely Rural	5.2	5.8	6.0	5.3	5.1	5.8	7.0	5.7	4.9	5.8
POVERTY LEVEL¹
Less Than 100%	6.2	6.4	4.0	4.6	6.5	6.7	9.7	9.2	5.6	6.1
100-199%	6.5^a	5.5	5.8	5.5	6.6^a	5.5	10.4	8.1	5.9	4.9
200% or More	7.3	7.8	8.5	8.5	7.2	7.7	11.4	12.1	6.7	7.2
HEALTH INSURANCE²
Private	7.5	7.9	8.2	8.2	7.4	7.9	12.9	12.9	6.7	7.2
Medicaid/CHIP	7.8	7.4	5.4	6.0	8.3	7.7	8.8	8.8	8.2	7.5
Other³	4.0	4.2	9.3	5.9	3.9	4.2	11.1	9.2	3.6	4.0
No Coverage	5.7	5.5	3.9	4.4	5.9	5.5	6.0	5.7	5.8	5.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.86A – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	3,922	3,899	230	203	3,692	3,696	1,066	973	2,626	2,723
GEOGRAPHIC REGION
Northeast	708	789	29	21	679	767	170	181	509	586
Midwest	903	789	46	27	858	763	251	219	607	544
South	1,468	1,389	104	83	1,365	1,305	385	356	980	950
West	843	932	53	72	791	861	261	217	530	644
COUNTY TYPE
Large Metro	2,267	2,287	139	108	2,128	2,179	589	494	1,539	1,685
Small Metro	1,298	1,242	77	76	1,222	1,166	396	364	825	802
Nonmetro	358	370	15	19	343	351	81	115	262	236
Urbanized	136	158	7	12	129	146	42	82	87	64
Less Urbanized	197	206	5	7	192	199	28	32	164	167
Completely Rural	24	6	*	*	22	6	11	*	11	4
POVERTY LEVEL¹
Less Than 100%	573	570	23	13	550	557	258	206	292	351
100-199%	660	543	44	33	616	510	268	194	349	316
200% or More	2,688	2,785	164	158	2,524	2,627	539	572	1,985	2,056
HEALTH INSURANCE²
Private	2,464	2,583	151	146	2,313	2,437	736	672	1,577	1,765
Medicaid/CHIP	932	746	66	55	866	691	207	163	659	528
Other³	425	388	26	14	399	374	98	71	301	303
No Coverage	363	478	3	*	360	470	98	96	262	374
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.86B – Misuse of Prescription Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.4	1.4	0.9	0.8	1.4	1.4	3.1	2.8	1.2	1.2
GEOGRAPHIC REGION
Northeast	1.4	1.6	0.7	0.5	1.5	1.7	3.0	3.1	1.3	1.5
Midwest	1.6	1.3	0.8	0.5	1.6	1.4	3.5	3.0	1.3	1.2
South	1.3	1.2	1.0	0.8	1.4	1.3	2.9	2.6	1.1	1.1
West	1.3	1.4	0.9	1.2	1.3	1.4	3.2	2.6	1.0	1.2
COUNTY TYPE
Large Metro	1.4	1.4	1.0	0.7	1.5	1.5	3.2	2.7	1.2	1.3
Small Metro	1.5	1.3	0.9	0.9	1.5	1.4	3.5	3.0	1.2	1.1
Nonmetro	1.0	1.1	0.4	0.7	1.0	1.1	1.9	2.6	0.9	0.9
Urbanized	0.9	1.1	0.6	1.1	0.9	1.1	2.3	3.8	0.7	0.6
Less Urbanized	1.0	1.2	0.3	0.5	1.1	1.3	1.3	1.7	1.1	1.2
Completely Rural	0.8	0.2	*	*	0.8	0.2	3.6	*	0.4	0.2
POVERTY LEVEL¹
Less Than 100%	1.3	1.2	0.4	0.2	1.4	1.4	3.1	2.5	0.9	1.1
100-199%	1.2	1.0	0.8	0.6	1.3	1.0	3.4	2.3	0.8	0.8
200% or More	1.5	1.5	1.1	1.0	1.5	1.5	3.0	3.2	1.3	1.3
HEALTH INSURANCE²
Private	1.4	1.5	1.1	1.0	1.5	1.5	3.9	3.4	1.1	1.2
Medicaid/CHIP	1.5	1.3	0.6	0.5	1.7	1.4	2.2	1.8	1.6	1.3
Other³	0.5	0.5	1.8	1.0	0.5	0.5	3.5	2.5	0.4	0.4
No Coverage	1.5	1.9	0.2	*	1.6	2.0	2.2	1.9	1.5	2.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.87A – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,163	1,239	32	33	1,131	1,206	308	210	823	995
GEOGRAPHIC REGION
Northeast	239	275	4	4	235	271	55	52	180	219
Midwest	300	193	11	6	289	187	86	57	203	130
South	413	497	9	20	404	477	115	63	289	414
West	211	275	8	3	203	271	52	39	150	232
COUNTY TYPE
Large Metro	624	804	11	16	613	788	173	121	440	667
Small Metro	431	327	21	17	410	310	118	58	292	251
Nonmetro	108	108	<1	<1	108	108	17	31	91	77
Urbanized	41	50	<1	*	41	50	14	19	26	31
Less Urbanized	67	58	<1	<1	67	58	3	11	64	46
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	207	144	1	5	206	138	101	54	104	84
100-199%	167	113	11	3	156	110	63	42	93	68
200% or More	788	983	19	25	769	958	144	114	625	844
HEALTH INSURANCE²
Private	704	861	15	24	689	837	204	159	485	677
Medicaid/CHIP	346^a	197	14	10	332	187	59	41	273	146
Other³	118	91	1	*	117	91	38	6	79	84
No Coverage	93	166	3	<1	91	166	28	7	63^a	159
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.87B – Misuse of Prescription Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.4	0.4	0.1	0.1	0.4	0.5	0.9	0.6	0.4	0.4
GEOGRAPHIC REGION
Northeast	0.5	0.6	0.1	0.1	0.5	0.6	1.0	0.9	0.5	0.6
Midwest	0.5	0.3	0.2	0.1	0.5	0.3	1.2	0.8	0.4	0.3
South	0.4	0.4	0.1	0.2	0.4	0.5	0.9	0.5	0.3	0.5
West	0.3	0.4	0.1	0.1	0.3	0.4	0.7	0.5	0.3	0.4
COUNTY TYPE
Large Metro	0.4	0.5	0.1	0.1	0.4	0.5	0.9	0.7	0.4	0.5
Small Metro	0.5	0.4	0.2	0.2	0.5	0.4	1.0	0.5	0.4	0.3
Nonmetro	0.3	0.3	<0.1	<0.1	0.3	0.3	0.4	0.7	0.3	0.3
Urbanized	0.3	0.4	<0.1	*	0.3	0.4	0.8	0.9	0.2	0.3
Less Urbanized	0.3	0.3	<0.1	<0.1	0.4	0.4	0.1	0.6	0.4	0.3
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.5	0.3	<0.1	0.1	0.5	0.3	1.2	0.7	0.3	0.3
100-199%	0.3	0.2	0.2	0.1	0.3	0.2	0.8	0.5	0.2	0.2
200% or More	0.4	0.5	0.1	0.2	0.5	0.6	0.8	0.6	0.4	0.6
HEALTH INSURANCE²
Private	0.4	0.5	0.1	0.2	0.4	0.5	1.1	0.8	0.4	0.5
Medicaid/CHIP	0.6	0.3	0.1	0.1	0.7	0.4	0.6	0.5	0.7	0.4
Other³	0.1	0.1	0.1	*	0.2	0.1	1.3	0.2	0.1	0.1
No Coverage	0.4	0.7	0.2	<0.1	0.4	0.7	0.6	0.1	0.3	0.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.88A – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	39,679	39,709	1,181^a	945	38,498	38,765	2,726	2,477	35,772	36,288
GEOGRAPHIC REGION
Northeast	6,884	6,499	188	130	6,697	6,369	449	451	6,247	5,918
Midwest	8,129	8,168	235	225	7,894	7,943	569	540	7,325	7,403
South	16,591	16,654	526	383	16,065	16,270	1,051	978	15,014	15,292
West	8,075	8,389	233	207	7,842	8,182	657^a	507	7,185	7,675
COUNTY TYPE
Large Metro	20,250	21,036	597	485	19,653	20,551	1,363	1,318	18,290	19,232
Small Metro	13,855	13,727	399	361	13,456	13,366	1,026	873	12,430	12,493
Nonmetro	5,574	4,946	185^a	98	5,390	4,848	338	285	5,051	4,563
Urbanized	2,121	1,887	59	47	2,062	1,840	136	109	1,925	1,731
Less Urbanized	2,995	2,683	76	48	2,919	2,635	183	163	2,735	2,472
Completely Rural	459	376	*	3	409	373	19	13	390	360
POVERTY LEVEL¹
Less Than 100%	5,829	5,756	210	204	5,620	5,551	606	535	5,014	5,016
100-199%	7,593	7,268	220	163	7,374	7,105	639	602	6,735	6,503
200% or More	26,254	26,677	752^a	577	25,502	26,100	1,480	1,331	24,023	24,769
HEALTH INSURANCE²
Private	23,996	24,223	684	567	23,312	23,656	1,652	1,456	21,660	22,201
Medicaid/CHIP	8,947	8,387	464	403	8,483	7,984	734	762	7,749	7,222
Other³	13,986	14,759	79^a	35	13,907	14,724	235	216	13,672	14,508
No Coverage	1,960	1,934	40	20	1,920	1,915	270	215	1,650	1,700
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.88B – Any Use of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	14.0	13.8	4.6^a	3.6	14.9	14.8	8.0^a	7.1	16.0	16.0
GEOGRAPHIC REGION
Northeast	14.1	13.1	4.6	3.2	14.9	14.0	7.8	7.6	16.0	14.9
Midwest	14.0	13.9	4.3	4.1	14.9	14.8	8.0	7.4	16.0	16.0
South	15.2	14.9	5.1	3.7	16.2	16.1	8.0	7.2	17.5	17.4
West	12.1	12.3	3.8	3.4	12.9	13.2	8.2^a	6.2	13.6	14.3
COUNTY TYPE
Large Metro	12.9	13.0	4.2	3.3	13.8	14.0	7.4	7.1	14.7	15.0
Small Metro	15.6	14.9	4.8	4.3	16.7	15.9	9.0^a	7.3	17.9	17.4
Nonmetro	14.8	14.3	5.5	3.4	15.7	15.3	7.9	6.5	16.9	16.7
Urbanized	14.0	13.2	4.8	4.1	14.8	14.0	7.2	5.0	16.0	15.8
Less Urbanized	15.5	15.4	4.1	3.1	16.7	16.5	8.8	8.6	17.8	17.6
Completely Rural	14.8	13.4	*	1.4	14.6	14.6	6.3	4.6	15.6	15.8
POVERTY LEVEL¹
Less Than 100%	12.9	12.4	3.7	3.7	14.2	13.6	7.2	6.4	16.2	15.4
100-199%	14.0	13.1	4.1	3.1	15.1	14.1	8.1	7.1	16.4	15.5
200% or More	14.3	14.3	5.1^a	3.8	15.1	15.3	8.3	7.4	15.9	16.2
HEALTH INSURANCE²
Private	14.0	13.8	4.9	3.9	14.8	14.7	8.7^a	7.4	15.7	15.7
Medicaid/CHIP	14.7	14.2	4.2	3.9	17.0	16.4	7.7	8.5	19.2	18.2
Other³	17.8	18.6	5.7^a	2.5	18.0	18.9	8.3	7.7	18.4	19.3
No Coverage	8.2	7.7	3.2	1.6	8.5	8.0	6.0	4.3	9.1	9.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.89A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	4,722	4,575	173	172	4,549	4,403	576	571	3,973	3,832
GEOGRAPHIC REGION
Northeast	845	725	15	21	831	704	81	47	750	657
Midwest	782	933	31	29	751	904	110	117	641	787
South	2,164	1,984	72	90	2,092	1,894	246	307	1,846	1,587
West	931	933	56	32	875	901	139	100	736	801
COUNTY TYPE
Large Metro	2,693	2,469	99	84	2,595	2,385	308	312	2,287	2,074
Small Metro	1,519	1,433	63	53	1,456	1,380	203	187	1,253	1,193
Nonmetro	510	673	12	35	498	638	65	72	433	565
Urbanized	229	311	6	18	224	293	22	23	202	270
Less Urbanized	269	310	6	17	262	293	41	45	221	248
Completely Rural	12	51	*	*	12	51	2	5	10	*
POVERTY LEVEL¹
Less Than 100%	761	931	25	26	736	906	130	137	607	769
100-199%	971	914	40	42	931	871	133	150	798	721
200% or More	2,989	2,729	108	103	2,881	2,625	313	283	2,568	2,342
HEALTH INSURANCE²
Private	2,580	2,275	112	101	2,467	2,174	327	283	2,140	1,891
Medicaid/CHIP	1,162	1,448	49	77	1,113	1,371	158	210	955	1,161
Other³	1,026	1,034	20	6	1,006	1,028	39	41	967	988
No Coverage	546	462	2	3	544	459	82	54	462	405
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.89B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.7	1.6	0.7	0.7	1.8	1.7	1.7	1.6	1.8	1.7
GEOGRAPHIC REGION
Northeast	1.7	1.5	0.4	0.5	1.8	1.5	1.4	0.8	1.9	1.7
Midwest	1.3	1.6	0.6	0.5	1.4	1.7	1.5	1.6	1.4	1.7
South	2.0	1.8	0.7	0.9	2.1	1.9	1.9	2.3	2.2	1.8
West	1.4	1.4	0.9	0.5	1.4	1.5	1.7	1.2	1.4	1.5
COUNTY TYPE
Large Metro	1.7	1.5	0.7	0.6	1.8	1.6	1.7	1.7	1.8	1.6
Small Metro	1.7	1.6	0.8	0.6	1.8	1.6	1.8	1.6	1.8	1.7
Nonmetro	1.4	1.9	0.3^a	1.2	1.5	2.0	1.5	1.7	1.4	2.1
Urbanized	1.5	2.2	0.5	1.6	1.6	2.2	1.1	1.1	1.7	2.5
Less Urbanized	1.4	1.8	0.3	1.1	1.5	1.8	2.0	2.4	1.4	1.8
Completely Rural	0.4	1.8	*	*	0.4	2.0	0.7	1.6	0.4	*
POVERTY LEVEL¹
Less Than 100%	1.7	2.0	0.4	0.5	1.9	2.2	1.5	1.6	2.0	2.4
100-199%	1.8	1.6	0.7	0.8	1.9	1.7	1.7	1.8	1.9	1.7
200% or More	1.6	1.5	0.7	0.7	1.7	1.5	1.8	1.6	1.7	1.5
HEALTH INSURANCE²
Private	1.5	1.3	0.8	0.7	1.6	1.3	1.7	1.4	1.6	1.3
Medicaid/CHIP	1.9	2.5	0.4	0.7	2.2	2.8	1.7	2.3	2.4	2.9
Other³	1.3	1.3	1.5	0.4	1.3	1.3	1.4	1.5	1.3	1.3
No Coverage	2.3	1.8	0.2	0.2	2.4	1.9	1.8	1.1	2.6	2.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.90A – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,236	1,480	44	38	1,192	1,442	159	160	1,033	1,282
GEOGRAPHIC REGION
Northeast	202	289	2	5	200	284	17	12	183	271
Midwest	237	326	2	13	235	313	24	41	211	272
South	569	568	23	16	546	552	65	74	481	479
West	228	297	17	4	211	293	53	33	158	260
COUNTY TYPE
Large Metro	650	837	21	13	629	824	77	97	552	727
Small Metro	411	364	21	12	390	352	71^a	23	319	328
Nonmetro	175	279	2	13	173	267	11	40	162	227
Urbanized	86	97	*	*	86	90	4	10	82	80
Less Urbanized	89	143	2	5	87	138	7	30	80	109
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	203^a	359	4	5	199^a	355	48	76	151	278
100-199%	250	254	12	7	238	247	34	30	205	217
200% or More	783	867	28	26	755	841	77	54	678	786
HEALTH INSURANCE²
Private	598	722	32	21	566	701	68	82	498	620
Medicaid/CHIP	380	519	12	17	368	502	59	74	310	428
Other³	284	309	*	*	284	309	17	2	267	307
No Coverage	142	167	*	*	142	167	21	5	121	161
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.90B – Misuse of Prescription Tranquilizers or Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.4	0.5	0.2	0.1	0.5	0.5	0.5	0.5	0.5	0.6
GEOGRAPHIC REGION
Northeast	0.4	0.6	0.1	0.1	0.4	0.6	0.3	0.2	0.5	0.7
Midwest	0.4	0.6	<0.1	0.2	0.4	0.6	0.3	0.6	0.5	0.6
South	0.5	0.5	0.2	0.2	0.6	0.5	0.5	0.5	0.6	0.5
West	0.3	0.4	0.3	0.1	0.3	0.5	0.7	0.4	0.3	0.5
COUNTY TYPE
Large Metro	0.4	0.5	0.1	0.1	0.4	0.6	0.4	0.5	0.4	0.6
Small Metro	0.5	0.4	0.3	0.1	0.5	0.4	0.6^a	0.2	0.5	0.5
Nonmetro	0.5	0.8	0.1	0.4	0.5	0.8	0.3	0.9	0.5	0.8
Urbanized	0.6	0.7	*	*	0.6	0.7	0.2	0.5	0.7	0.7
Less Urbanized	0.5	0.8	0.1	0.4	0.5	0.9	0.3	1.6	0.5	0.8
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.4	0.8	0.1	0.1	0.5	0.9	0.6	0.9	0.5	0.9
100-199%	0.5	0.5	0.2	0.1	0.5	0.5	0.4	0.3	0.5	0.5
200% or More	0.4	0.5	0.2	0.2	0.4	0.5	0.4	0.3	0.4	0.5
HEALTH INSURANCE²
Private	0.3	0.4	0.2	0.1	0.4	0.4	0.4	0.4	0.4	0.4
Medicaid/CHIP	0.6	0.9	0.1	0.2	0.7	1.0	0.6	0.8	0.8	1.1
Other³	0.4	0.4	*	*	0.4	0.4	0.6	0.1	0.4	0.4
No Coverage	0.6	0.7	*	*	0.6	0.7	0.5	0.1	0.7	0.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.91A – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	31,384	31,451	731^b	500	30,653	30,951	2,228^a	1,944	28,425	29,007
GEOGRAPHIC REGION
Northeast	5,504	5,388	109	82	5,395	5,306	339	350	5,056	4,956
Midwest	6,544	6,501	157	121	6,387	6,380	479	420	5,908	5,960
South	13,240	13,288	313	209	12,927	13,079	866	803	12,061	12,276
West	6,095	6,274	152^a	88	5,943	6,186	544^b	371	5,400	5,815
COUNTY TYPE
Large Metro	15,985	16,633	384^a	229	15,601	16,404	1,100	1,033	14,501	15,372
Small Metro	10,970	10,979	252	198	10,718	10,781	833	682	9,885	10,099
Nonmetro	4,429	3,839	95	73	4,334	3,766	295	230	4,039	3,536
Urbanized	1,660	1,383	35	33	1,626	1,350	114	88	1,512	1,261
Less Urbanized	2,409	2,135	37	38	2,372	2,097	164	131	2,208	1,967
Completely Rural	359	320	23	*	336	319	17	11	319	308
POVERTY LEVEL¹
Less Than 100%	4,886	4,706	128	119	4,758	4,587	510	422	4,248	4,165
100-199%	6,088	5,923	118	94	5,970	5,829	533	489	5,437	5,340
200% or More	20,408	20,816	486^b	287	19,923	20,529	1,183	1,027	18,740	19,502
HEALTH INSURANCE²
Private	18,746	18,959	436^a	287	18,310	18,671	1,333	1,145	16,977	17,527
Medicaid/CHIP	7,380	6,729	263	222	7,117	6,507	581	624	6,536	5,883
Other³	10,901	11,340	54	23	10,846	11,317	192	128	10,654	11,189
No Coverage	1,714	1,625	28	10	1,686	1,615	248	182	1,439	1,433
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.91B – Any Use of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	11.1	10.9	2.8^b	1.9	11.9	11.8	6.5^a	5.6	12.7	12.8
GEOGRAPHIC REGION
Northeast	11.2	10.8	2.7	2.0	12.0	11.6	5.9	5.9	12.9	12.5
Midwest	11.2	11.0	2.9	2.2	12.1	11.9	6.7	5.8	12.9	12.9
South	12.1	11.9	3.0	2.0	13.1	12.9	6.6	5.9	14.0	14.0
West	9.1	9.2	2.5^a	1.4	9.8	10.0	6.8^b	4.5	10.2	10.8
COUNTY TYPE
Large Metro	10.2	10.3	2.7^b	1.6	10.9	11.2	6.0	5.5	11.7	12.0
Small Metro	12.3	11.9	3.1	2.4	13.3	12.9	7.3^a	5.7	14.3	14.1
Nonmetro	11.8	11.1	2.8	2.5	12.7	11.9	6.9	5.3	13.5	13.0
Urbanized	10.9	9.7	2.8	2.9	11.7	10.3	6.0	4.1	12.5	11.5
Less Urbanized	12.5	12.2	2.0	2.5	13.6	13.2	7.9	6.9	14.3	14.0
Completely Rural	11.6	11.4	7.6	*	12.0	12.4	6.0	3.8	12.7	13.5
POVERTY LEVEL¹
Less Than 100%	10.8	10.1	2.2	2.2	12.1	11.2	6.1	5.0	13.7	12.8
100-199%	11.2	10.6	2.2	1.8	12.2	11.6	6.8	5.8	13.2	12.8
200% or More	11.1	11.2	3.3^b	1.9	11.8	12.0	6.7	5.7	12.4	12.8
HEALTH INSURANCE²
Private	11.0	10.8	3.1^a	2.0	11.7	11.6	7.0^a	5.8	12.3	12.4
Medicaid/CHIP	12.1	11.4	2.4	2.1	14.3	13.4	6.1	7.0	16.2	14.9
Other³	13.9	14.3	3.9	1.6	14.1	14.5	6.8	4.6	14.3	14.9
No Coverage	7.2	6.4	2.2	0.9	7.5	6.7	5.5^a	3.6	8.0	7.6
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.92A – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	3,993	3,829	119	126	3,874	3,703	522	522	3,351	3,181
GEOGRAPHIC REGION
Northeast	727	611	8	12	719	599	73	41	646	558
Midwest	678	813	26	26	652	787	101	92	551	695
South	1,790	1,692	47	70	1,742	1,622	220	301	1,522	1,321
West	797	713	38	18	760	695	128	88	631	607
COUNTY TYPE
Large Metro	2,275	2,091	64	61	2,212	2,030	285	285	1,927	1,745
Small Metro	1,264	1,231	48	36	1,217	1,196	172	170	1,044	1,025
Nonmetro	453	506	8	29	445	477	65	66	380	410
Urbanized	207	195	5	15	202	180	22	21	180	159
Less Urbanized	235	262	3	14	232	248	41	41	191	207
Completely Rural	12	49	*	*	12	49	2	5	10	*
POVERTY LEVEL¹
Less Than 100%	685	780	17	13	668	767	112	129	556	638
100-199%	851	822	33	31	818	791	116	144	702	647
200% or More	2,456	2,226	70	82	2,387	2,144	294	248	2,093	1,897
HEALTH INSURANCE²
Private	2,165	1,901	78	77	2,088	1,824	310	250	1,777	1,574
Medicaid/CHIP	1,035	1,217	37	55	999	1,162	142	196	856	966
Other³	732	785	11	6	721	779	35	38	686	741
No Coverage	471	432	2	2	469	430	61	51	408	379
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.92B – Misuse of Prescription Tranquilizers in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.4	1.3	0.5	0.5	1.5	1.4	1.5	1.5	1.5	1.4
GEOGRAPHIC REGION
Northeast	1.5	1.2	0.2	0.3	1.6	1.3	1.3	0.7	1.7	1.4
Midwest	1.2	1.4	0.5	0.5	1.2	1.5	1.4	1.3	1.2	1.5
South	1.6	1.5	0.5	0.7	1.8	1.6	1.7	2.2	1.8	1.5
West	1.2	1.0	0.6	0.3	1.2	1.1	1.6	1.1	1.2	1.1
COUNTY TYPE
Large Metro	1.5	1.3	0.4	0.4	1.6	1.4	1.6	1.5	1.6	1.4
Small Metro	1.4	1.3	0.6	0.4	1.5	1.4	1.5	1.4	1.5	1.4
Nonmetro	1.2	1.5	0.2^a	1.0	1.3	1.5	1.5	1.5	1.3	1.5
Urbanized	1.4	1.4	0.4	1.3	1.4	1.4	1.1	1.0	1.5	1.5
Less Urbanized	1.2	1.5	0.2	0.9	1.3	1.6	2.0	2.2	1.2	1.5
Completely Rural	0.4	1.8	*	*	0.4	1.9	0.7	1.6	0.4	*
POVERTY LEVEL¹
Less Than 100%	1.5	1.7	0.3	0.2	1.7	1.9	1.3	1.5	1.8	2.0
100-199%	1.6	1.5	0.6	0.6	1.7	1.6	1.5	1.7	1.7	1.5
200% or More	1.3	1.2	0.5	0.5	1.4	1.3	1.7	1.4	1.4	1.2
HEALTH INSURANCE²
Private	1.3	1.1	0.6	0.5	1.3	1.1	1.6	1.3	1.3	1.1
Medicaid/CHIP	1.7	2.1	0.3	0.5	2.0	2.4	1.5	2.2	2.1	2.4
Other³	0.9	1.0	0.8	0.4	0.9	1.0	1.2	1.4	0.9	1.0
No Coverage	2.0	1.7	0.2	0.1	2.1	1.8	1.4	1.0	2.3	2.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.93A – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,053	1,259	38	28	1,015	1,231	138	131	877	1,099
GEOGRAPHIC REGION
Northeast	190	220	1	5	189	215	15	12	174	203
Midwest	143^a	289	1	12	142^a	277	16	28	126	249
South	516	482	23	10	493	472	54	68	439	404
West	204	268	13	1	191	267	53	24	138	243
COUNTY TYPE
Large Metro	563	681	20	8	543	673	75	84	469	589
Small Metro	343	331	16	8	327	323	55^b	11	272	312
Nonmetro	146	246	1	12	145	234	8	36	137	199
Urbanized	85	89	*	*	85	82	4	8	82	74
Less Urbanized	61	121	1	5	60	116	5	27	55	88
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	190	310	4	1	186	309	39	66	147	243
100-199%	234	214	11	5	223	208	33	26	190	182
200% or More	628	735	22	22	607	713	66	39	541	674
HEALTH INSURANCE²
Private	505	592	26	17	478	575	55	58	423	517
Medicaid/CHIP	324	458	11	11	313	447	55	71	258	376
Other³	231	278	*	*	231	278	15	<1	216	278
No Coverage	133	140	*	*	133	140	16^a	3	117	137
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.93B – Misuse of Prescription Tranquilizers in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.4	0.4	0.1	0.1	0.4	0.5	0.4	0.4	0.4	0.5
GEOGRAPHIC REGION
Northeast	0.4	0.4	<0.1	0.1	0.4	0.5	0.3	0.2	0.4	0.5
Midwest	0.2^a	0.5	<0.1	0.2	0.3	0.5	0.2	0.4	0.3	0.5
South	0.5	0.4	0.2	0.1	0.5	0.5	0.4	0.5	0.5	0.5
West	0.3	0.4	0.2	<0.1	0.3	0.4	0.7	0.3	0.3	0.5
COUNTY TYPE
Large Metro	0.4	0.4	0.1	0.1	0.4	0.5	0.4	0.5	0.4	0.5
Small Metro	0.4	0.4	0.2	0.1	0.4	0.4	0.5^b	0.1	0.4	0.4
Nonmetro	0.4	0.7	<0.1	0.4	0.4	0.7	0.2	0.8	0.5	0.7
Urbanized	0.6	0.6	*	*	0.6	0.6	0.2	0.4	0.7	0.7
Less Urbanized	0.3	0.7	0.1	0.3	0.3	0.7	0.2	1.4	0.4	0.6
Completely Rural	*	*	*	*	*	*	*	*	*	*
POVERTY LEVEL¹
Less Than 100%	0.4	0.7	0.1	<0.1	0.5	0.8	0.5	0.8	0.5	0.7
100-199%	0.4	0.4	0.2	0.1	0.5	0.4	0.4	0.3	0.5	0.4
200% or More	0.3	0.4	0.1	0.1	0.4	0.4	0.4	0.2	0.4	0.4
HEALTH INSURANCE²
Private	0.3	0.3	0.2	0.1	0.3	0.4	0.3	0.3	0.3	0.4
Medicaid/CHIP	0.5	0.8	0.1	0.1	0.6	0.9	0.6	0.8	0.6	0.9
Other³	0.3	0.4	*	*	0.3	0.4	0.5	<0.1	0.3	0.4
No Coverage	0.6	0.6	*	*	0.6	0.6	0.4^a	0.1	0.7	0.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.94A – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	14,666	13,762	583	545	14,083	13,217	875	830	13,208	12,387
GEOGRAPHIC REGION
Northeast	2,410	1,891	88	69	2,322	1,823	140	127	2,183	1,695
Midwest	2,736	2,715	104	116	2,632	2,600	176	235	2,456	2,365
South	6,085	6,010	268	225	5,817	5,785	343	287	5,474	5,498
West	3,435	3,145	123	135	3,312	3,010	217	181	3,094	2,829
COUNTY TYPE
Large Metro	7,475	7,419	287	300	7,188	7,119	427	445	6,762	6,674
Small Metro	5,184	4,470	196	208	4,988	4,262	350	293	4,639	3,969
Nonmetro	2,006	1,873	100^b	36	1,907	1,836	99	93	1,807	1,743
Urbanized	832	745	33	22	800	723	48	38	752	685
Less Urbanized	1,048	998	40^a	13	1,008	985	47	53	961	932
Completely Rural	126	129	27	*	99	128	5	2	94	126
POVERTY LEVEL¹
Less Than 100%	1,994	2,105	103	108	1,891	1,997	182	217	1,709	1,780
100-199%	2,661	2,393	131	84	2,530	2,309	214	199	2,316	2,110
200% or More	10,009	9,261	349	353	9,661	8,909	478	412	9,182	8,497
HEALTH INSURANCE²
Private	9,005	8,375	303	337	8,702	8,037	539	449	8,163	7,589
Medicaid/CHIP	3,281	3,010	254	232	3,026	2,778	252	270	2,775	2,509
Other³	5,594	5,879	56^a	19	5,538	5,860	100	129	5,438	5,731
No Coverage	534	505	20	10	514	495	67	51	447	444
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.94B – Any Use of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	5.2	4.8	2.2	2.1	5.5	5.0	2.6	2.4	5.9	5.4
GEOGRAPHIC REGION
Northeast	4.9^a	3.8	2.2	1.7	5.2^a	4.0	2.4	2.2	5.6	4.3
Midwest	4.7	4.6	1.9	2.1	5.0	4.9	2.5	3.2	5.4	5.1
South	5.6	5.4	2.6	2.2	5.9	5.7	2.6	2.1	6.4	6.3
West	5.1	4.6	2.0	2.2	5.4	4.9	2.7	2.2	5.9	5.3
COUNTY TYPE
Large Metro	4.8	4.6	2.0	2.0	5.0	4.8	2.3	2.4	5.4	5.2
Small Metro	5.8^a	4.8	2.4	2.5	6.2^a	5.1	3.1	2.4	6.7^a	5.5
Nonmetro	5.3	5.4	2.9^a	1.3	5.6	5.8	2.3	2.1	6.0	6.4
Urbanized	5.5	5.2	2.7	1.9	5.7	5.5	2.6	1.7	6.2	6.3
Less Urbanized	5.4	5.7	2.2^a	0.8	5.8	6.2	2.2	2.8	6.2	6.6
Completely Rural	4.0	4.6	8.8	*	3.5	5.0	1.6	0.7	3.8	5.5
POVERTY LEVEL¹
Less Than 100%	4.4	4.5	1.8	2.0	4.8	4.9	2.2	2.6	5.5	5.5
100-199%	4.9	4.3	2.4	1.6	5.2	4.6	2.7	2.3	5.6	5.0
200% or More	5.4	5.0	2.3	2.3	5.7	5.2	2.7	2.3	6.1	5.6
HEALTH INSURANCE²
Private	5.3	4.8	2.2	2.3	5.5	5.0	2.8	2.3	5.9	5.4
Medicaid/CHIP	5.4	5.1	2.3	2.2	6.1	5.7	2.6	3.0	6.9	6.3
Other³	7.1	7.4	4.0^a	1.4	7.2	7.5	3.5	4.6	7.3	7.6
No Coverage	2.2	2.0	1.6	0.8	2.3	2.1	1.5	1.0	2.5	2.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.95A – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1,063	920	68	64	995	857	90	76	905	781
GEOGRAPHIC REGION
Northeast	174	167	7	10	167	157	10	10	157	147
Midwest	169	136	7	3	163	133	16	31	147	101
South	499	368	24	33	475	335	52^a	14	423	321
West	221	249	30	17	191	232	13	20	178	212
COUNTY TYPE
Large Metro	544	473	47	28	497	446	32	42	465	404
Small Metro	426	268	16	28	409	240	48	25	362	216
Nonmetro	93	179	4	8	89	171	11	10	78	161
Urbanized	34	123	1	4	33	119	1	6	32	113
Less Urbanized	57	53	4	4	54	49	8	4	46	45
Completely Rural	1	2	*	*	1	2	*	*	*	2
POVERTY LEVEL¹
Less Than 100%	120	218	12	13	109	205	23	22	86	183
100-199%	160	123	12	13	147	110	35	10	112	100
200% or More	782	579	44	37	738	542	32	44	707	498
HEALTH INSURANCE²
Private	587	424	43	29	544	395	34	44	510	351
Medicaid/CHIP	242	314	18	34	224	280	26	22	198	258
Other³	382	278	14	*	367	278	11	5	357	273
No Coverage	100	57	<1	1	100	56	25	9	76	47
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.95B – Misuse of Prescription Sedatives in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.4	0.3	0.3	0.2	0.4	0.3	0.3	0.2	0.4	0.3
GEOGRAPHIC REGION
Northeast	0.4	0.3	0.2	0.2	0.4	0.3	0.2	0.2	0.4	0.4
Midwest	0.3	0.2	0.1	0.1	0.3	0.2	0.2	0.4	0.3	0.2
South	0.5	0.3	0.2	0.3	0.5	0.3	0.4^a	0.1	0.5	0.4
West	0.3	0.4	0.5	0.3	0.3	0.4	0.2	0.2	0.3	0.4
COUNTY TYPE
Large Metro	0.3	0.3	0.3	0.2	0.3	0.3	0.2	0.2	0.4	0.3
Small Metro	0.5	0.3	0.2	0.3	0.5	0.3	0.4	0.2	0.5	0.3
Nonmetro	0.2	0.5	0.1	0.3	0.3	0.5	0.3	0.2	0.3	0.6
Urbanized	0.2	0.9	0.1	0.4	0.2	0.9	0.1	0.3	0.3	1.0
Less Urbanized	0.3	0.3	0.2	0.2	0.3	0.3	0.4	0.2	0.3	0.3
Completely Rural	<0.1	0.1	*	*	0.1	0.1	*	*	*	0.1
POVERTY LEVEL¹
Less Than 100%	0.3	0.5	0.2	0.2	0.3	0.5	0.3	0.3	0.3	0.6
100-199%	0.3	0.2	0.2	0.2	0.3	0.2	0.4	0.1	0.3	0.2
200% or More	0.4	0.3	0.3	0.2	0.4	0.3	0.2	0.2	0.5	0.3
HEALTH INSURANCE²
Private	0.3	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.4	0.2
Medicaid/CHIP	0.4	0.5	0.2	0.3	0.5	0.6	0.3	0.2	0.5	0.7
Other³	0.5	0.4	1.0	*	0.5	0.4	0.4	0.2	0.5	0.4
No Coverage	0.4	0.2	<0.1	0.1	0.4	0.2	0.5	0.2	0.4	0.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.96A – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	284	254	14	11	271	243	23	35	248	208
GEOGRAPHIC REGION
Northeast	54	77	2	1	53	76	2	1	51	75
Midwest	94	40	1	1	93	39	8	14	85	26
South	103	99	<1	6	103	93	12	10	91	83
West	33	38	11	4	22	34	1	10	21	24
COUNTY TYPE
Large Metro	108	179	7	5	101	174	3	18	97	156
Small Metro	137	41	5	5	132	36	17	13	115	24
Nonmetro	39	34	1	1	38	33	3	5	35	28
Urbanized	<1	9	*	1	<1	8	*	2	<1	6
Less Urbanized	39	23	1	1	37	23	3	3	35	20
Completely Rural	*	2	*	*	*	2	*	*	*	2
POVERTY LEVEL¹
Less Than 100%	33	61	3	5	29	56	8	14	21	43
100-199%	21	43	1	2	20	41	2	6	18	35
200% or More	230	150	9	4	221	146	13	15	208	131
HEALTH INSURANCE²
Private	129	141	9	4	120	137	13	25	108	112
Medicaid/CHIP	106	77	5	7	101	70	5	6	97	64
Other³	96	42	*	*	96	42	3	2	93	41
No Coverage	28	28	*	*	28	28	7	4	21	24
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.96B – Misuse of Prescription Sedatives in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.1	0.1	0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1
GEOGRAPHIC REGION
Northeast	0.1	0.2	<0.1	<0.1	0.1	0.2	<0.1	<0.1	0.1	0.2
Midwest	0.2	0.1	<0.1	<0.1	0.2	0.1	0.1	0.2	0.2	0.1
South	0.1	0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
West	<0.1	0.1	0.2	0.1	<0.1	0.1	<0.1	0.1	<0.1	<0.1
COUNTY TYPE
Large Metro	0.1	0.1	0.1	<0.1	0.1	0.1	<0.1	0.1	0.1	0.1
Small Metro	0.2	<0.1	0.1	0.1	0.2	<0.1	0.1	0.1	0.2	<0.1
Nonmetro	0.1	0.1	<0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1
Urbanized	<0.1	0.1	*	0.1	<0.1	0.1	*	0.1	<0.1	0.1
Less Urbanized	0.2	0.1	0.1	<0.1	0.2	0.1	0.1	0.1	0.2	0.1
Completely Rural	*	0.1	*	*	*	0.1	*	*	*	0.1
POVERTY LEVEL¹
Less Than 100%	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1
100-199%	<0.1	0.1	<0.1	<0.1	<0.1	0.1	<0.1	0.1	<0.1	0.1
200% or More	0.1	0.1	0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1
HEALTH INSURANCE²
Private	0.1	0.1	0.1	<0.1	0.1	0.1	0.1	0.1	0.1	0.1
Medicaid/CHIP	0.2	0.1	<0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.2
Other³	0.1	0.1	*	*	0.1	0.1	0.1	0.1	0.1	0.1
No Coverage	0.1	0.1	*	*	0.1	0.1	0.1	0.1	0.1	0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.97A – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	23,894	24,207	456	371	23,437	23,835	1,739	1,628	21,699	22,208
GEOGRAPHIC REGION
Northeast	4,289	4,248	67	60	4,222	4,188	281	283	3,941	3,905
Midwest	4,758	5,248	113	84	4,645	5,164	378	344	4,267	4,819
South	10,307	10,103	184	170	10,123	9,933	675	687	9,448	9,246
West	4,541	4,607	93	56	4,448	4,550	405	313	4,043	4,237
COUNTY TYPE
Large Metro	12,286	12,855	214	171	12,072	12,684	832	923	11,241	11,761
Small Metro	8,370	8,475	179	149	8,191	8,325	678^a	512	7,512	7,813
Nonmetro	3,238	2,877	64	51	3,174	2,826	229	192	2,946	2,634
Urbanized	1,217	1,076	19	15	1,198	1,061	94	77	1,105	984
Less Urbanized	1,769	1,553	28	34	1,742	1,519	118	110	1,623	1,409
Completely Rural	252	248	*	*	235	246	17	5	218	241
POVERTY LEVEL¹
Less Than 100%	3,748	3,683	92	107	3,656	3,576	357	330	3,299	3,246
100-199%	4,628	4,427	74	68	4,554	4,360	433	396	4,121	3,964
200% or More	15,515	16,091	290^a	196	15,225	15,895	947	897	14,278	14,997
HEALTH INSURANCE²
Private	14,116	14,517	263	194	13,853	14,324	1,024	978	12,829	13,345
Medicaid/CHIP	5,687	5,371	183	178	5,504	5,193	485	505	5,019	4,688
Other³	8,256	8,708	25	16	8,231	8,692	143	99	8,088	8,593
No Coverage	1,404	1,292	16	8	1,388	1,284	179	154	1,209	1,131
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.97B – Any Use of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	8.4	8.4	1.8	1.4	9.1	9.1	5.1	4.7	9.7	9.8
GEOGRAPHIC REGION
Northeast	8.8	8.5	1.6	1.5	9.4	9.2	4.9	4.8	10.1	9.8
Midwest	8.2	8.9	2.1	1.6	8.8	9.7	5.3	4.7	9.3	10.4
South	9.4	9.1	1.8	1.6	10.2	9.8	5.1	5.1	11.0	10.5
West	6.8	6.8	1.5	0.9	7.3	7.3	5.0	3.8	7.7	7.9
COUNTY TYPE
Large Metro	7.8	8.0	1.5	1.2	8.5	8.6	4.5	5.0	9.0	9.2
Small Metro	9.4	9.2	2.2	1.8	10.1	9.9	5.9^b	4.3	10.8	10.9
Nonmetro	8.6	8.3	1.9	1.8	9.3	8.9	5.4	4.4	9.8	9.7
Urbanized	8.0	7.5	1.5	1.3	8.6	8.1	5.0	3.6	9.2	9.0
Less Urbanized	9.1	8.9	1.5	2.2	10.0	9.5	5.7	5.8	10.5	10.0
Completely Rural	8.1	8.8	*	*	8.4	9.6	5.8	1.7	8.7	10.6
POVERTY LEVEL¹
Less Than 100%	8.3	7.9	1.6	1.9	9.3	8.7	4.2	3.9	10.6	10.0
100-199%	8.5	8.0	1.4	1.3	9.3	8.7	5.5	4.7	10.0	9.5
200% or More	8.4	8.7	2.0^a	1.3	9.0	9.3	5.3	5.0	9.4	9.8
HEALTH INSURANCE²
Private	8.3	8.3	1.9	1.3	8.8	8.9	5.4	5.0	9.3	9.4
Medicaid/CHIP	9.4	9.1	1.7	1.7	11.0	10.7	5.1	5.6	12.5	11.8
Other³	10.5	11.0	1.8	1.1	10.7	11.2	5.1	3.6	10.9	11.5
No Coverage	5.9	5.1	1.3	0.6	6.2	5.4	4.0	3.0	6.7	6.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.98A – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	3,696	3,360	111	107	3,585	3,253	480	488	3,105	2,766
GEOGRAPHIC REGION
Northeast	642	494	8	10	633	483	71	40	562	443
Midwest	589	742	26	18	563	724	97	85	466	639
South	1,738	1,476	40	61	1,699	1,415	200	286	1,498	1,129
West	727	648	37	17	690	631	111	77	579	554
COUNTY TYPE
Large Metro	2,151	1,728	63	45	2,087	1,683	251	283	1,836	1,400
Small Metro	1,139	1,116	41	39	1,097	1,077	169	141	928	936
Nonmetro	407	516	7	23	400	493	59	63	341	430
Urbanized	194	216	3	9	191	207	22	21	169	186
Less Urbanized	201	254	3	14	198	240	36	41	162	199
Completely Rural	12	*	*	*	12	*	2	2	10	*
POVERTY LEVEL¹
Less Than 100%	615	642	16	17	599	625	97	125	502	500
100-199%	759	659	31	28	729	631	120	126	609	505
200% or More	2,321	2,058	65	61	2,257	1,997	262	235	1,994	1,762
HEALTH INSURANCE²
Private	2,041	1,669	72	54	1,969	1,615	283	230	1,686	1,385
Medicaid/CHIP	924	1,092	34	58	890	1,033	136	192	754	841
Other³	672	604	11	2	661	602	24	28	637	574
No Coverage	453	406	2	1	451	405	64	51	388	354
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.98B – Misuse of Prescription Benzodiazepines in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.3	1.2	0.4	0.4	1.4	1.2	1.4	1.4	1.4	1.2
GEOGRAPHIC REGION
Northeast	1.3	1.0	0.2	0.3	1.4	1.1	1.2	0.7	1.4	1.1
Midwest	1.0	1.3	0.5	0.3	1.1	1.4	1.4	1.2	1.0	1.4
South	1.6	1.3	0.4	0.6	1.7	1.4	1.5	2.1	1.7	1.3
West	1.1	1.0	0.6	0.3	1.1	1.0	1.4	0.9	1.1	1.0
COUNTY TYPE
Large Metro	1.4	1.1	0.4	0.3	1.5	1.1	1.4	1.5	1.5^a	1.1
Small Metro	1.3	1.2	0.5	0.5	1.4	1.3	1.5	1.2	1.3	1.3
Nonmetro	1.1	1.5	0.2^a	0.8	1.2	1.6	1.4	1.5	1.1	1.6
Urbanized	1.3	1.5	0.3	0.8	1.4	1.6	1.1	0.9	1.4	1.7
Less Urbanized	1.0	1.5	0.2	0.9	1.1	1.5	1.7	2.2	1.1	1.4
Completely Rural	0.4	*	*	*	0.4	*	0.7	0.7	0.4	*
POVERTY LEVEL¹
Less Than 100%	1.4	1.4	0.3	0.3	1.5	1.5	1.2	1.5	1.6	1.5
100-199%	1.4	1.2	0.6	0.5	1.5	1.3	1.5	1.5	1.5	1.2
200% or More	1.3	1.1	0.4	0.4	1.3	1.2	1.5	1.3	1.3	1.2
HEALTH INSURANCE²
Private	1.2	0.9	0.5	0.4	1.3	1.0	1.5	1.2	1.2	1.0
Medicaid/CHIP	1.5	1.9	0.3	0.6	1.8	2.1	1.4	2.1	1.9	2.1
Other³	0.9	0.8	0.8	0.1	0.9	0.8	0.8	1.0	0.9	0.8
No Coverage	1.9	1.6	0.2	0.1	2.0	1.7	1.4	1.0	2.1	1.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.99A – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	60,980	63,203	2,690^a	2,998	58,290	60,204	4,889	4,741	53,401	55,464
GEOGRAPHIC REGION
Northeast	8,756	9,151	436	444	8,321	8,707	709	681	7,612	8,026
Midwest	12,912	13,086	552	618	12,360	12,468	957	985	11,404	11,483
South	25,568	26,152	1,221	1,227	24,347	24,925	2,047	2,059	22,300	22,866
West	13,743	14,813	482^b	709	13,261	14,104	1,176	1,016	12,086	13,089
COUNTY TYPE
Large Metro	30,928^a	33,418	1,459	1,546	29,468	31,872	2,496	2,344	26,973^a	29,528
Small Metro	20,745	20,855	895	1,059	19,850	19,796	1,710	1,706	18,140	18,089
Nonmetro	9,307	8,930	336	393	8,971	8,536	683	690	8,288	7,846
Urbanized	3,963	3,544	147	187	3,816	3,357	309	316	3,507	3,041
Less Urbanized	4,668	4,718	162	178	4,505	4,540	340	330	4,165	4,211
Completely Rural	676	667	26	28	650	639	34	44	616	595
POVERTY LEVEL¹
Less Than 100%	10,718	11,214	585	590	10,133	10,625	1,227	1,179	8,906	9,446
100-199%	12,430	13,335	547	675	11,882	12,661	1,169	1,140	10,713	11,521
200% or More	37,830	38,631	1,558	1,734	36,271	36,897	2,490	2,400	33,781	34,497
HEALTH INSURANCE²
Private	35,123	35,946	1,436	1,593	33,687	34,353	2,799	2,557	30,888	31,796
Medicaid/CHIP	15,255	15,380	1,193	1,346	14,063	14,035	1,493	1,447	12,570	12,587
Other³	21,616	22,757	146	154	21,470	22,602	422	412	21,048	22,190
No Coverage	3,632	3,943	111	119	3,521	3,823	554	560	2,967	3,263
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.99B – Any Use of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	21.5	21.9	10.4^a	11.6	22.6	23.0	14.4	13.6	23.9	24.4
GEOGRAPHIC REGION
Northeast	17.9	18.4	10.7	10.9	18.5	19.1	12.3	11.5	19.4	20.2
Midwest	22.2	22.2	10.2	11.4	23.4	23.3	13.4	13.5	25.0	24.8
South	23.4	23.5	11.9	11.9	24.6	24.6	15.6	15.2	26.0	26.1
West	20.5	21.8	7.8^b	11.6	21.8	22.8	14.6	12.3	22.9	24.4
COUNTY TYPE
Large Metro	19.7	20.7	10.2	10.5	20.7	21.7	13.6	12.6	21.7	23.0
Small Metro	23.3	22.6	10.8	12.7	24.6	23.6	15.0	14.3	26.2	25.2
Nonmetro	24.7	25.9	9.9^a	13.6	26.2	27.0	16.0	15.8	27.6	28.8
Urbanized	26.1	24.8	12.0	16.5	27.4	25.6	16.4	14.5	29.1	27.8
Less Urbanized	24.1	27.0	8.7	11.7	25.8	28.5	16.3	17.4	27.0	30.0
Completely Rural	21.7	23.8	8.6	11.9	23.2	24.9	11.6	15.8	24.5	26.1
POVERTY LEVEL¹
Less Than 100%	23.7	24.1	10.2	10.7	25.7	26.0	14.6	14.1	28.7	29.0
100-199%	22.9	24.0	10.2	12.7	24.3	25.2	14.8	13.4	26.1	27.5
200% or More	20.6	20.8	10.5	11.5	21.5	21.6	14.0	13.4	22.3	22.6
HEALTH INSURANCE²
Private	20.5	20.5	10.3	10.9	21.4	21.3	14.7^a	13.0	22.4	22.5
Medicaid/CHIP	25.1	26.1	10.9^a	12.9	28.2	28.9	15.7	16.1	31.2	31.8
Other³	27.5	28.7	10.5	11.2	27.8	29.1	15.0	14.8	28.3	29.6
No Coverage	15.3	15.6	8.8	9.9	15.6	15.9	12.4	11.1	16.4	17.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of opioids includes the use of heroin or any use of prescription opioids. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.100A – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	8,520	7,795	515	400	8,005	7,396	806	925	7,199	6,471
GEOGRAPHIC REGION
Northeast	1,226	1,281	65	48	1,160	1,233	116	133	1,044	1,100
Midwest	1,668	1,527	114	64	1,553	1,463	141	140	1,412	1,323
South	3,697	3,261	237	208	3,460	3,054	361	472	3,099	2,582
West	1,929	1,725	98	80	1,831	1,645	187	180	1,644	1,465
COUNTY TYPE
Large Metro	4,709	4,142	284	210	4,425	3,932	420	478	4,006	3,454
Small Metro	2,540	2,414	166	128	2,374	2,286	284	302	2,090	1,984
Nonmetro	1,271	1,239	65	61	1,206	1,178	102	145	1,103	1,033
Urbanized	521	497	29	30	492	467	48	71	445	395
Less Urbanized	665	685	34	30	630	655	52	73	578	582
Completely Rural	85	57	2	*	83	56	2	1	81	55
POVERTY LEVEL¹
Less Than 100%	1,817^a	2,400	129	117	1,688^a	2,283	241	246	1,447^a	2,037
100-199%	1,743	1,889	117	113	1,626	1,776	211	242	1,416	1,534
200% or More	4,959^b	3,504	269^a	170	4,690^b	3,334	353	435	4,337^b	2,899
HEALTH INSURANCE²
Private	4,192^a	3,433	227	175	3,966^a	3,258	386	493	3,580^a	2,765
Medicaid/CHIP	2,664	2,940	270	207	2,394	2,732	285	294	2,109	2,438
Other³	2,051	1,701	41	16	2,010	1,685	71	78	1,940	1,606
No Coverage	851	879	9	24	843	855	139	108	703	747
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.100B – Misuse of Opioids in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	3.0^a	2.7	2.0	1.5	3.1	2.8	2.4	2.6	3.2^a	2.8
GEOGRAPHIC REGION
Northeast	2.5	2.6	1.6	1.2	2.6	2.7	2.0	2.3	2.7	2.8
Midwest	2.9	2.6	2.1	1.2	2.9	2.7	2.0	1.9	3.1	2.9
South	3.4	2.9	2.3	2.0	3.5	3.0	2.8	3.5	3.6^a	2.9
West	2.9	2.5	1.6	1.3	3.0	2.7	2.3	2.2	3.1	2.7
COUNTY TYPE
Large Metro	3.0^a	2.6	2.0	1.4	3.1	2.7	2.3	2.6	3.2^a	2.7
Small Metro	2.9	2.6	2.0	1.5	2.9	2.7	2.5	2.5	3.0	2.8
Nonmetro	3.4	3.6	1.9	2.1	3.5	3.7	2.4	3.3	3.7	3.8
Urbanized	3.4	3.5	2.3	2.7	3.5	3.6	2.5	3.3	3.7	3.6
Less Urbanized	3.4	3.9	1.8	2.0	3.6	4.1	2.5	3.9	3.8	4.1
Completely Rural	2.7	2.0	0.7	*	3.0	2.2	0.7	0.3	3.2	2.4
POVERTY LEVEL¹
Less Than 100%	4.0^a	5.2	2.3	2.1	4.3^a	5.6	2.9	2.9	4.7^a	6.3
100-199%	3.2	3.4	2.2	2.1	3.3	3.5	2.7	2.9	3.4	3.7
200% or More	2.7^b	1.9	1.8^a	1.1	2.8^b	2.0	2.0	2.4	2.9^b	1.9
HEALTH INSURANCE²
Private	2.5^b	2.0	1.6	1.2	2.5^a	2.0	2.0	2.5	2.6^b	2.0
Medicaid/CHIP	4.4	5.0	2.5	2.0	4.8	5.6	3.0	3.3	5.2	6.2
Other³	2.6	2.1	2.9	1.1	2.6	2.2	2.5	2.8	2.6	2.1
No Coverage	3.6	3.5	0.7	2.0	3.7	3.6	3.1	2.2	3.9	3.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.101A – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	2,298	2,117	132	107	2,166	2,010	173	221	1,993	1,788
GEOGRAPHIC REGION
Northeast	306	449	12	14	294	435	11	33	283	403
Midwest	402	421	35^b	5	367	416	26	39	341	378
South	1,029	826	58	70	972	756	89	114	882	642
West	560	420	27	18	534	401	47	35	487	366
COUNTY TYPE
Large Metro	1,334	1,167	73	78	1,261	1,089	94	118	1,167	972
Small Metro	625	587	47	15	577	572	60	60	517	512
Nonmetro	340	362	12	14	328	348	19	44	309	305
Urbanized	130	138	10	4	120	133	4^a	27	116	107
Less Urbanized	204	203	1	8	203	195	15	*	187	178
Completely Rural	7	21	1	*	6	20	*	<1	6	20
POVERTY LEVEL¹
Less Than 100%	582	840	52	29	530	811	57	70	473	740
100-199%	545	479	23	36	523	444	42	66	481	377
200% or More	1,171^a	797	57	42	1,114^a	755	74	84	1,040^a	671
HEALTH INSURANCE²
Private	1,028^a	702	42	46	986^a	655	82	95	904^a	560
Medicaid/CHIP	977	1,011	92	43	885	968	65	103	819	865
Other³	393	414	7	12	386	401	14	16	371	385
No Coverage	236	250	3	12	233	238	28	17	205	221
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.101B – Misuse of Opioids in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	0.8	0.7	0.5	0.4	0.8	0.8	0.5	0.6	0.9	0.8
GEOGRAPHIC REGION
Northeast	0.6	0.9	0.3	0.3	0.7	1.0	0.2	0.6	0.7	1.0
Midwest	0.7	0.7	0.7^b	0.1	0.7	0.8	0.4	0.5	0.7	0.8
South	0.9	0.7	0.6	0.7	1.0	0.7	0.7	0.8	1.0	0.7
West	0.8	0.6	0.4	0.3	0.9	0.6	0.6	0.4	0.9	0.7
COUNTY TYPE
Large Metro	0.9	0.7	0.5	0.5	0.9	0.7	0.5	0.6	0.9	0.8
Small Metro	0.7	0.6	0.6	0.2	0.7	0.7	0.5	0.5	0.7	0.7
Nonmetro	0.9	1.0	0.4	0.5	1.0	1.1	0.4	1.0	1.0	1.1
Urbanized	0.9	1.0	0.8	0.4	0.9	1.0	0.2^a	1.2	1.0	1.0
Less Urbanized	1.1	1.2	<0.1	0.6	1.2	1.2	0.7	*	1.2	1.3
Completely Rural	0.2	0.8	0.4	*	0.2	0.8	*	0.1	0.2	0.9
POVERTY LEVEL¹
Less Than 100%	1.3	1.8	0.9	0.5	1.3	2.0	0.7	0.8	1.5	2.3
100-199%	1.0	0.9	0.4	0.7	1.1	0.9	0.5	0.8	1.2	0.9
200% or More	0.6^a	0.4	0.4	0.3	0.7^a	0.4	0.4	0.5	0.7^a	0.4
HEALTH INSURANCE²
Private	0.6^a	0.4	0.3	0.3	0.6^a	0.4	0.4	0.5	0.7^a	0.4
Medicaid/CHIP	1.6	1.7	0.8	0.4	1.8	2.0	0.7	1.1	2.0	2.2
Other³	0.5	0.5	0.5	0.9	0.5	0.5	0.5	0.6	0.5	0.5
No Coverage	1.0	1.0	0.2	1.0	1.0	1.0	0.6	0.3	1.1	1.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Some 2023 estimates may differ from previously published estimates due to updates in how opioids are defined beginning in 2024. See Chapter 4 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.102A – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	24,686	24,907	1,835	1,890	22,850	23,017	4,298	4,191	18,552	18,827
GEOGRAPHIC REGION
Northeast	4,019	4,002	283	259	3,736	3,743	758	744	2,978	3,000
Midwest	5,066	5,417	417	403	4,648	5,014	1,018	999	3,630	4,015
South	9,830	9,680	762	828	9,068	8,852	1,454	1,529	7,613	7,323
West	5,771	5,808	372	400	5,399	5,408	1,068	918	4,331	4,490
COUNTY TYPE
Large Metro	13,445	13,530	985	985	12,460	12,545	2,206	2,205	10,254	10,340
Small Metro	7,914	8,443	661	716	7,253	7,727	1,609	1,496	5,644	6,230
Nonmetro	3,327	2,935	189	189	3,137	2,746	483	489	2,654	2,256
Urbanized	1,369	1,217	76	86	1,293	1,131	263	256	1,030	875
Less Urbanized	1,753	1,481	95	90	1,658	1,391	197	217	1,461	1,174
Completely Rural	204	237	18	13	186	224	23	17	163	207
POVERTY LEVEL¹
Less Than 100%	4,196	4,483	236	286	3,960	4,197	966	862	2,993	3,335
100-199%	4,572	3,990	314	300	4,258	3,690	970	844	3,287	2,845
200% or More	15,914	16,420	1,285	1,304	14,629	15,116	2,357	2,470	12,272	12,646
HEALTH INSURANCE²
Private	14,748	15,549	1,162	1,227	13,586	14,322	2,820	2,828	10,766	11,494
Medicaid/CHIP	6,519	6,163	609	660	5,910	5,503	1,004	930	4,906	4,573
Other³	3,992	3,833	130	85	3,863	3,748	362	284	3,500	3,464
No Coverage	2,229	2,046	49	57	2,181	1,989	359	384	1,821	1,604
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.102B – Any Use of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	8.7	8.6	7.1	7.3	8.9	8.8	12.6	12.0	8.3	8.3
GEOGRAPHIC REGION
Northeast	8.2	8.0	7.0	6.3	8.3	8.2	13.2	12.6	7.6	7.5
Midwest	8.7	9.2	7.7	7.5	8.8	9.4	14.3	13.7	7.9	8.7
South	9.0	8.7	7.4	8.0	9.2	8.7	11.1	11.3	8.9	8.4
West	8.6	8.5	6.1	6.5	8.9	8.7	13.3	11.1	8.2	8.4
COUNTY TYPE
Large Metro	8.6	8.4	6.9	6.7	8.7	8.5	12.0	11.8	8.3	8.1
Small Metro	8.9	9.2	8.0	8.6	9.0	9.2	14.1	12.5	8.1	8.7
Nonmetro	8.8	8.5	5.6	6.5	9.2	8.7	11.3	11.2	8.9	8.3
Urbanized	9.0	8.5	6.2	7.6	9.3	8.6	14.0	11.8	8.5	8.0
Less Urbanized	9.1	8.5	5.1	5.9	9.5	8.7	9.5	11.4	9.5	8.4
Completely Rural	6.6	8.4	6.0	5.3	6.6	8.7	7.9	5.9	6.5	9.1
POVERTY LEVEL¹
Less Than 100%	9.3	9.7	4.1	5.2	10.0	10.3	11.5	10.3	9.6	10.2
100-199%	8.4^a	7.2	5.9	5.6	8.7^a	7.3	12.3	9.9	8.0	6.8
200% or More	8.7	8.8	8.7	8.6	8.7	8.8	13.3	13.8	8.1	8.3
HEALTH INSURANCE²
Private	8.6	8.9	8.3	8.4	8.6	8.9	14.8	14.4	7.8	8.1
Medicaid/CHIP	10.7	10.4	5.6	6.3	11.9	11.3	10.5	10.4	12.2	11.6
Other³	5.1	4.8	9.3	6.2	5.0	4.8	12.8	10.2	4.7	4.6
No Coverage	9.4	8.1	3.9	4.7	9.7	8.3	8.0	7.6	10.1	8.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Any use of central nervous system stimulants includes the use of cocaine, the use of methamphetamine, or any use of prescription stimulants. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.103A – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	9,659	9,031	285	293	9,374	8,738	1,895	1,646	7,479	7,092
GEOGRAPHIC REGION
Northeast	1,568	1,607	31	49	1,537	1,559	335	282	1,202	1,277
Midwest	1,884	1,757	67	42	1,818	1,715	408	363	1,410	1,352
South	3,523	3,200	126	104	3,396	3,096	617	598	2,779	2,498
West	2,685	2,467	61	99	2,623	2,368	535	403	2,088	1,964
COUNTY TYPE
Large Metro	5,456	5,355	176	160	5,280	5,195	1,027	870	4,253	4,324
Small Metro	2,981	2,548	92	105	2,889	2,443	669	558	2,220	1,885
Nonmetro	1,223	1,128	18	28	1,205	1,100	199	218	1,006	882
Urbanized	489	459	7	15	482	444	82	129	400	315
Less Urbanized	666	584	8	12	658	572	104	87	554	485
Completely Rural	68	85	*	*	65	85	13	2	52	83
POVERTY LEVEL¹
Less Than 100%	2,133	2,215	32	46	2,101	2,170	455^a	319	1,646	1,851
100-199%	1,825	1,654	51	45	1,774	1,609	467	373	1,307	1,236
200% or More	5,701	5,160	203	203	5,498	4,958	972	953	4,525	4,005
HEALTH INSURANCE²
Private	4,830	4,607	180	194	4,650	4,413	1,223	1,024	3,427	3,388
Medicaid/CHIP	2,980	2,811	91	95	2,889	2,716	404	353	2,485	2,363
Other³	1,383^a	967	26	16	1,357	951	159	112	1,198	838
No Coverage	1,359	1,241	6	11	1,354	1,229	212	198	1,142	1,031
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.103B – Misuse of Central Nervous System Stimulants in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	3.4	3.1	1.1	1.1	3.6	3.3	5.6^a	4.7	3.3	3.1
GEOGRAPHIC REGION
Northeast	3.2	3.2	0.8	1.2	3.4	3.4	5.8	4.8	3.1	3.2
Midwest	3.2	3.0	1.2	0.8	3.4	3.2	5.7	5.0	3.1	2.9
South	3.2	2.9	1.2	1.0	3.4	3.1	4.7	4.4	3.2	2.8
West	4.0	3.6	1.0	1.6	4.3	3.8	6.7	4.9	4.0	3.7
COUNTY TYPE
Large Metro	3.5	3.3	1.2	1.1	3.7	3.5	5.6	4.7	3.4	3.4
Small Metro	3.4^a	2.8	1.1	1.3	3.6^a	2.9	5.9	4.7	3.2	2.6
Nonmetro	3.3	3.3	0.5	1.0	3.5	3.5	4.7	5.0	3.4	3.2
Urbanized	3.2	3.2	0.6	1.4	3.5	3.4	4.4	5.9	3.3	2.9
Less Urbanized	3.4	3.3	0.4	0.8	3.8	3.6	5.0	4.6	3.6	3.5
Completely Rural	2.2	3.0	*	*	2.3	3.3	4.4	0.7	2.1	3.6
POVERTY LEVEL¹
Less Than 100%	4.7	4.8	0.6	0.8	5.3	5.3	5.4^a	3.8	5.3	5.7
100-199%	3.4	3.0	1.0	0.8	3.6	3.2	5.9	4.4	3.2	3.0
200% or More	3.1	2.8	1.4	1.3	3.3	2.9	5.5	5.3	3.0	2.6
HEALTH INSURANCE²
Private	2.8	2.6	1.3	1.3	3.0	2.7	6.4^a	5.2	2.5	2.4
Medicaid/CHIP	4.9	4.8	0.8	0.9	5.8	5.6	4.2	3.9	6.2	6.0
Other³	1.8^a	1.2	1.8	1.2	1.8^a	1.2	5.6	4.0	1.6	1.1
No Coverage	5.7	4.9	0.4	0.9	6.0	5.1	4.7	3.9	6.3	5.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.104A – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	4,175	3,934	72	80	4,103	3,854	546	466	3,557	3,388
GEOGRAPHIC REGION
Northeast	685	777	4	30	681	747	105	90	576	657
Midwest	850	704	16	10	834	695	123	110	710	584
South	1,434	1,461	41	28	1,393	1,432	193	166	1,200	1,267
West	1,206	992	10	12	1,196	980	125	100	1,071	880
COUNTY TYPE
Large Metro	2,420	2,370	37	41	2,382	2,328	309	257	2,074	2,071
Small Metro	1,198	1,036	34	35	1,164	1,000	183	144	981	856
Nonmetro	557	528	<1	3	557	525	54	64	502	461
Urbanized	264	218	<1	3	264	215	28	33	237	182
Less Urbanized	283	246	<1	<1	283	246	26	30	257	216
Completely Rural	9	64	*	*	9	64	*	<1	9	63
POVERTY LEVEL¹
Less Than 100%	1,147	1,144	3	14	1,145	1,131	160	103	984	1,028
100-199%	833	719	22	7	812	712	124	108	688	604
200% or More	2,194	2,071	48	60	2,147	2,011	262	255	1,885	1,756
HEALTH INSURANCE²
Private	1,779	1,629	47	56	1,732	1,572	340	269	1,391	1,303
Medicaid/CHIP	1,524	1,589	22	25	1,502	1,564	118	146	1,384	1,417
Other³	756^a	427	1	<1	755^a	426	61	19	695	408
No Coverage	622	548	3	<1	619	548	65	45	554	502
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.104B – Misuse of Central Nervous System Stimulants in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	1.5	1.4	0.3	0.3	1.6	1.5	1.6	1.3	1.6	1.5
GEOGRAPHIC REGION
Northeast	1.4	1.6	0.1	0.7	1.5	1.6	1.8	1.5	1.5	1.7
Midwest	1.5	1.2	0.3	0.2	1.6	1.3	1.7	1.5	1.6	1.3
South	1.3	1.3	0.4	0.3	1.4	1.4	1.5	1.2	1.4	1.4
West	1.8	1.5	0.2	0.2	2.0	1.6	1.6	1.2	2.0	1.6
COUNTY TYPE
Large Metro	1.5	1.5	0.3	0.3	1.7	1.6	1.7	1.4	1.7	1.6
Small Metro	1.3	1.1	0.4	0.4	1.4	1.2	1.6	1.2	1.4	1.2
Nonmetro	1.5	1.5	<0.1	0.1	1.6	1.7	1.3	1.5	1.7	1.7
Urbanized	1.7	1.5	<0.1	0.3	1.9	1.6	1.5	1.5	2.0	1.7
Less Urbanized	1.5	1.4	<0.1	<0.1	1.6	1.5	1.3	1.6	1.7	1.5
Completely Rural	0.3	2.3	*	*	0.3	2.5	*	0.1	0.4	2.8
POVERTY LEVEL¹
Less Than 100%	2.5	2.5	<0.1	0.2	2.9	2.8	1.9	1.2	3.2	3.2
100-199%	1.5	1.3	0.4	0.1	1.7	1.4	1.6	1.3	1.7	1.4
200% or More	1.2	1.1	0.3	0.4	1.3	1.2	1.5	1.4	1.2	1.1
HEALTH INSURANCE²
Private	1.0	0.9	0.3	0.4	1.1	1.0	1.8	1.4	1.0	0.9
Medicaid/CHIP	2.5	2.7	0.2	0.2	3.0	3.2	1.2	1.6	3.4	3.6
Other³	1.0^a	0.5	0.1	<0.1	1.0^a	0.5	2.1	0.7	0.9	0.5
No Coverage	2.6	2.2	0.2	<0.1	2.7	2.3	1.5	0.9	3.1	2.6
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.105A – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	25,825	--	1,840	--	23,985	--	4,501	--	19,484
GEOGRAPHIC REGION
Northeast	--	4,388	--	245	--	4,142	--	766	--	3,376
Midwest	--	4,834	--	332	--	4,502	--	828	--	3,674
South	--	9,422	--	748	--	8,673	--	1,714	--	6,959
West	--	7,182	--	514	--	6,668	--	1,194	--	5,474
COUNTY TYPE
Large Metro	--	15,045	--	1,069	--	13,976	--	2,472	--	11,504
Small Metro	--	7,791	--	574	--	7,217	--	1,516	--	5,701
Nonmetro	--	2,990	--	197	--	2,792	--	513	--	2,279
Urbanized	--	1,276	--	83	--	1,193	--	279	--	915
Less Urbanized	--	1,544	--	107	--	1,437	--	224	--	1,213
Completely Rural	--	170	--	8	--	162	--	10	--	152
POVERTY LEVEL¹
Less Than 100%	--	5,355	--	378	--	4,977	--	914	--	4,062
100-199%	--	4,767	--	390	--	4,377	--	1,010	--	3,367
200% or More	--	15,696	--	1,071	--	14,625	--	2,570	--	12,055
HEALTH INSURANCE²
Private	--	14,641	--	1,017	--	13,623	--	2,759	--	10,864
Medicaid/CHIP	--	6,903	--	753	--	6,150	--	1,002	--	5,148
Other³	--	3,907	--	78	--	3,828	--	303	--	3,526
No Coverage	--	2,923	--	99	--	2,824	--	607	--	2,217
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.105B – Use of Illicit Drugs Other Than Marijuana in Past Year: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	9.0	--	7.1	--	9.1	--	12.9	--	8.6
GEOGRAPHIC REGION
Northeast	--	8.8	--	6.0	--	9.1	--	13.0	--	8.5
Midwest	--	8.2	--	6.1	--	8.4	--	11.4	--	7.9
South	--	8.4	--	7.2	--	8.6	--	12.7	--	7.9
West	--	10.5	--	8.4	--	10.8	--	14.5	--	10.2
COUNTY TYPE
Large Metro	--	9.3	--	7.3	--	9.5	--	13.3	--	9.0
Small Metro	--	8.5	--	6.9	--	8.6	--	12.7	--	7.9
Nonmetro	--	8.7	--	6.8	--	8.8	--	11.8	--	8.4
Urbanized	--	8.9	--	7.3	--	9.1	--	12.8	--	8.4
Less Urbanized	--	8.8	--	7.0	--	9.0	--	11.8	--	8.6
Completely Rural	--	6.1	--	3.3	--	6.3	--	3.7	--	6.6
POVERTY LEVEL¹
Less Than 100%	--	11.5	--	6.9	--	12.2	--	10.9	--	12.5
100-199%	--	8.6	--	7.3	--	8.7	--	11.9	--	8.0
200% or More	--	8.4	--	7.1	--	8.6	--	14.3	--	7.9
HEALTH INSURANCE²
Private	--	8.3	--	6.9	--	8.5	--	14.0	--	7.7
Medicaid/CHIP	--	11.7	--	7.2	--	12.7	--	11.2	--	13.0
Other³	--	4.9	--	5.7	--	4.9	--	10.8	--	4.7
No Coverage	--	11.6	--	8.2	--	11.8	--	12.1	--	11.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.106A – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	9,444	--	583	--	8,861	--	1,255	--	7,606
GEOGRAPHIC REGION
Northeast	--	1,900	--	113	--	1,788	--	210	--	1,578
Midwest	--	1,771	--	97	--	1,674	--	252	--	1,422
South	--	3,402	--	255	--	3,147	--	474	--	2,673
West	--	2,371	--	119	--	2,252	--	318	--	1,934
COUNTY TYPE
Large Metro	--	5,733	--	352	--	5,381	--	683	--	4,698
Small Metro	--	2,606	--	169	--	2,437	--	416	--	2,021
Nonmetro	--	1,106	--	63	--	1,043	--	155	--	888
Urbanized	--	470	--	33	--	437	--	73	--	364
Less Urbanized	--	544	--	28	--	517	--	81	--	436
Completely Rural	--	92	--	2	--	90	--	1	--	88
POVERTY LEVEL¹
Less Than 100%	--	2,245	--	124	--	2,121	--	283	--	1,838
100-199%	--	1,738	--	139	--	1,599	--	270	--	1,328
200% or More	--	5,461	--	320	--	5,141	--	701	--	4,440
HEALTH INSURANCE²
Private	--	4,834	--	291	--	4,543	--	752	--	3,791
Medicaid/CHIP	--	3,038	--	264	--	2,774	--	349	--	2,425
Other³	--	1,246	--	23	--	1,223	--	69	--	1,154
No Coverage	--	1,197	--	30	--	1,167	--	131	--	1,036
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.106B – Use of Illicit Drugs Other Than Marijuana in Past Month: Among People Aged 12 or Older; by Age Group and Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
TOTAL	--	3.3	--	2.2	--	3.4	--	3.6	--	3.3
GEOGRAPHIC REGION
Northeast	--	3.8	--	2.8	--	3.9	--	3.5	--	4.0
Midwest	--	3.0	--	1.8	--	3.1	--	3.5	--	3.1
South	--	3.1	--	2.5	--	3.1	--	3.5	--	3.0
West	--	3.5	--	1.9	--	3.6	--	3.9	--	3.6
COUNTY TYPE
Large Metro	--	3.5	--	2.4	--	3.7	--	3.7	--	3.7
Small Metro	--	2.8	--	2.0	--	2.9	--	3.5	--	2.8
Nonmetro	--	3.2	--	2.2	--	3.3	--	3.6	--	3.3
Urbanized	--	3.3	--	2.9	--	3.3	--	3.4	--	3.3
Less Urbanized	--	3.1	--	1.8	--	3.2	--	4.2	--	3.1
Completely Rural	--	3.3	--	0.9	--	3.5	--	0.5	--	3.9
POVERTY LEVEL¹
Less Than 100%	--	4.8	--	2.2	--	5.2	--	3.4	--	5.6
100-199%	--	3.1	--	2.6	--	3.2	--	3.2	--	3.2
200% or More	--	2.9	--	2.1	--	3.0	--	3.9	--	2.9
HEALTH INSURANCE²
Private	--	2.8	--	2.0	--	2.8	--	3.8	--	2.7
Medicaid/CHIP	--	5.1	--	2.5	--	5.7	--	3.9	--	6.1
Other³	--	1.6	--	1.7	--	1.6	--	2.5	--	1.5
No Coverage	--	4.8	--	2.5	--	4.9	--	2.6	--	5.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. NOTE: Illicit drugs other than marijuana excludes respondents who used only marijuana but includes those who used marijuana in addition to other illicit drugs. NOTE: Does not include illegally made fentanyl (IMF). NOTE: Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ¹ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ² Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ³ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.107A – Any Fentanyl Use, Fentanyl Misuse, and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Numbers in Thousands, 2023 and 2024
Geographic/Socioeconomic Characteristic	Any Fentanyl Use¹ (2023)	Any Fentanyl Use¹ (2024)	Fentanyl Misuse² (2023)	Fentanyl Misuse² (2024)	IMF Use (2023)	IMF Use (2024)
TOTAL	2,894	3,486	828	816	627	668
GEOGRAPHIC REGION
Northeast	405	590	129	183	104	145
Midwest	669	812	187	133	117	97
South	1,044	1,155	295	285	217	230
West	776	929	218	215	189	196
COUNTY TYPE
Large Metro	1,593	1,716	454	383	361	306
Small Metro	915^a	1,271	254	313	190	254
Nonmetro	386	499	120	119	76	108
Urbanized	191	176	56	62	29	56
Less Urbanized	183	317	63	54	47	49
Completely Rural	12	6	1	3	*	3
POVERTY LEVEL³
Less Than 100%	758^a	1,180	333	380	239	328
100-199%	663	741	208	234	193	190
200% or More	1,471	1,564	288	202	194	149
HEALTH INSURANCE⁴
Private	1,297	1,386	226	156	141	100
Medicaid/CHIP	1,128	1,494	505	521	407	431
Other⁵	841^a	1,291	87	141	46^a	132
No Coverage	238	251	96	124	73	106
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. ³ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ⁴ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁵ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.107B – Any Fentanyl Use, Fentanyl Misuse, and Illegally Made Fentanyl (IMF) Use in Past Year: Among People Aged 12 or Older; by Geographic and Socioeconomic Characteristics, Percentages, 2023 and 2024
Geographic/Socioeconomic Characteristic	Any Fentanyl Use¹ (2023)	Any Fentanyl Use¹ (2024)	Fentanyl Misuse² (2023)	Fentanyl Misuse² (2024)	IMF Use (2023)	IMF Use (2024)
TOTAL	1.0	1.2	0.3	0.3	0.2	0.2
GEOGRAPHIC REGION
Northeast	0.8	1.2	0.3	0.4	0.2	0.3
Midwest	1.1	1.4	0.3	0.2	0.2	0.2
South	1.0	1.0	0.3	0.3	0.2	0.2
West	1.2	1.4	0.3	0.3	0.3	0.3
COUNTY TYPE
Large Metro	1.0	1.1	0.3	0.2	0.2	0.2
Small Metro	1.0	1.4	0.3	0.3	0.2	0.3
Nonmetro	1.0	1.4	0.3	0.3	0.2	0.3
Urbanized	1.3	1.2	0.4	0.4	0.2	0.4
Less Urbanized	0.9	1.8	0.3	0.3	0.2	0.3
Completely Rural	0.4	0.2	<0.1	0.1	*	0.1
POVERTY LEVEL³
Less Than 100%	1.7^a	2.5	0.7	0.8	0.5	0.7
100-199%	1.2	1.3	0.4	0.4	0.4	0.3
200% or More	0.8	0.8	0.2	0.1	0.1	0.1
HEALTH INSURANCE⁴
Private	0.8	0.8	0.1	0.1	0.1	0.1
Medicaid/CHIP	1.9^a	2.5	0.8	0.9	0.7	0.7
Other⁵	1.1^a	1.6	0.1	0.2	0.1^a	0.2
No Coverage	1.0	1.0	0.4	0.5	0.3	0.4
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Includes use of IMF or any use of prescription fentanyl in the past year. ² Includes use of IMF or the misuse of prescription fentanyl in the past year. ³ Respondents aged 18 to 22 who were living in a college dormitory were excluded. ⁴ Respondents could indicate multiple types of health insurance; thus, these response categories are not mutually exclusive. ⁵ Other health insurance is defined as having Medicare, military-related health care, or any other type of health insurance. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.108A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2023 and 2024
Drug or Method of Administration	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
HALLUCINOGENS	48,438^a	51,559	518	591	47,920^a	50,968	5,259	5,661	42,661^a	45,307
PCP	5,883	5,829	33	28	5,849	5,802	135	153	5,715	5,649
LSD	30,247	30,935	250	222	29,997	30,713	3,000	2,817	26,997	27,896
Peyote¹	4,723	5,211	13	23	4,710	5,188	98	80	4,613	5,108
Mescaline¹	6,299	6,731	8	16	6,291	6,715	103	57	6,188	6,658
Psilocybin	--	35,347	--	458	--	34,889	--	4,468	--	30,421
Ecstasy	22,276	22,060	131	127	22,145	21,933	2,151	1,920	19,995	20,013
Ketamine	5,283	5,973	44	73	5,239	5,900	625	555	4,614	5,345
DMT, AMT, or 5-MeO-DIPT/Foxy	4,188	4,221	49	40	4,139	4,181	631^a	473	3,508	3,707
Salvia divinorum	5,067	5,517	22	18	5,044	5,498	282	227	4,762	5,271
INHALANTS²	--	31,989	--	3,092	--	28,896	--	3,461	--	25,435
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush¹	--	10,090	--	115	--	9,975	--	819	--	9,157
Correction Fluid, Degreaser, or Cleaning Fluid¹	--	1,753	--	219	--	1,534	--	148	--	1,386
Gasoline or Lighter Fluid¹	--	3,565	--	781	--	2,783	--	442	--	2,342
Glue, Shoe Polish, or Toluene^1,3	--	nr	--	nr	--	nr	--	nr	--	nr
Halothane, Ether, or Other Anesthetics¹	--	1,245	--	34	--	1,211	--	47	--	1,164
Lacquer Thinner or Other Paint Solvents¹	--	1,334	--	152	--	1,182	--	162	--	1,020
Lighter Gases¹	--	799	--	136	--	663	--	172	--	492
Nitrous Oxide or Whippits¹	--	14,530	--	117	--	14,414	--	1,036	--	13,377
Felt-Tip Pens or Felt-Tip/Magic Markers^1,3	--	nr	--	nr	--	nr	--	nr	--	nr
Spray Paints¹	--	2,115	--	547	--	1,568	--	336	--	1,232
Computer Cleaner/Air Duster¹	--	2,864	--	216	--	2,648	--	308	--	2,340
Other Aerosol Sprays¹	--	1,820	--	175	--	1,645	--	221	--	1,423
NEEDLE USE^1,4	5,521	6,198	36	32	5,485	6,166	134	196	5,351	5,970
Heroin Needle Use¹	3,083	3,215	14	2	3,068	3,213	58	71	3,011	3,141
Cocaine Needle Use¹	2,530	2,799	4	1	2,526	2,798	26	45	2,500	2,753
Methamphetamine Needle Use¹	2,778	3,184	4	4	2,774	3,180	59	70	2,716	3,111
Illegally Made Fentanyl Needle Use^1,4	385^b	818	10	17	376^b	800	38	59	338^b	741
HEROIN	6,210	6,515	18	22	6,191	6,493	224	180	5,967	6,313
Smoke Heroin¹	2,807	3,049	14	16	2,793	3,033	118	127	2,675	2,905
Sniff or Snort Heroin¹	4,243	4,879	15	17	4,228	4,862	179^a	106	4,049	4,757
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ The 2024 estimates are not reported because of changes made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.108B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime: Among People Aged 12 or Older; by Age Group, Percentages, 2023 and 2024
Drug or Method of Administration	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
HALLUCINOGENS	17.1	17.9	2.0	2.3	18.6	19.4	15.5	16.2	19.1	19.9
PCP	2.1	2.0	0.1	0.1	2.3	2.2	0.4	0.4	2.6	2.5
LSD	10.7	10.7	1.0	0.9	11.6	11.7	8.8	8.1	12.1	12.3
Peyote¹	1.7	1.8	<0.1	0.1	1.8	2.0	0.3	0.2	2.1	2.2
Mescaline¹	2.2	2.3	<0.1	0.1	2.4	2.6	0.3	0.2	2.8	2.9
Psilocybin	--	12.3	--	1.8	--	13.3	--	12.8	--	13.4
Ecstasy	7.9	7.7	0.5	0.5	8.6	8.4	6.3	5.5	8.9	8.8
Ketamine	1.9	2.1	0.2	0.3	2.0	2.2	1.8	1.6	2.1	2.4
DMT, AMT, or 5-MeO-DIPT/Foxy	1.5	1.5	0.2	0.2	1.6	1.6	1.9^a	1.4	1.6	1.6
Salvia divinorum	1.8	1.9	0.1	0.1	2.0	2.1	0.8	0.7	2.1	2.3
INHALANTS²	--	11.1	--	11.9	--	11.0	--	9.9	--	11.2
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush¹	--	3.5	--	0.4	--	3.8	--	2.3	--	4.0
Correction Fluid, Degreaser, or Cleaning Fluid¹	--	0.6	--	0.8	--	0.6	--	0.4	--	0.6
Gasoline or Lighter Fluid¹	--	1.2	--	3.0	--	1.1	--	1.3	--	1.0
Glue, Shoe Polish, or Toluene^1,3	--	nr	--	nr	--	nr	--	nr	--	nr
Halothane, Ether, or Other Anesthetics¹	--	0.4	--	0.1	--	0.5	--	0.1	--	0.5
Lacquer Thinner or Other Paint Solvents¹	--	0.5	--	0.6	--	0.5	--	0.5	--	0.4
Lighter Gases¹	--	0.3	--	0.5	--	0.3	--	0.5	--	0.2
Nitrous Oxide or Whippits¹	--	5.0	--	0.5	--	5.5	--	3.0	--	5.9
Felt-Tip Pens or Felt-Tip/Magic Markers^1,3	--	nr	--	nr	--	nr	--	nr	--	nr
Spray Paints¹	--	0.7	--	2.1	--	0.6	--	1.0	--	0.5
Computer Cleaner/Air Duster¹	--	1.0	--	0.8	--	1.0	--	0.9	--	1.0
Other Aerosol Sprays¹	--	0.6	--	0.7	--	0.6	--	0.6	--	0.6
NEEDLE USE^1,4	1.9	2.2	0.1	0.1	2.1	2.4	0.4	0.6	2.4	2.6
Heroin Needle Use¹	1.1	1.1	0.1	<0.1	1.2	1.2	0.2	0.2	1.3	1.4
Cocaine Needle Use¹	0.9	1.0	<0.1	<0.1	1.0	1.1	0.1	0.1	1.1	1.2
Methamphetamine Needle Use¹	1.0	1.1	<0.1	<0.1	1.1	1.2	0.2	0.2	1.2	1.4
Illegally Made Fentanyl Needle Use^1,4	0.1^b	0.3	<0.1	0.1	0.1^b	0.3	0.1	0.2	0.2^b	0.3
HEROIN	2.2	2.3	0.1	0.1	2.4	2.5	0.7	0.5	2.7	2.8
Smoke Heroin¹	1.0	1.1	0.1	0.1	1.1	1.2	0.3	0.4	1.2	1.3
Sniff or Snort Heroin¹	1.5	1.7	0.1	0.1	1.6	1.9	0.5^a	0.3	1.8	2.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown specific drug information were excluded from the respective analyses. ² Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ³ The 2024 estimates are not reported because of changes made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ⁴ These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.109A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, Numbers in Thousands, 2023 and 2024
Drug or Method of Administration	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
HALLUCINOGENS	8,795^b	10,423	387	405	8,408^b	10,018	2,276	2,364	6,132^b	7,653
PCP	135	103	22	1	113	102	1^a	27	113	76
LSD	1,698	1,619	144	112	1,554	1,507	501^a	369	1,053	1,137
Psilocybin	--	7,890	--	311	--	7,579	--	1,898	--	5,681
Ecstasy	2,153	2,013	75	57	2,078	1,956	521	405	1,557	1,551
Ketamine	943^a	1,293	26	23	917^a	1,270	215	203	701^a	1,067
DMT, AMT, or 5-MeO-DIPT/Foxy	618	506	37	19	581	487	87	54	494	433
Salvia divinorum	94	66	9	16	85	49	24	7	61	42
INHALANTS¹	--	3,155	--	967	--	2,189	--	690	--	1,499
NEEDLE USE^2,3	878	1,046	20	21	857	1,025	31^b	110	826	915
Heroin Needle Use²	389	261	11	<1	378	261	5	17	373	244
Cocaine Needle Use²	114	133	4	<1	110	133	3	12	107	121
Methamphetamine Needle Use²	535	580	4	3	531	576	13	31	518	545
Illegally Made Fentanyl Needle Use^2,3	175	259	8	17	167	241	12	42	155	200
HEROIN	660	556	4	10	656	546	27	51	629	495
Smoke Heroin²	206	336	4	4	202	332	14	41	188	291
Sniff or Snort Heroin²	434	364	11	9	423	356	25	28	398	328
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Respondents with unknown specific drug information were excluded from the respective analyses. ³ These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.109B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Past Year: Among People Aged 12 or Older; by Age Group, Percentages, 2023 and 2024
Drug or Method of Administration	Aged 12+ (2023)	Aged 12+ (2024)	Aged 12-17 (2023)	Aged 12-17 (2024)	Aged 18+ (2023)	Aged 18+ (2024)	Aged 18-25 (2023)	Aged 18-25 (2024)	Aged 26+ (2023)	Aged 26+ (2024)
HALLUCINOGENS	3.1^b	3.6	1.5	1.6	3.3^b	3.8	6.7	6.8	2.7^b	3.4
PCP	<0.1	<0.1	0.1	<0.1	<0.1	<0.1	<0.1^a	0.1	0.1	<0.1
LSD	0.6	0.6	0.6	0.4	0.6	0.6	1.5^a	1.1	0.5	0.5
Psilocybin	--	2.7	--	1.2	--	2.9	--	5.4	--	2.5
Ecstasy	0.8	0.7	0.3	0.2	0.8	0.7	1.5	1.2	0.7	0.7
Ketamine	0.3	0.4	0.1	0.1	0.4	0.5	0.6	0.6	0.3^a	0.5
DMT, AMT, or 5-MeO-DIPT/Foxy	0.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.2	0.2
Salvia divinorum	<0.1	<0.1	<0.1	0.1	<0.1	<0.1	0.1	<0.1	<0.1	<0.1
INHALANTS¹	--	1.1	--	3.7	--	0.8	--	2.0	--	0.7
NEEDLE USE^2,3	0.3	0.4	0.1	0.1	0.3	0.4	0.1^b	0.3	0.4	0.4
Heroin Needle Use²	0.1	0.1	<0.1	<0.1	0.1	0.1	<0.1	<0.1	0.2	0.1
Cocaine Needle Use²	<0.1	<0.1	<0.1	<0.1	<0.1	0.1	<0.1	<0.1	<0.1	0.1
Methamphetamine Needle Use²	0.2	0.2	<0.1	<0.1	0.2	0.2	<0.1	0.1	0.2	0.2
Illegally Made Fentanyl Needle Use^2,3	0.1	0.1	<0.1	0.1	0.1	0.1	<0.1	0.1	0.1	0.1
HEROIN	0.2	0.2	<0.1	<0.1	0.3	0.2	0.1	0.1	0.3	0.2
Smoke Heroin²	0.1	0.1	<0.1	<0.1	0.1	0.1	<0.1	0.1	0.1	0.1
Sniff or Snort Heroin²	0.2	0.1	<0.1	<0.1	0.2	0.1	0.1	0.1	0.2	0.1
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Changes were made to the inhalant questions in 2024. See Chapter 3 of the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. ² Respondents with unknown specific drug information were excluded from the respective analyses. ³ These estimates exclude a subset of respondents who did not complete the questionnaire. The analysis weights and estimates were adjusted for the reduced sample size. See the 2024 National Survey on Drug Use and Health (NSDUH): Methodological Summary and Definitions for details. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.110A – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	60,821^a	63,149	8,196	7,570	13.5^a	12.0
Hydrocodone Products¹	33,819	34,674	3,611	3,402	10.7	9.8
Oxycodone Products¹	21,003	22,016	2,641	2,140	12.6^a	9.7
OxyContin^®	7,796	8,694	998	879	12.8	10.1
Tramadol Products¹	14,891	15,038	1,339	1,201	9.0	8.0
Codeine Products¹	19,658	19,790	2,001	1,972	10.2	10.0
Morphine Products¹	4,911^a	5,787	284	295	5.8	5.1
Prescription Fentanyl Products²	2,614	3,119	479	390	18.3	12.5
Buprenorphine Products¹	2,992	3,489	610	757	20.4	21.8
Oxymorphone Products¹	785	960	137	73	17.5^a	7.6
Demerol^®1	484^a	928	80	26	*	2.8
Hydromorphone Products¹	1,565	1,717	221	95	14.1	5.5
Methadone¹	1,435	1,317	206	214	14.3	16.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.110B – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 or Older; Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	21.5	21.9	2.9	2.6	13.5^a	12.0
Hydrocodone Products¹	12.0	12.1	1.3	1.2	10.7	9.8
Oxycodone Products¹	7.4	7.7	0.9^a	0.7	12.6^a	9.7
OxyContin^®	2.8	3.0	0.4	0.3	12.8	10.1
Tramadol Products¹	5.3	5.2	0.5	0.4	9.0	8.0
Codeine Products¹	7.0	6.9	0.7	0.7	10.2	10.0
Morphine Products¹	1.7	2.0	0.1	0.1	5.8	5.1
Prescription Fentanyl Products²	0.9	1.1	0.2	0.1	18.3	12.5
Buprenorphine Products¹	1.1	1.2	0.2	0.3	20.4	21.8
Oxymorphone Products¹	0.3	0.3	<0.1	<0.1	17.5^a	7.6
Demerol^®1	0.2^a	0.3	<0.1	<0.1	*	2.8
Hydromorphone Products¹	0.6	0.6	0.1	<0.1	14.1	5.5
Methadone¹	0.5	0.5	0.1	0.1	14.3	16.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.111A – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	2,686^a	2,998	511	395	19.0^b	13.2
Hydrocodone Products¹	668	737	73	88	10.9	11.9
Oxycodone Products¹	568	675	112	114	19.8	17.0
OxyContin^®	230	257	47	49	*	*
Tramadol Products¹	282	328	18	51	6.2	15.4
Codeine Products¹	1,442	1,469	255	208	17.7	14.2
Morphine Products¹	210	201	29	10	*	*
Prescription Fentanyl Products²	129	105	26	4	*	*
Buprenorphine Products¹	74	70	13	21	*	*
Oxymorphone Products¹	45	43	16	6	*	*
Demerol^®1	24	14	*	3	*	*
Hydromorphone Products¹	9	30	3	1	*	*
Methadone¹	40	24	14	5	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.111B – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 12 to 17; Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	10.4^a	11.6	2.0	1.5	19.0^b	13.2
Hydrocodone Products¹	2.6	2.9	0.3	0.3	10.9	11.9
Oxycodone Products¹	2.2	2.6	0.4	0.4	19.8	17.0
OxyContin^®	0.9	1.0	0.2	0.2	*	*
Tramadol Products¹	1.1	1.3	0.1	0.2	6.2	15.4
Codeine Products¹	5.6	5.7	1.0	0.8	17.7	14.2
Morphine Products¹	0.8	0.8	0.1	<0.1	*	*
Prescription Fentanyl Products²	0.5	0.4	0.1	<0.1	*	*
Buprenorphine Products¹	0.3	0.3	0.1	0.1	*	*
Oxymorphone Products¹	0.2	0.2	0.1	<0.1	*	*
Demerol^®1	0.1	0.1	*	<0.1	*	*
Hydromorphone Products¹	<0.1	0.1	<0.1	<0.1	*	*
Methadone¹	0.2	0.1	0.1	<0.1	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.112A – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	58,134	60,151	7,685	7,176	13.2	11.9
Hydrocodone Products¹	33,152	33,937	3,538	3,314	10.7	9.8
Oxycodone Products¹	20,435	21,341	2,530	2,026	12.4^a	9.5
OxyContin^®	7,566	8,438	951	830	12.6	9.8
Tramadol Products¹	14,609	14,710	1,321	1,151	9.0	7.8
Codeine Products¹	18,216	18,320	1,746	1,764	9.6	9.6
Morphine Products¹	4,701^a	5,586	255	286	5.4	5.1
Prescription Fentanyl Products²	2,485	3,015	453	386	18.2	12.8
Buprenorphine Products¹	2,918	3,420	597	736	20.5	21.6
Oxymorphone Products¹	741	917	121	67	16.4	7.3
Demerol^®1	460^b	913	80	23	*	2.5
Hydromorphone Products¹	1,556	1,686	218	94	14.0	5.6
Methadone¹	1,395	1,293	192	209	13.7	16.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.112B – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 or Older; Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	22.6	22.9	3.0	2.7	13.2	11.9
Hydrocodone Products¹	12.9	13.0	1.4	1.3	10.7	9.8
Oxycodone Products¹	8.0	8.1	1.0^a	0.8	12.4^a	9.5
OxyContin^®	2.9	3.2	0.4	0.3	12.6	9.8
Tramadol Products¹	5.7	5.6	0.5	0.4	9.0	7.8
Codeine Products¹	7.1	7.0	0.7	0.7	9.6	9.6
Morphine Products¹	1.8^a	2.1	0.1	0.1	5.4	5.1
Prescription Fentanyl Products²	1.0	1.1	0.2	0.1	18.2	12.8
Buprenorphine Products¹	1.1	1.3	0.2	0.3	20.5	21.6
Oxymorphone Products¹	0.3	0.4	<0.1	<0.1	16.4	7.3
Demerol^®1	0.2^b	0.3	<0.1	<0.1	*	2.5
Hydromorphone Products¹	0.6	0.6	0.1	<0.1	14.0	5.6
Methadone¹	0.5	0.5	0.1	0.1	13.7	16.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.113A – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	4,888	4,731	801	897	16.4	19.0
Hydrocodone Products¹	2,364	2,121	327	347	13.9	16.4
Oxycodone Products¹	1,762	1,543	344	332	19.5	21.6
OxyContin^®	706	623	150	118	21.3	19.0
Tramadol Products¹	876	745	129	147	14.7	19.8
Codeine Products¹	1,749	1,612	301	349	17.3	21.8
Morphine Products¹	497	548	21	25	4.2	4.5
Prescription Fentanyl Products²	279	237	63	50	22.4	21.0
Buprenorphine Products¹	201	149	47	41	23.3	*
Oxymorphone Products¹	111	88	32	12	*	*
Demerol^®1	15	19	*	4	*	*
Hydromorphone Products¹	64	80	10	6	*	*
Methadone¹	83	69	23	4	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.113B – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 18 to 25; Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	14.4	13.5	2.4	2.6	16.4	19.0
Hydrocodone Products¹	7.0^a	6.1	1.0	1.0	13.9	16.4
Oxycodone Products¹	5.2^a	4.4	1.0	1.0	19.5	21.6
OxyContin^®	2.1	1.8	0.4	0.3	21.3	19.0
Tramadol Products¹	2.6	2.1	0.4	0.4	14.7	19.8
Codeine Products¹	5.2	4.6	0.9	1.0	17.3	21.8
Morphine Products¹	1.5	1.6	0.1	0.1	4.2	4.5
Prescription Fentanyl Products²	0.8	0.7	0.2	0.1	22.4	21.0
Buprenorphine Products¹	0.6	0.4	0.1	0.1	23.3	*
Oxymorphone Products¹	0.3	0.3	0.1	<0.1	*	*
Demerol^®1	<0.1	0.1	*	<0.1	*	*
Hydromorphone Products¹	0.2	0.2	<0.1	<0.1	*	*
Methadone¹	0.2	0.2	0.1	<0.1	*	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.114A – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	53,246	55,420	6,884	6,279	12.9^a	11.3
Hydrocodone Products¹	30,788	31,816	3,211	2,967	10.4	9.3
Oxycodone Products¹	18,673	19,798	2,185	1,694	11.7^a	8.6
OxyContin^®	6,860	7,815	801	712	11.7	9.1
Tramadol Products¹	13,733	13,965	1,193	1,003	8.7	7.2
Codeine Products¹	16,467	16,708	1,445	1,415	8.8	8.5
Morphine Products¹	4,204^a	5,038	234	261	5.6	5.2
Prescription Fentanyl Products²	2,206^a	2,777	391	337	17.7	12.1
Buprenorphine Products¹	2,716	3,271	550	695	20.3	21.3
Oxymorphone Products¹	630	829	90	55	14.2	6.7
Demerol^®1	445^b	894	80	19	*	2.1
Hydromorphone Products¹	1,493	1,606	208	88	13.9	5.5
Methadone¹	1,312	1,225	169	205	12.8	16.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.114B – Any Use and Misuse of Prescription Opioid Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Opioid Subtypes in Past Year: Among Past Year Any Users of Prescription Opioid Subtypes Aged 26 or Older; Percentages, 2023 and 2024
Prescription Opioid Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Prescription Opioid Subtypes (2024)
ANY PRESCRIPTION OPIOID	23.8	24.4	3.1	2.8	12.9^a	11.3
Hydrocodone Products¹	13.8	14.0	1.4	1.3	10.4	9.3
Oxycodone Products¹	8.4	8.7	1.0^a	0.7	11.7^a	8.6
OxyContin^®	3.1	3.4	0.4	0.3	11.7	9.1
Tramadol Products¹	6.2	6.2	0.5	0.4	8.7	7.2
Codeine Products¹	7.4	7.4	0.6	0.6	8.8	8.5
Morphine Products¹	1.9	2.2	0.1	0.1	5.6	5.2
Prescription Fentanyl Products²	1.0	1.2	0.2	0.1	17.7	12.1
Buprenorphine Products¹	1.2	1.4	0.2	0.3	20.3	21.3
Oxymorphone Products¹	0.3	0.4	<0.1	<0.1	14.2	6.7
Demerol^®1	0.2^a	0.4	<0.1	<0.1	*	2.1
Hydromorphone Products¹	0.7	0.7	0.1	<0.1	13.9	5.5
Methadone¹	0.6	0.5	0.1	0.1	12.8	16.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Include fentanyl products that are available by prescription in the United States. Do not include illegally made fentanyl (IMF). Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.115A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	19,816	20,507	3,922	3,899	19.8	19.0
Amphetamines or Methylphenidate Products¹	15,430	16,168	3,681	3,616	23.9	22.4
Amphetamines¹	13,340	13,790	3,520	3,318	26.4	24.1
Methylphenidate Products¹	4,171	4,253	381	538	9.2	12.6
Anorectic (Weight-Loss) Stimulants¹	2,914	2,802	170	159	5.8	5.7
Provigil^®1	379	474	70	55	*	*
Any Other Prescription Stimulant^1,2	2,838	2,515	58	121	2.1	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.115B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 or Older; Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	7.0	7.1	1.4	1.4	19.8	19.0
Amphetamines or Methylphenidate Products¹	5.4	5.6	1.3	1.3	23.9	22.4
Amphetamines¹	4.7	4.8	1.2	1.2	26.4	24.1
Methylphenidate Products¹	1.5	1.5	0.1	0.2	9.2	12.6
Anorectic (Weight-Loss) Stimulants¹	1.0	1.0	0.1	0.1	5.8	5.7
Provigil^®1	0.1	0.2	<0.1	<0.1	*	*
Any Other Prescription Stimulant^1,2	1.0	0.9	<0.1	<0.1	2.1	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.116A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	1,807	1,830	230	203	12.8	11.1
Amphetamines or Methylphenidate Products¹	1,610	1,647	187	200	11.6	12.1
Amphetamines¹	1,174	1,107	158	162	13.5	14.7
Methylphenidate Products¹	680	761	44	67	6.4	8.9
Anorectic (Weight-Loss) Stimulants¹	76	80	15	17	*	*
Provigil^®1	15	10	1	*	*	*
Any Other Prescription Stimulant^1,2	320	317	25	3	*	1.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.116B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 12 to 17; Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	7.0	7.1	0.9	0.8	12.8	11.1
Amphetamines or Methylphenidate Products¹	6.2	6.4	0.7	0.8	11.6	12.1
Amphetamines¹	4.5	4.3	0.6	0.6	13.5	14.7
Methylphenidate Products¹	2.6	2.9	0.2	0.3	6.4	8.9
Anorectic (Weight-Loss) Stimulants¹	0.3	0.3	0.1	0.1	*	*
Provigil^®1	0.1	<0.1	<0.1	*	*	*
Any Other Prescription Stimulant^1,2	1.2	1.2	0.1	<0.1	*	1.0
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.117A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	18,009	18,677	3,692	3,696	20.5	19.8
Amphetamines or Methylphenidate Products¹	13,820	14,522	3,494	3,416	25.3	23.5
Amphetamines¹	12,166	12,683	3,361	3,155	27.6	24.9
Methylphenidate Products¹	3,491	3,492	337	470	9.7	13.5
Anorectic (Weight-Loss) Stimulants¹	2,837	2,723	155	142	5.5	5.2
Provigil^®1	364	464	69	55	*	*
Any Other Prescription Stimulant^1,2	2,518	2,198	33	118	1.4	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.117B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 or Older; Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	7.0	7.1	1.4	1.4	20.5	19.8
Amphetamines or Methylphenidate Products¹	5.4	5.5	1.4	1.3	25.3	23.5
Amphetamines¹	4.7	4.8	1.3	1.2	27.6	24.9
Methylphenidate Products¹	1.4	1.3	0.1	0.2	9.7	13.5
Anorectic (Weight-Loss) Stimulants¹	1.1	1.0	0.1	0.1	5.5	5.2
Provigil^®1	0.1	0.2	<0.1	<0.1	*	*
Any Other Prescription Stimulant^1,2	1.0	0.8	<0.1	<0.1	1.4	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.118A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	3,660	3,639	1,066	973	29.1	26.7
Amphetamines or Methylphenidate Products¹	3,370	3,267	1,032	949	30.6	29.1
Amphetamines¹	2,912	2,688	993	883	34.1	32.9
Methylphenidate Products¹	943	1,013	96	142	10.3	14.1
Anorectic (Weight-Loss) Stimulants¹	185	164	33	23	*	*
Provigil^®1	4^a	57	4	2	*	*
Any Other Prescription Stimulant^1,2	434	371	7	3	1.6	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.118B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 18 to 25; Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	10.8	10.4	3.1	2.8	29.1	26.7
Amphetamines or Methylphenidate Products¹	9.9	9.4	3.0	2.7	30.6	29.1
Amphetamines¹	8.6	7.7	2.9	2.5	34.1	32.9
Methylphenidate Products¹	2.8	2.9	0.3	0.4	10.3	14.1
Anorectic (Weight-Loss) Stimulants¹	0.5	0.5	0.1	0.1	*	*
Provigil^®1	<0.1^a	0.2	<0.1	<0.1	*	*
Any Other Prescription Stimulant^1,2	1.3	1.1	<0.1	<0.1	1.6	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.119A – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	14,349	15,038	2,626	2,723	18.3	18.1
Amphetamines or Methylphenidate Products¹	10,450	11,255	2,462	2,467	23.6	21.9
Amphetamines¹	9,254	9,994	2,368	2,272	25.6	22.8
Methylphenidate Products¹	2,548	2,479	241	328	9.5	13.2
Anorectic (Weight-Loss) Stimulants¹	2,652	2,558	122	119	4.6	4.6
Provigil^®1	360	407	65	54	*	*
Any Other Prescription Stimulant^1,2	2,084	1,827	26	114	1.3	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.119B – Any Use and Misuse of Prescription Stimulant Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Stimulant Subtypes in Past Year: Among Past Year Any Users of Prescription Stimulant Subtypes Aged 26 or Older; Percentages, 2023 and 2024
Stimulant Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Stimulant Subtypes (2024)
ANY PRESCRIPTION STIMULANT	6.4	6.6	1.2	1.2	18.3	18.1
Amphetamines or Methylphenidate Products¹	4.7	5.0	1.1	1.1	23.6	21.9
Amphetamines¹	4.1	4.4	1.1	1.0	25.6	22.8
Methylphenidate Products¹	1.1	1.1	0.1	0.1	9.5	13.2
Anorectic (Weight-Loss) Stimulants¹	1.2	1.1	0.1	0.1	4.6	4.6
Provigil^®1	0.2	0.2	<0.1	<0.1	*	*
Any Other Prescription Stimulant^1,2	0.9	0.8	<0.1	0.1	1.3	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of stimulants containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.120A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	31,384	31,451	3,993	3,829	12.7	12.2
Benzodiazepine Tranquilizers¹	22,861	23,172	3,530	3,252	15.4	14.0
Alprazolam Products¹	12,845	12,505	2,485	2,128	19.4	17.0
Lorazepam Products¹	6,361	6,398	577	504	9.1	7.9
Clonazepam Products¹	5,365	5,654	850	895	15.8	15.8
Diazepam Products¹	4,185	4,744	390	592	9.3	12.5
Muscle Relaxants¹	7,017	7,465	580	518	8.3	6.9
Cyclobenzaprine¹	6,496	6,835	447	475	6.9	7.0
Soma^®1	671	697	158^a	36	*	5.2
Any Other Prescription Tranquilizer^1,2	5,473^a	4,513	90	121	1.7	2.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.120B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 or Older; Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	11.1	10.9	1.4	1.3	12.7	12.2
Benzodiazepine Tranquilizers¹	8.1	8.0	1.2	1.1	15.4	14.0
Alprazolam Products¹	4.5	4.3	0.9	0.7	19.4	17.0
Lorazepam Products¹	2.2	2.2	0.2	0.2	9.1	7.9
Clonazepam Products¹	1.9	2.0	0.3	0.3	15.8	15.8
Diazepam Products¹	1.5	1.6	0.1	0.2	9.3	12.5
Muscle Relaxants¹	2.5	2.6	0.2	0.2	8.3	6.9
Cyclobenzaprine¹	2.3	2.4	0.2	0.2	6.9	7.0
Soma^®1	0.2	0.2	0.1^a	<0.1	*	5.2
Any Other Prescription Tranquilizer^1,2	1.9^b	1.6	<0.1	<0.1	1.7	2.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.121A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	731^b	500	119	126	16.3^a	25.2
Benzodiazepine Tranquilizers¹	387	314	110	96	28.5	30.6
Alprazolam Products¹	274	231	95	81	34.7	35.2
Lorazepam Products¹	72	63	20	21	*	*
Clonazepam Products¹	80	57	12	18	*	*
Diazepam Products¹	81	67	10	21	*	*
Muscle Relaxants¹	31	37	9	6	*	*
Cyclobenzaprine¹	22	31	8	5	*	*
Soma^®1	9	12	1	<1	*	*
Any Other Prescription Tranquilizer^1,2	337^b	167	8	3	*	2.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.121B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 12 to 17; Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	2.8^b	1.9	0.5	0.5	16.3^a	25.2
Benzodiazepine Tranquilizers¹	1.5	1.2	0.4	0.4	28.5	30.6
Alprazolam Products¹	1.1	0.9	0.4	0.3	34.7	35.2
Lorazepam Products¹	0.3	0.2	0.1	0.1	*	*
Clonazepam Products¹	0.3	0.2	<0.1	0.1	*	*
Diazepam Products¹	0.3	0.3	<0.1	0.1	*	*
Muscle Relaxants¹	0.1	0.1	<0.1	<0.1	*	*
Cyclobenzaprine¹	0.1	0.1	<0.1	<0.1	*	*
Soma^®1	<0.1	<0.1	<0.1	<0.1	*	*
Any Other Prescription Tranquilizer^1,2	1.3^b	0.6	<0.1	<0.1	*	2.3
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.122A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	30,653	30,951	3,874	3,703	12.6	12.0
Benzodiazepine Tranquilizers¹	22,474	22,859	3,420	3,156	15.2	13.8
Alprazolam Products¹	12,572	12,274	2,389	2,046	19.0	16.7
Lorazepam Products¹	6,289	6,335	557	483	8.9	7.6
Clonazepam Products¹	5,285	5,597	838	877	15.9	15.7
Diazepam Products¹	4,104	4,677	380	571	9.2	12.2
Muscle Relaxants¹	6,986	7,428	571	512	8.2	6.9
Cyclobenzaprine¹	6,473	6,805	439	470	6.8	6.9
Soma^®1	662	685	157^a	36	*	5.3
Any Other Prescription Tranquilizer^1,2	5,136^a	4,346	82	118	1.6	2.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.122B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 or Older; Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	11.9	11.8	1.5	1.4	12.6	12.0
Benzodiazepine Tranquilizers¹	8.7	8.7	1.3	1.2	15.2	13.8
Alprazolam Products¹	4.9	4.7	0.9	0.8	19.0	16.7
Lorazepam Products¹	2.4	2.4	0.2	0.2	8.9	7.6
Clonazepam Products¹	2.1	2.1	0.3	0.3	15.9	15.7
Diazepam Products¹	1.6	1.8	0.1	0.2	9.2	12.2
Muscle Relaxants¹	2.7	2.8	0.2	0.2	8.2	6.9
Cyclobenzaprine¹	2.5	2.6	0.2	0.2	6.8	6.9
Soma^®1	0.3	0.3	0.1^a	<0.1	*	5.3
Any Other Prescription Tranquilizer^1,2	2.0^a	1.7	<0.1	<0.1	1.6	2.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.123A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	2,228^a	1,944	522	522	23.4	26.8
Benzodiazepine Tranquilizers¹	1,679	1,555	459	475	27.5	30.6
Alprazolam Products¹	1,052	975	369	393	35.4	40.3
Lorazepam Products¹	510	394	85	55	16.6	14.1
Clonazepam Products¹	338	355	91	93	26.9	26.3
Diazepam Products¹	301	263	49	70	16.1	26.6
Muscle Relaxants¹	304^a	207	40	50	*	*
Cyclobenzaprine¹	280	192	28	49	*	*
Soma^®1	25	17	12	4	*	*
Any Other Prescription Tranquilizer^1,2	431	375	13	20	3.1	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.123B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 18 to 25; Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	6.5^a	5.6	1.5	1.5	23.4	26.8
Benzodiazepine Tranquilizers¹	4.9	4.4	1.3	1.4	27.5	30.6
Alprazolam Products¹	3.1	2.8	1.1	1.1	35.4	40.3
Lorazepam Products¹	1.5	1.1	0.2	0.2	16.6	14.1
Clonazepam Products¹	1.0	1.0	0.3	0.3	26.9	26.3
Diazepam Products¹	0.9	0.8	0.1	0.2	16.1	26.6
Muscle Relaxants¹	0.9^a	0.6	0.1	0.1	*	*
Cyclobenzaprine¹	0.8^a	0.5	0.1	0.1	*	*
Soma^®1	0.1	<0.1	<0.1	<0.1	*	*
Any Other Prescription Tranquilizer^1,2	1.3	1.1	<0.1	0.1	3.1	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.124A – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	28,425	29,007	3,351	3,181	11.8	11.0
Benzodiazepine Tranquilizers¹	20,795	21,304	2,961	2,681	14.2	12.6
Alprazolam Products¹	11,519	11,299	2,020	1,653	17.5	14.6
Lorazepam Products¹	5,779	5,941	472	427	8.2	7.2
Clonazepam Products¹	4,947	5,242	747	785	15.1	15.0
Diazepam Products¹	3,803	4,414	331	501	8.7	11.4
Muscle Relaxants¹	6,682	7,221	531	462	8.0	6.4
Cyclobenzaprine¹	6,194	6,613	411	421	6.7	6.4
Soma^®1	637	668	145^a	32	*	4.9
Any Other Prescription Tranquilizer^1,2	4,705^a	3,971	68	97	1.5	2.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.124B – Any Use and Misuse of Prescription Tranquilizer Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Tranquilizer Subtypes in Past Year: Among Past Year Any Users of Prescription Tranquilizer Subtypes Aged 26 or Older; Percentages, 2023 and 2024
Tranquilizer Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Tranquilizer Subtypes (2024)
ANY PRESCRIPTION TRANQUILIZER	12.7	12.8	1.5	1.4	11.8	11.0
Benzodiazepine Tranquilizers¹	9.3	9.4	1.3	1.2	14.2	12.6
Alprazolam Products¹	5.2	5.0	0.9	0.7	17.5	14.6
Lorazepam Products¹	2.6	2.6	0.2	0.2	8.2	7.2
Clonazepam Products¹	2.2	2.3	0.3	0.3	15.1	15.0
Diazepam Products¹	1.7	1.9	0.1	0.2	8.7	11.4
Muscle Relaxants¹	3.0	3.2	0.2	0.2	8.0	6.4
Cyclobenzaprine¹	2.8	2.9	0.2	0.2	6.7	6.4
Soma^®1	0.3	0.3	0.1^a	<0.1	*	4.9
Any Other Prescription Tranquilizer^1,2	2.1^a	1.7	<0.1	<0.1	1.5	2.5
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of tranquilizers containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.125A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	14,666	13,762	1,063	920	7.2	6.7
Zolpidem Products¹	6,789	6,004	678	588	10.0	9.8
Eszopiclone Products¹	905	1,022	50	48	5.6	4.7
Zaleplon Products¹	250	331	5	*	*	*
Benzodiazepine Sedatives¹	1,677	1,602	57	100	3.4	6.2
Flurazepam¹	136	44	1	4	*	*
Temazepam Products¹	830	850	49	70	5.9	*
Triazolam Products¹	786	740	14	26	1.7	3.5
Barbiturates¹	487	512	19	32	*	6.3
Any Other Prescription Sedative^1,2	6,493	6,258	264	134	4.1	2.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.125B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 or Older; Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	5.2	4.8	0.4	0.3	7.2	6.7
Zolpidem Products¹	2.4	2.1	0.2	0.2	10.0	9.8
Eszopiclone Products¹	0.3	0.4	<0.1	<0.1	5.6	4.7
Zaleplon Products¹	0.1	0.1	<0.1	*	*	*
Benzodiazepine Sedatives¹	0.6	0.6	<0.1	<0.1	3.4	6.2
Flurazepam¹	<0.1	<0.1	<0.1	<0.1	*	*
Temazepam Products¹	0.3	0.3	<0.1	<0.1	5.9	*
Triazolam Products¹	0.3	0.3	<0.1	<0.1	1.7	3.5
Barbiturates¹	0.2	0.2	<0.1	<0.1	*	6.3
Any Other Prescription Sedative^1,2	2.3	2.2	0.1	<0.1	4.1	2.2
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.126A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	583	545	68	64	11.6	11.7
Zolpidem Products¹	88	96	31	23	*	*
Eszopiclone Products¹	5	13	*	8	*	*
Zaleplon Products¹	12	17	*	*	*	*
Benzodiazepine Sedatives¹	83	63	7	15	*	*
Flurazepam¹	16	6	1	1	*	*
Temazepam Products¹	30	16	5	2	*	*
Triazolam Products¹	38	41	*	13	*	*
Barbiturates¹	34	27	*	10	*	*
Any Other Prescription Sedative^1,2	408	421	15	26	3.8	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.126B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 12 to 17; Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	2.2	2.1	0.3	0.2	11.6	11.7
Zolpidem Products¹	0.3	0.4	0.1	0.1	*	*
Eszopiclone Products¹	<0.1	0.1	*	<0.1	*	*
Zaleplon Products¹	<0.1	0.1	*	*	*	*
Benzodiazepine Sedatives¹	0.3	0.2	<0.1	0.1	*	*
Flurazepam¹	0.1	<0.1	<0.1	<0.1	*	*
Temazepam Products¹	0.1	0.1	<0.1	<0.1	*	*
Triazolam Products¹	0.1	0.2	*	<0.1	*	*
Barbiturates¹	0.1	0.1	*	<0.1	*	*
Any Other Prescription Sedative^1,2	1.6	1.6	0.1	0.1	3.8	*
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.127A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	14,083	13,217	995	857	7.1	6.5
Zolpidem Products¹	6,700	5,907	647	564	9.7	9.6
Eszopiclone Products¹	900	1,008	50	40	5.6	4.0
Zaleplon Products¹	239	314	5	*	*	*
Benzodiazepine Sedatives¹	1,593	1,539	50	84	3.2	5.5
Flurazepam¹	120	38	*	3	*	*
Temazepam Products¹	800	834	44	69	5.5	*
Triazolam Products¹	748	699	14	13	1.8	1.9
Barbiturates¹	454	485	19	22	*	*
Any Other Prescription Sedative^1,2	6,085	5,837	249	108	4.1	1.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.127B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 or Older; Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	5.5	5.0	0.4	0.3	7.1	6.5
Zolpidem Products¹	2.6	2.3	0.3	0.2	9.7	9.6
Eszopiclone Products¹	0.3	0.4	<0.1	<0.1	5.6	4.0
Zaleplon Products¹	0.1	0.1	<0.1	*	*	*
Benzodiazepine Sedatives¹	0.6	0.6	<0.1	<0.1	3.2	5.5
Flurazepam¹	<0.1	<0.1	*	<0.1	*	*
Temazepam Products¹	0.3	0.3	<0.1	<0.1	5.5	*
Triazolam Products¹	0.3	0.3	<0.1	<0.1	1.8	1.9
Barbiturates¹	0.2	0.2	<0.1	<0.1	*	*
Any Other Prescription Sedative^1,2	2.4	2.2	0.1	<0.1	4.1	1.9
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.128A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	875	830	90	76	10.3	9.1
Zolpidem Products¹	239	179	59	38	25.8	21.4
Eszopiclone Products¹	67	40	11	15	*	*
Zaleplon Products¹	15	34	*	*	*	*
Benzodiazepine Sedatives¹	112	115	7	10	*	*
Flurazepam¹	20	4	*	*	*	*
Temazepam Products¹	4^b	47	*	3	*	*
Triazolam Products¹	90	74	7	7	*	*
Barbiturates¹	55	32	6	3	*	*
Any Other Prescription Sedative^1,2	582	547	10	20	1.8	3.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.128B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 18 to 25; Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	2.6	2.4	0.3	0.2	10.3	9.1
Zolpidem Products¹	0.7	0.5	0.2	0.1	25.8	21.4
Eszopiclone Products¹	0.2	0.1	<0.1	<0.1	*	*
Zaleplon Products¹	<0.1	0.1	*	*	*	*
Benzodiazepine Sedatives¹	0.3	0.3	<0.1	<0.1	*	*
Flurazepam¹	0.1	<0.1	*	*	*	*
Temazepam Products¹	<0.1^b	0.1	*	<0.1	*	*
Triazolam Products¹	0.3	0.2	<0.1	<0.1	*	*
Barbiturates¹	0.2	0.1	<0.1	<0.1	*	*
Any Other Prescription Sedative^1,2	1.7	1.6	<0.1	0.1	1.8	3.8
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.129A – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	13,208	12,387	905	781	6.9	6.3
Zolpidem Products¹	6,461	5,729	588	526	9.1	9.2
Eszopiclone Products¹	833	969	40	25	4.8	2.5
Zaleplon Products¹	223	280	5	*	*	*
Benzodiazepine Sedatives¹	1,481	1,424	44	74	2.9	5.2
Flurazepam¹	101	34	*	3	*	*
Temazepam Products¹	796	787	44	65	5.5	*
Triazolam Products¹	658	625	7	6	1.0	0.9
Barbiturates¹	398	453	13	19	*	*
Any Other Prescription Sedative^1,2	5,503	5,290	239	88	4.4	1.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.129B – Any Use and Misuse of Prescription Sedative Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Sedative Subtypes in Past Year: Among Past Year Any Users of Prescription Sedative Subtypes Aged 26 or Older; Percentages, 2023 and 2024
Sedative Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Sedative Subtypes (2024)
ANY PRESCRIPTION SEDATIVE	5.9	5.4	0.4	0.3	6.9	6.3
Zolpidem Products¹	2.9	2.5	0.3	0.2	9.1	9.2
Eszopiclone Products¹	0.4	0.4	<0.1	<0.1	4.8	2.5
Zaleplon Products¹	0.1	0.1	<0.1	*	*	*
Benzodiazepine Sedatives¹	0.7	0.6	<0.1	<0.1	2.9	5.2
Flurazepam¹	<0.1	<0.1	*	<0.1	*	*
Temazepam Products¹	0.4	0.3	<0.1	<0.1	5.5	*
Triazolam Products¹	0.3	0.3	<0.1	<0.1	1.0	0.9
Barbiturates¹	0.2	0.2	<0.1	<0.1	*	*
Any Other Prescription Sedative^1,2	2.5	2.3	0.1	<0.1	4.4	1.7
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes use or misuse of sedatives containing other active ingredients. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.130A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	23,894	24,207	3,696	3,360	15.5	13.9
Benzodiazepine Tranquilizers¹	22,861	23,172	3,530	3,252	15.4	14.0
Alprazolam Products¹	12,845	12,505	2,485	2,128	19.4	17.0
Lorazepam Products¹	6,361	6,398	577	504	9.1	7.9
Clonazepam Products¹	5,365	5,654	850	895	15.8	15.8
Diazepam Products¹	4,185	4,744	390	592	9.3	12.5
Benzodiazepine Sedatives¹	1,677	1,602	57	100	3.4	6.2
Flurazepam¹	136	44	1	4	*	*
Temazepam Products¹	830	850	49	70	5.9	*
Triazolam Products¹	786	740	14	26	1.7	3.5
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	132	8	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.130B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 or Older; Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	8.4	8.4	1.3	1.2	15.5	13.9
Benzodiazepine Tranquilizers¹	8.1	8.0	1.2	1.1	15.4	14.0
Alprazolam Products¹	4.5	4.3	0.9	0.7	19.4	17.0
Lorazepam Products¹	2.2	2.2	0.2	0.2	9.1	7.9
Clonazepam Products¹	1.9	2.0	0.3	0.3	15.8	15.8
Diazepam Products¹	1.5	1.6	0.1	0.2	9.3	12.5
Benzodiazepine Sedatives¹	0.6	0.6	<0.1	<0.1	3.4	6.2
Flurazepam¹	<0.1	<0.1	<0.1	<0.1	*	*
Temazepam Products¹	0.3	0.3	<0.1	<0.1	5.9	*
Triazolam Products¹	0.3	0.3	<0.1	<0.1	1.7	3.5
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	<0.1	<0.1	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.131A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Numbers in Thousands and Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	456	371	111	107	24.4	28.7
Benzodiazepine Tranquilizers¹	387	314	110	96	28.5	30.6
Alprazolam Products¹	274	231	95	81	34.7	35.2
Lorazepam Products¹	72	63	20	21	*	*
Clonazepam Products¹	80	57	12	18	*	*
Diazepam Products¹	81	67	10	21	*	*
Benzodiazepine Sedatives¹	83	63	7	15	*	*
Flurazepam¹	16	6	1	1	*	*
Temazepam Products¹	30	16	5	2	*	*
Triazolam Products¹	38	41	*	13	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	1	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.131B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 12 to 17; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 12 to 17; Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	1.8	1.4	0.4	0.4	24.4	28.7
Benzodiazepine Tranquilizers¹	1.5	1.2	0.4	0.4	28.5	30.6
Alprazolam Products¹	1.1	0.9	0.4	0.3	34.7	35.2
Lorazepam Products¹	0.3	0.2	0.1	0.1	*	*
Clonazepam Products¹	0.3	0.2	<0.1	0.1	*	*
Diazepam Products¹	0.3	0.3	<0.1	0.1	*	*
Benzodiazepine Sedatives¹	0.3	0.2	<0.1	0.1	*	*
Flurazepam¹	0.1	<0.1	<0.1	<0.1	*	*
Temazepam Products¹	0.1	0.1	<0.1	<0.1	*	*
Triazolam Products¹	0.1	0.2	*	<0.1	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	<0.1	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.132A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	23,437	23,835	3,585	3,253	15.3	13.6
Benzodiazepine Tranquilizers¹	22,474	22,859	3,420	3,156	15.2	13.8
Alprazolam Products¹	12,572	12,274	2,389	2,046	19.0	16.7
Lorazepam Products¹	6,289	6,335	557	483	8.9	7.6
Clonazepam Products¹	5,285	5,597	838	877	15.9	15.7
Diazepam Products¹	4,104	4,677	380	571	9.2	12.2
Benzodiazepine Sedatives¹	1,593	1,539	50	84	3.2	5.5
Flurazepam¹	120	38	*	3	*	*
Temazepam Products¹	800	834	44	69	5.5	*
Triazolam Products¹	748	699	14	13	1.8	1.9
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	132	8	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.132B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 or Older; Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	9.1	9.1	1.4	1.2	15.3	13.6
Benzodiazepine Tranquilizers¹	8.7	8.7	1.3	1.2	15.2	13.8
Alprazolam Products¹	4.9	4.7	0.9	0.8	19.0	16.7
Lorazepam Products¹	2.4	2.4	0.2	0.2	8.9	7.6
Clonazepam Products¹	2.1	2.1	0.3	0.3	15.9	15.7
Diazepam Products¹	1.6	1.8	0.1	0.2	9.2	12.2
Benzodiazepine Sedatives¹	0.6	0.6	<0.1	<0.1	3.2	5.5
Flurazepam¹	<0.1	<0.1	*	<0.1	*	*
Temazepam Products¹	0.3	0.3	<0.1	<0.1	5.5	*
Triazolam Products¹	0.3	0.3	<0.1	<0.1	1.8	1.9
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	0.1	<0.1	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.133A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Numbers in Thousands and Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	1,739	1,628	480	488	27.6	30.0
Benzodiazepine Tranquilizers¹	1,679	1,555	459	475	27.5	30.6
Alprazolam Products¹	1,052	975	369	393	35.4	40.3
Lorazepam Products¹	510	394	85	55	16.6	14.1
Clonazepam Products¹	338	355	91	93	26.9	26.3
Diazepam Products¹	301	263	49	70	16.1	26.6
Benzodiazepine Sedatives¹	112	115	7	10	*	*
Flurazepam¹	20	4	*	*	*	*
Temazepam Products¹	4^b	47	*	3	*	*
Triazolam Products¹	90	74	7	7	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	2	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.133B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 18 to 25; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 18 to 25; Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	5.1	4.7	1.4	1.4	27.6	30.0
Benzodiazepine Tranquilizers¹	4.9	4.4	1.3	1.4	27.5	30.6
Alprazolam Products¹	3.1	2.8	1.1	1.1	35.4	40.3
Lorazepam Products¹	1.5	1.1	0.2	0.2	16.6	14.1
Clonazepam Products¹	1.0	1.0	0.3	0.3	26.9	26.3
Diazepam Products¹	0.9	0.8	0.1	0.2	16.1	26.6
Benzodiazepine Sedatives¹	0.3	0.3	<0.1	<0.1	*	*
Flurazepam¹	0.1	<0.1	*	*	*	*
Temazepam Products¹	<0.1^b	0.1	*	<0.1	*	*
Triazolam Products¹	0.3	0.2	<0.1	<0.1	*	*
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	*	<0.1	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.134A – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Numbers in Thousands and Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	21,699	22,208	3,105	2,766	14.3	12.5
Benzodiazepine Tranquilizers¹	20,795	21,304	2,961	2,681	14.2	12.6
Alprazolam Products¹	11,519	11,299	2,020	1,653	17.5	14.6
Lorazepam Products¹	5,779	5,941	472	427	8.2	7.2
Clonazepam Products¹	4,947	5,242	747	785	15.1	15.0
Diazepam Products¹	3,803	4,414	331	501	8.7	11.4
Benzodiazepine Sedatives¹	1,481	1,424	44	74	2.9	5.2
Flurazepam¹	101	34	*	3	*	*
Temazepam Products¹	796	787	44	65	5.5	*
Triazolam Products¹	658	625	7	6	1.0	0.9
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	132	5	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.

250520

Table 1.134B – Any Use and Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among People Aged 26 or Older; Misuse of Prescription Benzodiazepine Subtypes in Past Year: Among Past Year Any Users of Prescription Benzodiazepine Subtypes Aged 26 or Older; Percentages, 2023 and 2024
Benzodiazepine Subtype	Any Use in Past Year (2023)	Any Use in Past Year (2024)	Misuse in Past Year among Total Population (2023)	Misuse in Past Year among Total Population (2024)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2023)	Percentage Who Misused in Past Year among Past Year Any Users of Benzodiazepine Subtypes (2024)
ANY PRESCRIPTION BENZODIAZEPINE	9.7	9.8	1.4	1.2	14.3	12.5
Benzodiazepine Tranquilizers¹	9.3	9.4	1.3	1.2	14.2	12.6
Alprazolam Products¹	5.2	5.0	0.9	0.7	17.5	14.6
Lorazepam Products¹	2.6	2.6	0.2	0.2	8.2	7.2
Clonazepam Products¹	2.2	2.3	0.3	0.3	15.1	15.0
Diazepam Products¹	1.7	1.9	0.1	0.2	8.7	11.4
Benzodiazepine Sedatives¹	0.7	0.6	<0.1	<0.1	2.9	5.2
Flurazepam¹	<0.1	<0.1	*	<0.1	*	*
Temazepam Products¹	0.4	0.3	<0.1	<0.1	5.5	*
Triazolam Products¹	0.3	0.3	<0.1	<0.1	1.0	0.9
Any Miscellaneous Prescription Benzodiazepine Tranquilizers or Sedatives^1,2	da	da	0.1	<0.1	da	da
* = low precision; -- = not available or not comparable due to methodological or questionnaire changes; da = does not apply; nr = not reported due to measurement issues. ^a,b The difference between this estimate and the 2024 estimate is statistically significant at the .05 level (a) or .01 level (b). Rounding may make the estimates appear identical. ¹ Respondents with unknown prescription drug subtype information were excluded from the respective analyses. ² Includes misuse of benzodiazepine tranquilizers that were specified as other sedatives and benzodiazepine sedatives that were specified as other tranquilizers. Definitions: Measures and terms are defined in Appendix A. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2023 and 2024.